*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1dub_c00 2-ENOYL-COA HYDRATASE user 1 4 # 1 A 98 ALA A 27 ALA~? 11.39 NI NI A 501 A 141 GLY B 125 GLY.? 8.70 NI NI A 501 A 144 GLU B 124 GLU.? 12.68 NI NI A 501 A 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 58.27 102.60 178.19 59.43 101.66 178.07 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 59.27 103.88 173.55 59.11 104.69 173.45 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 61.78 103.61 169.93 62.63 102.26 171.29 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 65.46 104.88 175.81 64.47 105.72 174.12 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c00 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c00 naa= 4 ULMN 4 1dub_c01 2-ENOYL-COA HYDRATASE user 1 4 # 1 B 98 ALA A 27 ALA~? 11.39 NI NI A 501 B 141 GLY B 125 GLY.? 8.70 NI NI A 501 B 144 GLU B 124 GLU.? 12.68 NI NI A 501 B 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 93.67 115.22 150.99 93.63 113.90 150.22 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 88.87 114.43 152.30 88.45 115.15 152.32 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 85.20 111.99 152.05 86.60 110.89 150.91 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 88.14 113.46 145.73 86.79 113.92 147.30 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c01 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c01 naa= 4 ULMN 4 1dub_c02 2-ENOYL-COA HYDRATASE user 1 4 # 1 C 98 ALA A 27 ALA~? 11.39 NI NI A 501 C 141 GLY B 125 GLY.? 8.70 NI NI A 501 C 144 GLU B 124 GLU.? 12.68 NI NI A 501 C 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 53.00 102.79 132.36 53.08 101.42 133.06 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 56.28 104.55 135.84 56.09 105.34 136.05 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 58.46 103.90 139.48 57.57 102.00 139.16 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 51.71 102.03 140.09 53.02 103.62 140.54 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c02 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c02 naa= 4 ULMN 4 1dub_c03 2-ENOYL-COA HYDRATASE user 1 4 # 1 D 98 ALA A 27 ALA~? 11.39 NI NI A 501 D 141 GLY B 125 GLY.? 8.70 NI NI A 501 D 144 GLU B 124 GLU.? 12.68 NI NI A 501 D 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 88.91 81.99 128.63 88.96 83.34 129.32 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 86.19 80.64 132.77 86.38 79.85 132.93 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 84.75 81.24 136.88 85.62 83.14 136.43 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 91.47 83.05 136.24 90.35 81.38 136.84 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c03 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c03 naa= 4 ULMN 4 1dub_c04 2-ENOYL-COA HYDRATASE user 1 4 # 1 E 98 ALA A 27 ALA~? 11.39 NI NI A 501 E 141 GLY B 125 GLY.? 8.70 NI NI A 501 E 144 GLU B 124 GLU.? 12.68 NI NI A 501 E 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 91.93 82.37 174.92 90.77 83.36 175.00 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 90.07 81.07 170.50 90.23 80.26 170.38 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 87.05 81.30 167.53 86.38 82.74 168.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 84.40 80.02 173.80 85.08 79.06 172.03 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c04 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c04 naa= 4 ULMN 4 1dub_c05 2-ENOYL-COA HYDRATASE user 1 4 # 1 F 98 ALA A 27 ALA~? 11.39 NI NI A 501 F 141 GLY B 125 GLY.? 8.70 NI NI A 501 F 144 GLU B 124 GLU.? 12.68 NI NI A 501 F 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 52.21 69.79 154.56 52.11 71.07 153.72 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 57.12 70.68 155.10 57.52 69.95 155.02 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 60.62 73.13 154.21 59.05 74.26 153.35 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 56.75 71.71 148.46 58.44 71.01 149.54 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c05 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c05 naa= 4 ULMN 4 1hzd_c00 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 A 141 ALA B 27 ALA~? 11.43 NI NI A 502 A 186 GLY A 125 GLY.? 7.36 NI NI A 502 A 189 GLU A 86 GLU.? 9.00 NI NI A 502 A 209 GLU A 124 GLU.? 14.10 NI NI A 502 coo 37.84 0.78 41.05 36.64 1.72 41.12 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo 35.09 -2.80 36.98 35.21 -3.54 37.30 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 4 1hzd_c00 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 4 # 2 A 141 ALA B 30 ALA~? 10.79 NI NI A 502 A 186 GLY A 125 GLY.? 7.36 NI NI A 502 A 189 GLU A 86 GLU.? 9.00 NI NI A 502 A 209 GLU B 28 GLU~? 10.98 NI NI A 502 coo 37.84 0.78 41.05 36.64 1.72 41.12 -24.57 21.06 -37.88 -25.84 21.07 -37.01 coo 35.09 -2.80 36.98 35.21 -3.54 37.30 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -21.88 16.06 -32.91 -21.09 14.19 -32.27 1hzd_c00 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_c00 naa= 4 ULMN 4 1hzd_c01 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 B 141 ALA B 27 ALA~? 11.43 NI NI A 502 B 186 GLY A 125 GLY.? 7.36 NI NI A 502 B 189 GLU A 86 GLU.? 9.00 NI NI A 502 B 209 GLU A 124 GLU.? 14.10 NI NI A 502 coo -8.13 -16.22 36.72 -8.40 -15.53 35.38 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo -1.96 -15.64 35.87 -1.68 -16.38 36.08 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 4 1hzd_c01 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 4 # 2 B 141 ALA B 30 ALA~? 10.79 NI NI A 502 B 186 GLY A 125 GLY.? 7.36 NI NI A 502 B 189 GLU A 86 GLU.? 9.00 NI NI A 502 B 209 GLU B 28 GLU~? 10.98 NI NI A 502 coo -8.13 -16.22 36.72 -8.40 -15.53 35.38 -24.57 21.06 -37.88 -25.84 21.07 -37.01 coo -1.96 -15.64 35.87 -1.68 -16.38 36.08 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -21.88 16.06 -32.91 -21.09 14.19 -32.27 1hzd_c01 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_c01 naa= 4 ULMN 4 1hzd_c02 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 C 141 ALA B 27 ALA~? 11.43 NI NI A 502 C 186 GLY A 125 GLY.? 7.36 NI NI A 502 C 189 GLU A 86 GLU.? 9.00 NI NI A 502 C 209 GLU A 124 GLU.? 14.10 NI NI A 502 coo 24.08 -22.10 -0.34 24.67 -20.69 -0.31 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo 21.75 -21.33 5.24 22.01 -22.00 5.60 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 4 1hzd_c02 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 4 # 2 C 141 ALA B 30 ALA~? 10.79 NI NI A 502 C 186 GLY A 125 GLY.? 7.36 NI NI A 502 C 189 GLU A 86 GLU.? 9.00 NI NI A 502 C 209 GLU B 28 GLU~? 10.98 NI NI A 502 coo 24.08 -22.10 -0.34 24.67 -20.69 -0.31 -24.57 21.06 -37.88 -25.84 21.07 -37.01 coo 21.75 -21.33 5.24 22.01 -22.00 5.60 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -21.88 16.06 -32.91 -21.09 14.19 -32.27 1hzd_c02 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_c02 naa= 4 ULMN 4 1hzd_c03 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 D 141 ALA B 27 ALA~? 11.43 NI NI A 502 D 186 GLY A 125 GLY.? 7.36 NI NI A 502 D 189 GLU A 86 GLU.? 9.00 NI NI A 502 D 209 GLU A 124 GLU.? 14.10 NI NI A 502 coo -9.83 -0.92 -1.27 -9.83 -1.74 0.02 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo -5.10 2.47 0.73 -5.35 3.21 0.47 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 4 1hzd_c03 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 4 # 2 D 141 ALA B 30 ALA~? 10.79 NI NI A 502 D 186 GLY A 125 GLY.? 7.36 NI NI A 502 D 189 GLU A 86 GLU.? 9.00 NI NI A 502 D 209 GLU B 28 GLU~? 10.98 NI NI A 502 coo -9.83 -0.92 -1.27 -9.83 -1.74 0.02 -24.57 21.06 -37.88 -25.84 21.07 -37.01 coo -5.10 2.47 0.73 -5.35 3.21 0.47 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -21.88 16.06 -32.91 -21.09 14.19 -32.27 1hzd_c03 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_c03 naa= 4 ULMN 4 1hzd_c04 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 E 141 ALA B 27 ALA~? 11.43 NI NI A 502 E 186 GLY A 125 GLY.? 7.36 NI NI A 502 E 189 GLU A 86 GLU.? 9.00 NI NI A 502 E 209 GLU A 124 GLU.? 14.10 NI NI A 502 coo 2.89 21.88 40.63 4.19 21.12 40.89 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo 2.61 20.08 34.75 2.44 20.78 34.37 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 4.93 18.46 31.25 6.09 18.34 33.00 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 10.22 22.22 35.51 8.60 22.81 34.29 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 4 1hzd_c04 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 4 # 2 E 141 ALA B 30 ALA~? 10.79 NI NI A 502 E 186 GLY A 125 GLY.? 7.36 NI NI A 502 E 189 GLU A 86 GLU.? 9.00 NI NI A 502 E 209 GLU B 28 GLU~? 10.98 NI NI A 502 coo 2.89 21.88 40.63 4.19 21.12 40.89 -24.57 21.06 -37.88 -25.84 21.07 -37.01 coo 2.61 20.08 34.75 2.44 20.78 34.37 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 4.93 18.46 31.25 6.09 18.34 33.00 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 10.22 22.22 35.51 8.60 22.81 34.29 -21.88 16.06 -32.91 -21.09 14.19 -32.27 1hzd_c04 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_c04 naa= 4 ULMN 4 1og1_c00 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2user 1 4 # 1 A 147 SER B 87 SER.? 15.38 NI NI A 501 A 159 GLU A 28 GLU~? 13.04 NI NI A 501 A 184 ARG A 23 ARG~? 15.85 NI NI A 502 A 189 GLU B 124 GLU.? 12.68 NI NI A 501 coo 53.09 24.63 27.00 51.51 25.19 25.28 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 52.64 14.17 18.05 51.99 14.09 16.04 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 45.78 18.05 21.49 44.51 17.88 18.72 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 49.07 22.26 28.01 48.95 23.27 26.11 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1og1_c00 source 1og1 T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2 : 1 hits 1og1_c00 naa= 4 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 25 ARG~? 18.03 NI NI A 501 265 HIS A 31 HIS~? -4.16 NI NI A 501s 274 TYR A 60 TYR^? 20.44 NI NI A 501 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 0.94 52.26 9.16 1.95 54.78 9.91 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 25 ARG~? 18.03 NI NI A 501 265 HIS A 31 HIS~? -4.16 NI NI A 501s 274 TYR A 67 TYR^? 18.49 NI NI A 501 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 0.94 52.26 9.16 1.95 54.78 9.91 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 102 ARG.? 15.26 NI NI A 501 265 HIS B 126 HIS.? -4.79 NI NI A 501s 274 TYR A 60 TYR^? 20.44 NI NI A 501 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 0.94 52.26 9.16 1.95 54.78 9.91 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG A 102 ARG.? 15.26 NI NI A 501 265 HIS B 127 HIS.? 5.53 NI NI A 501 274 TYR A 60 TYR^? 20.44 NI NI A 501 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 0.94 52.26 9.16 1.95 54.78 9.91 -35.80 19.06 -5.58 -37.88 17.67 -4.34 1a41_c01 source 1a41 TOPOISOMERASE I : 4 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 31 HIS~? -4.16 NI NI A 501s B 40 LYS B 123 LYS^? 13.38 NI NI A 501 B 114 HIS B 127 HIS.? 5.53 NI NI A 501 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 126 HIS.? -3.75 NI NI A 502s B 40 LYS A 123 LYS^? 12.92 NI NI A 502 B 114 HIS A 127 HIS.? 7.54 NI NI A 502 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS B 31 HIS~? -3.92 NI NI A 502s B 40 LYS A 123 LYS^? 12.92 NI NI A 502 B 114 HIS A 127 HIS.? 7.54 NI NI A 502 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -20.75 31.16 -30.30 -19.37 32.72 -30.66 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 3 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 31 HIS~? -4.16 NI NI A 501s E 40 LYS B 123 LYS^? 13.38 NI NI A 501 E 114 HIS B 127 HIS.? 5.53 NI NI A 501 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 126 HIS.? -3.75 NI NI A 502s E 40 LYS A 123 LYS^? 12.92 NI NI A 502 E 114 HIS A 127 HIS.? 7.54 NI NI A 502 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS B 31 HIS~? -3.92 NI NI A 502s E 40 LYS A 123 LYS^? 12.92 NI NI A 502 E 114 HIS A 127 HIS.? 7.54 NI NI A 502 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -20.75 31.16 -30.30 -19.37 32.72 -30.66 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 3 hits 1a4y_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 82 ASP~? 15.20 NI NI A 502 187 GLU A 86 GLU.? 9.00 NI NI A 502 229 LYS A 123 LYS^? 12.92 NI NI A 502 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 82 ASP~? 15.20 NI NI A 502 187 GLU A 124 GLU.? 14.10 NI NI A 502 229 LYS A 123 LYS^? 12.92 NI NI A 502 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 82 ASP~? 13.99 NI NI A 501 187 GLU B 86 GLU.? 9.13 NI NI A 501 229 LYS B 123 LYS^? 13.38 NI NI A 501 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 82 ASP~? 13.99 NI NI A 501 187 GLU B 124 GLU.? 12.68 NI NI A 501 229 LYS B 123 LYS^? 13.38 NI NI A 501 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 82 ASP~? 15.20 NI NI A 502 214 ASP B 42 ASP.? 24.38 NI NI A 502 289 ASP B 88 ASP^? 15.06 NI NI A 502 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 26.86 59.76 46.36 25.42 58.23 45.92 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 82 ASP~? 13.99 NI NI A 501 214 ASP A 42 ASP.? 24.20 NI NI A 501 289 ASP A 88 ASP^? 14.52 NI NI A 501 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 26.86 59.76 46.36 25.42 58.23 45.92 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.37 17.64 -25.93 -33.10 15.61 -26.13 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 88 ASP^? 15.06 NI NI A 502 227 GLU B 28 GLU~? 10.98 NI NI A 502 289 ASP A 82 ASP~? 15.20 NI NI A 502 coo -0.62 65.95 29.97 0.31 67.47 31.05 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 3.96 55.76 41.24 4.83 57.69 41.17 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.79 30.16 -22.23 -31.29 29.65 -23.60 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c06 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 87 SER.? 14.75 NI NI A 502 A 292 ASP B 13 ASP~? 14.49 NI NI A 501 A 322 HIS A 127 HIS.? 7.54 NI NI A 502 coo 36.34 32.23 39.60 36.43 34.62 39.93 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 66 SER^? 13.28 NI NI A 502 A 292 ASP B 13 ASP~? 14.49 NI NI A 501 A 322 HIS A 127 HIS.? 7.54 NI NI A 502 coo 36.34 32.23 39.60 36.43 34.62 39.93 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.75 31.16 -30.30 -19.37 32.72 -30.66 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 87 SER.? 14.75 NI NI A 502 B 292 ASP B 13 ASP~? 14.49 NI NI A 501 B 322 HIS A 127 HIS.? 7.54 NI NI A 502 coo 35.42 71.28 22.94 36.24 69.06 22.37 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 66 SER^? 13.28 NI NI A 502 B 292 ASP B 13 ASP~? 14.49 NI NI A 501 B 322 HIS A 127 HIS.? 7.54 NI NI A 502 coo 35.42 71.28 22.94 36.24 69.06 22.37 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.75 31.16 -30.30 -19.37 32.72 -30.66 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 25 ARG~? 18.03 NI NI A 501 B 342 ASP A 42 ASP.? 24.20 NI NI A 501 B 531 ARG A 23 ARG~? 15.85 NI NI A 502 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -29.17 20.32 -15.53 -28.78 20.89 -18.53 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 1 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG B 23 ARG~? 15.67 NI NI A 501 A 342 ASP B 82 ASP~? 13.99 NI NI A 501 A 531 ARG B 17 ARG~? 8.61 NI NI A 501 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -32.06 1.37 -29.33 -31.49 1.19 -26.24 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 1 hits 1asy_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS B 126 HIS.? -4.79 NI NI A 501s A 171 ARG A 25 ARG~? 18.03 NI NI A 501 A 190 LYS B 123 LYS^? 13.38 NI NI A 501 coo 22.59 2.26 43.22 21.17 3.47 42.27 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 13.63 3.81 28.83 14.49 2.91 31.59 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 24.97 7.47 37.69 21.24 10.69 35.89 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 1 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS B 126 HIS.? -4.79 NI NI A 501s B 171 ARG A 25 ARG~? 18.03 NI NI A 501 B 190 LYS B 123 LYS^? 13.38 NI NI A 501 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 2.83 4.83 10.84 1.96 4.32 7.97 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 1 hits 1azy_c01 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 23 ARG~? 15.85 NI NI A 502 A 141 THR A 65 THR.? 13.82 NI NI A 501 A 235 ASP A 82 ASP~? 15.20 NI NI A 502 coo 6.21 93.81 36.58 4.58 96.33 37.17 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 6.80 92.87 28.33 4.91 92.74 27.40 -35.39 14.99 -13.24 -37.04 15.69 -14.45 coo 12.98 90.36 47.57 11.26 89.62 46.62 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG B 23 ARG~? 15.67 NI NI A 501 A 141 THR B 65 THR^? 14.18 NI NI A 502 A 235 ASP B 82 ASP~? 13.99 NI NI A 501 coo 6.21 93.81 36.58 4.58 96.33 37.17 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 6.80 92.87 28.33 4.91 92.74 27.40 -30.21 23.51 -34.34 -32.04 24.61 -34.02 coo 12.98 90.36 47.57 11.26 89.62 46.62 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 23 ARG~? 15.67 NI NI A 501 A 141 THR B 85 THR.? 12.36 NI NI A 501 A 235 ASP B 42 ASP.? 24.38 NI NI A 502 coo 6.21 93.81 36.58 4.58 96.33 37.17 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 6.80 92.87 28.33 4.91 92.74 27.40 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo 12.98 90.36 47.57 11.26 89.62 46.62 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG B 23 ARG~? 15.67 NI NI A 501 D 141 THR B 65 THR^? 14.18 NI NI A 502 D 235 ASP B 82 ASP~? 13.99 NI NI A 501 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -30.21 23.51 -34.34 -32.04 24.61 -34.02 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG B 23 ARG~? 15.67 NI NI A 501 D 141 THR B 85 THR.? 12.36 NI NI A 501 D 235 ASP B 42 ASP.? 24.38 NI NI A 502 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 23 ARG~? 15.85 NI NI A 502 C 141 THR A 65 THR.? 13.82 NI NI A 501 C 235 ASP A 82 ASP~? 15.20 NI NI A 502 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -35.39 14.99 -13.24 -37.04 15.69 -14.45 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG B 23 ARG~? 15.67 NI NI A 501 C 141 THR B 85 THR.? 12.36 NI NI A 501 C 235 ASP B 42 ASP.? 24.38 NI NI A 502 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 23 ARG~? 15.85 NI NI A 502 B 141 THR A 85 THR~? 12.80 NI NI A 502 B 235 ASP A 42 ASP.? 24.20 NI NI A 501 coo 8.13 67.41 100.27 7.18 68.35 97.45 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 8.28 67.78 108.81 6.22 67.65 109.43 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 14.55 73.52 89.47 12.81 73.95 90.56 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG B 23 ARG~? 15.67 NI NI A 501 B 141 THR B 85 THR.? 12.36 NI NI A 501 B 235 ASP B 42 ASP.? 24.38 NI NI A 502 coo 8.13 67.41 100.27 7.18 68.35 97.45 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 8.28 67.78 108.81 6.22 67.65 109.43 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo 14.55 73.52 89.47 12.81 73.95 90.56 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG B 23 ARG~? 15.67 NI NI A 501 A 451 GLU A 86 GLU.? 9.00 NI NI A 502 A 540 GLU A 124 GLU.? 14.10 NI NI A 502 coo 79.04 80.20 80.81 79.58 81.40 83.63 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 81.34 87.29 87.22 82.36 86.09 88.61 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 79.94 80.46 88.84 81.11 81.36 87.27 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 102 ARG.? 15.54 NI NI A 502 A 451 GLU A 86 GLU.? 9.00 NI NI A 502 A 540 GLU A 124 GLU.? 14.10 NI NI A 502 coo 79.04 80.20 80.81 79.58 81.40 83.63 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 81.34 87.29 87.22 82.36 86.09 88.61 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 79.94 80.46 88.84 81.11 81.36 87.27 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG B 102 ARG.? 15.54 NI NI A 502 B 451 GLU A 86 GLU.? 9.00 NI NI A 502 B 540 GLU A 124 GLU.? 14.10 NI NI A 502 coo 82.21 41.07 119.14 83.95 40.66 116.59 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 86.52 35.28 112.74 87.08 36.38 110.99 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 83.38 41.19 112.55 85.47 40.59 112.72 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG B 102 ARG.? 15.54 NI NI A 502 183 LYS A 123 LYS^? 12.92 NI NI A 502 317 ARG A 101 ARG.? 18.18 NI NI A 501 coo 76.57 109.19 73.41 73.86 110.26 72.16 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 82.09 117.51 66.37 80.60 114.32 71.44 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -45.57 11.90 -25.10 -47.16 9.28 -24.53 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 102 ARG.? 15.54 NI NI A 502 183 LYS A 123 LYS^? 12.92 NI NI A 502 317 ARG A 102 ARG.? 15.26 NI NI A 501 coo 76.57 109.19 73.41 73.86 110.26 72.16 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 82.09 117.51 66.37 80.60 114.32 71.44 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 65.21 120.62 58.76 63.62 123.14 59.66 -43.90 12.11 -18.64 -45.27 9.35 -19.00 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 2 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG B 102 ARG.? 15.54 NI NI A 502 A 128 GLU A 86 GLU.? 9.00 NI NI A 502 A 225 GLU A 124 GLU.? 14.10 NI NI A 502 coo 38.56 19.11 14.83 37.12 21.00 16.76 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 36.48 24.43 22.02 36.86 26.34 21.13 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 40.16 23.71 17.01 38.52 24.96 17.40 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS B 126 HIS.? -4.79 NI NI A 501s A 168 ARG A 25 ARG~? 18.03 NI NI A 501 A 187 LYS B 123 LYS^? 13.38 NI NI A 501 coo 62.47 12.00 59.65 61.76 10.14 60.31 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 55.10 8.37 73.00 55.48 9.59 70.20 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 66.76 10.09 66.23 61.80 8.06 65.82 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS B 126 HIS.? -4.79 NI NI A 501s A 168 ARG B 23 ARG~? 15.67 NI NI A 501 A 187 LYS B 123 LYS^? 13.38 NI NI A 501 coo 62.47 12.00 59.65 61.76 10.14 60.31 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 55.10 8.37 73.00 55.48 9.59 70.20 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 66.76 10.09 66.23 61.80 8.06 65.82 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 88 ASP^? 14.52 NI NI A 501 A 354 GLU A 86 GLU.? 9.00 NI NI A 502 A 421 ASP A 82 ASP~? 15.20 NI NI A 502 coo 31.05 49.37 64.51 31.97 51.11 63.85 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 29.07 50.42 58.36 29.02 52.18 59.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 30.82 59.76 58.47 31.12 59.02 60.40 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 88 ASP^? 14.52 NI NI A 501 A 354 GLU A 124 GLU.? 14.10 NI NI A 502 A 421 ASP A 82 ASP~? 15.20 NI NI A 502 coo 31.05 49.37 64.51 31.97 51.11 63.85 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 29.07 50.42 58.36 29.02 52.18 59.49 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 30.82 59.76 58.47 31.12 59.02 60.40 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 88 ASP^? 14.52 NI NI A 501 A 354 GLU B 86 GLU.? 9.13 NI NI A 501 A 421 ASP B 82 ASP~? 13.99 NI NI A 501 coo 31.05 49.37 64.51 31.97 51.11 63.85 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 29.07 50.42 58.36 29.02 52.18 59.49 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 30.82 59.76 58.47 31.12 59.02 60.40 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP B 88 ASP^? 15.06 NI NI A 502 A 354 GLU A 86 GLU.? 9.00 NI NI A 502 A 421 ASP A 82 ASP~? 15.20 NI NI A 502 coo 31.05 49.37 64.51 31.97 51.11 63.85 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 29.07 50.42 58.36 29.02 52.18 59.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 30.82 59.76 58.47 31.12 59.02 60.40 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP B 88 ASP^? 15.06 NI NI A 502 A 354 GLU B 86 GLU.? 9.13 NI NI A 501 A 421 ASP B 82 ASP~? 13.99 NI NI A 501 coo 31.05 49.37 64.51 31.97 51.11 63.85 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 29.07 50.42 58.36 29.02 52.18 59.49 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 30.82 59.76 58.47 31.12 59.02 60.40 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 5 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 88 ASP^? 14.52 NI NI A 501 B 354 GLU A 86 GLU.? 9.00 NI NI A 502 B 421 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.90 8.19 53.87 25.36 6.97 52.29 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 27.87 10.66 47.95 27.82 8.60 48.27 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 26.02 1.87 43.38 25.90 1.97 45.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 88 ASP^? 14.52 NI NI A 501 B 354 GLU A 124 GLU.? 14.10 NI NI A 502 B 421 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.90 8.19 53.87 25.36 6.97 52.29 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 27.87 10.66 47.95 27.82 8.60 48.27 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 26.02 1.87 43.38 25.90 1.97 45.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 88 ASP^? 14.52 NI NI A 501 B 354 GLU B 86 GLU.? 9.13 NI NI A 501 B 421 ASP B 82 ASP~? 13.99 NI NI A 501 coo 25.90 8.19 53.87 25.36 6.97 52.29 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 27.87 10.66 47.95 27.82 8.60 48.27 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 26.02 1.87 43.38 25.90 1.97 45.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 88 ASP^? 15.06 NI NI A 502 B 354 GLU A 86 GLU.? 9.00 NI NI A 502 B 421 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.90 8.19 53.87 25.36 6.97 52.29 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 27.87 10.66 47.95 27.82 8.60 48.27 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 26.02 1.87 43.38 25.90 1.97 45.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP B 88 ASP^? 15.06 NI NI A 502 B 354 GLU B 86 GLU.? 9.13 NI NI A 501 B 421 ASP B 82 ASP~? 13.99 NI NI A 501 coo 25.90 8.19 53.87 25.36 6.97 52.29 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 27.87 10.66 47.95 27.82 8.60 48.27 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 26.02 1.87 43.38 25.90 1.97 45.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 5 hits 1bvz_c09 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 101 ARG.? 18.18 NI NI A 501 127 ARG A 102 ARG.? 15.26 NI NI A 501 270 GLU B 86 GLU.? 9.13 NI NI A 501 coo -0.83 25.63 1.57 0.97 28.05 0.90 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG B 101 ARG.? 17.16 NI NI A 502 127 ARG B 102 ARG.? 15.54 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo -0.83 25.63 1.57 0.97 28.05 0.90 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 2 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 82 ASP~? 15.20 NI NI A 502 264 GLU B 28 GLU~? 10.98 NI NI A 502 328 ASP B 88 ASP^? 15.06 NI NI A 502 coo 45.62 80.42 43.69 45.65 82.01 45.07 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 59.69 92.71 39.85 58.53 92.03 41.47 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 45.39 90.72 40.63 45.07 89.14 41.90 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 82 ASP~? 13.99 NI NI A 501 264 GLU A 28 GLU~? 13.04 NI NI A 501 328 ASP A 88 ASP^? 14.52 NI NI A 501 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 59.69 92.71 39.85 58.53 92.03 41.47 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 45.39 90.72 40.63 45.07 89.14 41.90 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 82 ASP~? 13.99 NI NI A 501 264 GLU B 28 GLU~? 10.98 NI NI A 502 328 ASP A 88 ASP^? 14.52 NI NI A 501 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 59.69 92.71 39.85 58.53 92.03 41.47 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 45.39 90.72 40.63 45.07 89.14 41.90 -32.37 17.64 -25.93 -33.10 15.61 -26.13 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 3 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS B 31 HIS~? -3.92 NI NI A 502s A 262 GLU A 86 GLU.? 9.00 NI NI A 502 A 358 GLU A 124 GLU.? 14.10 NI NI A 502 coo 26.19 60.87 43.98 27.48 59.27 43.30 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 27.13 54.07 50.45 26.96 54.19 48.35 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 27.06 50.43 44.36 27.99 52.27 44.74 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS B 127 HIS.? 5.53 NI NI A 501 A 262 GLU B 86 GLU.? 9.13 NI NI A 501 A 358 GLU B 124 GLU.? 12.68 NI NI A 501 coo 26.19 60.87 43.98 27.48 59.27 43.30 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 27.13 54.07 50.45 26.96 54.19 48.35 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 27.06 50.43 44.36 27.99 52.27 44.74 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS B 127 HIS.? 5.53 NI NI A 501 A 262 GLU B 124 GLU.? 12.68 NI NI A 501 A 358 GLU B 86 GLU.? 9.13 NI NI A 501 coo 26.19 60.87 43.98 27.48 59.27 43.30 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 27.13 54.07 50.45 26.96 54.19 48.35 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 27.06 50.43 44.36 27.99 52.27 44.74 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 3 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 31 HIS~? -4.16 NI NI A 501s B 262 GLU B 86 GLU.? 9.13 NI NI A 501 B 358 GLU B 124 GLU.? 12.68 NI NI A 501 coo 44.98 77.01 48.39 44.42 78.67 47.18 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 41.60 83.57 54.16 42.46 83.24 52.25 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 44.05 87.61 48.73 43.15 85.67 48.52 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS B 31 HIS~? -3.92 NI NI A 502s B 262 GLU A 86 GLU.? 9.00 NI NI A 502 B 358 GLU A 124 GLU.? 14.10 NI NI A 502 coo 44.98 77.01 48.39 44.42 78.67 47.18 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 41.60 83.57 54.16 42.46 83.24 52.25 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 44.05 87.61 48.73 43.15 85.67 48.52 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS B 127 HIS.? 5.53 NI NI A 501 B 262 GLU B 86 GLU.? 9.13 NI NI A 501 B 358 GLU B 124 GLU.? 12.68 NI NI A 501 coo 44.98 77.01 48.39 44.42 78.67 47.18 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 41.60 83.57 54.16 42.46 83.24 52.25 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 44.05 87.61 48.73 43.15 85.67 48.52 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS B 127 HIS.? 5.53 NI NI A 501 B 262 GLU B 124 GLU.? 12.68 NI NI A 501 B 358 GLU B 86 GLU.? 9.13 NI NI A 501 coo 44.98 77.01 48.39 44.42 78.67 47.18 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 41.60 83.57 54.16 42.46 83.24 52.25 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 44.05 87.61 48.73 43.15 85.67 48.52 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 4 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 46 GLY.? 19.33 NI NI A 501 A 228 SER A 43 SER.? 23.77 NI NI A 501 A 549 ASP A 42 ASP.? 24.20 NI NI A 501 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -18.94 13.11 -6.31 -19.18 13.89 -6.25 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -20.78 14.34 -0.26 -20.70 12.54 1.43 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 125 GLY.? 7.36 NI NI A 502 A 228 SER A 87 SER.? 14.75 NI NI A 502 A 549 ASP A 88 ASP^? 14.52 NI NI A 501 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 125 GLY.? 7.36 NI NI A 502 A 228 SER A 87 SER.? 14.75 NI NI A 502 A 549 ASP B 88 ASP^? 15.06 NI NI A 502 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 125 GLY.? 8.70 NI NI A 501 A 228 SER B 87 SER.? 15.38 NI NI A 501 A 549 ASP A 88 ASP^? 14.52 NI NI A 501 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 125 GLY.? 8.70 NI NI A 501 A 228 SER B 87 SER.? 15.38 NI NI A 501 A 549 ASP B 88 ASP^? 15.06 NI NI A 502 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -31.42 19.31 -21.85 -30.03 20.81 -21.11 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 5 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 125 GLY.? 7.36 NI NI A 502 B1228 SER A 87 SER.? 14.75 NI NI A 502 B1549 ASP A 88 ASP^? 14.52 NI NI A 501 coo 126.34 72.75 125.66 125.95 73.27 126.11 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 125 GLY.? 7.36 NI NI A 502 B1228 SER A 87 SER.? 14.75 NI NI A 502 B1549 ASP B 88 ASP^? 15.06 NI NI A 502 coo 126.34 72.75 125.66 125.95 73.27 126.11 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 125 GLY.? 8.70 NI NI A 501 B1228 SER B 87 SER.? 15.38 NI NI A 501 B1549 ASP A 88 ASP^? 14.52 NI NI A 501 coo 126.34 72.75 125.66 125.95 73.27 126.11 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 131.65 74.68 129.41 130.31 72.73 128.82 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 134.72 69.43 130.42 133.03 70.65 130.08 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 125 GLY.? 8.70 NI NI A 501 B1228 SER B 87 SER.? 15.38 NI NI A 501 B1549 ASP B 88 ASP^? 15.06 NI NI A 502 coo 126.34 72.75 125.66 125.95 73.27 126.11 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 131.65 74.68 129.41 130.31 72.73 128.82 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.42 19.31 -21.85 -30.03 20.81 -21.11 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 4 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 28 GLU~? 13.04 NI NI A 501 A 89 GLU B 86 GLU.? 9.13 NI NI A 501 A 120 SER A 66 SER^? 13.16 NI NI A 501 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 28 GLU~? 10.98 NI NI A 502 A 89 GLU A 86 GLU.? 9.00 NI NI A 502 A 120 SER B 66 SER^? 13.28 NI NI A 502 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -31.33 20.29 -35.99 -29.23 19.21 -35.57 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 28 GLU~? 13.04 NI NI A 501 B 89 GLU B 86 GLU.? 9.13 NI NI A 501 B 120 SER A 66 SER^? 13.16 NI NI A 501 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 28 GLU~? 10.98 NI NI A 502 B 89 GLU A 124 GLU.? 14.10 NI NI A 502 B 120 SER B 66 SER^? 13.28 NI NI A 502 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -31.33 20.29 -35.99 -29.23 19.21 -35.57 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 86 GLU.? 9.13 NI NI A 501 B 89 GLU A 28 GLU~? 13.04 NI NI A 501 B 120 SER A 66 SER^? 13.16 NI NI A 501 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -32.58 17.24 -12.10 -30.98 15.55 -12.25 1cns_c01 source 1cns CHITINASE : 3 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 22 TYR~? 21.39 NI NI A 501 A 173 ASP A 42 ASP.? 24.20 NI NI A 501 C 48 ARG A 23 ARG~? 15.85 NI NI A 502 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 24.35 4.55 25.11 25.94 3.23 25.53 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 22 TYR~? 21.09 NI NI A 502 A 173 ASP B 42 ASP.? 24.38 NI NI A 502 C 48 ARG B 23 ARG~? 15.67 NI NI A 501 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 24.35 4.55 25.11 25.94 3.23 25.53 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 22 TYR~? 21.09 NI NI A 502 A 173 ASP B 42 ASP.? 24.38 NI NI A 502 C 48 ARG B 56 ARG.? 27.79 NI NI A 501 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 24.35 4.55 25.11 25.94 3.23 25.53 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 23 ARG~? 15.85 NI NI A 502 C 101 TYR A 22 TYR~? 21.39 NI NI A 501 C 173 ASP A 42 ASP.? 24.20 NI NI A 501 coo 32.27 5.62 48.15 31.93 6.48 51.06 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 29.64 3.64 57.39 31.22 5.14 55.65 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 23 ARG~? 15.67 NI NI A 501 C 101 TYR B 22 TYR~? 21.09 NI NI A 502 C 173 ASP B 42 ASP.? 24.38 NI NI A 502 coo 32.27 5.62 48.15 31.93 6.48 51.06 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 29.64 3.64 57.39 31.22 5.14 55.65 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 56 ARG.? 27.79 NI NI A 501 C 101 TYR B 22 TYR~? 21.09 NI NI A 502 C 173 ASP B 42 ASP.? 24.38 NI NI A 502 coo 32.27 5.62 48.15 31.93 6.48 51.06 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 29.64 3.64 57.39 31.22 5.14 55.65 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG B 23 ARG~? 15.67 NI NI A 501 D 101 TYR B 22 TYR~? 21.09 NI NI A 502 D 173 ASP B 42 ASP.? 24.38 NI NI A 502 coo 69.08 8.58 32.60 69.70 10.81 30.58 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 71.77 11.86 24.26 70.23 12.22 26.56 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 71.60 6.14 19.25 70.26 6.87 20.69 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 22 TYR~? 21.39 NI NI A 501 B 173 ASP A 42 ASP.? 24.20 NI NI A 501 D 48 ARG A 23 ARG~? 15.85 NI NI A 502 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 22 TYR~? 21.09 NI NI A 502 B 173 ASP B 42 ASP.? 24.38 NI NI A 502 D 48 ARG B 23 ARG~? 15.67 NI NI A 501 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 22 TYR~? 21.09 NI NI A 502 B 173 ASP B 42 ASP.? 24.38 NI NI A 502 D 48 ARG B 56 ARG.? 27.79 NI NI A 501 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 30 ALA~? 10.27 NI NI A 501 D 74 ASN A 33 ASN.? 14.07 NI NI A 501 D 75 GLY A 35 GLY.? 13.51 NI NI A 501 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -30.54 10.08 -9.93 -31.33 11.04 -10.82 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -30.87 7.88 -5.92 -29.26 7.53 -4.61 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -37.56 6.81 -6.55 -36.81 7.00 -6.45 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c07 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 88 ASP^? 14.52 NI NI A 501 A 56 ILE A 108 ILE.? 21.02 NI NI A 502 A 82 TYR B 67 TYR^? 18.53 NI NI A 502 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -39.96 25.11 -31.58 -38.90 24.14 -31.19 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -35.67 20.34 -36.33 -35.75 23.11 -35.83 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 88 ASP^? 14.52 NI NI A 501 B 56 ILE A 108 ILE.? 21.02 NI NI A 502 B 82 TYR B 67 TYR^? 18.53 NI NI A 502 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -39.96 25.11 -31.58 -38.90 24.14 -31.19 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -35.67 20.34 -36.33 -35.75 23.11 -35.83 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 1 hits 1d6o_c01 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 31 HIS~? -4.16 NI NI A 501s A 200 ASP B 82 ASP~? 13.99 NI NI A 501 A 229 LYS A 123 LYS^? 12.92 NI NI A 502 coo 1.13 77.49 40.64 0.62 75.57 39.98 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 0.84 91.24 49.01 2.91 91.61 49.23 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 10.53 97.56 43.71 9.33 93.71 47.17 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 31 HIS~? -3.92 NI NI A 502s A 200 ASP A 82 ASP~? 15.20 NI NI A 502 A 229 LYS B 123 LYS^? 13.38 NI NI A 501 coo 1.13 77.49 40.64 0.62 75.57 39.98 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 0.84 91.24 49.01 2.91 91.61 49.23 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 10.53 97.56 43.71 9.33 93.71 47.17 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 31 HIS~? -4.16 NI NI A 501s B 200 ASP B 82 ASP~? 13.99 NI NI A 501 B 229 LYS A 123 LYS^? 12.92 NI NI A 502 coo 9.24 94.26 88.22 8.02 94.07 89.92 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 17.54 90.31 75.01 17.17 92.01 73.80 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 22.32 101.61 71.64 17.89 98.63 71.55 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 31 HIS~? -3.92 NI NI A 502s B 200 ASP A 82 ASP~? 15.20 NI NI A 502 B 229 LYS B 123 LYS^? 13.38 NI NI A 501 coo 9.24 94.26 88.22 8.02 94.07 89.92 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 17.54 90.31 75.01 17.17 92.01 73.80 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 22.32 101.61 71.64 17.89 98.63 71.55 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 31 HIS~? -4.16 NI NI A 501s C 200 ASP B 82 ASP~? 13.99 NI NI A 501 C 229 LYS A 123 LYS^? 12.92 NI NI A 502 coo 26.77 65.84 83.49 27.06 67.76 84.27 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 19.52 52.01 79.59 20.28 51.65 77.65 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 28.90 45.91 73.55 25.22 49.72 72.97 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 31 HIS~? -3.92 NI NI A 502s C 200 ASP A 82 ASP~? 15.20 NI NI A 502 C 229 LYS B 123 LYS^? 13.38 NI NI A 501 coo 26.77 65.84 83.49 27.06 67.76 84.27 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 19.52 52.01 79.59 20.28 51.65 77.65 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 28.90 45.91 73.55 25.22 49.72 72.97 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 31 HIS~? -4.16 NI NI A 501s D 200 ASP B 82 ASP~? 13.99 NI NI A 501 D 229 LYS A 123 LYS^? 12.92 NI NI A 502 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 4.60 52.95 52.50 5.57 51.29 53.40 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 10.05 41.79 49.80 7.94 44.71 53.76 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 31 HIS~? -3.92 NI NI A 502s D 200 ASP A 82 ASP~? 15.20 NI NI A 502 D 229 LYS B 123 LYS^? 13.38 NI NI A 501 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 4.60 52.95 52.50 5.57 51.29 53.40 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 10.05 41.79 49.80 7.94 44.71 53.76 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 22 TYR~? 21.39 NI NI A 501 A 138 ARG A 25 ARG~? 18.03 NI NI A 501 A 161 LYS A 53 LYS.? 25.39 NI NI A 501 coo 29.03 88.95 86.80 28.09 90.57 84.75 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 23.31 93.18 82.88 23.00 93.71 79.86 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 33.83 91.15 88.62 31.07 91.06 83.02 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 22 TYR~? 21.09 NI NI A 502 A 138 ARG B 25 ARG~? 17.38 NI NI A 502 A 161 LYS B 53 LYS.? 26.24 NI NI A 502 coo 29.03 88.95 86.80 28.09 90.57 84.75 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 23.31 93.18 82.88 23.00 93.71 79.86 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 33.83 91.15 88.62 31.07 91.06 83.02 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 22 TYR~? 21.39 NI NI A 501 B 138 ARG A 25 ARG~? 18.03 NI NI A 501 B 161 LYS A 53 LYS.? 25.39 NI NI A 501 coo 4.62 122.69 99.88 5.46 122.82 97.24 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 10.44 122.27 94.08 11.02 123.87 91.53 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -0.17 119.75 99.65 2.51 123.83 95.70 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 22 TYR~? 21.09 NI NI A 502 B 138 ARG B 25 ARG~? 17.38 NI NI A 502 B 161 LYS B 53 LYS.? 26.24 NI NI A 502 coo 4.62 122.69 99.88 5.46 122.82 97.24 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 10.44 122.27 94.08 11.02 123.87 91.53 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo -0.17 119.75 99.65 2.51 123.83 95.70 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 85 THR~? 12.80 NI NI A 502 A 45 THR A 83 THR~? 11.66 NI NI A 502 A 161 LYS B 123 LYS^? 13.38 NI NI A 501 coo 26.16 88.25 79.16 25.22 89.47 80.71 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 27.73 89.90 76.08 29.24 91.46 75.95 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo 33.83 91.15 88.62 31.07 91.06 83.02 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 85 THR~? 12.80 NI NI A 502 B 45 THR A 83 THR~? 11.66 NI NI A 502 B 161 LYS B 123 LYS^? 13.38 NI NI A 501 coo 7.39 128.28 94.56 8.34 126.36 94.79 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 5.75 129.25 91.25 4.29 128.16 90.07 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo -0.17 119.75 99.65 2.51 123.83 95.70 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 67 TYR^? 18.49 NI NI A 501 150 LYS B 123 LYS^? 13.38 NI NI A 501 186 ASN B 95 ASN.? 31.89 NI NI A 501 coo 32.88 50.55 24.33 31.89 51.78 26.65 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 27.04 52.42 22.30 26.88 49.99 27.00 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 36.98 50.30 37.29 35.85 50.29 35.50 -44.53 31.85 -10.19 -42.56 32.26 -9.56 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 1 hits 1dhr_c00 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 125 GLY.? 7.36 NI NI A 502 B 144 GLU A 86 GLU.? 9.00 NI NI A 502 B 164 GLU A 124 GLU.? 14.10 NI NI A 502 coo 88.87 114.43 152.30 88.45 115.15 152.32 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 85.20 111.99 152.05 86.60 110.89 150.91 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 88.14 113.46 145.73 86.79 113.92 147.30 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 125 GLY.? 8.70 NI NI A 501 B 144 GLU B 86 GLU.? 9.13 NI NI A 501 B 164 GLU B 124 GLU.? 12.68 NI NI A 501 coo 88.87 114.43 152.30 88.45 115.15 152.32 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 85.20 111.99 152.05 86.60 110.89 150.91 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 88.14 113.46 145.73 86.79 113.92 147.30 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 125 GLY.? 8.70 NI NI A 501 B 144 GLU B 124 GLU.? 12.68 NI NI A 501 B 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 88.87 114.43 152.30 88.45 115.15 152.32 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 85.20 111.99 152.05 86.60 110.89 150.91 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 88.14 113.46 145.73 86.79 113.92 147.30 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 125 GLY.? 7.36 NI NI A 502 C 144 GLU A 86 GLU.? 9.00 NI NI A 502 C 164 GLU A 124 GLU.? 14.10 NI NI A 502 coo 56.28 104.55 135.84 56.09 105.34 136.05 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 58.46 103.90 139.48 57.57 102.00 139.16 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 51.71 102.03 140.09 53.02 103.62 140.54 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 125 GLY.? 8.70 NI NI A 501 C 144 GLU B 86 GLU.? 9.13 NI NI A 501 C 164 GLU B 124 GLU.? 12.68 NI NI A 501 coo 56.28 104.55 135.84 56.09 105.34 136.05 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 58.46 103.90 139.48 57.57 102.00 139.16 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 51.71 102.03 140.09 53.02 103.62 140.54 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 125 GLY.? 8.70 NI NI A 501 C 144 GLU B 124 GLU.? 12.68 NI NI A 501 C 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 56.28 104.55 135.84 56.09 105.34 136.05 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 58.46 103.90 139.48 57.57 102.00 139.16 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 51.71 102.03 140.09 53.02 103.62 140.54 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 125 GLY.? 7.36 NI NI A 502 D 144 GLU A 86 GLU.? 9.00 NI NI A 502 D 164 GLU A 124 GLU.? 14.10 NI NI A 502 coo 86.19 80.64 132.77 86.38 79.85 132.93 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 84.75 81.24 136.88 85.62 83.14 136.43 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 91.47 83.05 136.24 90.35 81.38 136.84 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 125 GLY.? 8.70 NI NI A 501 D 144 GLU B 86 GLU.? 9.13 NI NI A 501 D 164 GLU B 124 GLU.? 12.68 NI NI A 501 coo 86.19 80.64 132.77 86.38 79.85 132.93 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 84.75 81.24 136.88 85.62 83.14 136.43 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 91.47 83.05 136.24 90.35 81.38 136.84 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 125 GLY.? 8.70 NI NI A 501 D 144 GLU B 124 GLU.? 12.68 NI NI A 501 D 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 86.19 80.64 132.77 86.38 79.85 132.93 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 84.75 81.24 136.88 85.62 83.14 136.43 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 91.47 83.05 136.24 90.35 81.38 136.84 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 125 GLY.? 7.36 NI NI A 502 E 144 GLU A 86 GLU.? 9.00 NI NI A 502 E 164 GLU A 124 GLU.? 14.10 NI NI A 502 coo 90.07 81.07 170.50 90.23 80.26 170.38 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 87.05 81.30 167.53 86.38 82.74 168.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 84.40 80.02 173.80 85.08 79.06 172.03 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 125 GLY.? 8.70 NI NI A 501 E 144 GLU B 86 GLU.? 9.13 NI NI A 501 E 164 GLU B 124 GLU.? 12.68 NI NI A 501 coo 90.07 81.07 170.50 90.23 80.26 170.38 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 87.05 81.30 167.53 86.38 82.74 168.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 84.40 80.02 173.80 85.08 79.06 172.03 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 125 GLY.? 8.70 NI NI A 501 E 144 GLU B 124 GLU.? 12.68 NI NI A 501 E 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 90.07 81.07 170.50 90.23 80.26 170.38 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 87.05 81.30 167.53 86.38 82.74 168.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 84.40 80.02 173.80 85.08 79.06 172.03 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 125 GLY.? 7.36 NI NI A 502 F 144 GLU A 86 GLU.? 9.00 NI NI A 502 F 164 GLU A 124 GLU.? 14.10 NI NI A 502 coo 57.12 70.68 155.10 57.52 69.95 155.02 -25.75 23.74 -30.38 -26.07 24.38 -30.24 coo 60.62 73.13 154.21 59.05 74.26 153.35 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 56.75 71.71 148.46 58.44 71.01 149.54 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 125 GLY.? 8.70 NI NI A 501 F 144 GLU B 86 GLU.? 9.13 NI NI A 501 F 164 GLU B 124 GLU.? 12.68 NI NI A 501 coo 57.12 70.68 155.10 57.52 69.95 155.02 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 60.62 73.13 154.21 59.05 74.26 153.35 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 56.75 71.71 148.46 58.44 71.01 149.54 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 125 GLY.? 8.70 NI NI A 501 F 144 GLU B 124 GLU.? 12.68 NI NI A 501 F 164 GLU B 86 GLU.? 9.13 NI NI A 501 coo 57.12 70.68 155.10 57.52 69.95 155.02 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 60.62 73.13 154.21 59.05 74.26 153.35 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 56.75 71.71 148.46 58.44 71.01 149.54 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c17 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS B 31 HIS~? -3.92 NI NI A 502s B 43 HIS A 126 HIS.? -3.75 NI NI A 502s B 65 GLU A 124 GLU.? 14.10 NI NI A 502 coo 20.15 22.08 34.36 20.84 20.10 34.21 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 19.55 18.91 30.27 18.21 18.65 31.84 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 10.90 21.31 28.81 12.14 22.15 30.31 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS B 127 HIS.? 5.53 NI NI A 501 B 43 HIS B 126 HIS.? -4.79 NI NI A 501s B 65 GLU B 124 GLU.? 12.68 NI NI A 501 coo 20.15 22.08 34.36 20.84 20.10 34.21 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 19.55 18.91 30.27 18.21 18.65 31.84 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 2 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 68 ALA^? 20.28 NI NI A 501 A 136 TYR A 67 TYR^? 18.49 NI NI A 501 A 140 LYS B 123 LYS^? 13.38 NI NI A 501 coo 55.90 7.49 23.83 56.71 8.23 22.76 -30.23 23.05 -10.64 -28.84 22.71 -11.28 coo 59.38 10.02 17.51 59.95 9.89 20.21 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 59.52 3.69 18.67 62.31 6.19 22.58 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 121 ALA^? 17.77 NI NI A 501 A 136 TYR B 67 TYR^? 18.53 NI NI A 502 A 140 LYS A 123 LYS^? 12.92 NI NI A 502 coo 55.90 7.49 23.83 56.71 8.23 22.76 -36.81 15.24 -31.92 -35.97 14.07 -31.63 coo 59.38 10.02 17.51 59.95 9.89 20.21 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 59.52 3.69 18.67 62.31 6.19 22.58 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 68 ALA^? 20.27 NI NI A 502 A 136 TYR B 67 TYR^? 18.53 NI NI A 502 A 140 LYS A 123 LYS^? 12.92 NI NI A 502 coo 55.90 7.49 23.83 56.71 8.23 22.76 -34.96 14.51 -37.19 -34.01 13.41 -36.62 coo 59.38 10.02 17.51 59.95 9.89 20.21 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 59.52 3.69 18.67 62.31 6.19 22.58 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA B 121 ALA^? 18.32 NI NI A 502 A 136 TYR A 67 TYR^? 18.49 NI NI A 501 A 140 LYS B 123 LYS^? 13.38 NI NI A 501 coo 55.90 7.49 23.83 56.71 8.23 22.76 -31.28 23.98 -15.55 -29.77 23.75 -15.59 coo 59.38 10.02 17.51 59.95 9.89 20.21 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 59.52 3.69 18.67 62.31 6.19 22.58 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 4 hits 1e7q_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 68 ALA^? 20.28 NI NI A 501 A 257 ALA B 121 ALA^? 18.32 NI NI A 502 A 328 ASP B 88 ASP^? 15.06 NI NI A 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -30.23 23.05 -10.64 -28.84 22.71 -11.28 coo 43.22 26.73 5.37 41.81 27.09 5.79 -31.28 23.98 -15.55 -29.77 23.75 -15.59 coo 38.17 34.10 6.67 37.72 32.06 6.84 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 78 ALA~? 20.01 NI NI A 502 A 257 ALA A 79 ALA~? 16.59 NI NI A 502 A 328 ASP A 13 ASP~? 13.27 NI NI A 502 coo 39.84 24.12 8.44 38.50 24.23 9.11 -29.95 33.40 -17.76 -31.14 34.31 -17.94 coo 43.22 26.73 5.37 41.81 27.09 5.79 -28.00 34.07 -20.93 -27.53 35.45 -21.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA B 68 ALA^? 20.27 NI NI A 502 A 257 ALA A 121 ALA^? 17.77 NI NI A 501 A 328 ASP A 88 ASP^? 14.52 NI NI A 501 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.96 14.51 -37.19 -34.01 13.41 -36.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 -36.81 15.24 -31.92 -35.97 14.07 -31.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA B 78 ALA~? 18.91 NI NI A 501 A 257 ALA B 79 ALA~? 15.69 NI NI A 501 A 328 ASP B 13 ASP~? 14.49 NI NI A 501 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.38 9.26 -29.77 -44.67 10.03 -29.61 coo 43.22 26.73 5.37 41.81 27.09 5.79 -43.34 7.54 -26.46 -44.33 6.51 -26.01 coo 38.17 34.10 6.67 37.72 32.06 6.84 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 79 ALA~? 15.69 NI NI A 501 A 257 ALA B 78 ALA~? 18.91 NI NI A 501 A 328 ASP B 13 ASP~? 14.49 NI NI A 501 coo 39.84 24.12 8.44 38.50 24.23 9.11 -43.34 7.54 -26.46 -44.33 6.51 -26.01 coo 43.22 26.73 5.37 41.81 27.09 5.79 -43.38 9.26 -29.77 -44.67 10.03 -29.61 coo 38.17 34.10 6.67 37.72 32.06 6.84 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 5 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 18 SER~? 18.69 NI NI A 502 A 140 TYR A 22 TYR~? 21.39 NI NI A 501 A 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 34.67 35.79 48.83 33.57 37.88 49.47 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 29.60 38.99 53.89 30.10 37.88 51.36 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 32.73 32.94 54.42 29.29 32.83 50.35 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 18 SER~? 18.56 NI NI A 501 A 140 TYR B 22 TYR~? 21.09 NI NI A 502 A 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 34.67 35.79 48.83 33.57 37.88 49.47 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 29.60 38.99 53.89 30.10 37.88 51.36 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 32.73 32.94 54.42 29.29 32.83 50.35 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 18 SER~? 18.69 NI NI A 502 B 140 TYR A 22 TYR~? 21.39 NI NI A 501 B 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 30.90 35.65 89.60 29.85 37.72 88.83 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 24.43 38.83 86.53 27.07 38.03 86.12 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 25.13 32.62 89.49 27.74 32.61 84.91 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER B 18 SER~? 18.56 NI NI A 501 B 140 TYR B 22 TYR~? 21.09 NI NI A 502 B 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 30.90 35.65 89.60 29.85 37.72 88.83 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 24.43 38.83 86.53 27.07 38.03 86.12 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 25.13 32.62 89.49 27.74 32.61 84.91 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 18 SER~? 18.69 NI NI A 502 C 140 TYR A 22 TYR~? 21.39 NI NI A 501 C 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 18 SER~? 18.56 NI NI A 501 C 140 TYR B 22 TYR~? 21.09 NI NI A 502 C 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 18 SER~? 18.69 NI NI A 502 D 140 TYR A 22 TYR~? 21.39 NI NI A 501 D 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER B 18 SER~? 18.56 NI NI A 501 D 140 TYR B 22 TYR~? 21.09 NI NI A 502 D 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 18 SER~? 18.69 NI NI A 502 E 140 TYR A 22 TYR~? 21.39 NI NI A 501 E 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER B 18 SER~? 18.56 NI NI A 501 E 140 TYR B 22 TYR~? 21.09 NI NI A 502 E 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 18 SER~? 18.69 NI NI A 502 F 140 TYR A 22 TYR~? 21.39 NI NI A 501 F 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 55.30 92.46 56.72 55.15 90.39 55.38 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 54.49 89.31 49.65 53.35 90.16 52.06 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 56.78 95.62 51.15 51.59 95.31 52.37 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 18 SER~? 18.56 NI NI A 501 F 140 TYR B 22 TYR~? 21.09 NI NI A 502 F 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 55.30 92.46 56.72 55.15 90.39 55.38 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 54.49 89.31 49.65 53.35 90.16 52.06 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 56.78 95.62 51.15 51.59 95.31 52.37 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 18 SER~? 18.69 NI NI A 502 G 140 TYR A 22 TYR~? 21.39 NI NI A 501 G 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 76.25 95.63 21.56 75.29 93.40 21.36 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 69.78 91.62 20.06 71.51 92.68 22.02 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 71.19 98.21 18.32 70.69 97.75 23.67 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER B 18 SER~? 18.56 NI NI A 501 G 140 TYR B 22 TYR~? 21.09 NI NI A 502 G 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 76.25 95.63 21.56 75.29 93.40 21.36 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 69.78 91.62 20.06 71.51 92.68 22.02 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 71.19 98.21 18.32 70.69 97.75 23.67 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 18 SER~? 18.69 NI NI A 502 H 140 TYR A 22 TYR~? 21.39 NI NI A 501 H 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 15.45 90.62 47.70 16.55 88.57 46.97 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 21.92 87.58 44.67 19.30 88.41 44.23 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 21.26 93.70 47.67 18.47 93.68 43.08 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 18 SER~? 18.56 NI NI A 501 H 140 TYR B 22 TYR~? 21.09 NI NI A 502 H 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 15.45 90.62 47.70 16.55 88.57 46.97 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 21.92 87.58 44.67 19.30 88.41 44.23 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 21.26 93.70 47.67 18.47 93.68 43.08 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 18 SER~? 18.69 NI NI A 502 I 140 TYR A 22 TYR~? 21.39 NI NI A 501 I 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 11.78 90.82 7.18 12.84 88.72 7.93 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 16.78 87.76 12.19 16.39 88.69 9.59 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 13.67 93.83 12.65 17.08 93.94 8.58 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER B 18 SER~? 18.56 NI NI A 501 I 140 TYR B 22 TYR~? 21.09 NI NI A 502 I 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 11.78 90.82 7.18 12.84 88.72 7.93 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 16.78 87.76 12.19 16.39 88.69 9.59 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 13.67 93.83 12.65 17.08 93.94 8.58 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 18 SER~? 18.69 NI NI A 502 J 140 TYR A 22 TYR~? 21.39 NI NI A 501 J 144 LYS A 53 LYS.? 25.39 NI NI A 501 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 18 SER~? 18.56 NI NI A 501 J 140 TYR B 22 TYR~? 21.09 NI NI A 502 J 144 LYS B 53 LYS.? 26.24 NI NI A 502 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 85 THR~? 12.80 NI NI A 502 A 159 LYS B 123 LYS^? 13.38 NI NI A 501 A 193 GLU A 28 GLU~? 13.04 NI NI A 501 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 85 THR.? 12.36 NI NI A 501 A 159 LYS A 123 LYS^? 12.92 NI NI A 502 A 193 GLU B 28 GLU~? 10.98 NI NI A 502 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 85 THR.? 12.36 NI NI A 501 A 159 LYS B 123 LYS^? 13.38 NI NI A 501 A 193 GLU A 28 GLU~? 13.04 NI NI A 501 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -23.75 11.51 -14.04 -21.61 11.75 -14.14 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 3 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP B 88 ASP^? 15.06 NI NI A 502 260 GLU B 124 GLU.? 12.68 NI NI A 501 370 TYR A 67 TYR^? 18.49 NI NI A 501 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 123 LYS^? 12.92 NI NI A 502 B 105 HIS B 126 HIS.? -4.79 NI NI A 501s E 35 ASP B 82 ASP~? 13.99 NI NI A 501 coo 20.51 39.76 8.83 21.23 37.38 14.18 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 27.18 37.56 20.68 29.07 38.28 20.13 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 22 TYR~? 21.39 NI NI A 501 A 142 LEU A 20 LEU~? 13.99 NI NI A 502 A 165 LYS A 53 LYS.? 25.39 NI NI A 501 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -23.68 23.28 -16.79 -25.32 24.09 -17.98 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 67 TYR^? 18.49 NI NI A 501 A 142 LEU B 98 LEU^? 23.78 NI NI A 502 A 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -39.45 26.79 -17.30 -37.37 26.24 -17.07 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 67 TYR^? 18.49 NI NI A 501 A 142 LEU B 110 LEU.? 24.16 NI NI A 501 A 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -41.54 24.43 -11.34 -40.43 25.53 -12.93 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR B 22 TYR~? 21.09 NI NI A 502 A 142 LEU B 20 LEU~? 13.47 NI NI A 501 A 165 LYS B 53 LYS.? 26.24 NI NI A 502 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -31.93 8.55 -30.89 -33.52 9.40 -29.75 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR B 67 TYR^? 18.53 NI NI A 502 A 142 LEU A 98 LEU^? 23.32 NI NI A 501 A 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -43.01 20.87 -30.18 -41.71 19.20 -30.48 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR B 67 TYR^? 18.53 NI NI A 502 A 142 LEU A 110 LEU.? 24.15 NI NI A 502 A 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -42.15 23.45 -36.39 -41.58 21.98 -34.84 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 22 TYR~? 21.39 NI NI A 501 B 142 LEU A 20 LEU~? 13.99 NI NI A 502 B 165 LYS A 53 LYS.? 25.39 NI NI A 501 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -23.68 23.28 -16.79 -25.32 24.09 -17.98 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 67 TYR^? 18.49 NI NI A 501 B 142 LEU B 98 LEU^? 23.78 NI NI A 502 B 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -39.45 26.79 -17.30 -37.37 26.24 -17.07 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 67 TYR^? 18.49 NI NI A 501 B 142 LEU B 110 LEU.? 24.16 NI NI A 501 B 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -41.54 24.43 -11.34 -40.43 25.53 -12.93 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 22 TYR~? 21.09 NI NI A 502 B 142 LEU B 20 LEU~? 13.47 NI NI A 501 B 165 LYS B 53 LYS.? 26.24 NI NI A 502 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -31.93 8.55 -30.89 -33.52 9.40 -29.75 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR B 67 TYR^? 18.53 NI NI A 502 B 142 LEU A 98 LEU^? 23.32 NI NI A 501 B 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -43.01 20.87 -30.18 -41.71 19.20 -30.48 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR B 67 TYR^? 18.53 NI NI A 502 B 142 LEU A 110 LEU.? 24.15 NI NI A 502 B 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -42.15 23.45 -36.39 -41.58 21.98 -34.84 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 22 TYR~? 21.39 NI NI A 501 C 142 LEU A 20 LEU~? 13.99 NI NI A 502 C 165 LYS A 53 LYS.? 25.39 NI NI A 501 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -23.68 23.28 -16.79 -25.32 24.09 -17.98 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 67 TYR^? 18.49 NI NI A 501 C 142 LEU B 98 LEU^? 23.78 NI NI A 502 C 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -39.45 26.79 -17.30 -37.37 26.24 -17.07 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 67 TYR^? 18.49 NI NI A 501 C 142 LEU B 110 LEU.? 24.16 NI NI A 501 C 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -41.54 24.43 -11.34 -40.43 25.53 -12.93 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 22 TYR~? 21.09 NI NI A 502 C 142 LEU B 20 LEU~? 13.47 NI NI A 501 C 165 LYS B 53 LYS.? 26.24 NI NI A 502 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -31.93 8.55 -30.89 -33.52 9.40 -29.75 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR B 67 TYR^? 18.53 NI NI A 502 C 142 LEU A 98 LEU^? 23.32 NI NI A 501 C 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -43.01 20.87 -30.18 -41.71 19.20 -30.48 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR B 67 TYR^? 18.53 NI NI A 502 C 142 LEU A 110 LEU.? 24.15 NI NI A 502 C 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -42.15 23.45 -36.39 -41.58 21.98 -34.84 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 22 TYR~? 21.39 NI NI A 501 D 142 LEU A 20 LEU~? 13.99 NI NI A 502 D 165 LYS A 53 LYS.? 25.39 NI NI A 501 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -23.68 23.28 -16.79 -25.32 24.09 -17.98 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 67 TYR^? 18.49 NI NI A 501 D 142 LEU B 98 LEU^? 23.78 NI NI A 502 D 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -39.45 26.79 -17.30 -37.37 26.24 -17.07 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 67 TYR^? 18.49 NI NI A 501 D 142 LEU B 110 LEU.? 24.16 NI NI A 501 D 165 LYS B 123 LYS^? 13.38 NI NI A 501 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -41.54 24.43 -11.34 -40.43 25.53 -12.93 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 22 TYR~? 21.09 NI NI A 502 D 142 LEU B 20 LEU~? 13.47 NI NI A 501 D 165 LYS B 53 LYS.? 26.24 NI NI A 502 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -31.93 8.55 -30.89 -33.52 9.40 -29.75 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR B 67 TYR^? 18.53 NI NI A 502 D 142 LEU A 98 LEU^? 23.32 NI NI A 501 D 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -43.01 20.87 -30.18 -41.71 19.20 -30.48 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR B 67 TYR^? 18.53 NI NI A 502 D 142 LEU A 110 LEU.? 24.15 NI NI A 502 D 165 LYS A 123 LYS^? 12.92 NI NI A 502 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -42.15 23.45 -36.39 -41.58 21.98 -34.84 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 6 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG B 102 ARG.? 15.54 NI NI A 502 A 136 GLU A 86 GLU.? 9.00 NI NI A 502 A 246 GLU A 124 GLU.? 14.10 NI NI A 502 coo 13.48 30.30 107.06 11.75 30.99 109.44 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 9.46 32.37 115.82 8.50 34.20 115.47 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 11.99 34.33 109.92 10.08 34.19 110.77 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 1 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG B 102 ARG.? 15.54 NI NI A 502 A 136 GLU A 86 GLU.? 9.00 NI NI A 502 A 246 GLU A 124 GLU.? 14.10 NI NI A 502 coo 13.94 29.84 106.80 11.67 30.40 108.79 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 9.52 31.97 115.23 8.45 33.74 114.72 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 11.92 33.82 109.35 10.10 33.50 110.39 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 1 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 86 GLU.? 9.00 NI NI A 502 A 319 ASP A 88 ASP^? 14.52 NI NI A 501 A 359 ARG B 23 ARG~? 15.67 NI NI A 501 coo 14.41 12.40 16.42 12.92 13.74 15.71 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 12.25 13.04 23.85 11.56 15.02 23.93 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 10.89 14.95 28.28 12.39 12.53 29.31 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 86 GLU.? 9.00 NI NI A 502 A 319 ASP B 88 ASP^? 15.06 NI NI A 502 A 359 ARG A 23 ARG~? 15.85 NI NI A 502 coo 14.41 12.40 16.42 12.92 13.74 15.71 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 12.25 13.04 23.85 11.56 15.02 23.93 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 10.89 14.95 28.28 12.39 12.53 29.31 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU B 86 GLU.? 9.13 NI NI A 501 A 319 ASP A 88 ASP^? 14.52 NI NI A 501 A 359 ARG B 23 ARG~? 15.67 NI NI A 501 coo 14.41 12.40 16.42 12.92 13.74 15.71 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 12.25 13.04 23.85 11.56 15.02 23.93 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 10.89 14.95 28.28 12.39 12.53 29.31 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU B 124 GLU.? 12.68 NI NI A 501 A 319 ASP B 82 ASP~? 13.99 NI NI A 501 A 359 ARG A 101 ARG.? 18.18 NI NI A 501 coo 14.41 12.40 16.42 12.92 13.74 15.71 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 12.25 13.04 23.85 11.56 15.02 23.93 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 10.89 14.95 28.28 12.39 12.53 29.31 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 4 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 86 GLU.? 9.00 NI NI A 502 B 319 ASP B 88 ASP^? 15.06 NI NI A 502 B 359 ARG A 23 ARG~? 15.85 NI NI A 502 coo 10.77 13.13 40.94 11.03 14.73 39.51 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 3.77 12.64 38.21 3.35 14.53 37.39 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 124 GLU.? 14.10 NI NI A 502 B 319 ASP B 88 ASP^? 15.06 NI NI A 502 B 359 ARG A 23 ARG~? 15.85 NI NI A 502 coo 10.77 13.13 40.94 11.03 14.73 39.51 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 3.77 12.64 38.21 3.35 14.53 37.39 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU B 86 GLU.? 9.13 NI NI A 501 B 319 ASP A 88 ASP^? 14.52 NI NI A 501 B 359 ARG B 23 ARG~? 15.67 NI NI A 501 coo 10.77 13.13 40.94 11.03 14.73 39.51 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 3.77 12.64 38.21 3.35 14.53 37.39 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 124 GLU.? 12.68 NI NI A 501 B 319 ASP B 82 ASP~? 13.99 NI NI A 501 B 359 ARG A 101 ARG.? 18.18 NI NI A 501 coo 10.77 13.13 40.94 11.03 14.73 39.51 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 3.77 12.64 38.21 3.35 14.53 37.39 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 4 hits 1fr8_c01 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 23 ARG~? 15.85 NI NI A 502 A 201 HIS A 31 HIS~? -4.16 NI NI A 501s A 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 23 ARG~? 15.85 NI NI A 502 A 201 HIS B 126 HIS.? -4.79 NI NI A 501s A 204 HIS A 31 HIS~? -4.16 NI NI A 501s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG A 101 ARG.? 18.18 NI NI A 501 A 201 HIS B 127 HIS.? 5.53 NI NI A 501 A 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG B 17 ARG~? 8.61 NI NI A 501 A 201 HIS A 31 HIS~? -4.16 NI NI A 501s A 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG B 17 ARG~? 8.61 NI NI A 501 A 201 HIS B 127 HIS.? 5.53 NI NI A 501 A 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 6 3 # 6 A 197 ARG B 101 ARG.? 17.16 NI NI A 502 A 201 HIS A 126 HIS.? -3.75 NI NI A 502s A 204 HIS A 127 HIS.? 7.54 NI NI A 502 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 7 3 # 7 A 197 ARG B 102 ARG.? 15.54 NI NI A 502 A 201 HIS B 31 HIS~? -3.92 NI NI A 502s A 204 HIS A 126 HIS.? -3.75 NI NI A 502s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -22.12 24.45 -27.89 -21.28 22.78 -28.85 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 7 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 28 GLU~? 13.04 NI NI A 501 516 HIS B 126 HIS.? -4.79 NI NI A 501s 559 HIS A 31 HIS~? -4.16 NI NI A 501s coo 49.01 14.50 52.53 46.99 14.61 52.78 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 41.59 7.83 54.15 41.16 9.87 53.87 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 42.22 14.55 52.50 43.91 14.87 53.60 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 86 GLU.? 9.00 NI NI A 502 516 HIS A 127 HIS.? 7.54 NI NI A 502 559 HIS A 126 HIS.? -3.75 NI NI A 502s coo 49.01 14.50 52.53 46.99 14.61 52.78 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 41.59 7.83 54.15 41.16 9.87 53.87 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 42.22 14.55 52.50 43.91 14.87 53.60 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU A 86 GLU.? 9.00 NI NI A 502 516 HIS B 31 HIS~? -3.92 NI NI A 502s 559 HIS A 126 HIS.? -3.75 NI NI A 502s coo 49.01 14.50 52.53 46.99 14.61 52.78 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 41.59 7.83 54.15 41.16 9.87 53.87 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 42.22 14.55 52.50 43.91 14.87 53.60 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU B 28 GLU~? 10.98 NI NI A 502 516 HIS A 126 HIS.? -3.75 NI NI A 502s 559 HIS B 31 HIS~? -3.92 NI NI A 502s coo 49.01 14.50 52.53 46.99 14.61 52.78 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 41.59 7.83 54.15 41.16 9.87 53.87 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 42.22 14.55 52.50 43.91 14.87 53.60 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU B 86 GLU.? 9.13 NI NI A 501 516 HIS B 127 HIS.? 5.53 NI NI A 501 559 HIS A 31 HIS~? -4.16 NI NI A 501s coo 49.01 14.50 52.53 46.99 14.61 52.78 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 41.59 7.83 54.15 41.16 9.87 53.87 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 42.22 14.55 52.50 43.91 14.87 53.60 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU B 124 GLU.? 12.68 NI NI A 501 516 HIS B 127 HIS.? 5.53 NI NI A 501 559 HIS B 126 HIS.? -4.79 NI NI A 501s coo 49.01 14.50 52.53 46.99 14.61 52.78 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 41.59 7.83 54.15 41.16 9.87 53.87 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 42.22 14.55 52.50 43.91 14.87 53.60 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 6 hits 1gal_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 123 LYS^? 12.92 NI NI A 502 210 ARG A 101 ARG.? 18.18 NI NI A 501 225 ARG A 102 ARG.? 15.26 NI NI A 501 coo 17.51 28.50 73.42 17.24 23.02 75.86 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 24.74 11.56 73.05 25.29 14.32 71.80 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 27.81 15.44 77.10 25.66 16.50 75.19 -43.90 12.11 -18.64 -45.27 9.35 -19.00 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 123 LYS^? 12.92 NI NI A 502 210 ARG A 102 ARG.? 15.26 NI NI A 501 225 ARG A 101 ARG.? 18.18 NI NI A 501 coo 17.51 28.50 73.42 17.24 23.02 75.86 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 24.74 11.56 73.05 25.29 14.32 71.80 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 27.81 15.44 77.10 25.66 16.50 75.19 -45.57 11.90 -25.10 -47.16 9.28 -24.53 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 123 LYS^? 13.38 NI NI A 501 210 ARG B 101 ARG.? 17.16 NI NI A 502 225 ARG B 102 ARG.? 15.54 NI NI A 502 coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 24.74 11.56 73.05 25.29 14.32 71.80 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 27.81 15.44 77.10 25.66 16.50 75.19 -32.48 30.10 -28.35 -33.10 28.08 -26.10 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 123 LYS^? 13.38 NI NI A 501 210 ARG B 102 ARG.? 15.54 NI NI A 502 225 ARG B 101 ARG.? 17.16 NI NI A 502 coo 17.51 28.50 73.42 17.24 23.02 75.86 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 24.74 11.56 73.05 25.29 14.32 71.80 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 27.81 15.44 77.10 25.66 16.50 75.19 -33.01 33.14 -24.23 -30.56 34.78 -23.33 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 4 hits 1gsa_c00 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 18 SER~? 18.69 NI NI A 502 A 164 TYR A 22 TYR~? 21.39 NI NI A 501 A 168 LYS A 53 LYS.? 25.39 NI NI A 501 coo 32.37 52.40 49.35 31.32 53.88 47.74 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 29.69 55.04 42.83 31.98 53.56 43.49 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 26.96 50.99 47.03 31.03 48.83 44.33 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER B 18 SER~? 18.56 NI NI A 501 A 164 TYR B 22 TYR~? 21.09 NI NI A 502 A 168 LYS B 53 LYS.? 26.24 NI NI A 502 coo 32.37 52.40 49.35 31.32 53.88 47.74 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 29.69 55.04 42.83 31.98 53.56 43.49 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 26.96 50.99 47.03 31.03 48.83 44.33 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 18 SER~? 18.69 NI NI A 502 B 164 TYR A 22 TYR~? 21.39 NI NI A 501 B 168 LYS A 53 LYS.? 25.39 NI NI A 501 coo 13.08 50.93 56.67 13.12 48.99 55.27 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 11.52 46.03 51.32 10.06 47.90 52.76 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 15.72 50.86 51.22 10.77 52.35 51.39 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER B 18 SER~? 18.56 NI NI A 501 B 164 TYR B 22 TYR~? 21.09 NI NI A 502 B 168 LYS B 53 LYS.? 26.24 NI NI A 502 coo 13.08 50.93 56.67 13.12 48.99 55.27 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 11.52 46.03 51.32 10.06 47.90 52.76 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 15.72 50.86 51.22 10.77 52.35 51.39 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 18 SER~? 18.69 NI NI A 502 C 164 TYR A 22 TYR~? 21.39 NI NI A 501 C 168 LYS A 53 LYS.? 25.39 NI NI A 501 coo 11.22 34.38 82.32 11.07 36.29 83.78 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 8.83 39.27 87.38 7.60 37.43 85.69 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 12.98 34.46 88.14 8.11 32.96 87.14 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER B 18 SER~? 18.56 NI NI A 501 C 164 TYR B 22 TYR~? 21.09 NI NI A 502 C 168 LYS B 53 LYS.? 26.24 NI NI A 502 coo 11.22 34.38 82.32 11.07 36.29 83.78 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 8.83 39.27 87.38 7.60 37.43 85.69 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 12.98 34.46 88.14 8.11 32.96 87.14 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 18 SER~? 18.69 NI NI A 502 D 164 TYR A 22 TYR~? 21.39 NI NI A 501 D 168 LYS A 53 LYS.? 25.39 NI NI A 501 coo 29.15 32.90 92.57 27.86 31.44 94.02 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 25.49 30.28 98.59 27.88 31.73 98.26 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 23.46 34.31 94.02 27.08 36.46 97.29 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER B 18 SER~? 18.56 NI NI A 501 D 164 TYR B 22 TYR~? 21.09 NI NI A 502 D 168 LYS B 53 LYS.? 26.24 NI NI A 502 coo 29.15 32.90 92.57 27.86 31.44 94.02 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 25.49 30.28 98.59 27.88 31.73 98.26 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 23.46 34.31 94.02 27.08 36.46 97.29 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c03 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS B 123 LYS^? 13.38 NI NI A 501 B 107 HIS B 126 HIS.? -4.79 NI NI A 501s B 137 SER A 66 SER^? 13.16 NI NI A 501 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -32.58 17.24 -12.10 -30.98 15.55 -12.25 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 1 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 12 VAL~? 18.87 NI NI A 502 A 200 ASP A 82 ASP~? 15.20 NI NI A 502 A 226 LYS B 123 LYS^? 13.38 NI NI A 501 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.83 34.91 -14.90 -22.53 36.25 -15.06 coo 24.51 43.28 11.18 25.17 44.50 9.58 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 34.47 51.09 7.19 28.58 51.18 7.53 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL B 12 VAL~? 18.35 NI NI A 501 A 200 ASP B 82 ASP~? 13.99 NI NI A 501 A 226 LYS A 123 LYS^? 12.92 NI NI A 502 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -40.60 0.69 -33.04 -42.72 1.13 -32.51 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 34.47 51.09 7.19 28.58 51.18 7.53 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1i29_c03 source 1i29 CSDB : 2 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 87 SER.? 14.75 NI NI A 502 A 173 ARG B 101 ARG.? 17.16 NI NI A 502 A 211 ASP A 88 ASP^? 14.52 NI NI A 501 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 18.77 77.82 11.69 20.55 80.22 10.73 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 87 SER.? 15.38 NI NI A 501 A 173 ARG A 101 ARG.? 18.18 NI NI A 501 A 211 ASP B 88 ASP^? 15.06 NI NI A 502 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 18.77 77.82 11.69 20.55 80.22 10.73 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -31.42 19.31 -21.85 -30.03 20.81 -21.11 1ig8_c00 source 1ig8 HEXOKINASE PII : 2 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 82 ASP~? 15.20 NI NI A 502 158 THR A 85 THR~? 12.80 NI NI A 502 317 ASP A 13 ASP~? 13.27 NI NI A 502 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 82 ASP~? 15.20 NI NI A 502 158 THR B 100 THR.? 19.64 NI NI A 502 317 ASP A 88 ASP^? 14.52 NI NI A 501 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 88 ASP^? 14.52 NI NI A 501 158 THR B 65 THR^? 14.18 NI NI A 502 317 ASP A 82 ASP~? 15.20 NI NI A 502 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -30.21 23.51 -34.34 -32.04 24.61 -34.02 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 82 ASP~? 13.99 NI NI A 501 158 THR B 85 THR.? 12.36 NI NI A 501 317 ASP B 13 ASP~? 14.49 NI NI A 501 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP B 88 ASP^? 15.06 NI NI A 502 158 THR A 65 THR.? 13.82 NI NI A 501 317 ASP B 82 ASP~? 13.99 NI NI A 501 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -35.39 14.99 -13.24 -37.04 15.69 -14.45 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 5 hits 1inp_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 28 GLU~? 13.04 NI NI A 501 A 61 GLU B 124 GLU.? 12.68 NI NI A 501 A 162 HIS A 31 HIS~? -4.16 NI NI A 501s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 28 GLU~? 10.98 NI NI A 502 A 61 GLU A 124 GLU.? 14.10 NI NI A 502 A 162 HIS B 31 HIS~? -3.92 NI NI A 502s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 124 GLU.? 12.68 NI NI A 501 A 61 GLU A 28 GLU~? 13.04 NI NI A 501 A 162 HIS B 126 HIS.? -4.79 NI NI A 501s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 3 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 101 ARG.? 18.18 NI NI A 501 A 201 HIS B 127 HIS.? 5.53 NI NI A 501 A 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG B 17 ARG~? 8.61 NI NI A 501 A 201 HIS B 127 HIS.? 5.53 NI NI A 501 A 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG B 101 ARG.? 17.16 NI NI A 502 A 201 HIS A 126 HIS.? -3.75 NI NI A 502s A 204 HIS A 127 HIS.? 7.54 NI NI A 502 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG B 102 ARG.? 15.54 NI NI A 502 A 201 HIS B 31 HIS~? -3.92 NI NI A 502s A 204 HIS A 126 HIS.? -3.75 NI NI A 502s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -22.12 24.45 -27.89 -21.28 22.78 -28.85 1j70_c00 source 1j70 ATP SULPHURYLASE : 4 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 101 ARG.? 18.18 NI NI A 501 B 201 HIS B 127 HIS.? 5.53 NI NI A 501 B 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG B 17 ARG~? 8.61 NI NI A 501 B 201 HIS B 127 HIS.? 5.53 NI NI A 501 B 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG B 23 ARG~? 15.67 NI NI A 501 B 201 HIS A 126 HIS.? -3.75 NI NI A 502s B 204 HIS B 31 HIS~? -3.92 NI NI A 502s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG B 101 ARG.? 17.16 NI NI A 502 B 201 HIS A 126 HIS.? -3.75 NI NI A 502s B 204 HIS A 127 HIS.? 7.54 NI NI A 502 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG B 101 ARG.? 17.16 NI NI A 502 B 201 HIS A 127 HIS.? 7.54 NI NI A 502 B 204 HIS A 126 HIS.? -3.75 NI NI A 502s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG B 102 ARG.? 15.54 NI NI A 502 B 201 HIS B 31 HIS~? -3.92 NI NI A 502s B 204 HIS A 126 HIS.? -3.75 NI NI A 502s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -22.12 24.45 -27.89 -21.28 22.78 -28.85 1j70_c01 source 1j70 ATP SULPHURYLASE : 6 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 101 ARG.? 18.18 NI NI A 501 C 201 HIS B 127 HIS.? 5.53 NI NI A 501 C 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo 30.92 14.23 15.70 28.82 13.90 13.48 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 20.16 5.55 18.86 20.00 7.59 19.34 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 24.92 3.29 16.90 24.41 4.92 15.69 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG B 17 ARG~? 8.61 NI NI A 501 C 201 HIS B 127 HIS.? 5.53 NI NI A 501 C 204 HIS B 126 HIS.? -4.79 NI NI A 501s coo 30.92 14.23 15.70 28.82 13.90 13.48 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 20.16 5.55 18.86 20.00 7.59 19.34 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 24.92 3.29 16.90 24.41 4.92 15.69 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG B 101 ARG.? 17.16 NI NI A 502 C 201 HIS A 126 HIS.? -3.75 NI NI A 502s C 204 HIS A 127 HIS.? 7.54 NI NI A 502 coo 30.92 14.23 15.70 28.82 13.90 13.48 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 20.16 5.55 18.86 20.00 7.59 19.34 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 24.92 3.29 16.90 24.41 4.92 15.69 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG B 101 ARG.? 17.16 NI NI A 502 C 201 HIS A 127 HIS.? 7.54 NI NI A 502 C 204 HIS A 126 HIS.? -3.75 NI NI A 502s coo 30.92 14.23 15.70 28.82 13.90 13.48 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 20.16 5.55 18.86 20.00 7.59 19.34 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 24.92 3.29 16.90 24.41 4.92 15.69 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG B 102 ARG.? 15.54 NI NI A 502 C 201 HIS B 31 HIS~? -3.92 NI NI A 502s C 204 HIS A 126 HIS.? -3.75 NI NI A 502s coo 30.92 14.23 15.70 28.82 13.90 13.48 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 20.16 5.55 18.86 20.00 7.59 19.34 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 24.92 3.29 16.90 24.41 4.92 15.69 -22.12 24.45 -27.89 -21.28 22.78 -28.85 1j70_c02 source 1j70 ATP SULPHURYLASE : 5 hits 1j70_c02 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 88 ASP^? 14.52 NI NI A 501 A 58 ASP B 88 ASP^? 15.06 NI NI A 502 A 424 GLU A 86 GLU.? 9.00 NI NI A 502 coo 58.42 47.76 20.67 58.01 49.10 19.12 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 58.59 41.80 18.81 58.94 43.89 18.94 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 52.85 46.34 13.34 54.09 44.97 14.42 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 88 ASP^? 14.52 NI NI A 501 A 58 ASP B 88 ASP^? 15.06 NI NI A 502 A 424 GLU A 124 GLU.? 14.10 NI NI A 502 coo 58.42 47.76 20.67 58.01 49.10 19.12 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 58.59 41.80 18.81 58.94 43.89 18.94 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 52.85 46.34 13.34 54.09 44.97 14.42 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP A 88 ASP^? 14.52 NI NI A 501 A 58 ASP B 88 ASP^? 15.06 NI NI A 502 A 424 GLU B 86 GLU.? 9.13 NI NI A 501 coo 58.42 47.76 20.67 58.01 49.10 19.12 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 58.59 41.80 18.81 58.94 43.89 18.94 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 52.85 46.34 13.34 54.09 44.97 14.42 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP A 88 ASP^? 14.52 NI NI A 501 A 58 ASP B 88 ASP^? 15.06 NI NI A 502 A 424 GLU B 124 GLU.? 12.68 NI NI A 501 coo 58.42 47.76 20.67 58.01 49.10 19.12 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 58.59 41.80 18.81 58.94 43.89 18.94 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 52.85 46.34 13.34 54.09 44.97 14.42 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 88 ASP^? 15.06 NI NI A 502 A 58 ASP A 88 ASP^? 14.52 NI NI A 501 A 424 GLU A 86 GLU.? 9.00 NI NI A 502 coo 58.42 47.76 20.67 58.01 49.10 19.12 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 58.59 41.80 18.81 58.94 43.89 18.94 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.85 46.34 13.34 54.09 44.97 14.42 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 88 ASP^? 15.06 NI NI A 502 A 58 ASP A 88 ASP^? 14.52 NI NI A 501 A 424 GLU A 124 GLU.? 14.10 NI NI A 502 coo 58.42 47.76 20.67 58.01 49.10 19.12 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 58.59 41.80 18.81 58.94 43.89 18.94 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.85 46.34 13.34 54.09 44.97 14.42 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP B 88 ASP^? 15.06 NI NI A 502 A 58 ASP A 88 ASP^? 14.52 NI NI A 501 A 424 GLU B 86 GLU.? 9.13 NI NI A 501 coo 58.42 47.76 20.67 58.01 49.10 19.12 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 58.59 41.80 18.81 58.94 43.89 18.94 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.85 46.34 13.34 54.09 44.97 14.42 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP B 88 ASP^? 15.06 NI NI A 502 A 58 ASP A 88 ASP^? 14.52 NI NI A 501 A 424 GLU B 124 GLU.? 12.68 NI NI A 501 coo 58.42 47.76 20.67 58.01 49.10 19.12 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 58.59 41.80 18.81 58.94 43.89 18.94 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.85 46.34 13.34 54.09 44.97 14.42 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 8 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 88 ASP^? 14.52 NI NI A 501 B 58 ASP B 88 ASP^? 15.06 NI NI A 502 B 424 GLU A 86 GLU.? 9.00 NI NI A 502 coo 112.10 61.46 19.99 111.82 60.65 18.07 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 117.85 63.62 21.08 115.96 63.25 20.18 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 118.47 57.23 15.57 119.32 58.77 16.73 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 88 ASP^? 14.52 NI NI A 501 B 58 ASP B 88 ASP^? 15.06 NI NI A 502 B 424 GLU A 124 GLU.? 14.10 NI NI A 502 coo 112.10 61.46 19.99 111.82 60.65 18.07 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 117.85 63.62 21.08 115.96 63.25 20.18 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 118.47 57.23 15.57 119.32 58.77 16.73 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP A 88 ASP^? 14.52 NI NI A 501 B 58 ASP B 88 ASP^? 15.06 NI NI A 502 B 424 GLU B 86 GLU.? 9.13 NI NI A 501 coo 112.10 61.46 19.99 111.82 60.65 18.07 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 117.85 63.62 21.08 115.96 63.25 20.18 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 118.47 57.23 15.57 119.32 58.77 16.73 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP A 88 ASP^? 14.52 NI NI A 501 B 58 ASP B 88 ASP^? 15.06 NI NI A 502 B 424 GLU B 124 GLU.? 12.68 NI NI A 501 coo 112.10 61.46 19.99 111.82 60.65 18.07 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 117.85 63.62 21.08 115.96 63.25 20.18 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 118.47 57.23 15.57 119.32 58.77 16.73 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP B 88 ASP^? 15.06 NI NI A 502 B 58 ASP A 88 ASP^? 14.52 NI NI A 501 B 424 GLU A 86 GLU.? 9.00 NI NI A 502 coo 112.10 61.46 19.99 111.82 60.65 18.07 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 117.85 63.62 21.08 115.96 63.25 20.18 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 118.47 57.23 15.57 119.32 58.77 16.73 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP B 88 ASP^? 15.06 NI NI A 502 B 58 ASP A 88 ASP^? 14.52 NI NI A 501 B 424 GLU A 124 GLU.? 14.10 NI NI A 502 coo 112.10 61.46 19.99 111.82 60.65 18.07 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 117.85 63.62 21.08 115.96 63.25 20.18 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 118.47 57.23 15.57 119.32 58.77 16.73 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP B 88 ASP^? 15.06 NI NI A 502 B 58 ASP A 88 ASP^? 14.52 NI NI A 501 B 424 GLU B 86 GLU.? 9.13 NI NI A 501 coo 112.10 61.46 19.99 111.82 60.65 18.07 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 117.85 63.62 21.08 115.96 63.25 20.18 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 118.47 57.23 15.57 119.32 58.77 16.73 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP B 88 ASP^? 15.06 NI NI A 502 B 58 ASP A 88 ASP^? 14.52 NI NI A 501 B 424 GLU B 124 GLU.? 12.68 NI NI A 501 coo 112.10 61.46 19.99 111.82 60.65 18.07 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 117.85 63.62 21.08 115.96 63.25 20.18 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 118.47 57.23 15.57 119.32 58.77 16.73 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 8 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 86 GLU.? 9.00 NI NI A 502 A 56 LYS A 123 LYS^? 12.92 NI NI A 502 A 258 ARG A 23 ARG~? 15.85 NI NI A 502 coo 42.33 1.56 26.99 42.38 2.91 28.66 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 86 GLU.? 9.13 NI NI A 501 A 56 LYS B 123 LYS^? 13.38 NI NI A 501 A 258 ARG B 23 ARG~? 15.67 NI NI A 501 coo 42.33 1.56 26.99 42.38 2.91 28.66 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 86 GLU.? 9.00 NI NI A 502 B 56 LYS A 123 LYS^? 12.92 NI NI A 502 B 258 ARG A 23 ARG~? 15.85 NI NI A 502 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 2.64 1.83 34.81 1.56 1.13 32.02 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 86 GLU.? 9.13 NI NI A 501 B 56 LYS B 123 LYS^? 13.38 NI NI A 501 B 258 ARG B 23 ARG~? 15.67 NI NI A 501 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 2.64 1.83 34.81 1.56 1.13 32.02 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 86 GLU.? 9.00 NI NI A 502 C 56 LYS A 123 LYS^? 12.92 NI NI A 502 C 258 ARG A 23 ARG~? 15.85 NI NI A 502 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 86 GLU.? 9.13 NI NI A 501 C 56 LYS B 123 LYS^? 13.38 NI NI A 501 C 258 ARG B 23 ARG~? 15.67 NI NI A 501 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 86 GLU.? 9.00 NI NI A 502 D 56 LYS A 123 LYS^? 12.92 NI NI A 502 D 258 ARG A 23 ARG~? 15.85 NI NI A 502 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 86 GLU.? 9.13 NI NI A 501 D 56 LYS B 123 LYS^? 13.38 NI NI A 501 D 258 ARG B 23 ARG~? 15.67 NI NI A 501 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 116 GLU.? 34.96 NI NI A 501 A 163 ARG A 93 ARG^? 27.22 NI NI A 502 A 222 ARG A 94 ARG.? 33.91 NI NI A 501 coo 51.27 81.34 48.31 51.67 80.79 50.28 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 48.06 78.22 50.94 48.51 78.27 53.98 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 54.85 84.16 52.60 54.26 81.23 53.34 -52.83 19.63 -33.61 -55.45 21.14 -33.98 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 116 GLU.? 34.96 NI NI A 501 A 163 ARG A 94 ARG.? 33.91 NI NI A 501 A 222 ARG A 93 ARG^? 27.22 NI NI A 502 coo 51.27 81.34 48.31 51.67 80.79 50.28 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 48.06 78.22 50.94 48.51 78.27 53.98 -52.83 19.63 -33.61 -55.45 21.14 -33.98 coo 54.85 84.16 52.60 54.26 81.23 53.34 -45.46 21.14 -37.27 -43.99 23.01 -39.26 1kim_c00 source 1kim THYMIDINE KINASE : 2 hits 1kim_c00 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 88 ASP^? 14.52 NI NI A 501 262 LYS B 123 LYS^? 13.38 NI NI A 501 336 ARG A 101 ARG.? 18.18 NI NI A 501 coo 61.88 50.78 12.96 63.84 50.60 13.71 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 63.59 44.40 18.32 63.20 49.74 17.95 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 72.60 57.42 15.86 71.61 56.68 18.70 -45.57 11.90 -25.10 -47.16 9.28 -24.53 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 88 ASP^? 14.52 NI NI A 501 262 LYS B 123 LYS^? 13.38 NI NI A 501 336 ARG B 102 ARG.? 15.54 NI NI A 502 coo 61.88 50.78 12.96 63.84 50.60 13.71 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 63.59 44.40 18.32 63.20 49.74 17.95 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 72.60 57.42 15.86 71.61 56.68 18.70 -32.48 30.10 -28.35 -33.10 28.08 -26.10 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 42 ASP.? 24.38 NI NI A 502 262 LYS B 53 LYS.? 26.24 NI NI A 502 336 ARG B 23 ARG~? 15.67 NI NI A 501 coo 61.88 50.78 12.96 63.84 50.60 13.71 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 63.59 44.40 18.32 63.20 49.74 17.95 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo 72.60 57.42 15.86 71.61 56.68 18.70 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 88 ASP^? 15.06 NI NI A 502 262 LYS A 123 LYS^? 12.92 NI NI A 502 336 ARG B 101 ARG.? 17.16 NI NI A 502 coo 61.88 50.78 12.96 63.84 50.60 13.71 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 63.59 44.40 18.32 63.20 49.74 17.95 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 -33.01 33.14 -24.23 -30.56 34.78 -23.33 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 4 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 23 ARG~? 15.85 NI NI A 502 245 HIS A 126 HIS.? -3.75 NI NI A 502s 343 THR A 83 THR~? 11.66 NI NI A 502 coo 18.11 85.25 41.19 18.04 83.33 43.59 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 5.34 86.23 43.48 6.16 87.26 45.12 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 9.06 92.76 42.80 7.04 92.63 42.14 -25.75 29.45 -24.12 -25.45 31.51 -23.71 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 101 ARG.? 18.18 NI NI A 501 245 HIS B 126 HIS.? -4.79 NI NI A 501s 343 THR B 85 THR.? 12.36 NI NI A 501 coo 18.11 85.25 41.19 18.04 83.33 43.59 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 5.34 86.23 43.48 6.16 87.26 45.12 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 9.06 92.76 42.80 7.04 92.63 42.14 -33.81 10.96 -25.09 -35.41 11.74 -26.39 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG B 17 ARG~? 8.61 NI NI A 501 245 HIS B 126 HIS.? -4.79 NI NI A 501s 343 THR B 83 THR~? 9.81 NI NI A 501 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 5.34 86.23 43.48 6.16 87.26 45.12 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 9.06 92.76 42.80 7.04 92.63 42.14 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 17 ARG~? 8.61 NI NI A 501 245 HIS B 126 HIS.? -4.79 NI NI A 501s 343 THR B 85 THR.? 12.36 NI NI A 501 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 5.34 86.23 43.48 6.16 87.26 45.12 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 9.06 92.76 42.80 7.04 92.63 42.14 -33.81 10.96 -25.09 -35.41 11.74 -26.39 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG B 17 ARG~? 8.61 NI NI A 501 245 HIS B 127 HIS.? 5.53 NI NI A 501 343 THR B 83 THR~? 9.81 NI NI A 501 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 5.34 86.23 43.48 6.16 87.26 45.12 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 9.06 92.76 42.80 7.04 92.63 42.14 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG B 23 ARG~? 15.67 NI NI A 501 245 HIS B 126 HIS.? -4.79 NI NI A 501s 343 THR B 83 THR~? 9.81 NI NI A 501 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 5.34 86.23 43.48 6.16 87.26 45.12 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 9.06 92.76 42.80 7.04 92.63 42.14 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 3 1lci_c00 LUCIFERASE user 7 3 # 7 218 ARG B 101 ARG.? 17.16 NI NI A 502 245 HIS A 126 HIS.? -3.75 NI NI A 502s 343 THR A 85 THR~? 12.80 NI NI A 502 coo 18.11 85.25 41.19 18.04 83.33 43.59 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 5.34 86.23 43.48 6.16 87.26 45.12 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 9.06 92.76 42.80 7.04 92.63 42.14 -26.43 24.20 -22.83 -27.87 24.69 -21.30 ULMN 3 1lci_c00 LUCIFERASE user 8 3 # 8 218 ARG B 102 ARG.? 15.54 NI NI A 502 245 HIS A 126 HIS.? -3.75 NI NI A 502s 343 THR A 85 THR~? 12.80 NI NI A 502 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 5.34 86.23 43.48 6.16 87.26 45.12 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 9.06 92.76 42.80 7.04 92.63 42.14 -26.43 24.20 -22.83 -27.87 24.69 -21.30 1lci_c00 source 1lci LUCIFERASE : 8 hits 1lci_c00 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 31 HIS~? -4.16 NI NI A 501s A 45 HIS B 127 HIS.? 5.53 NI NI A 501 A 261 PHE A 36 PHE.? 17.17 NI NI A 501 coo 49.89 1.93 30.83 50.54 1.43 32.81 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -33.77 10.70 -3.73 -32.61 12.88 -2.30 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS B 127 HIS.? 5.53 NI NI A 501 A 45 HIS A 31 HIS~? -4.16 NI NI A 501s A 261 PHE A 36 PHE.? 17.17 NI NI A 501 coo 49.89 1.93 30.83 50.54 1.43 32.81 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -33.77 10.70 -3.73 -32.61 12.88 -2.30 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 2 hits 1luc_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS B 126 HIS.? -4.79 NI NI A 501s B 246 HIS A 31 HIS~? -4.16 NI NI A 501s B 255 TYR A 29 TYR~? 15.38 NI NI A 501 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS B 127 HIS.? 5.53 NI NI A 501 B 246 HIS A 31 HIS~? -4.16 NI NI A 501s B 255 TYR A 29 TYR~? 15.38 NI NI A 501 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -27.09 11.47 -6.47 -27.56 10.92 -3.78 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 2 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS B 126 HIS.? -4.79 NI NI A 501s C 246 HIS A 31 HIS~? -4.16 NI NI A 501s C 255 TYR A 29 TYR~? 15.38 NI NI A 501 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS B 127 HIS.? 5.53 NI NI A 501 C 246 HIS A 31 HIS~? -4.16 NI NI A 501s C 255 TYR A 29 TYR~? 15.38 NI NI A 501 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -27.09 11.47 -6.47 -27.56 10.92 -3.78 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 2 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS B 126 HIS.? -4.79 NI NI A 501s D 246 HIS A 31 HIS~? -4.16 NI NI A 501s D 255 TYR A 29 TYR~? 15.38 NI NI A 501 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS B 127 HIS.? 5.53 NI NI A 501 D 246 HIS A 31 HIS~? -4.16 NI NI A 501s D 255 TYR A 29 TYR~? 15.38 NI NI A 501 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -27.09 11.47 -6.47 -27.56 10.92 -3.78 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 2 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 91 GLY^? 20.30 NI NI A 501 A 501 ASP B 42 ASP.? 24.38 NI NI A 502 B 367 TYR A 22 TYR~? 21.39 NI NI A 501 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -42.92 15.52 -29.58 -42.49 15.51 -30.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 117 GLY.? 28.74 NI NI A 502 A 501 ASP A 42 ASP.? 24.20 NI NI A 501 B 367 TYR B 67 TYR^? 18.53 NI NI A 502 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.36 34.22 -10.59 -37.25 33.52 -10.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -35.67 20.34 -36.33 -35.75 23.11 -35.83 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 2 hits 1mro_c00 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 126 HIS.? -3.75 NI NI A 502s A 290 LYS A 123 LYS^? 12.92 NI NI A 502 A 405 ARG B 102 ARG.? 15.54 NI NI A 502 coo 41.33 25.99 28.05 41.95 26.95 29.80 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 37.11 33.75 31.82 38.72 27.95 29.90 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 42.28 27.98 41.30 43.16 28.14 38.35 -32.48 30.10 -28.35 -33.10 28.08 -26.10 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 1 hits 1nhx_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 24 SER~? 14.80 NI NI A 501 A 154 ASP A 42 ASP.? 24.20 NI NI A 501 A 261 ARG A 25 ARG~? 18.03 NI NI A 501 coo 16.10 74.10 3.11 17.18 73.52 5.20 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 16.07 84.71 8.14 15.20 82.81 8.14 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 10.59 77.85 4.81 13.09 76.36 5.76 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER B 24 SER~? 15.42 NI NI A 502 A 154 ASP B 42 ASP.? 24.38 NI NI A 502 A 261 ARG B 25 ARG~? 17.38 NI NI A 502 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 16.07 84.71 8.14 15.20 82.81 8.14 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 10.59 77.85 4.81 13.09 76.36 5.76 -23.60 10.54 -37.24 -21.22 8.75 -36.58 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 2 hits 1o98_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 16 ALA~? 14.70 NI NI A 502 A 126 LEU A 15 LEU~? 20.52 NI NI A 502 A 158 GLU A 11 GLU.? 16.09 NI NI A 502 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -22.94 29.19 -15.51 -23.04 29.75 -16.99 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -21.59 31.90 -12.06 -22.96 31.73 -10.25 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 10 ALA.? 19.85 NI NI A 501 A 126 LEU B 9 LEU.? 19.19 NI NI A 501 A 158 GLU B 8 GLU.? 22.17 NI NI A 501 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -43.38 -3.73 -31.16 -44.23 -2.54 -31.55 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -43.64 -6.87 -27.88 -42.11 -8.47 -28.23 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA B 10 ALA.? 19.85 NI NI A 501 B 126 LEU B 9 LEU.? 19.19 NI NI A 501 B 158 GLU B 8 GLU.? 22.17 NI NI A 501 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -43.38 -3.73 -31.16 -44.23 -2.54 -31.55 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -43.64 -6.87 -27.88 -42.11 -8.47 -28.23 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 1 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 16 ALA~? 14.70 NI NI A 502 C 126 LEU A 15 LEU~? 20.52 NI NI A 502 C 158 GLU A 11 GLU.? 16.09 NI NI A 502 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -22.94 29.19 -15.51 -23.04 29.75 -16.99 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -21.59 31.90 -12.06 -22.96 31.73 -10.25 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 10 ALA.? 19.85 NI NI A 501 C 126 LEU B 9 LEU.? 19.19 NI NI A 501 C 158 GLU B 8 GLU.? 22.17 NI NI A 501 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -43.38 -3.73 -31.16 -44.23 -2.54 -31.55 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -43.64 -6.87 -27.88 -42.11 -8.47 -28.23 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 45 LEU.? 18.52 NI NI A 501 A 58 ASP A 42 ASP.? 24.20 NI NI A 501 A 120 LYS A 53 LYS.? 25.39 NI NI A 501 coo 34.02 69.29 75.26 34.82 67.82 76.74 -22.96 15.22 -5.37 -24.96 15.74 -5.90 coo 34.46 72.45 78.57 32.82 72.75 77.28 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 28.96 77.64 81.19 29.05 74.53 77.51 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 89 LEU^? 19.60 NI NI A 501 A 58 ASP A 88 ASP^? 14.52 NI NI A 501 A 120 LYS B 123 LYS^? 13.38 NI NI A 501 coo 34.02 69.29 75.26 34.82 67.82 76.74 -37.86 19.08 -27.07 -37.89 20.89 -26.15 coo 34.46 72.45 78.57 32.82 72.75 77.28 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 28.96 77.64 81.19 29.05 74.53 77.51 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU B 45 LEU.? 18.70 NI NI A 502 A 58 ASP B 42 ASP.? 24.38 NI NI A 502 A 120 LYS B 53 LYS.? 26.24 NI NI A 502 coo 34.02 69.29 75.26 34.82 67.82 76.74 -25.05 12.30 -42.06 -26.93 13.28 -42.67 coo 34.46 72.45 78.57 32.82 72.75 77.28 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 28.96 77.64 81.19 29.05 74.53 77.51 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU B 89 LEU^? 19.86 NI NI A 501 A 58 ASP B 88 ASP^? 15.06 NI NI A 502 A 120 LYS A 123 LYS^? 12.92 NI NI A 502 coo 34.02 69.29 75.26 34.82 67.82 76.74 -35.58 23.22 -20.64 -37.07 22.05 -21.66 coo 34.46 72.45 78.57 32.82 72.75 77.28 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 28.96 77.64 81.19 29.05 74.53 77.51 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 4 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 45 LEU.? 18.52 NI NI A 501 B 58 ASP A 42 ASP.? 24.20 NI NI A 501 B 120 LYS A 53 LYS.? 25.39 NI NI A 501 coo 54.50 104.32 58.69 55.83 105.69 59.81 -22.96 15.22 -5.37 -24.96 15.74 -5.90 coo 57.63 101.19 59.83 56.60 100.89 57.99 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 61.58 95.88 55.22 58.18 99.30 54.71 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 89 LEU^? 19.60 NI NI A 501 B 58 ASP A 88 ASP^? 14.52 NI NI A 501 B 120 LYS B 123 LYS^? 13.38 NI NI A 501 coo 54.50 104.32 58.69 55.83 105.69 59.81 -37.86 19.08 -27.07 -37.89 20.89 -26.15 coo 57.63 101.19 59.83 56.60 100.89 57.99 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 61.58 95.88 55.22 58.18 99.30 54.71 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU B 45 LEU.? 18.70 NI NI A 502 B 58 ASP B 42 ASP.? 24.38 NI NI A 502 B 120 LYS B 53 LYS.? 26.24 NI NI A 502 coo 54.50 104.32 58.69 55.83 105.69 59.81 -25.05 12.30 -42.06 -26.93 13.28 -42.67 coo 57.63 101.19 59.83 56.60 100.89 57.99 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 61.58 95.88 55.22 58.18 99.30 54.71 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU B 89 LEU^? 19.86 NI NI A 501 B 58 ASP B 88 ASP^? 15.06 NI NI A 502 B 120 LYS A 123 LYS^? 12.92 NI NI A 502 coo 54.50 104.32 58.69 55.83 105.69 59.81 -35.58 23.22 -20.64 -37.07 22.05 -21.66 coo 57.63 101.19 59.83 56.60 100.89 57.99 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 61.58 95.88 55.22 58.18 99.30 54.71 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 4 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 13 ASP~? 13.27 NI NI A 502 A 68 ALA A 16 ALA~? 14.70 NI NI A 502 A 72 LEU A 15 LEU~? 20.52 NI NI A 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 48.88 4.35 16.59 48.73 5.09 15.20 -22.94 29.19 -15.51 -23.04 29.75 -16.99 coo 53.89 6.25 15.09 52.88 7.92 14.14 -21.59 31.90 -12.06 -22.96 31.73 -10.25 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 13 ASP~? 13.27 NI NI A 502 A 68 ALA A 16 ALA~? 14.70 NI NI A 502 A 72 LEU A 77 LEU~? 20.03 NI NI A 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 48.88 4.35 16.59 48.73 5.09 15.20 -22.94 29.19 -15.51 -23.04 29.75 -16.99 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.88 34.03 -14.42 -26.39 32.32 -13.23 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 13 ASP~? 13.27 NI NI A 502 A 68 ALA A 80 ALA~? 15.06 NI NI A 502 A 72 LEU A 77 LEU~? 20.03 NI NI A 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 48.88 4.35 16.59 48.73 5.09 15.20 -24.77 32.46 -19.75 -23.88 32.85 -18.61 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.88 34.03 -14.42 -26.39 32.32 -13.23 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 82 ASP~? 15.20 NI NI A 502 A 68 ALA A 78 ALA~? 20.01 NI NI A 502 A 72 LEU A 77 LEU~? 20.03 NI NI A 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 48.88 4.35 16.59 48.73 5.09 15.20 -29.95 33.40 -17.76 -31.14 34.31 -17.94 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.88 34.03 -14.42 -26.39 32.32 -13.23 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP A 82 ASP~? 15.20 NI NI A 502 A 68 ALA A 79 ALA~? 16.59 NI NI A 502 A 72 LEU A 77 LEU~? 20.03 NI NI A 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 48.88 4.35 16.59 48.73 5.09 15.20 -28.00 34.07 -20.93 -27.53 35.45 -21.31 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.88 34.03 -14.42 -26.39 32.32 -13.23 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP A 82 ASP~? 15.20 NI NI A 502 A 68 ALA A 80 ALA~? 15.06 NI NI A 502 A 72 LEU A 77 LEU~? 20.03 NI NI A 502 coo 46.76 7.59 18.65 45.27 6.01 18.52 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 48.88 4.35 16.59 48.73 5.09 15.20 -24.77 32.46 -19.75 -23.88 32.85 -18.61 coo 53.89 6.25 15.09 52.88 7.92 14.14 -26.88 34.03 -14.42 -26.39 32.32 -13.23 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP B 13 ASP~? 14.49 NI NI A 501 A 68 ALA B 16 ALA~? 14.52 NI NI A 501 A 72 LEU B 15 LEU~? 20.01 NI NI A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 48.88 4.35 16.59 48.73 5.09 15.20 -36.81 5.30 -32.32 -37.54 5.16 -30.96 coo 53.89 6.25 15.09 52.88 7.92 14.14 -38.35 2.65 -35.68 -38.89 3.74 -37.46 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP B 13 ASP~? 14.49 NI NI A 501 A 68 ALA B 16 ALA~? 14.52 NI NI A 501 A 72 LEU B 77 LEU~? 19.46 NI NI A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 48.88 4.35 16.59 48.73 5.09 15.20 -36.81 5.30 -32.32 -37.54 5.16 -30.96 coo 53.89 6.25 15.09 52.88 7.92 14.14 -43.13 6.21 -33.11 -41.36 6.93 -34.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP B 13 ASP~? 14.49 NI NI A 501 A 68 ALA B 80 ALA~? 14.09 NI NI A 501 A 72 LEU B 77 LEU~? 19.46 NI NI A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 48.88 4.35 16.59 48.73 5.09 15.20 -40.53 5.12 -27.34 -40.58 4.10 -28.46 coo 53.89 6.25 15.09 52.88 7.92 14.14 -43.13 6.21 -33.11 -41.36 6.93 -34.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP B 82 ASP~? 13.99 NI NI A 501 A 68 ALA B 78 ALA~? 18.91 NI NI A 501 A 72 LEU B 77 LEU~? 19.46 NI NI A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 48.88 4.35 16.59 48.73 5.09 15.20 -43.38 9.26 -29.77 -44.67 10.03 -29.61 coo 53.89 6.25 15.09 52.88 7.92 14.14 -43.13 6.21 -33.11 -41.36 6.93 -34.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP B 82 ASP~? 13.99 NI NI A 501 A 68 ALA B 79 ALA~? 15.69 NI NI A 501 A 72 LEU B 77 LEU~? 19.46 NI NI A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 48.88 4.35 16.59 48.73 5.09 15.20 -43.34 7.54 -26.46 -44.33 6.51 -26.01 coo 53.89 6.25 15.09 52.88 7.92 14.14 -43.13 6.21 -33.11 -41.36 6.93 -34.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 12 3 # 12 A 67 ASP B 82 ASP~? 13.99 NI NI A 501 A 68 ALA B 80 ALA~? 14.09 NI NI A 501 A 72 LEU B 77 LEU~? 19.46 NI NI A 501 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 48.88 4.35 16.59 48.73 5.09 15.20 -40.53 5.12 -27.34 -40.58 4.10 -28.46 coo 53.89 6.25 15.09 52.88 7.92 14.14 -43.13 6.21 -33.11 -41.36 6.93 -34.36 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 12 hits 1q6l_c05 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 23 ARG~? 15.85 NI NI A 502 C 163 TYR A 22 TYR~? 21.39 NI NI A 501 C 236 ASP A 42 ASP.? 24.20 NI NI A 501 coo 39.01 29.77 22.02 37.48 31.30 19.84 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 39.51 34.34 13.63 37.63 32.61 14.79 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 45.78 31.11 9.51 44.25 30.06 10.53 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 23 ARG~? 15.67 NI NI A 501 C 163 TYR B 22 TYR~? 21.09 NI NI A 502 C 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 39.01 29.77 22.02 37.48 31.30 19.84 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 56 ARG.? 27.79 NI NI A 501 C 163 TYR B 22 TYR~? 21.09 NI NI A 502 C 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 39.01 29.77 22.02 37.48 31.30 19.84 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 39.51 34.34 13.63 37.63 32.61 14.79 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 23 ARG~? 15.85 NI NI A 502 D 163 TYR A 22 TYR~? 21.39 NI NI A 501 D 236 ASP A 42 ASP.? 24.20 NI NI A 501 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 23 ARG~? 15.67 NI NI A 501 D 163 TYR B 22 TYR~? 21.09 NI NI A 502 D 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 56 ARG.? 27.79 NI NI A 501 D 163 TYR B 22 TYR~? 21.09 NI NI A 502 D 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 22 TYR~? 21.39 NI NI A 501 A 236 ASP A 42 ASP.? 24.20 NI NI A 501 C 110 ARG A 23 ARG~? 15.85 NI NI A 502 coo 55.48 26.51 40.65 55.39 23.99 39.43 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 48.87 29.19 44.63 49.10 27.34 43.63 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 52.39 23.42 32.10 54.51 23.27 34.29 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 22 TYR~? 21.09 NI NI A 502 A 236 ASP B 42 ASP.? 24.38 NI NI A 502 C 110 ARG B 23 ARG~? 15.67 NI NI A 501 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 52.39 23.42 32.10 54.51 23.27 34.29 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 22 TYR~? 21.09 NI NI A 502 A 236 ASP B 42 ASP.? 24.38 NI NI A 502 C 110 ARG B 56 ARG.? 27.79 NI NI A 501 coo 55.48 26.51 40.65 55.39 23.99 39.43 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 52.39 23.42 32.10 54.51 23.27 34.29 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 22 TYR~? 21.39 NI NI A 501 B 236 ASP A 42 ASP.? 24.20 NI NI A 501 D 110 ARG A 23 ARG~? 15.85 NI NI A 502 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 22 TYR~? 21.09 NI NI A 502 B 236 ASP B 42 ASP.? 24.38 NI NI A 502 D 110 ARG B 23 ARG~? 15.67 NI NI A 501 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 22 TYR~? 21.09 NI NI A 502 B 236 ASP B 42 ASP.? 24.38 NI NI A 502 D 110 ARG B 56 ARG.? 27.79 NI NI A 501 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 23 ARG~? 15.85 NI NI A 502 G 163 TYR A 22 TYR~? 21.39 NI NI A 501 G 236 ASP A 42 ASP.? 24.20 NI NI A 501 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 23 ARG~? 15.67 NI NI A 501 G 163 TYR B 22 TYR~? 21.09 NI NI A 502 G 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 56 ARG.? 27.79 NI NI A 501 G 163 TYR B 22 TYR~? 21.09 NI NI A 502 G 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 23 ARG~? 15.85 NI NI A 502 H 163 TYR A 22 TYR~? 21.39 NI NI A 501 H 236 ASP A 42 ASP.? 24.20 NI NI A 501 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 23 ARG~? 15.67 NI NI A 501 H 163 TYR B 22 TYR~? 21.09 NI NI A 502 H 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 56 ARG.? 27.79 NI NI A 501 H 163 TYR B 22 TYR~? 21.09 NI NI A 502 H 236 ASP B 42 ASP.? 24.38 NI NI A 502 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 22 TYR~? 21.39 NI NI A 501 E 236 ASP A 42 ASP.? 24.20 NI NI A 501 G 110 ARG A 23 ARG~? 15.85 NI NI A 502 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 22 TYR~? 21.09 NI NI A 502 E 236 ASP B 42 ASP.? 24.38 NI NI A 502 G 110 ARG B 23 ARG~? 15.67 NI NI A 501 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 22 TYR~? 21.39 NI NI A 501 F 236 ASP A 42 ASP.? 24.20 NI NI A 501 H 110 ARG A 23 ARG~? 15.85 NI NI A 502 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 22 TYR~? 21.09 NI NI A 502 F 236 ASP B 42 ASP.? 24.38 NI NI A 502 H 110 ARG B 23 ARG~? 15.67 NI NI A 501 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 22 TYR~? 21.09 NI NI A 502 F 236 ASP B 42 ASP.? 24.38 NI NI A 502 H 110 ARG B 56 ARG.? 27.79 NI NI A 501 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 82 ASP~? 15.20 NI NI A 502 A 147 THR A 85 THR~? 12.80 NI NI A 502 A 294 ASP A 13 ASP~? 13.27 NI NI A 502 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -18.74 32.48 -18.59 -19.60 33.57 -20.27 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 13 ASP~? 13.27 NI NI A 502 A 261 ASP A 88 ASP^? 14.52 NI NI A 501 A 329 ASP A 82 ASP~? 15.20 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 34.02 79.89 42.60 34.73 78.01 41.86 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.79 30.16 -22.23 -31.29 29.65 -23.60 1qho_c05 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c05 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR B 65 THR^? 14.18 NI NI A 502 A 182 TYR B 67 TYR^? 18.53 NI NI A 502 A 186 LYS A 123 LYS^? 12.92 NI NI A 502 coo 69.38 87.38 24.64 71.11 88.47 25.40 -30.21 23.51 -34.34 -32.04 24.61 -34.02 coo 73.61 90.42 31.12 71.36 89.66 29.64 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 73.54 84.00 28.64 69.01 86.68 29.71 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 1 hits 1qrr_c01 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 126 HIS.? -3.75 NI NI A 502s A 41 LYS A 123 LYS^? 12.92 NI NI A 502 A 119 HIS A 127 HIS.? 7.54 NI NI A 502 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS B 31 HIS~? -3.92 NI NI A 502s A 41 LYS A 123 LYS^? 12.92 NI NI A 502 A 119 HIS A 127 HIS.? 7.54 NI NI A 502 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -20.75 31.16 -30.30 -19.37 32.72 -30.66 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 2 hits 1rbn_c01 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 31 HIS~? -4.16 NI NI A 501s B 80 GLU A 28 GLU~? 13.04 NI NI A 501 B 223 ARG A 93 ARG^? 27.22 NI NI A 502 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -45.46 21.14 -37.27 -43.99 23.01 -39.26 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 31 HIS~? -4.16 NI NI A 501s B 80 GLU A 28 GLU~? 13.04 NI NI A 501 B 223 ARG B 56 ARG.? 27.79 NI NI A 501 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -40.99 6.23 -42.31 -42.32 3.75 -43.46 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 31 HIS~? -3.92 NI NI A 502s B 80 GLU B 28 GLU~? 10.98 NI NI A 502 B 223 ARG A 52 ARG.? 31.42 NI NI A 501 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -14.75 24.67 -0.61 -16.95 23.86 1.49 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 31 HIS~? -3.92 NI NI A 502s B 80 GLU B 28 GLU~? 10.98 NI NI A 502 B 223 ARG A 56 ARG.? 29.85 NI NI A 502 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -24.80 32.93 -3.59 -22.51 32.38 -1.45 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 31 HIS~? -3.92 NI NI A 502s B 80 GLU B 28 GLU~? 10.98 NI NI A 502 B 223 ARG A 94 ARG.? 33.91 NI NI A 501 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -52.83 19.63 -33.61 -55.45 21.14 -33.98 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS B 31 HIS~? -3.92 NI NI A 502s B 80 GLU B 28 GLU~? 10.98 NI NI A 502 B 223 ARG B 93 ARG^? 28.43 NI NI A 501 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -40.21 29.12 -9.93 -42.89 27.96 -8.94 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS B 31 HIS~? -3.92 NI NI A 502s B 80 GLU B 28 GLU~? 10.98 NI NI A 502 B 223 ARG B 94 ARG^? 29.28 NI NI A 502 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -40.67 35.58 -16.18 -42.20 37.17 -18.35 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 7 hits 1t0u_c01 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER B 87 SER.? 15.38 NI NI A 501 A 90 SER A 87 SER.? 14.75 NI NI A 502 A 145 LYS A 123 LYS^? 12.92 NI NI A 502 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 1.47 40.03 18.48 2.45 41.37 16.68 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 7.35 44.71 16.29 4.71 40.98 14.52 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER B 87 SER.? 15.38 NI NI A 501 B 90 SER A 87 SER.? 14.75 NI NI A 502 B 145 LYS A 123 LYS^? 12.92 NI NI A 502 coo 61.01 10.03 12.97 58.78 10.97 12.69 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 56.85 12.22 16.37 55.62 11.34 14.45 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 49.80 9.51 14.88 53.14 11.99 12.77 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c01 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU B 28 GLU~? 10.98 NI NI A 502 B 126 LYS A 123 LYS^? 12.92 NI NI A 502 B 171 ALA B 27 ALA~? 11.43 NI NI A 502 coo 20.47 87.42 16.54 20.16 87.17 14.45 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 24.73 94.37 14.59 21.08 89.84 11.98 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 24.38 86.32 12.71 22.88 86.54 12.71 -26.40 17.57 -34.37 -26.38 16.93 -32.99 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 28 GLU~? 10.98 NI NI A 502 B 126 LYS A 123 LYS^? 12.92 NI NI A 502 B 171 ALA B 30 ALA~? 10.79 NI NI A 502 coo 20.47 87.42 16.54 20.16 87.17 14.45 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 24.73 94.37 14.59 21.08 89.84 11.98 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 24.38 86.32 12.71 22.88 86.54 12.71 -24.57 21.06 -37.88 -25.84 21.07 -37.01 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 82 ASP~? 13.99 NI NI A 501 242 GLU B 8 GLU.? 22.17 NI NI A 501 329 ASP A 88 ASP^? 14.52 NI NI A 501 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 30.42 34.74 5.00 29.09 35.09 3.38 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.37 17.64 -25.93 -33.10 15.61 -26.13 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU B 116 GLU.? 34.45 NI NI A 502 A 596 ARG B 93 ARG^? 28.43 NI NI A 501 A 647 ARG B 94 ARG^? 29.28 NI NI A 502 coo 69.13 32.20 28.58 68.39 32.96 30.44 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 70.89 37.31 29.70 69.54 36.29 32.39 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 66.09 40.54 34.70 66.92 37.69 35.49 -40.67 35.58 -16.18 -42.20 37.17 -18.35 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU B 124 GLU.? 12.68 NI NI A 501 A 596 ARG A 102 ARG.? 15.26 NI NI A 501 A 647 ARG A 101 ARG.? 18.18 NI NI A 501 coo 69.13 32.20 28.58 68.39 32.96 30.44 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 70.89 37.31 29.70 69.54 36.29 32.39 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 66.09 40.54 34.70 66.92 37.69 35.49 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU B 116 GLU.? 34.45 NI NI A 502 B 596 ARG B 93 ARG^? 28.43 NI NI A 501 B 647 ARG B 94 ARG^? 29.28 NI NI A 502 coo 38.22 57.83 70.36 36.82 56.74 69.18 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 34.24 60.89 68.08 33.31 57.93 67.63 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 31.43 57.38 61.97 31.90 55.58 64.41 -40.67 35.58 -16.18 -42.20 37.17 -18.35 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU B 124 GLU.? 12.68 NI NI A 501 B 596 ARG A 102 ARG.? 15.26 NI NI A 501 B 647 ARG A 101 ARG.? 18.18 NI NI A 501 coo 38.22 57.83 70.36 36.82 56.74 69.18 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 34.24 60.89 68.08 33.31 57.93 67.63 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 31.43 57.38 61.97 31.90 55.58 64.41 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU B 116 GLU.? 34.45 NI NI A 502 C 596 ARG B 93 ARG^? 28.43 NI NI A 501 C 647 ARG B 94 ARG^? 29.28 NI NI A 502 coo 11.31 31.26 27.00 13.31 30.71 26.58 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 13.44 32.78 22.07 15.56 30.91 23.37 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 21.00 33.35 22.82 19.83 30.82 24.09 -40.67 35.58 -16.18 -42.20 37.17 -18.35 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU B 124 GLU.? 12.68 NI NI A 501 C 596 ARG A 102 ARG.? 15.26 NI NI A 501 C 647 ARG A 101 ARG.? 18.18 NI NI A 501 coo 11.31 31.26 27.00 13.31 30.71 26.58 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 13.44 32.78 22.07 15.56 30.91 23.37 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 21.00 33.35 22.82 19.83 30.82 24.09 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU B 116 GLU.? 34.45 NI NI A 502 D 596 ARG B 93 ARG^? 28.43 NI NI A 501 D 647 ARG B 94 ARG^? 29.28 NI NI A 502 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -40.67 35.58 -16.18 -42.20 37.17 -18.35 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU B 124 GLU.? 12.68 NI NI A 501 D 596 ARG A 102 ARG.? 15.26 NI NI A 501 D 647 ARG A 101 ARG.? 18.18 NI NI A 501 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU B 116 GLU.? 34.45 NI NI A 502 E 596 ARG B 93 ARG^? 28.43 NI NI A 501 E 647 ARG B 94 ARG^? 29.28 NI NI A 502 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -40.67 35.58 -16.18 -42.20 37.17 -18.35 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU B 124 GLU.? 12.68 NI NI A 501 E 596 ARG A 102 ARG.? 15.26 NI NI A 501 E 647 ARG A 101 ARG.? 18.18 NI NI A 501 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU B 116 GLU.? 34.45 NI NI A 502 F 596 ARG B 93 ARG^? 28.43 NI NI A 501 F 647 ARG B 94 ARG^? 29.28 NI NI A 502 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -40.67 35.58 -16.18 -42.20 37.17 -18.35 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU B 124 GLU.? 12.68 NI NI A 501 F 596 ARG A 102 ARG.? 15.26 NI NI A 501 F 647 ARG A 101 ARG.? 18.18 NI NI A 501 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -45.57 11.90 -25.10 -47.16 9.28 -24.53 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE B 36 PHE.? 17.03 NI NI A 502 B 197 ASN B 33 ASN.? 13.74 NI NI A 502 B 198 PRO B 34 PRO.? 9.33 NI NI A 502 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 -26.15 23.36 -43.90 -26.62 21.39 -45.87 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -21.15 22.18 -41.67 -19.86 21.73 -43.34 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 -19.80 26.53 -38.25 -21.53 25.95 -39.54 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 1 hits 1vq1_c01 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR B 29 TYR~? 14.52 NI NI A 502 A 40 ASP B 42 ASP.? 24.38 NI NI A 502 A 103 LEU B 26 LEU~? 16.29 NI NI A 502 coo 12.09 16.13 10.57 11.28 18.80 10.73 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 7.55 25.51 14.34 9.65 25.73 14.24 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 11.83 18.73 16.99 10.99 19.71 15.26 -28.62 16.28 -37.92 -30.02 16.04 -39.49 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 1 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR B 29 TYR~? 14.52 NI NI A 502 B 40 ASP B 42 ASP.? 24.38 NI NI A 502 B 103 LEU B 26 LEU~? 16.29 NI NI A 502 coo 14.25 20.09 37.35 13.48 17.40 37.38 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 9.39 10.77 34.53 11.50 10.63 34.41 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 12.89 17.60 31.13 12.34 16.51 32.90 -28.62 16.28 -37.92 -30.02 16.04 -39.49 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 1 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 126 HIS.? -3.75 NI NI A 502s A 169 ASP A 88 ASP^? 14.52 NI NI A 501 A 288 GLU B 86 GLU.? 9.13 NI NI A 501 coo 67.72 35.99 30.87 69.77 36.13 31.33 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 73.17 30.66 22.56 72.87 30.30 20.46 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 74.06 28.51 15.92 73.77 29.56 17.73 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 126 HIS.? -3.75 NI NI A 502s A 169 ASP B 88 ASP^? 15.06 NI NI A 502 A 288 GLU B 86 GLU.? 9.13 NI NI A 501 coo 67.72 35.99 30.87 69.77 36.13 31.33 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 73.17 30.66 22.56 72.87 30.30 20.46 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 74.06 28.51 15.92 73.77 29.56 17.73 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS B 126 HIS.? -4.79 NI NI A 501s A 169 ASP A 88 ASP^? 14.52 NI NI A 501 A 288 GLU A 86 GLU.? 9.00 NI NI A 502 coo 67.72 35.99 30.87 69.77 36.13 31.33 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 73.17 30.66 22.56 72.87 30.30 20.46 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 74.06 28.51 15.92 73.77 29.56 17.73 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS B 126 HIS.? -4.79 NI NI A 501s A 169 ASP A 88 ASP^? 14.52 NI NI A 501 A 288 GLU A 124 GLU.? 14.10 NI NI A 502 coo 67.72 35.99 30.87 69.77 36.13 31.33 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 73.17 30.66 22.56 72.87 30.30 20.46 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 74.06 28.51 15.92 73.77 29.56 17.73 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS B 126 HIS.? -4.79 NI NI A 501s A 169 ASP B 88 ASP^? 15.06 NI NI A 502 A 288 GLU A 86 GLU.? 9.00 NI NI A 502 coo 67.72 35.99 30.87 69.77 36.13 31.33 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 73.17 30.66 22.56 72.87 30.30 20.46 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 74.06 28.51 15.92 73.77 29.56 17.73 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 5 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY B 125 GLY.? 8.70 NI NI A 501 B 419 GLY A 64 GLY.? 11.90 NI NI A 501 B 420 ALA A 63 ALA.? 14.98 NI NI A 501 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -36.44 11.95 -11.26 -37.01 12.61 -11.38 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -39.71 12.00 -9.27 -40.78 12.21 -10.34 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 1 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 27 ALA~? 11.39 NI NI A 501 B 182 GLY A 64 GLY.? 11.90 NI NI A 501 B 183 GLY B 125 GLY.? 8.70 NI NI A 501 coo 38.36-101.47-135.52 39.62-101.29-136.35 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 41.93-102.35-126.87 41.52-101.89-126.30 -36.44 11.95 -11.26 -37.01 12.61 -11.38 coo 38.37-101.99-128.11 38.63-102.24-127.37 -33.85 11.71 -15.90 -34.49 11.70 -16.45 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 1 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 27 ALA~? 11.39 NI NI A 501 B 126 ARG A 25 ARG~? 18.03 NI NI A 501 B 138 GLU B 86 GLU.? 9.13 NI NI A 501 coo 2.11 4.00 19.31 3.14 4.86 19.99 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 2.45 5.53 11.28 3.59 7.56 13.29 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 6.10 2.00 25.24 6.12 1.84 23.13 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 71 ALA.? 29.56 NI NI A 502 B 126 ARG A 56 ARG.? 29.85 NI NI A 502 B 138 GLU B 116 GLU.? 34.45 NI NI A 502 coo 2.11 4.00 19.31 3.14 4.86 19.99 -32.67 31.92 -6.68 -33.14 31.47 -5.26 coo 2.45 5.53 11.28 3.59 7.56 13.29 -24.80 32.93 -3.59 -22.51 32.38 -1.45 coo 6.10 2.00 25.24 6.12 1.84 23.13 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA A 118 ALA.? 26.51 NI NI A 501 B 126 ARG B 56 ARG.? 27.79 NI NI A 501 B 138 GLU A 116 GLU.? 34.96 NI NI A 501 coo 2.11 4.00 19.31 3.14 4.86 19.99 -44.86 13.94 -37.78 -43.80 14.69 -38.56 coo 2.45 5.53 11.28 3.59 7.56 13.29 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 6.10 2.00 25.24 6.12 1.84 23.13 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 27 ALA~? 11.43 NI NI A 502 B 126 ARG B 25 ARG~? 17.38 NI NI A 502 B 138 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.11 4.00 19.31 3.14 4.86 19.99 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo 2.45 5.53 11.28 3.59 7.56 13.29 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 6.10 2.00 25.24 6.12 1.84 23.13 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 27 ALA~? 11.39 NI NI A 501 C 126 ARG A 25 ARG~? 18.03 NI NI A 501 C 138 GLU B 86 GLU.? 9.13 NI NI A 501 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 71 ALA.? 29.56 NI NI A 502 C 126 ARG A 56 ARG.? 29.85 NI NI A 502 C 138 GLU B 116 GLU.? 34.45 NI NI A 502 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -32.67 31.92 -6.68 -33.14 31.47 -5.26 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -24.80 32.93 -3.59 -22.51 32.38 -1.45 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 118 ALA.? 26.51 NI NI A 501 C 126 ARG B 56 ARG.? 27.79 NI NI A 501 C 138 GLU A 116 GLU.? 34.96 NI NI A 501 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -44.86 13.94 -37.78 -43.80 14.69 -38.56 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA B 27 ALA~? 11.43 NI NI A 502 C 126 ARG B 25 ARG~? 17.38 NI NI A 502 C 138 GLU A 86 GLU.? 9.00 NI NI A 502 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 27 ALA~? 11.39 NI NI A 501 D 126 ARG A 25 ARG~? 18.03 NI NI A 501 D 138 GLU B 86 GLU.? 9.13 NI NI A 501 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 6.23 0.50 57.10 5.93 0.72 59.19 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 71 ALA.? 29.56 NI NI A 502 D 126 ARG A 56 ARG.? 29.85 NI NI A 502 D 138 GLU B 116 GLU.? 34.45 NI NI A 502 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -32.67 31.92 -6.68 -33.14 31.47 -5.26 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -24.80 32.93 -3.59 -22.51 32.38 -1.45 coo 6.23 0.50 57.10 5.93 0.72 59.19 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 118 ALA.? 26.51 NI NI A 501 D 126 ARG B 56 ARG.? 27.79 NI NI A 501 D 138 GLU A 116 GLU.? 34.96 NI NI A 501 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -44.86 13.94 -37.78 -43.80 14.69 -38.56 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo 6.23 0.50 57.10 5.93 0.72 59.19 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA B 27 ALA~? 11.43 NI NI A 502 D 126 ARG B 25 ARG~? 17.38 NI NI A 502 D 138 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 6.23 0.50 57.10 5.93 0.72 59.19 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 27 ALA~? 11.39 NI NI A 501 E 126 ARG A 25 ARG~? 18.03 NI NI A 501 E 138 GLU B 86 GLU.? 9.13 NI NI A 501 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 71 ALA.? 29.56 NI NI A 502 E 126 ARG A 56 ARG.? 29.85 NI NI A 502 E 138 GLU B 116 GLU.? 34.45 NI NI A 502 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -32.67 31.92 -6.68 -33.14 31.47 -5.26 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -24.80 32.93 -3.59 -22.51 32.38 -1.45 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 118 ALA.? 26.51 NI NI A 501 E 126 ARG B 56 ARG.? 27.79 NI NI A 501 E 138 GLU A 116 GLU.? 34.96 NI NI A 501 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -44.86 13.94 -37.78 -43.80 14.69 -38.56 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 27 ALA~? 11.43 NI NI A 502 E 126 ARG B 25 ARG~? 17.38 NI NI A 502 E 138 GLU A 86 GLU.? 9.00 NI NI A 502 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 27 ALA~? 11.39 NI NI A 501 F 126 ARG A 25 ARG~? 18.03 NI NI A 501 F 138 GLU B 86 GLU.? 9.13 NI NI A 501 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -28.32 13.75 -12.96 -28.23 14.16 -14.50 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 71 ALA.? 29.56 NI NI A 502 F 126 ARG A 56 ARG.? 29.85 NI NI A 502 F 138 GLU B 116 GLU.? 34.45 NI NI A 502 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -32.67 31.92 -6.68 -33.14 31.47 -5.26 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -24.80 32.93 -3.59 -22.51 32.38 -1.45 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 118 ALA.? 26.51 NI NI A 501 F 126 ARG B 56 ARG.? 27.79 NI NI A 501 F 138 GLU A 116 GLU.? 34.96 NI NI A 501 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -44.86 13.94 -37.78 -43.80 14.69 -38.56 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -40.99 6.23 -42.31 -42.32 3.75 -43.46 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA B 27 ALA~? 11.43 NI NI A 502 F 126 ARG B 25 ARG~? 17.38 NI NI A 502 F 138 GLU A 86 GLU.? 9.00 NI NI A 502 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -26.40 17.57 -34.37 -26.38 16.93 -32.99 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 4 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 91 GLY^? 20.30 NI NI A 501 B 175 ARG A 93 ARG^? 27.22 NI NI A 502 B 242 TYR B 67 TYR^? 18.53 NI NI A 502 coo 99.45 58.28 3.33 99.57 58.61 4.10 -42.92 15.52 -29.58 -42.49 15.51 -30.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 100.93 69.04 4.38 99.52 68.48 2.09 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 91 GLY^? 20.30 NI NI A 501 B 175 ARG B 23 ARG~? 15.67 NI NI A 501 B 242 TYR B 67 TYR^? 18.53 NI NI A 502 coo 99.45 58.28 3.33 99.57 58.61 4.10 -42.92 15.52 -29.58 -42.49 15.51 -30.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 100.93 69.04 4.38 99.52 68.48 2.09 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 91 GLY^? 20.73 NI NI A 502 B 175 ARG A 23 ARG~? 15.85 NI NI A 502 B 242 TYR A 67 TYR^? 18.49 NI NI A 501 coo 99.45 58.28 3.33 99.57 58.61 4.10 -34.90 29.27 -18.25 -34.72 28.89 -17.49 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 100.93 69.04 4.38 99.52 68.48 2.09 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 91 GLY^? 20.73 NI NI A 502 B 175 ARG B 93 ARG^? 28.43 NI NI A 501 B 242 TYR A 67 TYR^? 18.49 NI NI A 501 coo 99.45 58.28 3.33 99.57 58.61 4.10 -34.90 29.27 -18.25 -34.72 28.89 -17.49 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 100.93 69.04 4.38 99.52 68.48 2.09 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 125 GLY.? 8.70 NI NI A 501 B 175 ARG A 23 ARG~? 15.85 NI NI A 502 B 242 TYR A 67 TYR^? 18.49 NI NI A 501 coo 99.45 58.28 3.33 99.57 58.61 4.10 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 100.93 69.04 4.38 99.52 68.48 2.09 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 5 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 18 SER~? 18.69 NI NI A 502 A 178 TYR A 22 TYR~? 21.39 NI NI A 501 A 182 LYS A 53 LYS.? 25.39 NI NI A 501 coo 81.46 10.53 21.66 82.20 10.82 19.39 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 87.67 8.69 17.10 86.62 10.83 18.52 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 85.30 6.17 22.83 87.26 11.02 23.50 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER B 18 SER~? 18.56 NI NI A 501 A 178 TYR B 22 TYR~? 21.09 NI NI A 502 A 182 LYS B 53 LYS.? 26.24 NI NI A 502 coo 81.46 10.53 21.66 82.20 10.82 19.39 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 87.67 8.69 17.10 86.62 10.83 18.52 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 85.30 6.17 22.83 87.26 11.02 23.50 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 18 SER~? 18.69 NI NI A 502 B 178 TYR A 22 TYR~? 21.39 NI NI A 501 B 182 LYS A 53 LYS.? 25.39 NI NI A 501 coo 61.22 3.61 34.51 60.46 1.86 35.98 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 57.40 2.23 30.19 55.43 5.44 33.87 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER B 18 SER~? 18.56 NI NI A 501 B 178 TYR B 22 TYR~? 21.09 NI NI A 502 B 182 LYS B 53 LYS.? 26.24 NI NI A 502 coo 61.22 3.61 34.51 60.46 1.86 35.98 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 57.40 2.23 30.19 55.43 5.44 33.87 -31.78 4.80 -43.31 -32.04 8.63 -45.75 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 13 ASP~? 13.27 NI NI A 502 231 ASP A 42 ASP.? 24.20 NI NI A 501 294 ASP A 82 ASP~? 15.20 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 88 ASP^? 14.52 NI NI A 501 231 ASP B 42 ASP.? 24.38 NI NI A 502 294 ASP B 82 ASP~? 13.99 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 13 ASP~? 14.49 NI NI A 501 231 ASP B 42 ASP.? 24.38 NI NI A 502 294 ASP B 82 ASP~? 13.99 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 88 ASP^? 15.06 NI NI A 502 231 ASP A 42 ASP.? 24.20 NI NI A 501 294 ASP A 82 ASP~? 15.20 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.79 30.16 -22.23 -31.29 29.65 -23.60 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 4 hits 2amg_c06 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 28 GLU~? 13.04 NI NI A 501 A 156 GLU B 86 GLU.? 9.13 NI NI A 501 A 194 ASN A 33 ASN.? 14.07 NI NI A 501 coo 74.14 15.91 8.55 72.08 15.36 8.63 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 67.47 20.07 1.34 65.99 20.06 2.88 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 67.44 25.26 13.91 67.54 23.65 15.28 -30.87 7.88 -5.92 -29.26 7.53 -4.61 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU B 28 GLU~? 10.98 NI NI A 502 A 156 GLU A 86 GLU.? 9.00 NI NI A 502 A 194 ASN B 33 ASN.? 13.74 NI NI A 502 coo 74.14 15.91 8.55 72.08 15.36 8.63 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 67.47 20.07 1.34 65.99 20.06 2.88 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 67.44 25.26 13.91 67.54 23.65 15.28 -21.15 22.18 -41.67 -19.86 21.73 -43.34 2dbt_c00 source 2dbt CHITINASE C : 2 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 28 GLU~? 13.04 NI NI A 501 B 156 GLU B 86 GLU.? 9.13 NI NI A 501 B 194 ASN A 33 ASN.? 14.07 NI NI A 501 coo 45.64 63.11 17.20 47.48 62.43 16.45 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 54.43 67.89 19.82 55.62 67.90 18.07 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 49.79 70.75 7.78 50.10 68.90 6.86 -30.87 7.88 -5.92 -29.26 7.53 -4.61 2dbt_c01 source 2dbt CHITINASE C : 1 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 28 GLU~? 13.04 NI NI A 501 C 156 GLU B 86 GLU.? 9.13 NI NI A 501 C 194 ASN A 33 ASN.? 14.07 NI NI A 501 coo 41.23 29.31 13.28 43.03 29.85 12.29 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 44.75 23.09 5.51 46.77 22.91 6.12 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 49.75 21.00 18.12 50.45 23.02 18.26 -30.87 7.88 -5.92 -29.26 7.53 -4.61 2dbt_c02 source 2dbt CHITINASE C : 1 hits 2dbt_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 31 HIS~? -4.16 NI NI A 501s A 341 GLU A 28 GLU~? 13.04 NI NI A 501 A 356 HIS B 126 HIS.? -4.79 NI NI A 501s coo 121.00 36.37 19.26 121.57 38.37 19.56 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 125.72 32.70 19.75 124.44 34.16 18.84 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 124.34 41.73 25.55 123.79 42.60 23.72 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 126 HIS.? -3.75 NI NI A 502s A 341 GLU A 86 GLU.? 9.00 NI NI A 502 A 356 HIS A 127 HIS.? 7.54 NI NI A 502 coo 121.00 36.37 19.26 121.57 38.37 19.56 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 125.72 32.70 19.75 124.44 34.16 18.84 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 124.34 41.73 25.55 123.79 42.60 23.72 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS B 126 HIS.? -4.79 NI NI A 501s A 341 GLU B 124 GLU.? 12.68 NI NI A 501 A 356 HIS A 31 HIS~? -4.16 NI NI A 501s coo 121.00 36.37 19.26 121.57 38.37 19.56 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 125.72 32.70 19.75 124.44 34.16 18.84 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 124.34 41.73 25.55 123.79 42.60 23.72 -28.46 6.43 -14.65 -28.67 4.98 -16.17 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 3 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 31 HIS~? -4.16 NI NI A 501s B 341 GLU A 28 GLU~? 13.04 NI NI A 501 B 356 HIS B 126 HIS.? -4.79 NI NI A 501s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 126 HIS.? -3.75 NI NI A 502s B 341 GLU A 86 GLU.? 9.00 NI NI A 502 B 356 HIS A 127 HIS.? 7.54 NI NI A 502 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS B 126 HIS.? -4.79 NI NI A 501s B 341 GLU B 124 GLU.? 12.68 NI NI A 501 B 356 HIS A 31 HIS~? -4.16 NI NI A 501s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -28.46 6.43 -14.65 -28.67 4.98 -16.17 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 3 hits 2isd_c01 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 126 HIS.? -3.75 NI NI A 502s A 40 LYS A 123 LYS^? 12.92 NI NI A 502 A 116 HIS A 127 HIS.? 7.54 NI NI A 502 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 18.50 3.53 20.10 16.17 2.61 14.41 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 14.70 6.01 5.61 14.27 7.69 6.78 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS B 31 HIS~? -3.92 NI NI A 502s A 40 LYS A 123 LYS^? 12.92 NI NI A 502 A 116 HIS A 127 HIS.? 7.54 NI NI A 502 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 18.50 3.53 20.10 16.17 2.61 14.41 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 14.70 6.01 5.61 14.27 7.69 6.78 -20.75 31.16 -30.30 -19.37 32.72 -30.66 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 126 HIS.? -3.75 NI NI A 502s B 40 LYS A 123 LYS^? 12.92 NI NI A 502 B 116 HIS A 127 HIS.? 7.54 NI NI A 502 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS B 31 HIS~? -3.92 NI NI A 502s B 40 LYS A 123 LYS^? 12.92 NI NI A 502 B 116 HIS A 127 HIS.? 7.54 NI NI A 502 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -20.75 31.16 -30.30 -19.37 32.72 -30.66 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 2 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 88 ASP^? 14.52 NI NI A 501 166 GLY B 76 GLY~? 18.88 NI NI A 501 169 GLU B 11 GLU~? 14.38 NI NI A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -45.85 3.88 -29.84 -45.63 4.32 -30.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP B 13 ASP~? 14.49 NI NI A 501 166 GLY B 125 GLY.? 8.70 NI NI A 501 169 GLU A 28 GLU~? 13.04 NI NI A 501 coo 8.28 6.87 1.62 10.08 5.77 1.34 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -33.85 11.71 -15.90 -34.49 11.70 -16.45 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 88 ASP^? 15.06 NI NI A 502 166 GLY B 96 GLY.? 29.19 NI NI A 501 169 GLU B 116 GLU.? 34.45 NI NI A 502 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -46.09 28.23 -12.79 -45.33 28.55 -13.13 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -40.98 33.61 -5.94 -39.53 34.29 -4.51 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 3 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 52 ARG.? 31.42 NI NI A 501 A 130 SER A 43 SER.? 23.77 NI NI A 501 A 159 LYS A 53 LYS.? 25.39 NI NI A 501 coo 18.35 45.84 20.99 16.20 47.83 21.89 -14.75 24.67 -0.61 -16.95 23.86 1.49 coo 15.14 43.67 10.77 15.61 44.43 13.04 -20.78 14.34 -0.26 -20.70 12.54 1.43 coo 11.57 48.49 22.18 13.51 49.99 17.21 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 52 ARG.? 29.95 NI NI A 501 A 130 SER B 43 SER.? 24.88 NI NI A 502 A 159 LYS B 53 LYS.? 26.24 NI NI A 502 coo 18.35 45.84 20.99 16.20 47.83 21.89 -30.29 0.12 -47.40 -29.74 3.21 -47.94 coo 15.14 43.67 10.77 15.61 44.43 13.04 -23.40 10.48 -47.49 -24.52 10.60 -49.63 coo 11.57 48.49 22.18 13.51 49.99 17.21 -31.78 4.80 -43.31 -32.04 8.63 -45.75 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 52 ARG.? 31.42 NI NI A 501 B 130 SER A 43 SER.? 23.77 NI NI A 501 B 159 LYS A 53 LYS.? 25.39 NI NI A 501 coo 58.72 31.58 20.45 60.80 29.39 20.94 -14.75 24.67 -0.61 -16.95 23.86 1.49 coo 61.66 35.17 10.39 61.29 34.14 12.56 -20.78 14.34 -0.26 -20.70 12.54 1.43 coo 65.38 28.77 21.17 63.49 28.03 16.12 -20.26 25.10 -4.42 -25.18 23.47 -3.20 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c01 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG B 101 ARG.? 17.16 NI NI A 502 127 ARG B 102 ARG.? 15.54 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo -1.14 25.72 1.64 0.76 28.10 1.50 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG B 102 ARG.? 15.54 NI NI A 502 127 ARG B 101 ARG.? 17.16 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo -1.14 25.72 1.64 0.76 28.10 1.50 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 2 hits 5cpa_c01 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 31 HIS~? -4.16 NI NI A 501s 41 LYS B 123 LYS^? 13.38 NI NI A 501 119 HIS B 127 HIS.? 5.53 NI NI A 501 coo 28.18 18.67 11.43 28.83 17.39 9.89 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 25.33 8.32 6.30 27.86 13.90 7.82 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 33.68 19.99 5.35 34.98 18.36 5.19 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 126 HIS.? -3.75 NI NI A 502s 41 LYS A 123 LYS^? 12.92 NI NI A 502 119 HIS A 127 HIS.? 7.54 NI NI A 502 coo 28.18 18.67 11.43 28.83 17.39 9.89 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.33 8.32 6.30 27.86 13.90 7.82 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 33.68 19.99 5.35 34.98 18.36 5.19 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS B 31 HIS~? -3.92 NI NI A 502s 41 LYS A 123 LYS^? 12.92 NI NI A 502 119 HIS A 127 HIS.? 7.54 NI NI A 502 coo 28.18 18.67 11.43 28.83 17.39 9.89 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 25.33 8.32 6.30 27.86 13.90 7.82 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 33.68 19.99 5.35 34.98 18.36 5.19 -20.75 31.16 -30.30 -19.37 32.72 -30.66 5rsa_c01 source 5rsa RIBONUCLEASE A : 3 hits 5rsa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 33 ASN.? 14.07 NI NI A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.87 7.88 -5.92 -29.26 7.53 -4.61 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 95 ASN.? 33.32 NI NI A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 -51.35 22.78 -35.72 -51.57 21.49 -37.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 33 ASN.? 13.74 NI NI A 502 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.15 22.18 -41.67 -19.86 21.73 -43.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 95 ASN.? 31.89 NI NI A 501 coo 5.80 63.03 55.85 5.52 65.03 56.45 -44.53 31.85 -10.19 -42.56 32.26 -9.56 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 4 hits 1kbk_p00 naa= 1 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 56 ARG.? 29.85 NI NI A 502 A 148 SER A 72 SER.? 30.35 NI NI A 502 A 152 ALA B 118 ALA.? 27.09 NI NI A 502 A 194 GLU B 116 GLU.? 34.45 NI NI A 502 coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -24.80 32.93 -3.59 -22.51 32.38 -1.45 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -31.43 35.56 -6.74 -30.88 37.60 -5.53 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -34.73 31.50 -10.05 -34.79 30.28 -9.12 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -40.98 33.61 -5.94 -39.53 34.29 -4.51 2cl8_p00 source 2cl8 DECTIN-1 : 1 hits 2cl8_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 23 ARG~? 15.85 NI NI A 502 A 188 TYR A 60 TYR^? 20.44 NI NI A 501 A 190 SER A 66 SER^? 13.16 NI NI A 501 coo 37.69 7.64 13.51 38.82 8.84 16.11 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 47.14 12.10 13.73 48.75 12.33 16.01 -35.80 19.06 -5.58 -37.88 17.67 -4.34 coo 43.77 6.93 15.46 45.49 7.21 17.11 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 23 ARG~? 15.67 NI NI A 501 A 188 TYR B 60 TYR^? 21.49 NI NI A 502 A 190 SER B 66 SER^? 13.28 NI NI A 502 coo 37.69 7.64 13.51 38.82 8.84 16.11 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 47.14 12.10 13.73 48.75 12.33 16.01 -35.15 21.17 -42.13 -35.63 23.37 -43.86 coo 43.77 6.93 15.46 45.49 7.21 17.11 -31.33 20.29 -35.99 -29.23 19.21 -35.57 2p3i_p00 source 2p3i VP4 : 2 hits 2p3i_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 23 ARG~? 15.85 NI NI A 502 B 6 THR A 85 THR~? 12.80 NI NI A 502 B 8 THR A 83 THR~? 11.66 NI NI A 502 coo 40.52 16.08 100.90 37.97 16.41 102.60 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 36.11 13.64 95.03 34.54 14.86 95.91 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 32.72 8.05 92.39 31.25 9.11 91.35 -25.75 29.45 -24.12 -25.45 31.51 -23.71 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 102 ARG.? 15.26 NI NI A 501 B 6 THR A 100 THR^? 19.44 NI NI A 501 B 8 THR A 106 THR^? 23.59 NI NI A 501 coo 40.52 16.08 100.90 37.97 16.41 102.60 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 36.11 13.64 95.03 34.54 14.86 95.91 -44.82 16.79 -25.89 -42.97 17.43 -25.07 coo 32.72 8.05 92.39 31.25 9.11 91.35 -44.11 24.18 -26.65 -42.38 22.71 -26.31 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 23 ARG~? 15.67 NI NI A 501 B 6 THR B 85 THR.? 12.36 NI NI A 501 B 8 THR B 83 THR~? 9.81 NI NI A 501 coo 40.52 16.08 100.90 37.97 16.41 102.60 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 36.11 13.64 95.03 34.54 14.86 95.91 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo 32.72 8.05 92.39 31.25 9.11 91.35 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 102 ARG.? 15.54 NI NI A 502 B 6 THR B 100 THR.? 19.64 NI NI A 502 B 8 THR B 106 THR^? 23.70 NI NI A 502 coo 40.52 16.08 100.90 37.97 16.41 102.60 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo 32.72 8.05 92.39 31.25 9.11 91.35 -42.71 26.17 -21.12 -40.64 25.57 -21.68 1b01_d00 source 1b01 GENE REGULATION/DNA : 4 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 67 TYR^? 18.49 NI NI A 501 I 306 VAL B 120 VAL^? 22.88 NI NI A 502 I 308 VAL B 90 VAL^? 17.22 NI NI A 502 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 23.55 29.53 9.81 23.15 27.39 10.24 -32.94 26.82 -13.65 -35.02 26.37 -12.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 -32.98 26.11 -19.04 -30.91 26.45 -19.77 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 67 TYR^? 18.49 NI NI A 501 I 306 VAL B 120 VAL^? 22.88 NI NI A 502 I 308 VAL B 92 VAL^? 24.17 NI NI A 502 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 23.55 29.53 9.81 23.15 27.39 10.24 -32.94 26.82 -13.65 -35.02 26.37 -12.94 coo 16.43 30.18 9.35 15.05 30.67 11.01 -36.17 31.63 -15.52 -35.78 33.78 -15.35 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 67 TYR^? 18.49 NI NI A 501 I 306 VAL B 122 VAL^? 17.94 NI NI A 501 I 308 VAL B 90 VAL^? 17.22 NI NI A 502 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 23.55 29.53 9.81 23.15 27.39 10.24 -33.52 21.01 -16.15 -35.73 21.42 -16.06 coo 16.43 30.18 9.35 15.05 30.67 11.01 -32.98 26.11 -19.04 -30.91 26.45 -19.77 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 67 TYR^? 18.53 NI NI A 502 I 306 VAL A 120 VAL^? 22.45 NI NI A 501 I 308 VAL A 90 VAL^? 16.72 NI NI A 501 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 -39.85 15.11 -34.09 -40.35 17.13 -34.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 -39.33 15.34 -28.32 -38.74 13.21 -28.29 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 67 TYR^? 18.53 NI NI A 502 I 306 VAL A 120 VAL^? 22.45 NI NI A 501 I 308 VAL A 92 VAL^? 23.74 NI NI A 501 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 -39.85 15.11 -34.09 -40.35 17.13 -34.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 -45.38 15.77 -32.55 -47.22 14.58 -31.94 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 67 TYR^? 18.53 NI NI A 502 I 306 VAL A 122 VAL^? 17.90 NI NI A 502 I 308 VAL A 90 VAL^? 16.72 NI NI A 501 coo 26.18 35.24 6.87 24.33 35.18 8.97 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 -34.97 18.56 -31.68 -36.07 20.43 -31.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 -39.33 15.34 -28.32 -38.74 13.21 -28.29 1cqt_d00 source 1cqt GENE REGULATION/DNA : 6 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 40 PRO.? 18.63 NI NI A 501 A 272 LEU A 26 LEU~? 16.65 NI NI A 501 A 276 ARG A 23 ARG~? 15.85 NI NI A 502 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -28.81 14.96 -4.55 -28.95 15.26 -2.36 coo 10.97 0.43 16.73 11.31 2.11 18.06 -27.81 16.98 -10.04 -28.60 18.09 -8.34 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 40 PRO.? 18.63 NI NI A 501 A 272 LEU A 26 LEU~? 16.65 NI NI A 501 A 276 ARG A 25 ARG~? 18.03 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -28.81 14.96 -4.55 -28.95 15.26 -2.36 coo 10.97 0.43 16.73 11.31 2.11 18.06 -27.81 16.98 -10.04 -28.60 18.09 -8.34 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 40 PRO.? 18.63 NI NI A 501 A 272 LEU A 45 LEU.? 18.52 NI NI A 501 A 276 ARG A 25 ARG~? 18.03 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -28.81 14.96 -4.55 -28.95 15.26 -2.36 coo 10.97 0.43 16.73 11.31 2.11 18.06 -22.96 15.22 -5.37 -24.96 15.74 -5.90 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO A 48 PRO.? 22.43 NI NI A 502 A 272 LEU A 21 LEU~? 17.63 NI NI A 502 A 276 ARG A 17 ARG~? 9.21 NI NI A 502 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -15.36 18.97 -9.56 -15.07 17.49 -7.87 coo 10.97 0.43 16.73 11.31 2.11 18.06 -20.00 21.79 -13.26 -18.56 20.78 -12.09 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO A 48 PRO.? 22.43 NI NI A 502 A 272 LEU A 47 LEU.? 22.37 NI NI A 501 A 276 ARG A 52 ARG.? 31.42 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -15.36 18.97 -9.56 -15.07 17.49 -7.87 coo 10.97 0.43 16.73 11.31 2.11 18.06 -19.01 17.90 -6.76 -19.69 18.63 -4.76 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -14.75 24.67 -0.61 -16.95 23.86 1.49 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO A 54 PRO.? 25.21 NI NI A 502 A 272 LEU A 15 LEU~? 20.52 NI NI A 502 A 276 ARG A 17 ARG~? 9.21 NI NI A 502 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -20.55 29.13 -6.12 -21.27 28.05 -4.30 coo 10.97 0.43 16.73 11.31 2.11 18.06 -21.59 31.90 -12.06 -22.96 31.73 -10.25 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO B 40 PRO.? 18.96 NI NI A 502 A 272 LEU B 26 LEU~? 16.29 NI NI A 502 A 276 ARG B 23 ARG~? 15.67 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -27.55 17.37 -43.60 -28.66 17.38 -45.62 coo 10.97 0.43 16.73 11.31 2.11 18.06 -28.62 16.28 -37.92 -30.02 16.04 -39.49 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO B 48 PRO.? 22.56 NI NI A 501 A 272 LEU B 21 LEU~? 17.41 NI NI A 501 A 276 ARG B 17 ARG~? 8.61 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -24.03 4.11 -38.25 -22.85 4.40 -40.21 coo 10.97 0.43 16.73 11.31 2.11 18.06 -28.75 6.52 -34.37 -27.41 5.60 -35.64 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO B 54 PRO.? 24.81 NI NI A 501 A 272 LEU B 15 LEU~? 20.01 NI NI A 501 A 276 ARG B 17 ARG~? 8.61 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -35.57 3.81 -41.47 -34.84 4.31 -43.51 coo 10.97 0.43 16.73 11.31 2.11 18.06 -38.35 2.65 -35.68 -38.89 3.74 -37.46 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO B 54 PRO.? 24.81 NI NI A 501 A 272 LEU B 19 LEU~? 18.22 NI NI A 501 A 276 ARG B 17 ARG~? 8.61 NI NI A 501 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -35.57 3.81 -41.47 -34.84 4.31 -43.51 coo 10.97 0.43 16.73 11.31 2.11 18.06 -35.48 8.49 -34.80 -36.46 10.43 -34.44 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -32.06 1.37 -29.33 -31.49 1.19 -26.24 1emh_d00 source 1emh HYDROLASE/DNA : 10 hits 1emh_d00 naa= 3 ULMN 4 1pt3_d00 HYDROLASE/DNA user 1 4 # 1 A 493 ASP B 88 ASP^? 15.06 NI NI A 502 A 496 ARG A 23 ARG~? 15.85 NI NI A 502 A 497 LYS B 123 LYS^? 13.38 NI NI A 501 A 538 ARG A 17 ARG~? 9.21 NI NI A 502 coo 15.86 25.80 6.36 15.63 24.95 4.48 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 13.63 31.13 3.81 13.19 28.14 4.37 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 13.35 31.27 9.53 12.86 25.24 10.46 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 9.10 29.26 -6.38 11.11 30.45 -8.37 -19.20 27.45 -18.86 -18.35 28.58 -21.68 1pt3_d00 source 1pt3 HYDROLASE/DNA : 1 hits 1pt3_d00 naa= 4 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 23 ARG~? 15.85 NI NI A 502 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 46 ARG A 17 ARG~? 9.21 NI NI A 502 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG A 23 ARG~? 15.85 NI NI A 502 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 46 ARG A 25 ARG~? 18.03 NI NI A 501 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG B 23 ARG~? 15.67 NI NI A 501 A 32 LYS A 123 LYS^? 12.92 NI NI A 502 A 46 ARG B 25 ARG~? 17.38 NI NI A 502 coo -8.00 4.27 27.74 -7.09 2.66 30.09 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -23.60 10.54 -37.24 -21.22 8.75 -36.58 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 3 hits 2ky8_d00 naa= 3 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 24 SER~? 14.80 NI NI A 501 360 GLU A 28 GLU~? 13.04 NI NI A 501 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 3.38 8.39 11.51 1.79 8.22 12.92 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 2 2 # 2 246 SER A 66 SER^? 13.16 NI NI A 501 360 GLU B 124 GLU.? 12.68 NI NI A 501 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 3.38 8.39 11.51 1.79 8.22 12.92 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 3 2 # 3 246 SER A 87 SER.? 14.75 NI NI A 502 360 GLU A 86 GLU.? 9.00 NI NI A 502 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 3.38 8.39 11.51 1.79 8.22 12.92 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 4 2 # 4 246 SER A 87 SER.? 14.75 NI NI A 502 360 GLU A 124 GLU.? 14.10 NI NI A 502 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 3.38 8.39 11.51 1.79 8.22 12.92 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 5 2 # 5 246 SER B 24 SER~? 15.42 NI NI A 502 360 GLU B 28 GLU~? 10.98 NI NI A 502 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 3.38 8.39 11.51 1.79 8.22 12.92 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 6 2 # 6 246 SER B 66 SER^? 13.28 NI NI A 502 360 GLU A 124 GLU.? 14.10 NI NI A 502 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 3.38 8.39 11.51 1.79 8.22 12.92 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 7 2 # 7 246 SER B 87 SER.? 15.38 NI NI A 501 360 GLU B 86 GLU.? 9.13 NI NI A 501 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 3.38 8.39 11.51 1.79 8.22 12.92 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 8 2 # 8 246 SER B 87 SER.? 15.38 NI NI A 501 360 GLU B 124 GLU.? 12.68 NI NI A 501 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 3.38 8.39 11.51 1.79 8.22 12.92 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1oxa_c00 source 1oxa CYTOCHROME P450 ERYF : 8 hits 1oxa_c00 naa= 2 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 123 LYS^? 12.92 NI NI A 502 X 56 TYR B 22 TYR~? 21.09 NI NI A 502 coo 9.69 63.83 35.55 11.00 62.83 41.36 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 10.51 70.44 44.57 10.41 68.10 43.00 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 123 LYS^? 12.92 NI NI A 502 X 56 TYR B 60 TYR^? 21.49 NI NI A 502 coo 9.69 63.83 35.55 11.00 62.83 41.36 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 10.51 70.44 44.57 10.41 68.10 43.00 -35.15 21.17 -42.13 -35.63 23.37 -43.86 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS B 123 LYS^? 13.38 NI NI A 501 X 56 TYR A 22 TYR~? 21.39 NI NI A 501 coo 9.69 63.83 35.55 11.00 62.83 41.36 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 10.51 70.44 44.57 10.41 68.10 43.00 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS B 123 LYS^? 13.38 NI NI A 501 X 56 TYR A 60 TYR^? 20.44 NI NI A 501 coo 9.69 63.83 35.55 11.00 62.83 41.36 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 10.51 70.44 44.57 10.41 68.10 43.00 -35.80 19.06 -5.58 -37.88 17.67 -4.34 1pae_c01 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 4 hits 1pae_c01 naa= 2 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 86 GLU.? 9.00 NI NI A 502 A 375 GLU A 124 GLU.? 14.10 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 61.89 10.05 27.30 63.60 9.39 28.40 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 124 GLU.? 14.10 NI NI A 502 A 375 GLU A 86 GLU.? 9.00 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 61.89 10.05 27.30 63.60 9.39 28.40 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU B 86 GLU.? 9.13 NI NI A 501 A 375 GLU B 124 GLU.? 12.68 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 61.89 10.05 27.30 63.60 9.39 28.40 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU B 124 GLU.? 12.68 NI NI A 501 A 375 GLU B 86 GLU.? 9.13 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 61.89 10.05 27.30 63.60 9.39 28.40 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1pbg_c02 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c02 naa= 2 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 86 GLU.? 9.00 NI NI A 502 B 375 GLU A 124 GLU.? 14.10 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 21.67 20.74 89.92 23.35 20.55 88.67 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 124 GLU.? 14.10 NI NI A 502 B 375 GLU A 86 GLU.? 9.00 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 21.67 20.74 89.92 23.35 20.55 88.67 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU B 86 GLU.? 9.13 NI NI A 501 B 375 GLU B 124 GLU.? 12.68 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 21.67 20.74 89.92 23.35 20.55 88.67 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU B 124 GLU.? 12.68 NI NI A 501 B 375 GLU B 86 GLU.? 9.13 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 21.67 20.74 89.92 23.35 20.55 88.67 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1pbg_c03 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c03 naa= 2 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 11 GLU.? 16.09 NI NI A 502 A 269 GLU B 28 GLU~? 10.98 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.68 34.30 -16.31 -14.02 33.99 -17.68 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 11 GLU.? 16.09 NI NI A 502 A 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.68 34.30 -16.31 -14.02 33.99 -17.68 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 11 GLU.? 16.09 NI NI A 502 A 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.68 34.30 -16.31 -14.02 33.99 -17.68 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 28 GLU~? 13.04 NI NI A 501 A 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU A 86 GLU.? 9.00 NI NI A 502 A 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU A 86 GLU.? 9.00 NI NI A 502 A 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 A 160 GLU A 86 GLU.? 9.00 NI NI A 502 A 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 A 160 GLU A 116 GLU.? 34.96 NI NI A 501 A 269 GLU A 86 GLU.? 9.00 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 A 160 GLU A 116 GLU.? 34.96 NI NI A 501 A 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 A 160 GLU A 116 GLU.? 34.96 NI NI A 501 A 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 A 160 GLU A 116 GLU.? 34.96 NI NI A 501 A 269 GLU B 124 GLU.? 12.68 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 A 160 GLU A 124 GLU.? 14.10 NI NI A 502 A 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 A 160 GLU B 8 GLU.? 22.17 NI NI A 501 A 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 A 160 GLU B 8 GLU.? 22.17 NI NI A 501 A 269 GLU B 124 GLU.? 12.68 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 A 160 GLU B 11 GLU~? 14.38 NI NI A 501 A 269 GLU A 28 GLU~? 13.04 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 A 160 GLU B 11 GLU~? 14.38 NI NI A 501 A 269 GLU A 86 GLU.? 9.00 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 A 160 GLU B 11 GLU~? 14.38 NI NI A 501 A 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 A 160 GLU B 11 GLU~? 14.38 NI NI A 501 A 269 GLU B 28 GLU~? 10.98 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 A 160 GLU B 28 GLU~? 10.98 NI NI A 502 A 269 GLU A 11 GLU.? 16.09 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 20 2 # 20 A 160 GLU B 28 GLU~? 10.98 NI NI A 502 A 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 21 2 # 21 A 160 GLU B 86 GLU.? 9.13 NI NI A 501 A 269 GLU A 11 GLU.? 16.09 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 22 2 # 22 A 160 GLU B 86 GLU.? 9.13 NI NI A 501 A 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 23 2 # 23 A 160 GLU B 86 GLU.? 9.13 NI NI A 501 A 269 GLU B 8 GLU.? 22.17 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 24 2 # 24 A 160 GLU B 86 GLU.? 9.13 NI NI A 501 A 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 25 2 # 25 A 160 GLU B 116 GLU.? 34.45 NI NI A 502 A 269 GLU A 11 GLU.? 16.09 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 26 2 # 26 A 160 GLU B 116 GLU.? 34.45 NI NI A 502 A 269 GLU A 86 GLU.? 9.00 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 27 2 # 27 A 160 GLU B 116 GLU.? 34.45 NI NI A 502 A 269 GLU A 124 GLU.? 14.10 NI NI A 502 coo 63.94 10.02 33.47 64.31 8.24 32.38 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 28 2 # 28 A 160 GLU B 116 GLU.? 34.45 NI NI A 502 A 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 29 2 # 29 A 160 GLU B 124 GLU.? 12.68 NI NI A 501 A 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 30 2 # 30 A 160 GLU B 124 GLU.? 12.68 NI NI A 501 A 269 GLU B 8 GLU.? 22.17 NI NI A 501 coo 63.94 10.02 33.47 64.31 8.24 32.38 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 1pbg_c04 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 30 hits 1pbg_c04 naa= 2 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 11 GLU.? 16.09 NI NI A 502 B 269 GLU B 28 GLU~? 10.98 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.68 34.30 -16.31 -14.02 33.99 -17.68 coo 21.20 8.49 59.63 20.88 8.62 57.55 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 11 GLU.? 16.09 NI NI A 502 B 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.68 34.30 -16.31 -14.02 33.99 -17.68 coo 21.20 8.49 59.63 20.88 8.62 57.55 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU A 11 GLU.? 16.09 NI NI A 502 B 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.68 34.30 -16.31 -14.02 33.99 -17.68 coo 21.20 8.49 59.63 20.88 8.62 57.55 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU A 28 GLU~? 13.04 NI NI A 501 B 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 21.20 8.49 59.63 20.88 8.62 57.55 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 B 160 GLU A 86 GLU.? 9.00 NI NI A 502 B 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 21.20 8.49 59.63 20.88 8.62 57.55 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 B 160 GLU A 86 GLU.? 9.00 NI NI A 502 B 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 21.20 8.49 59.63 20.88 8.62 57.55 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 B 160 GLU A 86 GLU.? 9.00 NI NI A 502 B 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 21.20 8.49 59.63 20.88 8.62 57.55 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 B 160 GLU A 116 GLU.? 34.96 NI NI A 501 B 269 GLU A 86 GLU.? 9.00 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 21.20 8.49 59.63 20.88 8.62 57.55 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 B 160 GLU A 116 GLU.? 34.96 NI NI A 501 B 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 21.20 8.49 59.63 20.88 8.62 57.55 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 B 160 GLU A 116 GLU.? 34.96 NI NI A 501 B 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 21.20 8.49 59.63 20.88 8.62 57.55 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 B 160 GLU A 116 GLU.? 34.96 NI NI A 501 B 269 GLU B 124 GLU.? 12.68 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -49.93 20.01 -40.14 -51.36 19.66 -41.66 coo 21.20 8.49 59.63 20.88 8.62 57.55 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 B 160 GLU A 124 GLU.? 14.10 NI NI A 502 B 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 21.20 8.49 59.63 20.88 8.62 57.55 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 B 160 GLU B 8 GLU.? 22.17 NI NI A 501 B 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo 21.20 8.49 59.63 20.88 8.62 57.55 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 B 160 GLU B 8 GLU.? 22.17 NI NI A 501 B 269 GLU B 124 GLU.? 12.68 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo 21.20 8.49 59.63 20.88 8.62 57.55 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 B 160 GLU B 11 GLU~? 14.38 NI NI A 501 B 269 GLU A 28 GLU~? 13.04 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 21.20 8.49 59.63 20.88 8.62 57.55 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 B 160 GLU B 11 GLU~? 14.38 NI NI A 501 B 269 GLU A 86 GLU.? 9.00 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 21.20 8.49 59.63 20.88 8.62 57.55 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 B 160 GLU B 11 GLU~? 14.38 NI NI A 501 B 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 21.20 8.49 59.63 20.88 8.62 57.55 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 B 160 GLU B 11 GLU~? 14.38 NI NI A 501 B 269 GLU B 28 GLU~? 10.98 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 coo 21.20 8.49 59.63 20.88 8.62 57.55 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 B 160 GLU B 28 GLU~? 10.98 NI NI A 502 B 269 GLU A 11 GLU.? 16.09 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 20 2 # 20 B 160 GLU B 28 GLU~? 10.98 NI NI A 502 B 269 GLU B 11 GLU~? 14.38 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 21.20 8.49 59.63 20.88 8.62 57.55 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 21 2 # 21 B 160 GLU B 86 GLU.? 9.13 NI NI A 501 B 269 GLU A 11 GLU.? 16.09 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 22 2 # 22 B 160 GLU B 86 GLU.? 9.13 NI NI A 501 B 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 21.20 8.49 59.63 20.88 8.62 57.55 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 23 2 # 23 B 160 GLU B 86 GLU.? 9.13 NI NI A 501 B 269 GLU B 8 GLU.? 22.17 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 21.20 8.49 59.63 20.88 8.62 57.55 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 24 2 # 24 B 160 GLU B 86 GLU.? 9.13 NI NI A 501 B 269 GLU B 116 GLU.? 34.45 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 21.20 8.49 59.63 20.88 8.62 57.55 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 25 2 # 25 B 160 GLU B 116 GLU.? 34.45 NI NI A 502 B 269 GLU A 11 GLU.? 16.09 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 26 2 # 26 B 160 GLU B 116 GLU.? 34.45 NI NI A 502 B 269 GLU A 86 GLU.? 9.00 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 21.20 8.49 59.63 20.88 8.62 57.55 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 27 2 # 27 B 160 GLU B 116 GLU.? 34.45 NI NI A 502 B 269 GLU A 124 GLU.? 14.10 NI NI A 502 coo 23.66 16.69 85.20 24.17 18.76 84.94 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 21.20 8.49 59.63 20.88 8.62 57.55 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 28 2 # 28 B 160 GLU B 116 GLU.? 34.45 NI NI A 502 B 269 GLU B 86 GLU.? 9.13 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -40.98 33.61 -5.94 -39.53 34.29 -4.51 coo 21.20 8.49 59.63 20.88 8.62 57.55 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 29 2 # 29 B 160 GLU B 124 GLU.? 12.68 NI NI A 501 B 269 GLU A 116 GLU.? 34.96 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 21.20 8.49 59.63 20.88 8.62 57.55 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 30 2 # 30 B 160 GLU B 124 GLU.? 12.68 NI NI A 501 B 269 GLU B 8 GLU.? 22.17 NI NI A 501 coo 23.66 16.69 85.20 24.17 18.76 84.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 21.20 8.49 59.63 20.88 8.62 57.55 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 1pbg_c05 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 30 hits 1pbg_c05 naa= 2 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 1 2 # 1 A 178 TYR A 22 TYR~? 21.39 NI NI A 501 A 283 TYR A 29 TYR~? 15.38 NI NI A 501 coo 29.64 7.69 5.12 29.91 9.25 2.80 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 25.32 16.13 3.80 24.28 14.46 1.84 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 2 2 # 2 A 178 TYR A 22 TYR~? 21.39 NI NI A 501 A 283 TYR A 67 TYR^? 18.49 NI NI A 501 coo 29.64 7.69 5.12 29.91 9.25 2.80 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 25.32 16.13 3.80 24.28 14.46 1.84 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 3 2 # 3 A 178 TYR A 29 TYR~? 15.38 NI NI A 501 A 283 TYR A 22 TYR~? 21.39 NI NI A 501 coo 29.64 7.69 5.12 29.91 9.25 2.80 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 25.32 16.13 3.80 24.28 14.46 1.84 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 4 2 # 4 A 178 TYR A 29 TYR~? 15.38 NI NI A 501 A 283 TYR A 60 TYR^? 20.44 NI NI A 501 coo 29.64 7.69 5.12 29.91 9.25 2.80 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 25.32 16.13 3.80 24.28 14.46 1.84 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 5 2 # 5 A 178 TYR A 60 TYR^? 20.44 NI NI A 501 A 283 TYR A 29 TYR~? 15.38 NI NI A 501 coo 29.64 7.69 5.12 29.91 9.25 2.80 -35.80 19.06 -5.58 -37.88 17.67 -4.34 coo 25.32 16.13 3.80 24.28 14.46 1.84 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 6 2 # 6 A 178 TYR A 67 TYR^? 18.49 NI NI A 501 A 283 TYR A 22 TYR~? 21.39 NI NI A 501 coo 29.64 7.69 5.12 29.91 9.25 2.80 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 25.32 16.13 3.80 24.28 14.46 1.84 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 7 2 # 7 A 178 TYR B 22 TYR~? 21.09 NI NI A 502 A 283 TYR B 29 TYR~? 14.52 NI NI A 502 coo 29.64 7.69 5.12 29.91 9.25 2.80 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 25.32 16.13 3.80 24.28 14.46 1.84 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 8 2 # 8 A 178 TYR B 22 TYR~? 21.09 NI NI A 502 A 283 TYR B 67 TYR^? 18.53 NI NI A 502 coo 29.64 7.69 5.12 29.91 9.25 2.80 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 25.32 16.13 3.80 24.28 14.46 1.84 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 9 2 # 9 A 178 TYR B 29 TYR~? 14.52 NI NI A 502 A 283 TYR B 22 TYR~? 21.09 NI NI A 502 coo 29.64 7.69 5.12 29.91 9.25 2.80 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 25.32 16.13 3.80 24.28 14.46 1.84 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 10 2 # 10 A 178 TYR B 67 TYR^? 18.53 NI NI A 502 A 283 TYR B 22 TYR~? 21.09 NI NI A 502 coo 29.64 7.69 5.12 29.91 9.25 2.80 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 25.32 16.13 3.80 24.28 14.46 1.84 -30.89 10.60 -39.31 -31.13 12.07 -41.74 1peg_c00 source 1peg HISTONE H3 METHYLTRANSFERASE DIM-5 : 10 hits 1peg_c00 naa= 2 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 1 2 # 1 B 178 TYR A 22 TYR~? 21.39 NI NI A 501 B 283 TYR A 29 TYR~? 15.38 NI NI A 501 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 2 2 # 2 B 178 TYR A 22 TYR~? 21.39 NI NI A 501 B 283 TYR A 67 TYR^? 18.49 NI NI A 501 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 3 2 # 3 B 178 TYR A 29 TYR~? 15.38 NI NI A 501 B 283 TYR A 22 TYR~? 21.39 NI NI A 501 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 4 2 # 4 B 178 TYR A 29 TYR~? 15.38 NI NI A 501 B 283 TYR A 60 TYR^? 20.44 NI NI A 501 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 5 2 # 5 B 178 TYR A 60 TYR^? 20.44 NI NI A 501 B 283 TYR A 29 TYR~? 15.38 NI NI A 501 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -35.80 19.06 -5.58 -37.88 17.67 -4.34 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 6 2 # 6 B 178 TYR A 67 TYR^? 18.49 NI NI A 501 B 283 TYR A 22 TYR~? 21.39 NI NI A 501 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 7 2 # 7 B 178 TYR B 22 TYR~? 21.09 NI NI A 502 B 283 TYR B 29 TYR~? 14.52 NI NI A 502 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 8 2 # 8 B 178 TYR B 22 TYR~? 21.09 NI NI A 502 B 283 TYR B 67 TYR^? 18.53 NI NI A 502 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 9 2 # 9 B 178 TYR B 29 TYR~? 14.52 NI NI A 502 B 283 TYR B 22 TYR~? 21.09 NI NI A 502 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 10 2 # 10 B 178 TYR B 67 TYR^? 18.53 NI NI A 502 B 283 TYR B 22 TYR~? 21.09 NI NI A 502 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -30.89 10.60 -39.31 -31.13 12.07 -41.74 1peg_c01 source 1peg HISTONE H3 METHYLTRANSFERASE DIM-5 : 10 hits 1peg_c01 naa= 2 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 1 2 # 1 60 ASP A 82 ASP~? 15.20 NI NI A 502 206 GLU A 86 GLU.? 9.00 NI NI A 502 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 2 2 # 2 60 ASP A 82 ASP~? 15.20 NI NI A 502 206 GLU A 124 GLU.? 14.10 NI NI A 502 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 3 2 # 3 60 ASP A 88 ASP^? 14.52 NI NI A 501 206 GLU A 86 GLU.? 9.00 NI NI A 502 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 4 2 # 4 60 ASP A 88 ASP^? 14.52 NI NI A 501 206 GLU A 124 GLU.? 14.10 NI NI A 502 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 5 2 # 5 60 ASP A 88 ASP^? 14.52 NI NI A 501 206 GLU B 86 GLU.? 9.13 NI NI A 501 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 6 2 # 6 60 ASP A 88 ASP^? 14.52 NI NI A 501 206 GLU B 124 GLU.? 12.68 NI NI A 501 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 7 2 # 7 60 ASP B 82 ASP~? 13.99 NI NI A 501 206 GLU B 86 GLU.? 9.13 NI NI A 501 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 8 2 # 8 60 ASP B 82 ASP~? 13.99 NI NI A 501 206 GLU B 124 GLU.? 12.68 NI NI A 501 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 9 2 # 9 60 ASP B 88 ASP^? 15.06 NI NI A 502 206 GLU A 86 GLU.? 9.00 NI NI A 502 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 10 2 # 10 60 ASP B 88 ASP^? 15.06 NI NI A 502 206 GLU A 124 GLU.? 14.10 NI NI A 502 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 11 2 # 11 60 ASP B 88 ASP^? 15.06 NI NI A 502 206 GLU B 86 GLU.? 9.13 NI NI A 501 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 12 2 # 12 60 ASP B 88 ASP^? 15.06 NI NI A 502 206 GLU B 124 GLU.? 12.68 NI NI A 501 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1pgs_c00 source 1pgs PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSAMINYL) AS: 12 hits 1pgs_c00 naa= 2 ULMN 2 1ps1_c00 PENTALENENE SYNTHASE user 1 2 # 1 A 77 PHE A 36 PHE.? 17.17 NI NI A 501 A 309 HIS A 31 HIS~? -4.16 NI NI A 501s coo 50.92 66.26 27.35 49.39 65.20 29.47 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 40.83 63.47 32.68 42.69 62.61 32.19 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1ps1_c00 PENTALENENE SYNTHASE user 2 2 # 2 A 77 PHE A 36 PHE.? 17.17 NI NI A 501 A 309 HIS B 127 HIS.? 5.53 NI NI A 501 coo 50.92 66.26 27.35 49.39 65.20 29.47 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 40.83 63.47 32.68 42.69 62.61 32.19 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1ps1_c00 PENTALENENE SYNTHASE user 3 2 # 3 A 77 PHE B 36 PHE.? 17.03 NI NI A 502 A 309 HIS B 31 HIS~? -3.92 NI NI A 502s coo 50.92 66.26 27.35 49.39 65.20 29.47 -26.15 23.36 -43.90 -26.62 21.39 -45.87 coo 40.83 63.47 32.68 42.69 62.61 32.19 -20.11 22.22 -33.67 -18.33 23.04 -32.88 1ps1_c00 source 1ps1 PENTALENENE SYNTHASE : 3 hits 1ps1_c00 naa= 2 ULMN 2 1ps1_c01 PENTALENENE SYNTHASE user 1 2 # 1 B 77 PHE A 36 PHE.? 17.17 NI NI A 501 B 309 HIS A 31 HIS~? -4.16 NI NI A 501s coo 70.89 30.37 52.79 69.71 32.41 54.33 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 69.54 37.51 61.78 69.32 37.78 59.70 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1ps1_c01 PENTALENENE SYNTHASE user 2 2 # 2 B 77 PHE A 36 PHE.? 17.17 NI NI A 501 B 309 HIS B 127 HIS.? 5.53 NI NI A 501 coo 70.89 30.37 52.79 69.71 32.41 54.33 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 69.54 37.51 61.78 69.32 37.78 59.70 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1ps1_c01 PENTALENENE SYNTHASE user 3 2 # 3 B 77 PHE B 36 PHE.? 17.03 NI NI A 502 B 309 HIS B 31 HIS~? -3.92 NI NI A 502s coo 70.89 30.37 52.79 69.71 32.41 54.33 -26.15 23.36 -43.90 -26.62 21.39 -45.87 coo 69.54 37.51 61.78 69.32 37.78 59.70 -20.11 22.22 -33.67 -18.33 23.04 -32.88 1ps1_c01 source 1ps1 PENTALENENE SYNTHASE : 3 hits 1ps1_c01 naa= 2 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 A 269 GLU A 28 GLU~? 13.04 NI NI A 501 A 292 HIS A 31 HIS~? -4.16 NI NI A 501s coo 38.27 25.19 38.30 39.02 23.31 37.65 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 41.07 20.90 35.69 40.38 19.20 36.71 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 2 2 # 2 A 269 GLU A 86 GLU.? 9.00 NI NI A 502 A 292 HIS A 126 HIS.? -3.75 NI NI A 502s coo 38.27 25.19 38.30 39.02 23.31 37.65 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 41.07 20.90 35.69 40.38 19.20 36.71 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 3 2 # 3 A 269 GLU B 28 GLU~? 10.98 NI NI A 502 A 292 HIS B 31 HIS~? -3.92 NI NI A 502s coo 38.27 25.19 38.30 39.02 23.31 37.65 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 41.07 20.90 35.69 40.38 19.20 36.71 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 4 2 # 4 A 269 GLU B 86 GLU.? 9.13 NI NI A 501 A 292 HIS B 126 HIS.? -4.79 NI NI A 501s coo 38.27 25.19 38.30 39.02 23.31 37.65 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 41.07 20.90 35.69 40.38 19.20 36.71 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 5 2 # 5 A 269 GLU B 124 GLU.? 12.68 NI NI A 501 A 292 HIS B 126 HIS.? -4.79 NI NI A 501s coo 38.27 25.19 38.30 39.02 23.31 37.65 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 41.07 20.90 35.69 40.38 19.20 36.71 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1psd_c00 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 5 hits 1psd_c00 naa= 2 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 B 269 GLU A 28 GLU~? 13.04 NI NI A 501 B 292 HIS A 31 HIS~? -4.16 NI NI A 501s coo 73.23 38.34 28.02 73.78 36.50 28.89 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 73.82 33.94 31.43 75.53 32.98 30.68 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 2 2 # 2 B 269 GLU A 86 GLU.? 9.00 NI NI A 502 B 292 HIS A 126 HIS.? -3.75 NI NI A 502s coo 73.23 38.34 28.02 73.78 36.50 28.89 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 73.82 33.94 31.43 75.53 32.98 30.68 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 3 2 # 3 B 269 GLU B 28 GLU~? 10.98 NI NI A 502 B 292 HIS B 31 HIS~? -3.92 NI NI A 502s coo 73.23 38.34 28.02 73.78 36.50 28.89 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 73.82 33.94 31.43 75.53 32.98 30.68 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 4 2 # 4 B 269 GLU B 86 GLU.? 9.13 NI NI A 501 B 292 HIS B 126 HIS.? -4.79 NI NI A 501s coo 73.23 38.34 28.02 73.78 36.50 28.89 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 73.82 33.94 31.43 75.53 32.98 30.68 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1psd_c01 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 4 hits 1psd_c01 naa= 2 ULMN 2 1pwv_c00 LETHAL FACTOR user 1 2 # 1 A 687 GLU A 28 GLU~? 13.04 NI NI A 501 A 728 TYR A 22 TYR~? 21.39 NI NI A 501 coo 77.63 40.02 139.16 79.74 39.94 138.95 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 84.86 31.94 140.08 85.28 34.63 139.44 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1pwv_c00 LETHAL FACTOR user 2 2 # 2 A 687 GLU B 28 GLU~? 10.98 NI NI A 502 A 728 TYR B 22 TYR~? 21.09 NI NI A 502 coo 77.63 40.02 139.16 79.74 39.94 138.95 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 84.86 31.94 140.08 85.28 34.63 139.44 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1pwv_c00 LETHAL FACTOR user 3 2 # 3 A 687 GLU B 124 GLU.? 12.68 NI NI A 501 A 728 TYR A 60 TYR^? 20.44 NI NI A 501 coo 77.63 40.02 139.16 79.74 39.94 138.95 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 84.86 31.94 140.08 85.28 34.63 139.44 -35.80 19.06 -5.58 -37.88 17.67 -4.34 1pwv_c00 source 1pwv LETHAL FACTOR : 3 hits 1pwv_c00 naa= 2 ULMN 2 1pwv_c01 LETHAL FACTOR user 1 2 # 1 B 687 GLU A 28 GLU~? 13.04 NI NI A 501 B 728 TYR A 22 TYR~? 21.39 NI NI A 501 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 105.30 6.94 120.65 104.99 4.15 120.81 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1pwv_c01 LETHAL FACTOR user 2 2 # 2 B 687 GLU B 28 GLU~? 10.98 NI NI A 502 B 728 TYR B 22 TYR~? 21.09 NI NI A 502 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 105.30 6.94 120.65 104.99 4.15 120.81 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1pwv_c01 LETHAL FACTOR user 3 2 # 3 B 687 GLU B 124 GLU.? 12.68 NI NI A 501 B 728 TYR A 60 TYR^? 20.44 NI NI A 501 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 105.30 6.94 120.65 104.99 4.15 120.81 -35.80 19.06 -5.58 -37.88 17.67 -4.34 1pwv_c01 source 1pwv LETHAL FACTOR : 3 hits 1pwv_c01 naa= 2 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 A 62 ASP A 42 ASP.? 24.20 NI NI A 501 A 64 LYS A 53 LYS.? 25.39 NI NI A 501 coo 61.71 14.20 19.64 60.68 14.94 21.37 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 55.72 12.42 20.66 58.31 17.81 21.97 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 A 62 ASP A 88 ASP^? 14.52 NI NI A 501 A 64 LYS A 123 LYS^? 12.92 NI NI A 502 coo 61.71 14.20 19.64 60.68 14.94 21.37 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 55.72 12.42 20.66 58.31 17.81 21.97 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 A 62 ASP B 42 ASP.? 24.38 NI NI A 502 A 64 LYS B 53 LYS.? 26.24 NI NI A 502 coo 61.71 14.20 19.64 60.68 14.94 21.37 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 55.72 12.42 20.66 58.31 17.81 21.97 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 2 # 4 A 62 ASP B 88 ASP^? 15.06 NI NI A 502 A 64 LYS B 123 LYS^? 13.38 NI NI A 501 coo 61.71 14.20 19.64 60.68 14.94 21.37 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 55.72 12.42 20.66 58.31 17.81 21.97 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1q6l_c00 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_c00 naa= 2 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 B 62 ASP A 42 ASP.? 24.20 NI NI A 501 B 64 LYS A 53 LYS.? 25.39 NI NI A 501 coo 45.81 14.64 11.83 45.04 13.82 13.65 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 48.63 16.35 17.25 45.95 10.72 16.28 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 B 62 ASP A 88 ASP^? 14.52 NI NI A 501 B 64 LYS A 123 LYS^? 12.92 NI NI A 502 coo 45.81 14.64 11.83 45.04 13.82 13.65 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 48.63 16.35 17.25 45.95 10.72 16.28 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 B 62 ASP B 42 ASP.? 24.38 NI NI A 502 B 64 LYS B 53 LYS.? 26.24 NI NI A 502 coo 45.81 14.64 11.83 45.04 13.82 13.65 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 48.63 16.35 17.25 45.95 10.72 16.28 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 2 # 4 B 62 ASP B 88 ASP^? 15.06 NI NI A 502 B 64 LYS B 123 LYS^? 13.38 NI NI A 501 coo 45.81 14.64 11.83 45.04 13.82 13.65 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 48.63 16.35 17.25 45.95 10.72 16.28 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1q6l_c01 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_c01 naa= 2 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 A 334 HIS A 31 HIS~? -4.16 NI NI A 501s A 550 SER A 24 SER~? 14.80 NI NI A 501 coo 38.40 88.96 58.48 39.26 87.53 59.75 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 46.35 85.43 65.37 45.80 86.30 63.18 -24.49 16.91 -14.42 -22.87 15.82 -15.86 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 2 2 # 2 A 334 HIS A 31 HIS~? -4.16 NI NI A 501s A 550 SER A 66 SER^? 13.16 NI NI A 501 coo 38.40 88.96 58.48 39.26 87.53 59.75 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 46.35 85.43 65.37 45.80 86.30 63.18 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 3 2 # 3 A 334 HIS A 126 HIS.? -3.75 NI NI A 502s A 550 SER A 87 SER.? 14.75 NI NI A 502 coo 38.40 88.96 58.48 39.26 87.53 59.75 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 46.35 85.43 65.37 45.80 86.30 63.18 -31.76 21.87 -25.29 -32.13 24.17 -24.48 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 4 2 # 4 A 334 HIS A 126 HIS.? -3.75 NI NI A 502s A 550 SER B 66 SER^? 13.28 NI NI A 502 coo 38.40 88.96 58.48 39.26 87.53 59.75 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 46.35 85.43 65.37 45.80 86.30 63.18 -31.33 20.29 -35.99 -29.23 19.21 -35.57 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 5 2 # 5 A 334 HIS B 31 HIS~? -3.92 NI NI A 502s A 550 SER B 24 SER~? 15.42 NI NI A 502 coo 38.40 88.96 58.48 39.26 87.53 59.75 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 46.35 85.43 65.37 45.80 86.30 63.18 -26.98 12.98 -33.60 -27.18 11.97 -31.48 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 6 2 # 6 A 334 HIS B 31 HIS~? -3.92 NI NI A 502s A 550 SER B 66 SER^? 13.28 NI NI A 502 coo 38.40 88.96 58.48 39.26 87.53 59.75 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 46.35 85.43 65.37 45.80 86.30 63.18 -31.33 20.29 -35.99 -29.23 19.21 -35.57 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 7 2 # 7 A 334 HIS B 126 HIS.? -4.79 NI NI A 501s A 550 SER A 66 SER^? 13.16 NI NI A 501 coo 38.40 88.96 58.48 39.26 87.53 59.75 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 46.35 85.43 65.37 45.80 86.30 63.18 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 8 2 # 8 A 334 HIS B 127 HIS.? 5.53 NI NI A 501 A 550 SER A 66 SER^? 13.16 NI NI A 501 coo 38.40 88.96 58.48 39.26 87.53 59.75 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 46.35 85.43 65.37 45.80 86.30 63.18 -32.58 17.24 -12.10 -30.98 15.55 -12.25 1q6x_c02 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 8 hits 1q6x_c02 naa= 2 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 B 334 HIS A 31 HIS~? -4.16 NI NI A 501s B 550 SER A 24 SER~? 14.80 NI NI A 501 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -24.49 16.91 -14.42 -22.87 15.82 -15.86 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 2 2 # 2 B 334 HIS A 31 HIS~? -4.16 NI NI A 501s B 550 SER A 66 SER^? 13.16 NI NI A 501 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 3 2 # 3 B 334 HIS A 126 HIS.? -3.75 NI NI A 502s B 550 SER A 87 SER.? 14.75 NI NI A 502 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -31.76 21.87 -25.29 -32.13 24.17 -24.48 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 4 2 # 4 B 334 HIS A 126 HIS.? -3.75 NI NI A 502s B 550 SER B 66 SER^? 13.28 NI NI A 502 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -31.33 20.29 -35.99 -29.23 19.21 -35.57 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 5 2 # 5 B 334 HIS B 31 HIS~? -3.92 NI NI A 502s B 550 SER B 24 SER~? 15.42 NI NI A 502 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -26.98 12.98 -33.60 -27.18 11.97 -31.48 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 6 2 # 6 B 334 HIS B 31 HIS~? -3.92 NI NI A 502s B 550 SER B 66 SER^? 13.28 NI NI A 502 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -31.33 20.29 -35.99 -29.23 19.21 -35.57 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 7 2 # 7 B 334 HIS B 126 HIS.? -4.79 NI NI A 501s B 550 SER A 66 SER^? 13.16 NI NI A 501 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -32.58 17.24 -12.10 -30.98 15.55 -12.25 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 8 2 # 8 B 334 HIS B 127 HIS.? 5.53 NI NI A 501 B 550 SER A 66 SER^? 13.16 NI NI A 501 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -32.58 17.24 -12.10 -30.98 15.55 -12.25 1q6x_c03 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 8 hits 1q6x_c03 naa= 2 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 1 2 # 1 A 59 GLU A 28 GLU~? 13.04 NI NI A 501 A 101 ASN A 33 ASN.? 14.07 NI NI A 501 coo 17.21 39.80 29.23 17.83 38.53 27.67 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 11.70 33.75 21.15 12.72 34.11 19.33 -30.87 7.88 -5.92 -29.26 7.53 -4.61 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 2 2 # 2 A 59 GLU B 28 GLU~? 10.98 NI NI A 502 A 101 ASN B 33 ASN.? 13.74 NI NI A 502 coo 17.21 39.80 29.23 17.83 38.53 27.67 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 11.70 33.75 21.15 12.72 34.11 19.33 -21.15 22.18 -41.67 -19.86 21.73 -43.34 1qam_c00 source 1qam ERMC' METHYLTRANSFERASE : 2 hits 1qam_c00 naa= 2 ULMN 2 1qba_c00 CHITOBIASE user 1 2 # 1 539 ASP A 13 ASP~? 13.27 NI NI A 502 540 GLU A 11 GLU.? 16.09 NI NI A 502 coo 29.81 50.17 23.56 27.68 49.90 23.71 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 30.20 53.24 26.35 28.57 54.55 26.04 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1qba_c00 CHITOBIASE user 2 2 # 2 539 ASP B 13 ASP~? 14.49 NI NI A 501 540 GLU B 11 GLU~? 14.38 NI NI A 501 coo 29.81 50.17 23.56 27.68 49.90 23.71 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 30.20 53.24 26.35 28.57 54.55 26.04 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 1qba_c00 source 1qba CHITOBIASE : 2 hits 1qba_c00 naa= 2 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 1 2 # 1 C 142 HIS A 31 HIS~? -4.16 NI NI A 501s D 146 GLY A 84 GLY~? 9.33 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 15.87 13.94 20.94 16.37 13.66 20.42 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 2 2 # 2 C 142 HIS A 31 HIS~? -4.16 NI NI A 501s D 146 GLY A 91 GLY^? 20.30 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 15.87 13.94 20.94 16.37 13.66 20.42 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 3 2 # 3 C 142 HIS A 31 HIS~? -4.16 NI NI A 501s D 146 GLY A 125 GLY.? 7.36 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 15.87 13.94 20.94 16.37 13.66 20.42 -25.75 23.74 -30.38 -26.07 24.38 -30.24 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 4 2 # 4 C 142 HIS A 31 HIS~? -4.16 NI NI A 501s D 146 GLY B 76 GLY~? 18.88 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 15.87 13.94 20.94 16.37 13.66 20.42 -45.85 3.88 -29.84 -45.63 4.32 -30.50 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 5 2 # 5 C 142 HIS A 126 HIS.? -3.75 NI NI A 502s D 146 GLY A 59 GLY^? 20.99 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 15.87 13.94 20.94 16.37 13.66 20.42 -30.45 21.23 -6.47 -30.72 21.32 -5.76 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 6 2 # 6 C 142 HIS A 126 HIS.? -3.75 NI NI A 502s D 146 GLY A 91 GLY^? 20.30 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 15.87 13.94 20.94 16.37 13.66 20.42 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 7 2 # 7 C 142 HIS A 126 HIS.? -3.75 NI NI A 502s D 146 GLY B 46 GLY.? 19.27 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 15.87 13.94 20.94 16.37 13.66 20.42 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 8 2 # 8 C 142 HIS A 126 HIS.? -3.75 NI NI A 502s D 146 GLY B 84 GLY~? 8.68 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 15.87 13.94 20.94 16.37 13.66 20.42 -34.57 7.23 -25.18 -34.90 7.95 -25.10 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 9 2 # 9 C 142 HIS A 126 HIS.? -3.75 NI NI A 502s D 146 GLY B 104 GLY.? 24.06 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 15.87 13.94 20.94 16.37 13.66 20.42 -41.18 30.77 -25.05 -40.69 30.21 -24.71 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 10 2 # 10 C 142 HIS A 126 HIS.? -3.75 NI NI A 502s D 146 GLY B 125 GLY.? 8.70 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 15.87 13.94 20.94 16.37 13.66 20.42 -33.85 11.71 -15.90 -34.49 11.70 -16.45 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 11 2 # 11 C 142 HIS A 127 HIS.? 7.54 NI NI A 502 D 146 GLY B 59 GLY^? 20.93 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 15.87 13.94 20.94 16.37 13.66 20.42 -33.81 15.50 -40.90 -34.10 15.72 -41.69 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 12 2 # 12 C 142 HIS A 127 HIS.? 7.54 NI NI A 502 D 146 GLY B 104 GLY.? 24.06 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 15.87 13.94 20.94 16.37 13.66 20.42 -41.18 30.77 -25.05 -40.69 30.21 -24.71 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 13 2 # 13 C 142 HIS B 31 HIS~? -3.92 NI NI A 502s D 146 GLY A 76 GLY~? 19.91 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 15.87 13.94 20.94 16.37 13.66 20.42 -26.21 37.86 -17.31 -26.74 37.42 -16.86 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 14 2 # 14 C 142 HIS B 31 HIS~? -3.92 NI NI A 502s D 146 GLY B 84 GLY~? 8.68 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 15.87 13.94 20.94 16.37 13.66 20.42 -34.57 7.23 -25.18 -34.90 7.95 -25.10 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 15 2 # 15 C 142 HIS B 31 HIS~? -3.92 NI NI A 502s D 146 GLY B 91 GLY^? 20.73 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 15.87 13.94 20.94 16.37 13.66 20.42 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 16 2 # 16 C 142 HIS B 126 HIS.? -4.79 NI NI A 501s D 146 GLY A 46 GLY.? 19.33 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 15.87 13.94 20.94 16.37 13.66 20.42 -18.94 13.11 -6.31 -19.18 13.89 -6.25 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 17 2 # 17 C 142 HIS B 126 HIS.? -4.79 NI NI A 501s D 146 GLY A 84 GLY~? 9.33 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 15.87 13.94 20.94 16.37 13.66 20.42 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 18 2 # 18 C 142 HIS B 126 HIS.? -4.79 NI NI A 501s D 146 GLY A 117 GLY.? 28.20 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 15.87 13.94 20.94 16.37 13.66 20.42 -48.49 15.00 -37.16 -47.79 15.28 -37.35 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 19 2 # 19 C 142 HIS B 126 HIS.? -4.79 NI NI A 501s D 146 GLY A 125 GLY.? 7.36 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 15.87 13.94 20.94 16.37 13.66 20.42 -25.75 23.74 -30.38 -26.07 24.38 -30.24 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 20 2 # 20 C 142 HIS B 126 HIS.? -4.79 NI NI A 501s D 146 GLY B 59 GLY^? 20.93 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 15.87 13.94 20.94 16.37 13.66 20.42 -33.81 15.50 -40.90 -34.10 15.72 -41.69 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 21 2 # 21 C 142 HIS B 126 HIS.? -4.79 NI NI A 501s D 146 GLY B 91 GLY^? 20.73 NI NI A 502 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 15.87 13.94 20.94 16.37 13.66 20.42 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 22 2 # 22 C 142 HIS B 127 HIS.? 5.53 NI NI A 501 D 146 GLY A 46 GLY.? 19.33 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 15.87 13.94 20.94 16.37 13.66 20.42 -18.94 13.11 -6.31 -19.18 13.89 -6.25 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 23 2 # 23 C 142 HIS B 127 HIS.? 5.53 NI NI A 501 D 146 GLY A 104 GLY^? 23.74 NI NI A 501 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 15.87 13.94 20.94 16.37 13.66 20.42 -47.38 20.44 -22.49 -46.62 20.24 -22.80 1qd6_c00 source 1qd6 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA) : 23 hits 1qd6_c00 naa= 2 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 72 GLU A 86 GLU.? 9.00 NI NI A 502 A 147 THR A 83 THR~? 11.66 NI NI A 502 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -25.75 29.45 -24.12 -25.45 31.51 -23.71 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 72 GLU A 86 GLU.? 9.00 NI NI A 502 A 147 THR B 65 THR^? 14.18 NI NI A 502 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -30.21 23.51 -34.34 -32.04 24.61 -34.02 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 72 GLU A 124 GLU.? 14.10 NI NI A 502 A 147 THR A 83 THR~? 11.66 NI NI A 502 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -25.75 29.45 -24.12 -25.45 31.51 -23.71 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 72 GLU A 124 GLU.? 14.10 NI NI A 502 A 147 THR A 85 THR~? 12.80 NI NI A 502 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -26.43 24.20 -22.83 -27.87 24.69 -21.30 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 5 2 # 5 A 72 GLU A 124 GLU.? 14.10 NI NI A 502 A 147 THR B 100 THR.? 19.64 NI NI A 502 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -36.82 30.10 -22.17 -36.51 28.20 -23.14 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 6 2 # 6 A 72 GLU B 28 GLU~? 10.98 NI NI A 502 A 147 THR B 65 THR^? 14.18 NI NI A 502 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -30.21 23.51 -34.34 -32.04 24.61 -34.02 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 7 2 # 7 A 72 GLU B 86 GLU.? 9.13 NI NI A 501 A 147 THR A 65 THR.? 13.82 NI NI A 501 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -35.39 14.99 -13.24 -37.04 15.69 -14.45 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 8 2 # 8 A 72 GLU B 86 GLU.? 9.13 NI NI A 501 A 147 THR B 83 THR~? 9.81 NI NI A 501 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 9 2 # 9 A 72 GLU B 124 GLU.? 12.68 NI NI A 501 A 147 THR A 100 THR^? 19.44 NI NI A 501 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -44.82 16.79 -25.89 -42.97 17.43 -25.07 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 10 2 # 10 A 72 GLU B 124 GLU.? 12.68 NI NI A 501 A 147 THR B 83 THR~? 9.81 NI NI A 501 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 11 2 # 11 A 72 GLU B 124 GLU.? 12.68 NI NI A 501 A 147 THR B 85 THR.? 12.36 NI NI A 501 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -33.81 10.96 -25.09 -35.41 11.74 -26.39 1qgx_c00 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 11 hits 1qgx_c00 naa= 2 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 32 LYS A 53 LYS.? 25.39 NI NI A 501 A 147 THR A 14 THR~? 17.42 NI NI A 502 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -17.69 30.48 -14.71 -15.64 30.77 -13.94 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 32 LYS A 123 LYS^? 12.92 NI NI A 502 A 147 THR A 83 THR~? 11.66 NI NI A 502 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -25.75 29.45 -24.12 -25.45 31.51 -23.71 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 32 LYS A 123 LYS^? 12.92 NI NI A 502 A 147 THR A 85 THR~? 12.80 NI NI A 502 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -26.43 24.20 -22.83 -27.87 24.69 -21.30 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 32 LYS A 123 LYS^? 12.92 NI NI A 502 A 147 THR A 106 THR^? 23.59 NI NI A 501 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -44.11 24.18 -26.65 -42.38 22.71 -26.31 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 5 2 # 5 A 32 LYS A 123 LYS^? 12.92 NI NI A 502 A 147 THR B 85 THR.? 12.36 NI NI A 501 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -33.81 10.96 -25.09 -35.41 11.74 -26.39 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 6 2 # 6 A 32 LYS B 53 LYS.? 26.24 NI NI A 502 A 147 THR B 14 THR~? 17.57 NI NI A 501 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -35.43 0.02 -33.01 -34.98 -1.69 -34.29 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 7 2 # 7 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 147 THR A 85 THR~? 12.80 NI NI A 502 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -26.43 24.20 -22.83 -27.87 24.69 -21.30 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 8 2 # 8 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 147 THR B 83 THR~? 9.81 NI NI A 501 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 9 2 # 9 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 147 THR B 85 THR.? 12.36 NI NI A 501 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -33.81 10.96 -25.09 -35.41 11.74 -26.39 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 10 2 # 10 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 147 THR B 100 THR.? 19.64 NI NI A 502 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -36.82 30.10 -22.17 -36.51 28.20 -23.14 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 11 2 # 11 A 32 LYS B 123 LYS^? 13.38 NI NI A 501 A 147 THR B 106 THR^? 23.70 NI NI A 502 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -42.71 26.17 -21.12 -40.64 25.57 -21.68 1qgx_c01 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 11 hits 1qgx_c01 naa= 2 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 1 2 # 1 A 118 SER A 18 SER~? 18.69 NI NI A 502 A 151 LYS A 53 LYS.? 25.39 NI NI A 501 coo 17.70 9.25 13.10 16.68 11.30 13.99 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 25.75 6.80 15.75 21.60 9.40 11.84 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 2 2 # 2 A 118 SER A 24 SER~? 14.80 NI NI A 501 A 151 LYS B 123 LYS^? 13.38 NI NI A 501 coo 17.70 9.25 13.10 16.68 11.30 13.99 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 25.75 6.80 15.75 21.60 9.40 11.84 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 3 2 # 3 A 118 SER A 87 SER.? 14.75 NI NI A 502 A 151 LYS B 123 LYS^? 13.38 NI NI A 501 coo 17.70 9.25 13.10 16.68 11.30 13.99 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 25.75 6.80 15.75 21.60 9.40 11.84 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 4 2 # 4 A 118 SER B 18 SER~? 18.56 NI NI A 501 A 151 LYS B 53 LYS.? 26.24 NI NI A 502 coo 17.70 9.25 13.10 16.68 11.30 13.99 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 25.75 6.80 15.75 21.60 9.40 11.84 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 5 2 # 5 A 118 SER B 24 SER~? 15.42 NI NI A 502 A 151 LYS A 123 LYS^? 12.92 NI NI A 502 coo 17.70 9.25 13.10 16.68 11.30 13.99 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 25.75 6.80 15.75 21.60 9.40 11.84 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 6 2 # 6 A 118 SER B 87 SER.? 15.38 NI NI A 501 A 151 LYS A 123 LYS^? 12.92 NI NI A 502 coo 17.70 9.25 13.10 16.68 11.30 13.99 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 25.75 6.80 15.75 21.60 9.40 11.84 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qh9_c00 source 1qh9 2-HALOACID DEHALOGENASE : 6 hits 1qh9_c00 naa= 2 ULMN 2 1qho_c00 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 13 ASP~? 13.27 NI NI A 502 A 253 LEU A 9 LEU.? 22.07 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.61 42.87 -19.34 -18.59 44.82 -19.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 13 ASP~? 13.27 NI NI A 502 A 253 LEU A 19 LEU~? 18.89 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.30 26.43 -12.77 -27.38 26.52 -13.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 13 ASP~? 13.27 NI NI A 502 A 253 LEU A 20 LEU~? 13.99 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.68 23.28 -16.79 -25.32 24.09 -17.98 ULMN 2 1qho_c00 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 13 ASP~? 13.27 NI NI A 502 A 253 LEU A 21 LEU~? 17.63 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 18.60 67.37 33.24 17.63 66.99 31.31 -20.00 21.79 -13.26 -18.56 20.78 -12.09 ULMN 2 1qho_c00 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 42 ASP.? 24.20 NI NI A 501 A 253 LEU A 19 LEU~? 18.89 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.30 26.43 -12.77 -27.38 26.52 -13.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP A 42 ASP.? 24.20 NI NI A 501 A 253 LEU A 21 LEU~? 17.63 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 18.60 67.37 33.24 17.63 66.99 31.31 -20.00 21.79 -13.26 -18.56 20.78 -12.09 ULMN 2 1qho_c00 ALPHA-AMYLASE user 7 2 # 7 A 228 ASP A 42 ASP.? 24.20 NI NI A 501 A 253 LEU A 26 LEU~? 16.65 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 18.60 67.37 33.24 17.63 66.99 31.31 -27.81 16.98 -10.04 -28.60 18.09 -8.34 ULMN 2 1qho_c00 ALPHA-AMYLASE user 8 2 # 8 A 228 ASP A 82 ASP~? 15.20 NI NI A 502 A 253 LEU A 15 LEU~? 20.52 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 18.60 67.37 33.24 17.63 66.99 31.31 -21.59 31.90 -12.06 -22.96 31.73 -10.25 ULMN 2 1qho_c00 ALPHA-AMYLASE user 9 2 # 9 A 228 ASP A 82 ASP~? 15.20 NI NI A 502 A 253 LEU A 19 LEU~? 18.89 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.30 26.43 -12.77 -27.38 26.52 -13.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 10 2 # 10 A 228 ASP A 82 ASP~? 15.20 NI NI A 502 A 253 LEU A 20 LEU~? 13.99 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.68 23.28 -16.79 -25.32 24.09 -17.98 ULMN 2 1qho_c00 ALPHA-AMYLASE user 11 2 # 11 A 228 ASP A 82 ASP~? 15.20 NI NI A 502 A 253 LEU B 98 LEU^? 23.78 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 18.60 67.37 33.24 17.63 66.99 31.31 -39.45 26.79 -17.30 -37.37 26.24 -17.07 ULMN 2 1qho_c00 ALPHA-AMYLASE user 12 2 # 12 A 228 ASP A 82 ASP~? 15.20 NI NI A 502 A 253 LEU B 103 LEU.? 19.56 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 18.60 67.37 33.24 17.63 66.99 31.31 -38.67 26.80 -26.55 -36.71 26.45 -27.60 ULMN 2 1qho_c00 ALPHA-AMYLASE user 13 2 # 13 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU A 20 LEU~? 13.99 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.68 23.28 -16.79 -25.32 24.09 -17.98 ULMN 2 1qho_c00 ALPHA-AMYLASE user 14 2 # 14 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU A 98 LEU^? 23.32 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -43.01 20.87 -30.18 -41.71 19.20 -30.48 ULMN 2 1qho_c00 ALPHA-AMYLASE user 15 2 # 15 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU A 103 LEU.? 18.67 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -42.90 18.98 -21.57 -40.90 18.28 -20.84 ULMN 2 1qho_c00 ALPHA-AMYLASE user 16 2 # 16 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU B 19 LEU~? 18.22 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -35.48 8.49 -34.80 -36.46 10.43 -34.44 ULMN 2 1qho_c00 ALPHA-AMYLASE user 17 2 # 17 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU B 20 LEU~? 13.47 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.93 8.55 -30.89 -33.52 9.40 -29.75 ULMN 2 1qho_c00 ALPHA-AMYLASE user 18 2 # 18 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU B 26 LEU~? 16.29 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -28.62 16.28 -37.92 -30.02 16.04 -39.49 ULMN 2 1qho_c00 ALPHA-AMYLASE user 19 2 # 19 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 253 LEU B 103 LEU.? 19.56 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 18.60 67.37 33.24 17.63 66.99 31.31 -38.67 26.80 -26.55 -36.71 26.45 -27.60 ULMN 2 1qho_c00 ALPHA-AMYLASE user 20 2 # 20 A 228 ASP B 13 ASP~? 14.49 NI NI A 501 A 253 LEU B 19 LEU~? 18.22 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 18.60 67.37 33.24 17.63 66.99 31.31 -35.48 8.49 -34.80 -36.46 10.43 -34.44 ULMN 2 1qho_c00 ALPHA-AMYLASE user 21 2 # 21 A 228 ASP B 13 ASP~? 14.49 NI NI A 501 A 253 LEU B 20 LEU~? 13.47 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.93 8.55 -30.89 -33.52 9.40 -29.75 ULMN 2 1qho_c00 ALPHA-AMYLASE user 22 2 # 22 A 228 ASP B 13 ASP~? 14.49 NI NI A 501 A 253 LEU B 21 LEU~? 17.41 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 18.60 67.37 33.24 17.63 66.99 31.31 -28.75 6.52 -34.37 -27.41 5.60 -35.64 ULMN 2 1qho_c00 ALPHA-AMYLASE user 23 2 # 23 A 228 ASP B 42 ASP.? 24.38 NI NI A 502 A 253 LEU B 19 LEU~? 18.22 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -35.48 8.49 -34.80 -36.46 10.43 -34.44 ULMN 2 1qho_c00 ALPHA-AMYLASE user 24 2 # 24 A 228 ASP B 42 ASP.? 24.38 NI NI A 502 A 253 LEU B 21 LEU~? 17.41 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -28.75 6.52 -34.37 -27.41 5.60 -35.64 ULMN 2 1qho_c00 ALPHA-AMYLASE user 25 2 # 25 A 228 ASP B 82 ASP~? 13.99 NI NI A 501 A 253 LEU A 98 LEU^? 23.32 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 18.60 67.37 33.24 17.63 66.99 31.31 -43.01 20.87 -30.18 -41.71 19.20 -30.48 ULMN 2 1qho_c00 ALPHA-AMYLASE user 26 2 # 26 A 228 ASP B 82 ASP~? 13.99 NI NI A 501 A 253 LEU B 15 LEU~? 20.01 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 18.60 67.37 33.24 17.63 66.99 31.31 -38.35 2.65 -35.68 -38.89 3.74 -37.46 ULMN 2 1qho_c00 ALPHA-AMYLASE user 27 2 # 27 A 228 ASP B 82 ASP~? 13.99 NI NI A 501 A 253 LEU B 19 LEU~? 18.22 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 18.60 67.37 33.24 17.63 66.99 31.31 -35.48 8.49 -34.80 -36.46 10.43 -34.44 ULMN 2 1qho_c00 ALPHA-AMYLASE user 28 2 # 28 A 228 ASP B 82 ASP~? 13.99 NI NI A 501 A 253 LEU B 20 LEU~? 13.47 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.93 8.55 -30.89 -33.52 9.40 -29.75 ULMN 2 1qho_c00 ALPHA-AMYLASE user 29 2 # 29 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 253 LEU A 19 LEU~? 18.89 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.30 26.43 -12.77 -27.38 26.52 -13.05 ULMN 2 1qho_c00 ALPHA-AMYLASE user 30 2 # 30 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 253 LEU A 26 LEU~? 16.65 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -27.81 16.98 -10.04 -28.60 18.09 -8.34 ULMN 2 1qho_c00 ALPHA-AMYLASE user 31 2 # 31 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 253 LEU A 103 LEU.? 18.67 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -42.90 18.98 -21.57 -40.90 18.28 -20.84 ULMN 2 1qho_c00 ALPHA-AMYLASE user 32 2 # 32 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 253 LEU B 20 LEU~? 13.47 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.93 8.55 -30.89 -33.52 9.40 -29.75 ULMN 2 1qho_c00 ALPHA-AMYLASE user 33 2 # 33 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 253 LEU B 98 LEU^? 23.78 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -39.45 26.79 -17.30 -37.37 26.24 -17.07 ULMN 2 1qho_c00 ALPHA-AMYLASE user 34 2 # 34 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 253 LEU B 103 LEU.? 19.56 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 18.60 67.37 33.24 17.63 66.99 31.31 -38.67 26.80 -26.55 -36.71 26.45 -27.60 1qho_c00 source 1qho ALPHA-AMYLASE : 34 hits 1qho_c00 naa= 2 ULMN 2 1qho_c02 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 256 GLU A 86 GLU.? 9.00 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 30.54 71.65 32.58 31.73 72.26 30.92 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1qho_c02 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 256 GLU A 124 GLU.? 14.10 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 30.54 71.65 32.58 31.73 72.26 30.92 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1qho_c02 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 A 256 GLU B 86 GLU.? 9.13 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 30.54 71.65 32.58 31.73 72.26 30.92 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1qho_c02 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 256 GLU A 86 GLU.? 9.00 NI NI A 502 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 30.54 71.65 32.58 31.73 72.26 30.92 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1qho_c02 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 A 256 GLU B 86 GLU.? 9.13 NI NI A 501 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 30.54 71.65 32.58 31.73 72.26 30.92 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1qho_c02 source 1qho ALPHA-AMYLASE : 5 hits 1qho_c02 naa= 2 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 1 2 # 1 A 341 LYS A 123 LYS^? 12.92 NI NI A 502 A 418 HIS A 127 HIS.? 7.54 NI NI A 502 coo 104.35 34.37 32.90 100.82 36.32 29.09 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 96.54 35.93 21.66 94.52 36.26 22.15 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 2 2 # 2 A 341 LYS A 123 LYS^? 12.92 NI NI A 502 A 418 HIS B 31 HIS~? -3.92 NI NI A 502s coo 104.35 34.37 32.90 100.82 36.32 29.09 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 96.54 35.93 21.66 94.52 36.26 22.15 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 3 2 # 3 A 341 LYS A 123 LYS^? 12.92 NI NI A 502 A 418 HIS B 126 HIS.? -4.79 NI NI A 501s coo 104.35 34.37 32.90 100.82 36.32 29.09 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 96.54 35.93 21.66 94.52 36.26 22.15 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 4 2 # 4 A 341 LYS B 123 LYS^? 13.38 NI NI A 501 A 418 HIS A 31 HIS~? -4.16 NI NI A 501s coo 104.35 34.37 32.90 100.82 36.32 29.09 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 96.54 35.93 21.66 94.52 36.26 22.15 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 5 2 # 5 A 341 LYS B 123 LYS^? 13.38 NI NI A 501 A 418 HIS B 127 HIS.? 5.53 NI NI A 501 coo 104.35 34.37 32.90 100.82 36.32 29.09 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 96.54 35.93 21.66 94.52 36.26 22.15 -36.21 5.24 -15.46 -36.02 3.20 -15.94 1qi9_c00 source 1qi9 VANADIUM BROMOPEROXIDASE : 5 hits 1qi9_c00 naa= 2 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 1 2 # 1 B 341 LYS A 123 LYS^? 12.92 NI NI A 502 B 418 HIS A 127 HIS.? 7.54 NI NI A 502 coo 86.35 -0.78 12.68 84.14 3.90 10.48 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 81.39 11.93 10.46 82.24 12.93 8.84 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 2 2 # 2 B 341 LYS A 123 LYS^? 12.92 NI NI A 502 B 418 HIS B 31 HIS~? -3.92 NI NI A 502s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 81.39 11.93 10.46 82.24 12.93 8.84 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 3 2 # 3 B 341 LYS A 123 LYS^? 12.92 NI NI A 502 B 418 HIS B 126 HIS.? -4.79 NI NI A 501s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 81.39 11.93 10.46 82.24 12.93 8.84 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 4 2 # 4 B 341 LYS B 123 LYS^? 13.38 NI NI A 501 B 418 HIS A 31 HIS~? -4.16 NI NI A 501s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 81.39 11.93 10.46 82.24 12.93 8.84 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 5 2 # 5 B 341 LYS B 123 LYS^? 13.38 NI NI A 501 B 418 HIS B 127 HIS.? 5.53 NI NI A 501 coo 86.35 -0.78 12.68 84.14 3.90 10.48 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 81.39 11.93 10.46 82.24 12.93 8.84 -36.21 5.24 -15.46 -36.02 3.20 -15.94 1qi9_c01 source 1qi9 VANADIUM BROMOPEROXIDASE : 5 hits 1qi9_c01 naa= 2 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 B 240 GLN A 58 GLN^? 27.85 NI NI A 501 B 387 ARG A 23 ARG~? 15.85 NI NI A 502 coo 41.56 93.59 65.64 41.16 91.60 64.94 -29.85 25.85 -3.23 -31.48 26.66 -2.24 coo 33.50 85.40 62.90 31.25 87.48 62.36 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 B 240 GLN A 58 GLN^? 27.85 NI NI A 501 B 387 ARG B 93 ARG^? 28.43 NI NI A 501 coo 41.56 93.59 65.64 41.16 91.60 64.94 -29.85 25.85 -3.23 -31.48 26.66 -2.24 coo 33.50 85.40 62.90 31.25 87.48 62.36 -40.21 29.12 -9.93 -42.89 27.96 -8.94 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 3 2 # 3 B 240 GLN B 58 GLN^? 27.70 NI NI A 502 B 387 ARG A 93 ARG^? 27.22 NI NI A 502 coo 41.56 93.59 65.64 41.16 91.60 64.94 -37.80 12.84 -44.22 -39.12 14.17 -45.19 coo 33.50 85.40 62.90 31.25 87.48 62.36 -45.46 21.14 -37.27 -43.99 23.01 -39.26 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 4 2 # 4 B 240 GLN B 58 GLN^? 27.70 NI NI A 502 B 387 ARG B 23 ARG~? 15.67 NI NI A 501 coo 41.56 93.59 65.64 41.16 91.60 64.94 -37.80 12.84 -44.22 -39.12 14.17 -45.19 coo 33.50 85.40 62.90 31.25 87.48 62.36 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1qj2_c02 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 4 hits 1qj2_c02 naa= 2 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 H 240 GLN A 58 GLN^? 27.85 NI NI A 501 H 387 ARG A 23 ARG~? 15.85 NI NI A 502 coo 41.71 128.87 87.62 42.13 130.32 89.13 -29.85 25.85 -3.23 -31.48 26.66 -2.24 coo 49.59 134.55 94.31 52.01 134.13 92.45 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 H 240 GLN A 58 GLN^? 27.85 NI NI A 501 H 387 ARG B 93 ARG^? 28.43 NI NI A 501 coo 41.71 128.87 87.62 42.13 130.32 89.13 -29.85 25.85 -3.23 -31.48 26.66 -2.24 coo 49.59 134.55 94.31 52.01 134.13 92.45 -40.21 29.12 -9.93 -42.89 27.96 -8.94 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 3 2 # 3 H 240 GLN B 58 GLN^? 27.70 NI NI A 502 H 387 ARG A 93 ARG^? 27.22 NI NI A 502 coo 41.71 128.87 87.62 42.13 130.32 89.13 -37.80 12.84 -44.22 -39.12 14.17 -45.19 coo 49.59 134.55 94.31 52.01 134.13 92.45 -45.46 21.14 -37.27 -43.99 23.01 -39.26 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 4 2 # 4 H 240 GLN B 58 GLN^? 27.70 NI NI A 502 H 387 ARG B 23 ARG~? 15.67 NI NI A 501 coo 41.71 128.87 87.62 42.13 130.32 89.13 -37.80 12.84 -44.22 -39.12 14.17 -45.19 coo 49.59 134.55 94.31 52.01 134.13 92.45 -32.41 14.62 -32.24 -32.62 14.64 -29.16 1qj2_c03 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 4 hits 1qj2_c03 naa= 2 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 A 221 ASP A 13 ASP~? 13.27 NI NI A 502 A 401 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.04 36.98 34.15 26.35 36.27 32.62 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 33.28 34.18 40.93 33.02 35.91 42.11 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 A 221 ASP A 82 ASP~? 15.20 NI NI A 502 A 401 ASP A 13 ASP~? 13.27 NI NI A 502 coo 25.04 36.98 34.15 26.35 36.27 32.62 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 33.28 34.18 40.93 33.02 35.91 42.11 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 A 221 ASP A 82 ASP~? 15.20 NI NI A 502 A 401 ASP B 88 ASP^? 15.06 NI NI A 502 coo 25.04 36.98 34.15 26.35 36.27 32.62 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 33.28 34.18 40.93 33.02 35.91 42.11 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 A 221 ASP A 88 ASP^? 14.52 NI NI A 501 A 401 ASP B 82 ASP~? 13.99 NI NI A 501 coo 25.04 36.98 34.15 26.35 36.27 32.62 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 33.28 34.18 40.93 33.02 35.91 42.11 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 A 221 ASP B 13 ASP~? 14.49 NI NI A 501 A 401 ASP B 82 ASP~? 13.99 NI NI A 501 coo 25.04 36.98 34.15 26.35 36.27 32.62 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 33.28 34.18 40.93 33.02 35.91 42.11 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 A 221 ASP B 82 ASP~? 13.99 NI NI A 501 A 401 ASP A 88 ASP^? 14.52 NI NI A 501 coo 25.04 36.98 34.15 26.35 36.27 32.62 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 33.28 34.18 40.93 33.02 35.91 42.11 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 7 2 # 7 A 221 ASP B 82 ASP~? 13.99 NI NI A 501 A 401 ASP B 13 ASP~? 14.49 NI NI A 501 coo 25.04 36.98 34.15 26.35 36.27 32.62 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 33.28 34.18 40.93 33.02 35.91 42.11 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 1qk2_c02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 8 2 # 8 A 221 ASP B 88 ASP^? 15.06 NI NI A 502 A 401 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.04 36.98 34.15 26.35 36.27 32.62 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 33.28 34.18 40.93 33.02 35.91 42.11 -29.79 30.16 -22.23 -31.29 29.65 -23.60 1qk2_c02 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 8 hits 1qk2_c02 naa= 2 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 B 221 ASP A 13 ASP~? 13.27 NI NI A 502 B 401 ASP A 82 ASP~? 15.20 NI NI A 502 coo 39.21 84.85 78.75 40.59 84.11 77.32 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 47.27 82.90 85.84 46.75 84.63 86.91 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 B 221 ASP A 82 ASP~? 15.20 NI NI A 502 B 401 ASP A 13 ASP~? 13.27 NI NI A 502 coo 39.21 84.85 78.75 40.59 84.11 77.32 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 47.27 82.90 85.84 46.75 84.63 86.91 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 B 221 ASP A 82 ASP~? 15.20 NI NI A 502 B 401 ASP B 88 ASP^? 15.06 NI NI A 502 coo 39.21 84.85 78.75 40.59 84.11 77.32 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 47.27 82.90 85.84 46.75 84.63 86.91 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 B 221 ASP A 88 ASP^? 14.52 NI NI A 501 B 401 ASP B 82 ASP~? 13.99 NI NI A 501 coo 39.21 84.85 78.75 40.59 84.11 77.32 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 47.27 82.90 85.84 46.75 84.63 86.91 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 B 221 ASP B 13 ASP~? 14.49 NI NI A 501 B 401 ASP B 82 ASP~? 13.99 NI NI A 501 coo 39.21 84.85 78.75 40.59 84.11 77.32 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 47.27 82.90 85.84 46.75 84.63 86.91 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 B 221 ASP B 82 ASP~? 13.99 NI NI A 501 B 401 ASP A 88 ASP^? 14.52 NI NI A 501 coo 39.21 84.85 78.75 40.59 84.11 77.32 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 47.27 82.90 85.84 46.75 84.63 86.91 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 7 2 # 7 B 221 ASP B 82 ASP~? 13.99 NI NI A 501 B 401 ASP B 13 ASP~? 14.49 NI NI A 501 coo 39.21 84.85 78.75 40.59 84.11 77.32 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 47.27 82.90 85.84 46.75 84.63 86.91 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 1qk2_c03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 8 2 # 8 B 221 ASP B 88 ASP^? 15.06 NI NI A 502 B 401 ASP A 82 ASP~? 15.20 NI NI A 502 coo 39.21 84.85 78.75 40.59 84.11 77.32 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 47.27 82.90 85.84 46.75 84.63 86.91 -29.79 30.16 -22.23 -31.29 29.65 -23.60 1qk2_c03 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 8 hits 1qk2_c03 naa= 2 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 2 # 1 A 182 TYR A 22 TYR~? 21.39 NI NI A 501 A 186 LYS A 53 LYS.? 25.39 NI NI A 501 coo 73.61 90.42 31.12 71.36 89.66 29.64 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 73.54 84.00 28.64 69.01 86.68 29.71 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 2 # 2 A 182 TYR A 67 TYR^? 18.49 NI NI A 501 A 186 LYS B 123 LYS^? 13.38 NI NI A 501 coo 73.61 90.42 31.12 71.36 89.66 29.64 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 73.54 84.00 28.64 69.01 86.68 29.71 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 2 # 3 A 182 TYR B 22 TYR~? 21.09 NI NI A 502 A 186 LYS B 53 LYS.? 26.24 NI NI A 502 coo 73.61 90.42 31.12 71.36 89.66 29.64 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 73.54 84.00 28.64 69.01 86.68 29.71 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 2 # 4 A 182 TYR B 67 TYR^? 18.53 NI NI A 502 A 186 LYS A 123 LYS^? 12.92 NI NI A 502 coo 73.61 90.42 31.12 71.36 89.66 29.64 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 73.54 84.00 28.64 69.01 86.68 29.71 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qrr_c02 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 4 hits 1qrr_c02 naa= 2 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 A 156 TYR A 22 TYR~? 21.39 NI NI A 501 A 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo 11.31 14.43 4.90 11.33 12.74 7.13 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 12.44 6.23 6.82 12.36 8.68 11.73 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 A 156 TYR A 67 TYR^? 18.49 NI NI A 501 A 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo 11.31 14.43 4.90 11.33 12.74 7.13 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 12.44 6.23 6.82 12.36 8.68 11.73 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 A 156 TYR B 22 TYR~? 21.09 NI NI A 502 A 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo 11.31 14.43 4.90 11.33 12.74 7.13 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 12.44 6.23 6.82 12.36 8.68 11.73 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 A 156 TYR B 67 TYR^? 18.53 NI NI A 502 A 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo 11.31 14.43 4.90 11.33 12.74 7.13 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 12.44 6.23 6.82 12.36 8.68 11.73 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c00 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c00 naa= 2 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 B 156 TYR A 22 TYR~? 21.39 NI NI A 501 B 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 B 156 TYR A 67 TYR^? 18.49 NI NI A 501 B 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 B 156 TYR B 22 TYR~? 21.09 NI NI A 502 B 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 B 156 TYR B 67 TYR^? 18.53 NI NI A 502 B 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c01 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c01 naa= 2 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 C 156 TYR A 22 TYR~? 21.39 NI NI A 501 C 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 C 156 TYR A 67 TYR^? 18.49 NI NI A 501 C 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 C 156 TYR B 22 TYR~? 21.09 NI NI A 502 C 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 C 156 TYR B 67 TYR^? 18.53 NI NI A 502 C 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c02 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c02 naa= 2 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 D 156 TYR A 22 TYR~? 21.39 NI NI A 501 D 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 D 156 TYR A 67 TYR^? 18.49 NI NI A 501 D 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 D 156 TYR B 22 TYR~? 21.09 NI NI A 502 D 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 D 156 TYR B 67 TYR^? 18.53 NI NI A 502 D 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c03 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c03 naa= 2 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 E 156 TYR A 22 TYR~? 21.39 NI NI A 501 E 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo 58.73 53.92 40.85 59.76 52.11 42.68 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 60.51 45.70 41.25 62.67 47.81 45.91 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 E 156 TYR A 67 TYR^? 18.49 NI NI A 501 E 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo 58.73 53.92 40.85 59.76 52.11 42.68 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 60.51 45.70 41.25 62.67 47.81 45.91 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 E 156 TYR B 22 TYR~? 21.09 NI NI A 502 E 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo 58.73 53.92 40.85 59.76 52.11 42.68 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 60.51 45.70 41.25 62.67 47.81 45.91 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 E 156 TYR B 67 TYR^? 18.53 NI NI A 502 E 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo 58.73 53.92 40.85 59.76 52.11 42.68 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 60.51 45.70 41.25 62.67 47.81 45.91 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c04 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c04 naa= 2 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 F 156 TYR A 22 TYR~? 21.39 NI NI A 501 F 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo 60.02 29.87 32.03 59.43 31.82 30.12 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 58.88 38.21 31.46 58.96 36.46 26.25 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 F 156 TYR A 67 TYR^? 18.49 NI NI A 501 F 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo 60.02 29.87 32.03 59.43 31.82 30.12 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 58.88 38.21 31.46 58.96 36.46 26.25 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 F 156 TYR B 22 TYR~? 21.09 NI NI A 502 F 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo 60.02 29.87 32.03 59.43 31.82 30.12 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 58.88 38.21 31.46 58.96 36.46 26.25 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 F 156 TYR B 67 TYR^? 18.53 NI NI A 502 F 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo 60.02 29.87 32.03 59.43 31.82 30.12 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 58.88 38.21 31.46 58.96 36.46 26.25 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c05 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c05 naa= 2 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 G 156 TYR A 22 TYR~? 21.39 NI NI A 501 G 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo 35.34 25.18 46.17 35.45 26.86 48.38 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 34.29 33.26 48.25 34.81 30.77 53.10 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 G 156 TYR A 67 TYR^? 18.49 NI NI A 501 G 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo 35.34 25.18 46.17 35.45 26.86 48.38 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 34.29 33.26 48.25 34.81 30.77 53.10 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 G 156 TYR B 22 TYR~? 21.09 NI NI A 502 G 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo 35.34 25.18 46.17 35.45 26.86 48.38 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 34.29 33.26 48.25 34.81 30.77 53.10 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 G 156 TYR B 67 TYR^? 18.53 NI NI A 502 G 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo 35.34 25.18 46.17 35.45 26.86 48.38 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 34.29 33.26 48.25 34.81 30.77 53.10 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c06 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c06 naa= 2 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 H 156 TYR A 22 TYR~? 21.39 NI NI A 501 H 163 LYS A 53 LYS.? 25.39 NI NI A 501 coo 30.12 49.87 41.75 29.53 48.20 39.59 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 30.50 41.69 39.85 27.67 43.89 35.58 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 H 156 TYR A 67 TYR^? 18.49 NI NI A 501 H 163 LYS B 123 LYS^? 13.38 NI NI A 501 coo 30.12 49.87 41.75 29.53 48.20 39.59 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 30.50 41.69 39.85 27.67 43.89 35.58 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 H 156 TYR B 22 TYR~? 21.09 NI NI A 502 H 163 LYS B 53 LYS.? 26.24 NI NI A 502 coo 30.12 49.87 41.75 29.53 48.20 39.59 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 30.50 41.69 39.85 27.67 43.89 35.58 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 H 156 TYR B 67 TYR^? 18.53 NI NI A 502 H 163 LYS A 123 LYS^? 12.92 NI NI A 502 coo 30.12 49.87 41.75 29.53 48.20 39.59 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 30.50 41.69 39.85 27.67 43.89 35.58 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1qsg_c07 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 4 hits 1qsg_c07 naa= 2 ULMN 2 1qz9_c00 KYNURENINASE user 1 2 # 1 A 129 PHE A 51 PHE.? 22.00 NI NI A 502 A 201 ASP A 42 ASP.? 24.20 NI NI A 501 coo 23.39 49.81 32.16 21.33 51.68 32.26 -17.08 22.63 -7.72 -19.58 23.81 -8.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 1qz9_c00 KYNURENINASE user 2 2 # 2 A 129 PHE B 51 PHE.? 21.73 NI NI A 501 A 201 ASP B 42 ASP.? 24.38 NI NI A 502 coo 23.39 49.81 32.16 21.33 51.68 32.26 -28.14 3.62 -40.16 -30.39 4.96 -39.18 coo 25.52 45.12 37.98 23.98 46.65 37.85 -27.64 9.52 -45.35 -29.70 9.87 -45.82 1qz9_c00 source 1qz9 KYNURENINASE : 2 hits 1qz9_c00 naa= 2 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 1 2 # 1 A 98 GLU A 28 GLU~? 13.04 NI NI A 501 A 179 GLU B 86 GLU.? 9.13 NI NI A 501 coo 34.76 2.28 18.45 36.75 1.46 18.65 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 2 2 # 2 A 98 GLU A 86 GLU.? 9.00 NI NI A 502 A 179 GLU B 86 GLU.? 9.13 NI NI A 501 coo 34.76 2.28 18.45 36.75 1.46 18.65 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 3 2 # 3 A 98 GLU A 124 GLU.? 14.10 NI NI A 502 A 179 GLU B 28 GLU~? 10.98 NI NI A 502 coo 34.76 2.28 18.45 36.75 1.46 18.65 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 4 2 # 4 A 98 GLU B 28 GLU~? 10.98 NI NI A 502 A 179 GLU A 124 GLU.? 14.10 NI NI A 502 coo 34.76 2.28 18.45 36.75 1.46 18.65 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 5 2 # 5 A 98 GLU B 86 GLU.? 9.13 NI NI A 501 A 179 GLU A 28 GLU~? 13.04 NI NI A 501 coo 34.76 2.28 18.45 36.75 1.46 18.65 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 6 2 # 6 A 98 GLU B 86 GLU.? 9.13 NI NI A 501 A 179 GLU A 86 GLU.? 9.00 NI NI A 502 coo 34.76 2.28 18.45 36.75 1.46 18.65 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r16_c00 source 1r16 ADP-RIBOSYL CYCLASE : 6 hits 1r16_c00 naa= 2 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 1 2 # 1 B 98 GLU A 28 GLU~? 13.04 NI NI A 501 B 179 GLU B 86 GLU.? 9.13 NI NI A 501 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 2 2 # 2 B 98 GLU A 86 GLU.? 9.00 NI NI A 502 B 179 GLU B 86 GLU.? 9.13 NI NI A 501 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 3 2 # 3 B 98 GLU A 124 GLU.? 14.10 NI NI A 502 B 179 GLU B 28 GLU~? 10.98 NI NI A 502 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 4 2 # 4 B 98 GLU B 28 GLU~? 10.98 NI NI A 502 B 179 GLU A 124 GLU.? 14.10 NI NI A 502 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 5 2 # 5 B 98 GLU B 86 GLU.? 9.13 NI NI A 501 B 179 GLU A 28 GLU~? 13.04 NI NI A 501 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 6 2 # 6 B 98 GLU B 86 GLU.? 9.13 NI NI A 501 B 179 GLU A 86 GLU.? 9.00 NI NI A 502 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r16_c01 source 1r16 ADP-RIBOSYL CYCLASE : 6 hits 1r16_c01 naa= 2 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 A 71 ARG A 17 ARG~? 9.21 NI NI A 502 A 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 18.49 20.71 4.77 20.29 21.80 4.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 A 71 ARG A 23 ARG~? 15.85 NI NI A 502 A 181 GLU A 28 GLU~? 13.04 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 18.49 20.71 4.77 20.29 21.80 4.49 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 A 71 ARG A 23 ARG~? 15.85 NI NI A 502 A 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 18.49 20.71 4.77 20.29 21.80 4.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 A 71 ARG A 23 ARG~? 15.85 NI NI A 502 A 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 18.49 20.71 4.77 20.29 21.80 4.49 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 5 2 # 5 A 71 ARG A 23 ARG~? 15.85 NI NI A 502 A 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 18.49 20.71 4.77 20.29 21.80 4.49 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 6 2 # 6 A 71 ARG A 101 ARG.? 18.18 NI NI A 501 A 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 18.49 20.71 4.77 20.29 21.80 4.49 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 7 2 # 7 A 71 ARG A 102 ARG.? 15.26 NI NI A 501 A 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 18.49 20.71 4.77 20.29 21.80 4.49 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 8 2 # 8 A 71 ARG B 17 ARG~? 8.61 NI NI A 501 A 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 18.49 20.71 4.77 20.29 21.80 4.49 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 9 2 # 9 A 71 ARG B 23 ARG~? 15.67 NI NI A 501 A 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 18.49 20.71 4.77 20.29 21.80 4.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 10 2 # 10 A 71 ARG B 23 ARG~? 15.67 NI NI A 501 A 181 GLU B 28 GLU~? 10.98 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 18.49 20.71 4.77 20.29 21.80 4.49 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 11 2 # 11 A 71 ARG B 23 ARG~? 15.67 NI NI A 501 A 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 29.52 23.28 0.51 26.83 22.05 1.22 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 18.49 20.71 4.77 20.29 21.80 4.49 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 12 2 # 12 A 71 ARG B 94 ARG^? 29.28 NI NI A 502 A 181 GLU B 116 GLU.? 34.45 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo 18.49 20.71 4.77 20.29 21.80 4.49 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 13 2 # 13 A 71 ARG B 101 ARG.? 17.16 NI NI A 502 A 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 18.49 20.71 4.77 20.29 21.80 4.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 14 2 # 14 A 71 ARG B 101 ARG.? 17.16 NI NI A 502 A 181 GLU A 124 GLU.? 14.10 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 18.49 20.71 4.77 20.29 21.80 4.49 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 15 2 # 15 A 71 ARG B 102 ARG.? 15.54 NI NI A 502 A 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 29.52 23.28 0.51 26.83 22.05 1.22 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 18.49 20.71 4.77 20.29 21.80 4.49 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r44_c00 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 15 hits 1r44_c00 naa= 2 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 B 71 ARG A 17 ARG~? 9.21 NI NI A 502 B 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 20.92 9.87 25.44 22.46 10.92 26.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 B 71 ARG A 23 ARG~? 15.85 NI NI A 502 B 181 GLU A 28 GLU~? 13.04 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 20.92 9.87 25.44 22.46 10.92 26.39 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 B 71 ARG A 23 ARG~? 15.85 NI NI A 502 B 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 20.92 9.87 25.44 22.46 10.92 26.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 B 71 ARG A 23 ARG~? 15.85 NI NI A 502 B 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 20.92 9.87 25.44 22.46 10.92 26.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 5 2 # 5 B 71 ARG A 23 ARG~? 15.85 NI NI A 502 B 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 20.92 9.87 25.44 22.46 10.92 26.39 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 6 2 # 6 B 71 ARG A 101 ARG.? 18.18 NI NI A 501 B 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 20.92 9.87 25.44 22.46 10.92 26.39 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 7 2 # 7 B 71 ARG A 102 ARG.? 15.26 NI NI A 501 B 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 20.92 9.87 25.44 22.46 10.92 26.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 8 2 # 8 B 71 ARG B 17 ARG~? 8.61 NI NI A 501 B 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 20.92 9.87 25.44 22.46 10.92 26.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 9 2 # 9 B 71 ARG B 23 ARG~? 15.67 NI NI A 501 B 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 20.92 9.87 25.44 22.46 10.92 26.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 10 2 # 10 B 71 ARG B 23 ARG~? 15.67 NI NI A 501 B 181 GLU B 28 GLU~? 10.98 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 20.92 9.87 25.44 22.46 10.92 26.39 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 11 2 # 11 B 71 ARG B 23 ARG~? 15.67 NI NI A 501 B 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo 25.64 17.80 33.30 23.89 16.05 31.49 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 20.92 9.87 25.44 22.46 10.92 26.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 12 2 # 12 B 71 ARG B 94 ARG^? 29.28 NI NI A 502 B 181 GLU B 116 GLU.? 34.45 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo 20.92 9.87 25.44 22.46 10.92 26.39 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 13 2 # 13 B 71 ARG B 101 ARG.? 17.16 NI NI A 502 B 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 20.92 9.87 25.44 22.46 10.92 26.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 14 2 # 14 B 71 ARG B 101 ARG.? 17.16 NI NI A 502 B 181 GLU A 124 GLU.? 14.10 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 20.92 9.87 25.44 22.46 10.92 26.39 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 15 2 # 15 B 71 ARG B 102 ARG.? 15.54 NI NI A 502 B 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo 25.64 17.80 33.30 23.89 16.05 31.49 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 20.92 9.87 25.44 22.46 10.92 26.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r44_c01 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 15 hits 1r44_c01 naa= 2 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 C 71 ARG A 17 ARG~? 9.21 NI NI A 502 C 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 C 71 ARG A 23 ARG~? 15.85 NI NI A 502 C 181 GLU A 28 GLU~? 13.04 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 C 71 ARG A 23 ARG~? 15.85 NI NI A 502 C 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 C 71 ARG A 23 ARG~? 15.85 NI NI A 502 C 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 5 2 # 5 C 71 ARG A 23 ARG~? 15.85 NI NI A 502 C 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 6 2 # 6 C 71 ARG A 101 ARG.? 18.18 NI NI A 501 C 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 7 2 # 7 C 71 ARG A 102 ARG.? 15.26 NI NI A 501 C 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 8 2 # 8 C 71 ARG B 17 ARG~? 8.61 NI NI A 501 C 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 9 2 # 9 C 71 ARG B 23 ARG~? 15.67 NI NI A 501 C 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 10 2 # 10 C 71 ARG B 23 ARG~? 15.67 NI NI A 501 C 181 GLU B 28 GLU~? 10.98 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 11 2 # 11 C 71 ARG B 23 ARG~? 15.67 NI NI A 501 C 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 12 2 # 12 C 71 ARG B 94 ARG^? 29.28 NI NI A 502 C 181 GLU B 116 GLU.? 34.45 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 13 2 # 13 C 71 ARG B 101 ARG.? 17.16 NI NI A 502 C 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 14 2 # 14 C 71 ARG B 101 ARG.? 17.16 NI NI A 502 C 181 GLU A 124 GLU.? 14.10 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 15 2 # 15 C 71 ARG B 102 ARG.? 15.54 NI NI A 502 C 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r44_c02 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 15 hits 1r44_c02 naa= 2 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 D 71 ARG A 17 ARG~? 9.21 NI NI A 502 D 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 2.99 23.21 78.86 1.22 24.31 78.95 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 D 71 ARG A 23 ARG~? 15.85 NI NI A 502 D 181 GLU A 28 GLU~? 13.04 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 2.99 23.21 78.86 1.22 24.31 78.95 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 D 71 ARG A 23 ARG~? 15.85 NI NI A 502 D 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 2.99 23.21 78.86 1.22 24.31 78.95 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 D 71 ARG A 23 ARG~? 15.85 NI NI A 502 D 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 2.99 23.21 78.86 1.22 24.31 78.95 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 5 2 # 5 D 71 ARG A 23 ARG~? 15.85 NI NI A 502 D 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 2.99 23.21 78.86 1.22 24.31 78.95 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 6 2 # 6 D 71 ARG A 101 ARG.? 18.18 NI NI A 501 D 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 2.99 23.21 78.86 1.22 24.31 78.95 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 7 2 # 7 D 71 ARG A 102 ARG.? 15.26 NI NI A 501 D 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 2.99 23.21 78.86 1.22 24.31 78.95 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 8 2 # 8 D 71 ARG B 17 ARG~? 8.61 NI NI A 501 D 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 2.99 23.21 78.86 1.22 24.31 78.95 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 9 2 # 9 D 71 ARG B 23 ARG~? 15.67 NI NI A 501 D 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 2.99 23.21 78.86 1.22 24.31 78.95 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 10 2 # 10 D 71 ARG B 23 ARG~? 15.67 NI NI A 501 D 181 GLU B 28 GLU~? 10.98 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 2.99 23.21 78.86 1.22 24.31 78.95 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 11 2 # 11 D 71 ARG B 23 ARG~? 15.67 NI NI A 501 D 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 2.99 23.21 78.86 1.22 24.31 78.95 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 12 2 # 12 D 71 ARG B 94 ARG^? 29.28 NI NI A 502 D 181 GLU B 116 GLU.? 34.45 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo 2.99 23.21 78.86 1.22 24.31 78.95 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 13 2 # 13 D 71 ARG B 101 ARG.? 17.16 NI NI A 502 D 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 2.99 23.21 78.86 1.22 24.31 78.95 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 14 2 # 14 D 71 ARG B 101 ARG.? 17.16 NI NI A 502 D 181 GLU A 124 GLU.? 14.10 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 2.99 23.21 78.86 1.22 24.31 78.95 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 15 2 # 15 D 71 ARG B 102 ARG.? 15.54 NI NI A 502 D 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 2.99 23.21 78.86 1.22 24.31 78.95 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r44_c03 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 15 hits 1r44_c03 naa= 2 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 E 71 ARG A 17 ARG~? 9.21 NI NI A 502 E 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 E 71 ARG A 23 ARG~? 15.85 NI NI A 502 E 181 GLU A 28 GLU~? 13.04 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 E 71 ARG A 23 ARG~? 15.85 NI NI A 502 E 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 E 71 ARG A 23 ARG~? 15.85 NI NI A 502 E 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 5 2 # 5 E 71 ARG A 23 ARG~? 15.85 NI NI A 502 E 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 6 2 # 6 E 71 ARG A 101 ARG.? 18.18 NI NI A 501 E 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 7 2 # 7 E 71 ARG A 102 ARG.? 15.26 NI NI A 501 E 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 8 2 # 8 E 71 ARG B 17 ARG~? 8.61 NI NI A 501 E 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 9 2 # 9 E 71 ARG B 23 ARG~? 15.67 NI NI A 501 E 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 10 2 # 10 E 71 ARG B 23 ARG~? 15.67 NI NI A 501 E 181 GLU B 28 GLU~? 10.98 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 11 2 # 11 E 71 ARG B 23 ARG~? 15.67 NI NI A 501 E 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 12 2 # 12 E 71 ARG B 94 ARG^? 29.28 NI NI A 502 E 181 GLU B 116 GLU.? 34.45 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 13 2 # 13 E 71 ARG B 101 ARG.? 17.16 NI NI A 502 E 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 14 2 # 14 E 71 ARG B 101 ARG.? 17.16 NI NI A 502 E 181 GLU A 124 GLU.? 14.10 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 15 2 # 15 E 71 ARG B 102 ARG.? 15.54 NI NI A 502 E 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r44_c04 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 15 hits 1r44_c04 naa= 2 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 F 71 ARG A 17 ARG~? 9.21 NI NI A 502 F 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 F 71 ARG A 23 ARG~? 15.85 NI NI A 502 F 181 GLU A 28 GLU~? 13.04 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 F 71 ARG A 23 ARG~? 15.85 NI NI A 502 F 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 F 71 ARG A 23 ARG~? 15.85 NI NI A 502 F 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 5 2 # 5 F 71 ARG A 23 ARG~? 15.85 NI NI A 502 F 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 6 2 # 6 F 71 ARG A 101 ARG.? 18.18 NI NI A 501 F 181 GLU B 124 GLU.? 12.68 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 7 2 # 7 F 71 ARG A 102 ARG.? 15.26 NI NI A 501 F 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 8 2 # 8 F 71 ARG B 17 ARG~? 8.61 NI NI A 501 F 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 9 2 # 9 F 71 ARG B 23 ARG~? 15.67 NI NI A 501 F 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 10 2 # 10 F 71 ARG B 23 ARG~? 15.67 NI NI A 501 F 181 GLU B 28 GLU~? 10.98 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 11 2 # 11 F 71 ARG B 23 ARG~? 15.67 NI NI A 501 F 181 GLU B 86 GLU.? 9.13 NI NI A 501 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 12 2 # 12 F 71 ARG B 94 ARG^? 29.28 NI NI A 502 F 181 GLU B 116 GLU.? 34.45 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 13 2 # 13 F 71 ARG B 101 ARG.? 17.16 NI NI A 502 F 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 14 2 # 14 F 71 ARG B 101 ARG.? 17.16 NI NI A 502 F 181 GLU A 124 GLU.? 14.10 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 15 2 # 15 F 71 ARG B 102 ARG.? 15.54 NI NI A 502 F 181 GLU A 86 GLU.? 9.00 NI NI A 502 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1r44_c05 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 15 hits 1r44_c05 naa= 2 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 1 2 # 1 A 133 ARG A 17 ARG~? 9.21 NI NI A 502 A 235 LYS A 123 LYS^? 12.92 NI NI A 502 coo 31.15 12.07 13.86 31.85 13.16 16.74 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 27.79 29.07 13.69 29.71 23.15 14.63 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 2 2 # 2 A 133 ARG A 17 ARG~? 9.21 NI NI A 502 A 235 LYS B 123 LYS^? 13.38 NI NI A 501 coo 31.15 12.07 13.86 31.85 13.16 16.74 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 27.79 29.07 13.69 29.71 23.15 14.63 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 3 2 # 3 A 133 ARG A 93 ARG^? 27.22 NI NI A 502 A 235 LYS A 123 LYS^? 12.92 NI NI A 502 coo 31.15 12.07 13.86 31.85 13.16 16.74 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 27.79 29.07 13.69 29.71 23.15 14.63 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 4 2 # 4 A 133 ARG A 101 ARG.? 18.18 NI NI A 501 A 235 LYS A 123 LYS^? 12.92 NI NI A 502 coo 31.15 12.07 13.86 31.85 13.16 16.74 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 27.79 29.07 13.69 29.71 23.15 14.63 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 5 2 # 5 A 133 ARG A 101 ARG.? 18.18 NI NI A 501 A 235 LYS B 123 LYS^? 13.38 NI NI A 501 coo 31.15 12.07 13.86 31.85 13.16 16.74 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 27.79 29.07 13.69 29.71 23.15 14.63 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 6 2 # 6 A 133 ARG A 102 ARG.? 15.26 NI NI A 501 A 235 LYS A 123 LYS^? 12.92 NI NI A 502 coo 31.15 12.07 13.86 31.85 13.16 16.74 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 27.79 29.07 13.69 29.71 23.15 14.63 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 7 2 # 7 A 133 ARG B 17 ARG~? 8.61 NI NI A 501 A 235 LYS A 123 LYS^? 12.92 NI NI A 502 coo 31.15 12.07 13.86 31.85 13.16 16.74 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 27.79 29.07 13.69 29.71 23.15 14.63 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 8 2 # 8 A 133 ARG B 23 ARG~? 15.67 NI NI A 501 A 235 LYS B 123 LYS^? 13.38 NI NI A 501 coo 31.15 12.07 13.86 31.85 13.16 16.74 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 27.79 29.07 13.69 29.71 23.15 14.63 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 9 2 # 9 A 133 ARG B 93 ARG^? 28.43 NI NI A 501 A 235 LYS B 123 LYS^? 13.38 NI NI A 501 coo 31.15 12.07 13.86 31.85 13.16 16.74 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 27.79 29.07 13.69 29.71 23.15 14.63 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 10 2 # 10 A 133 ARG B 101 ARG.? 17.16 NI NI A 502 A 235 LYS B 123 LYS^? 13.38 NI NI A 501 coo 31.15 12.07 13.86 31.85 13.16 16.74 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 27.79 29.07 13.69 29.71 23.15 14.63 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 11 2 # 11 A 133 ARG B 102 ARG.? 15.54 NI NI A 502 A 235 LYS B 123 LYS^? 13.38 NI NI A 501 coo 31.15 12.07 13.86 31.85 13.16 16.74 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 27.79 29.07 13.69 29.71 23.15 14.63 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1r6w_c00 source 1r6w O-SUCCINYLBENZOATE SYNTHASE : 11 hits 1r6w_c00 naa= 2 ULMN 2 1r76_c00 PECTATE LYASE user 1 2 # 1 A 172 ASN A 33 ASN.? 14.07 NI NI A 501 A 307 ARG A 25 ARG~? 18.03 NI NI A 501 coo 22.99 58.57 18.19 23.89 56.65 18.30 -30.87 7.88 -5.92 -29.26 7.53 -4.61 coo 20.34 46.40 20.83 22.83 48.18 20.99 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 1r76_c00 PECTATE LYASE user 2 2 # 2 A 172 ASN B 33 ASN.? 13.74 NI NI A 502 A 307 ARG B 25 ARG~? 17.38 NI NI A 502 coo 22.99 58.57 18.19 23.89 56.65 18.30 -21.15 22.18 -41.67 -19.86 21.73 -43.34 coo 20.34 46.40 20.83 22.83 48.18 20.99 -23.60 10.54 -37.24 -21.22 8.75 -36.58 1r76_c00 source 1r76 PECTATE LYASE : 2 hits 1r76_c00 naa= 2 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 1 2 # 1 A 156 GLN A 97 GLN.? 30.16 NI NI A 501 A 217 GLU A 116 GLU.? 34.96 NI NI A 501 coo 0.57 24.33 98.25 1.75 23.60 99.87 -47.88 25.55 -30.56 -49.01 25.51 -28.74 coo 5.48 17.66 105.85 5.34 19.71 105.34 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 2 2 # 2 A 156 GLN B 97 GLN^? 29.66 NI NI A 501 A 217 GLU B 116 GLU.? 34.45 NI NI A 502 coo 0.57 24.33 98.25 1.75 23.60 99.87 -45.65 29.87 -16.62 -46.56 29.05 -18.37 coo 5.48 17.66 105.85 5.34 19.71 105.34 -40.98 33.61 -5.94 -39.53 34.29 -4.51 1ra0_c00 source 1ra0 CYTOSINE DEAMINASE : 2 hits 1ra0_c00 naa= 2 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 A 126 THR A 14 THR~? 17.42 NI NI A 502 A 160 ARG A 17 ARG~? 9.21 NI NI A 502 coo 51.19 2.52 10.94 50.16 2.43 9.01 -17.69 30.48 -14.71 -15.64 30.77 -13.94 coo 51.97 0.60 16.16 51.18 3.08 14.54 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 A 126 THR A 100 THR^? 19.44 NI NI A 501 A 160 ARG A 101 ARG.? 18.18 NI NI A 501 coo 51.19 2.52 10.94 50.16 2.43 9.01 -44.82 16.79 -25.89 -42.97 17.43 -25.07 coo 51.97 0.60 16.16 51.18 3.08 14.54 -45.57 11.90 -25.10 -47.16 9.28 -24.53 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 3 2 # 3 A 126 THR B 14 THR~? 17.57 NI NI A 501 A 160 ARG B 17 ARG~? 8.61 NI NI A 501 coo 51.19 2.52 10.94 50.16 2.43 9.01 -35.43 0.02 -33.01 -34.98 -1.69 -34.29 coo 51.97 0.60 16.16 51.18 3.08 14.54 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 4 2 # 4 A 126 THR B 100 THR.? 19.64 NI NI A 502 A 160 ARG B 101 ARG.? 17.16 NI NI A 502 coo 51.19 2.52 10.94 50.16 2.43 9.01 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo 51.97 0.60 16.16 51.18 3.08 14.54 -33.01 33.14 -24.23 -30.56 34.78 -23.33 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 5 2 # 5 A 126 THR B 100 THR.? 19.64 NI NI A 502 A 160 ARG B 102 ARG.? 15.54 NI NI A 502 coo 51.19 2.52 10.94 50.16 2.43 9.01 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo 51.97 0.60 16.16 51.18 3.08 14.54 -32.48 30.10 -28.35 -33.10 28.08 -26.10 1rql_c00 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 5 hits 1rql_c00 naa= 2 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 B 126 THR A 14 THR~? 17.42 NI NI A 502 B 160 ARG A 17 ARG~? 9.21 NI NI A 502 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -17.69 30.48 -14.71 -15.64 30.77 -13.94 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 B 126 THR A 100 THR^? 19.44 NI NI A 501 B 160 ARG A 101 ARG.? 18.18 NI NI A 501 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -44.82 16.79 -25.89 -42.97 17.43 -25.07 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -45.57 11.90 -25.10 -47.16 9.28 -24.53 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 3 2 # 3 B 126 THR B 14 THR~? 17.57 NI NI A 501 B 160 ARG B 17 ARG~? 8.61 NI NI A 501 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -35.43 0.02 -33.01 -34.98 -1.69 -34.29 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 4 2 # 4 B 126 THR B 100 THR.? 19.64 NI NI A 502 B 160 ARG B 101 ARG.? 17.16 NI NI A 502 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -33.01 33.14 -24.23 -30.56 34.78 -23.33 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 5 2 # 5 B 126 THR B 100 THR.? 19.64 NI NI A 502 B 160 ARG B 102 ARG.? 15.54 NI NI A 502 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -32.48 30.10 -28.35 -33.10 28.08 -26.10 1rql_c01 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 5 hits 1rql_c01 naa= 2 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 195 SER A 37 SER.? 17.24 NI NI A 501 B 196 GLY A 38 GLY.? 19.66 NI NI A 501 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -36.37 13.52 -4.47 -38.41 12.46 -5.07 coo 0.64 25.09 37.94 0.51 25.31 37.16 -33.78 15.59 -2.58 -33.85 16.00 -3.16 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 2 # 2 B 195 SER A 39 SER.? 22.71 NI NI A 501 B 196 GLY A 38 GLY.? 19.66 NI NI A 501 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -30.74 17.86 -2.39 -32.21 19.67 -1.89 coo 0.64 25.09 37.94 0.51 25.31 37.16 -33.78 15.59 -2.58 -33.85 16.00 -3.16 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 2 # 3 B 195 SER A 39 SER.? 22.71 NI NI A 501 B 196 GLY A 59 GLY^? 20.99 NI NI A 501 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -30.74 17.86 -2.39 -32.21 19.67 -1.89 coo 0.64 25.09 37.94 0.51 25.31 37.16 -30.45 21.23 -6.47 -30.72 21.32 -5.76 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 2 # 4 B 195 SER B 37 SER.? 18.11 NI NI A 502 B 196 GLY B 38 GLY.? 18.77 NI NI A 502 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -30.28 24.83 -43.53 -31.09 26.93 -42.73 coo 0.64 25.09 37.94 0.51 25.31 37.16 -30.40 21.09 -44.03 -30.15 21.71 -44.55 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 2 # 5 B 195 SER B 39 SER.? 22.22 NI NI A 502 B 196 GLY B 38 GLY.? 18.77 NI NI A 502 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -31.34 18.90 -45.43 -33.73 18.83 -45.04 coo 0.64 25.09 37.94 0.51 25.31 37.16 -30.40 21.09 -44.03 -30.15 21.71 -44.55 1rtf_c01 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 5 hits 1rtf_c01 naa= 2 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 1 2 # 1 A 53 GLN A 97 GLN.? 30.16 NI NI A 501 A 136 GLU A 116 GLU.? 34.96 NI NI A 501 coo 80.69 40.00 16.06 79.05 40.72 17.21 -47.88 25.55 -30.56 -49.01 25.51 -28.74 coo 71.34 40.73 18.57 73.36 41.35 18.80 -49.93 20.01 -40.14 -51.36 19.66 -41.66 1s2k_c00 source 1s2k ALA-ILE-HIS TRIPEPTIDE : 1 hits 1s2k_c00 naa= 2 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 1 2 # 1 A 176 HIS A 126 HIS.? -3.75 NI NI A 502s A 307 GLU A 86 GLU.? 9.00 NI NI A 502 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 2 2 # 2 A 176 HIS B 31 HIS~? -3.92 NI NI A 502s A 307 GLU B 28 GLU~? 10.98 NI NI A 502 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 3 2 # 3 A 176 HIS B 126 HIS.? -4.79 NI NI A 501s A 307 GLU B 86 GLU.? 9.13 NI NI A 501 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1snz_c00 source 1snz ALDOSE 1-EPIMERASE : 3 hits 1snz_c00 naa= 2 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 1 2 # 1 B 176 HIS A 126 HIS.? -3.75 NI NI A 502s B 307 GLU A 86 GLU.? 9.00 NI NI A 502 coo 24.63 93.76 22.10 25.63 93.50 23.91 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 26.56 90.05 20.00 27.80 91.02 21.36 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 2 2 # 2 B 176 HIS B 31 HIS~? -3.92 NI NI A 502s B 307 GLU B 28 GLU~? 10.98 NI NI A 502 coo 24.63 93.76 22.10 25.63 93.50 23.91 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 26.56 90.05 20.00 27.80 91.02 21.36 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1snz_c01 ALDOSE 1-EPIMERASE user 3 2 # 3 B 176 HIS B 126 HIS.? -4.79 NI NI A 501s B 307 GLU B 86 GLU.? 9.13 NI NI A 501 coo 24.63 93.76 22.10 25.63 93.50 23.91 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 26.56 90.05 20.00 27.80 91.02 21.36 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1snz_c01 source 1snz ALDOSE 1-EPIMERASE : 3 hits 1snz_c01 naa= 2 ULMN 2 1sox_c00 SULFITE OXIDASE user 1 2 # 1 A 138 ARG A 23 ARG~? 15.85 NI NI A 502 A 322 TYR A 22 TYR~? 21.39 NI NI A 501 coo 29.11 98.43 27.28 31.52 97.24 28.79 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 28.34 90.08 25.08 29.22 92.59 25.94 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1sox_c00 SULFITE OXIDASE user 2 2 # 2 A 138 ARG A 23 ARG~? 15.85 NI NI A 502 A 322 TYR A 67 TYR^? 18.49 NI NI A 501 coo 29.11 98.43 27.28 31.52 97.24 28.79 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 28.34 90.08 25.08 29.22 92.59 25.94 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1sox_c00 SULFITE OXIDASE user 3 2 # 3 A 138 ARG A 25 ARG~? 18.03 NI NI A 501 A 322 TYR A 22 TYR~? 21.39 NI NI A 501 coo 29.11 98.43 27.28 31.52 97.24 28.79 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 28.34 90.08 25.08 29.22 92.59 25.94 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1sox_c00 SULFITE OXIDASE user 4 2 # 4 A 138 ARG A 25 ARG~? 18.03 NI NI A 501 A 322 TYR A 29 TYR~? 15.38 NI NI A 501 coo 29.11 98.43 27.28 31.52 97.24 28.79 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 28.34 90.08 25.08 29.22 92.59 25.94 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1sox_c00 SULFITE OXIDASE user 5 2 # 5 A 138 ARG A 93 ARG^? 27.22 NI NI A 502 A 322 TYR B 67 TYR^? 18.53 NI NI A 502 coo 29.11 98.43 27.28 31.52 97.24 28.79 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 28.34 90.08 25.08 29.22 92.59 25.94 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1sox_c00 SULFITE OXIDASE user 6 2 # 6 A 138 ARG B 23 ARG~? 15.67 NI NI A 501 A 322 TYR B 22 TYR~? 21.09 NI NI A 502 coo 29.11 98.43 27.28 31.52 97.24 28.79 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 28.34 90.08 25.08 29.22 92.59 25.94 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1sox_c00 SULFITE OXIDASE user 7 2 # 7 A 138 ARG B 23 ARG~? 15.67 NI NI A 501 A 322 TYR B 67 TYR^? 18.53 NI NI A 502 coo 29.11 98.43 27.28 31.52 97.24 28.79 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 28.34 90.08 25.08 29.22 92.59 25.94 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1sox_c00 SULFITE OXIDASE user 8 2 # 8 A 138 ARG B 25 ARG~? 17.38 NI NI A 502 A 322 TYR B 22 TYR~? 21.09 NI NI A 502 coo 29.11 98.43 27.28 31.52 97.24 28.79 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 28.34 90.08 25.08 29.22 92.59 25.94 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1sox_c00 SULFITE OXIDASE user 9 2 # 9 A 138 ARG B 25 ARG~? 17.38 NI NI A 502 A 322 TYR B 29 TYR~? 14.52 NI NI A 502 coo 29.11 98.43 27.28 31.52 97.24 28.79 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 28.34 90.08 25.08 29.22 92.59 25.94 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1sox_c00 SULFITE OXIDASE user 10 2 # 10 A 138 ARG B 93 ARG^? 28.43 NI NI A 501 A 322 TYR A 67 TYR^? 18.49 NI NI A 501 coo 29.11 98.43 27.28 31.52 97.24 28.79 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 28.34 90.08 25.08 29.22 92.59 25.94 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1sox_c00 source 1sox SULFITE OXIDASE : 10 hits 1sox_c00 naa= 2 ULMN 2 1sox_c01 SULFITE OXIDASE user 1 2 # 1 B 138 ARG A 23 ARG~? 15.85 NI NI A 502 B 322 TYR A 22 TYR~? 21.39 NI NI A 501 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1sox_c01 SULFITE OXIDASE user 2 2 # 2 B 138 ARG A 23 ARG~? 15.85 NI NI A 502 B 322 TYR A 67 TYR^? 18.49 NI NI A 501 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1sox_c01 SULFITE OXIDASE user 3 2 # 3 B 138 ARG A 25 ARG~? 18.03 NI NI A 501 B 322 TYR A 22 TYR~? 21.39 NI NI A 501 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1sox_c01 SULFITE OXIDASE user 4 2 # 4 B 138 ARG A 25 ARG~? 18.03 NI NI A 501 B 322 TYR A 29 TYR~? 15.38 NI NI A 501 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1sox_c01 SULFITE OXIDASE user 5 2 # 5 B 138 ARG A 93 ARG^? 27.22 NI NI A 502 B 322 TYR B 67 TYR^? 18.53 NI NI A 502 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1sox_c01 SULFITE OXIDASE user 6 2 # 6 B 138 ARG B 23 ARG~? 15.67 NI NI A 501 B 322 TYR B 22 TYR~? 21.09 NI NI A 502 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1sox_c01 SULFITE OXIDASE user 7 2 # 7 B 138 ARG B 23 ARG~? 15.67 NI NI A 501 B 322 TYR B 67 TYR^? 18.53 NI NI A 502 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1sox_c01 SULFITE OXIDASE user 8 2 # 8 B 138 ARG B 25 ARG~? 17.38 NI NI A 502 B 322 TYR B 22 TYR~? 21.09 NI NI A 502 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1sox_c01 SULFITE OXIDASE user 9 2 # 9 B 138 ARG B 25 ARG~? 17.38 NI NI A 502 B 322 TYR B 29 TYR~? 14.52 NI NI A 502 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1sox_c01 SULFITE OXIDASE user 10 2 # 10 B 138 ARG B 93 ARG^? 28.43 NI NI A 501 B 322 TYR A 67 TYR^? 18.49 NI NI A 501 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1sox_c01 source 1sox SULFITE OXIDASE : 10 hits 1sox_c01 naa= 2 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 82 ASP~? 15.20 NI NI A 502 E 170 GLU A 86 GLU.? 9.00 NI NI A 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 2.36 26.80 21.76 1.58 25.84 20.04 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 82 ASP~? 15.20 NI NI A 502 E 170 GLU A 124 GLU.? 14.10 NI NI A 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 2.36 26.80 21.76 1.58 25.84 20.04 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 88 ASP^? 14.52 NI NI A 501 E 170 GLU B 28 GLU~? 10.98 NI NI A 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 2.36 26.80 21.76 1.58 25.84 20.04 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP A 88 ASP^? 14.52 NI NI A 501 E 170 GLU B 124 GLU.? 12.68 NI NI A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 2.36 26.80 21.76 1.58 25.84 20.04 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 5 2 # 5 E 166 ASP B 82 ASP~? 13.99 NI NI A 501 E 170 GLU B 86 GLU.? 9.13 NI NI A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 2.36 26.80 21.76 1.58 25.84 20.04 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 6 2 # 6 E 166 ASP B 82 ASP~? 13.99 NI NI A 501 E 170 GLU B 124 GLU.? 12.68 NI NI A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 2.36 26.80 21.76 1.58 25.84 20.04 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 7 2 # 7 E 166 ASP B 88 ASP^? 15.06 NI NI A 502 E 170 GLU A 124 GLU.? 14.10 NI NI A 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 2.36 26.80 21.76 1.58 25.84 20.04 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1stc_c00 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 7 hits 1stc_c00 naa= 2 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 42 ASP.? 24.20 NI NI A 501 E 168 LYS A 53 LYS.? 25.39 NI NI A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 88 ASP^? 14.52 NI NI A 501 E 168 LYS B 123 LYS^? 13.38 NI NI A 501 coo 5.36 16.20 22.10 3.88 17.00 23.31 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 5.06 22.32 18.11 1.02 22.08 22.74 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP B 42 ASP.? 24.38 NI NI A 502 E 168 LYS B 53 LYS.? 26.24 NI NI A 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 5.06 22.32 18.11 1.02 22.08 22.74 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP B 88 ASP^? 15.06 NI NI A 502 E 168 LYS A 123 LYS^? 12.92 NI NI A 502 coo 5.36 16.20 22.10 3.88 17.00 23.31 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 5.06 22.32 18.11 1.02 22.08 22.74 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1stc_c01 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c01 naa= 2 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 1 2 # 1 A 8 HIS A 31 HIS~? -4.16 NI NI A 501s A 80 GLU A 28 GLU~? 13.04 NI NI A 501 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 2 2 # 2 A 8 HIS A 126 HIS.? -3.75 NI NI A 502s A 80 GLU A 86 GLU.? 9.00 NI NI A 502 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 3 2 # 3 A 8 HIS B 31 HIS~? -3.92 NI NI A 502s A 80 GLU B 28 GLU~? 10.98 NI NI A 502 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 4 2 # 4 A 8 HIS B 126 HIS.? -4.79 NI NI A 501s A 80 GLU B 86 GLU.? 9.13 NI NI A 501 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1t0u_c00 source 1t0u URIDINE PHOSPHORYLASE : 4 hits 1t0u_c00 naa= 2 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 53 LYS.? 25.39 NI NI A 501 288 SER A 24 SER~? 14.80 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -24.49 16.91 -14.42 -22.87 15.82 -15.86 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 53 LYS.? 25.39 NI NI A 501 288 SER A 39 SER.? 22.71 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -30.74 17.86 -2.39 -32.21 19.67 -1.89 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 53 LYS.? 25.39 NI NI A 501 288 SER A 43 SER.? 23.77 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -20.78 14.34 -0.26 -20.70 12.54 1.43 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 4 2 # 4 62 LYS A 123 LYS^? 12.92 NI NI A 502 288 SER B 37 SER.? 18.11 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -30.28 24.83 -43.53 -31.09 26.93 -42.73 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 5 2 # 5 62 LYS A 123 LYS^? 12.92 NI NI A 502 288 SER B 39 SER.? 22.22 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -31.34 18.90 -45.43 -33.73 18.83 -45.04 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 6 2 # 6 62 LYS B 53 LYS.? 26.24 NI NI A 502 288 SER B 24 SER~? 15.42 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -26.98 12.98 -33.60 -27.18 11.97 -31.48 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 7 2 # 7 62 LYS B 53 LYS.? 26.24 NI NI A 502 288 SER B 39 SER.? 22.22 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -31.34 18.90 -45.43 -33.73 18.83 -45.04 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 8 2 # 8 62 LYS B 53 LYS.? 26.24 NI NI A 502 288 SER B 43 SER.? 24.88 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -23.40 10.48 -47.49 -24.52 10.60 -49.63 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 9 2 # 9 62 LYS B 123 LYS^? 13.38 NI NI A 501 288 SER A 37 SER.? 17.24 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -36.37 13.52 -4.47 -38.41 12.46 -5.07 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 10 2 # 10 62 LYS B 123 LYS^? 13.38 NI NI A 501 288 SER A 39 SER.? 22.71 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -30.74 17.86 -2.39 -32.21 19.67 -1.89 1tdj_c00 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 10 hits 1tdj_c00 naa= 2 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 53 LYS.? 25.39 NI NI A 501 315 SER A 18 SER~? 18.69 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -20.61 25.64 -12.14 -18.92 27.29 -11.48 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 123 LYS^? 12.92 NI NI A 502 315 SER B 24 SER~? 15.42 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -26.98 12.98 -33.60 -27.18 11.97 -31.48 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 123 LYS^? 12.92 NI NI A 502 315 SER B 87 SER.? 15.38 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -34.52 16.29 -22.30 -36.75 17.25 -22.69 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 4 2 # 4 62 LYS B 53 LYS.? 26.24 NI NI A 502 315 SER B 18 SER~? 18.56 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -32.39 4.87 -35.49 -32.99 2.69 -36.46 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 5 2 # 5 62 LYS B 123 LYS^? 13.38 NI NI A 501 315 SER A 24 SER~? 14.80 NI NI A 501 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -24.49 16.91 -14.42 -22.87 15.82 -15.86 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 6 2 # 6 62 LYS B 123 LYS^? 13.38 NI NI A 501 315 SER A 87 SER.? 14.75 NI NI A 502 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -31.76 21.87 -25.29 -32.13 24.17 -24.48 1tdj_c02 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 6 hits 1tdj_c02 naa= 2 ULMN 2 1teh_c00 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 1 2 # 1 A 47 HIS A 126 HIS.? -3.75 NI NI A 502s A 48 THR A 85 THR~? 12.80 NI NI A 502 coo 19.48 46.71 6.01 18.00 45.25 6.29 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 18.23 48.52 1.91 16.89 50.17 1.48 -26.43 24.20 -22.83 -27.87 24.69 -21.30 ULMN 2 1teh_c00 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 2 2 # 2 A 47 HIS B 126 HIS.? -4.79 NI NI A 501s A 48 THR B 83 THR~? 9.81 NI NI A 501 coo 19.48 46.71 6.01 18.00 45.25 6.29 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 18.23 48.52 1.91 16.89 50.17 1.48 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 2 1teh_c00 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 3 2 # 3 A 47 HIS B 126 HIS.? -4.79 NI NI A 501s A 48 THR B 85 THR.? 12.36 NI NI A 501 coo 19.48 46.71 6.01 18.00 45.25 6.29 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 18.23 48.52 1.91 16.89 50.17 1.48 -33.81 10.96 -25.09 -35.41 11.74 -26.39 1teh_c00 source 1teh HUMAN CHICHI ALCOHOL DEHYDROGENASE : 3 hits 1teh_c00 naa= 2 ULMN 2 1teh_c01 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 1 2 # 1 B 47 HIS A 126 HIS.? -3.75 NI NI A 502s B 48 THR A 85 THR~? 12.80 NI NI A 502 coo 20.93 8.91 26.51 19.58 7.34 26.17 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 23.42 10.24 22.80 22.81 11.85 21.53 -26.43 24.20 -22.83 -27.87 24.69 -21.30 ULMN 2 1teh_c01 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 2 2 # 2 B 47 HIS B 126 HIS.? -4.79 NI NI A 501s B 48 THR B 83 THR~? 9.81 NI NI A 501 coo 20.93 8.91 26.51 19.58 7.34 26.17 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 23.42 10.24 22.80 22.81 11.85 21.53 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 2 1teh_c01 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 3 2 # 3 B 47 HIS B 126 HIS.? -4.79 NI NI A 501s B 48 THR B 85 THR.? 12.36 NI NI A 501 coo 20.93 8.91 26.51 19.58 7.34 26.17 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 23.42 10.24 22.80 22.81 11.85 21.53 -33.81 10.96 -25.09 -35.41 11.74 -26.39 1teh_c01 source 1teh HUMAN CHICHI ALCOHOL DEHYDROGENASE : 3 hits 1teh_c01 naa= 2 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 1 2 # 1 E 143 GLU A 28 GLU~? 13.04 NI NI A 501 E 231 HIS B 126 HIS.? -4.79 NI NI A 501s coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 2 2 # 2 E 143 GLU A 86 GLU.? 9.00 NI NI A 502 E 231 HIS A 127 HIS.? 7.54 NI NI A 502 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 3 2 # 3 E 143 GLU A 124 GLU.? 14.10 NI NI A 502 E 231 HIS A 126 HIS.? -3.75 NI NI A 502s coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 4 2 # 4 E 143 GLU A 124 GLU.? 14.10 NI NI A 502 E 231 HIS A 127 HIS.? 7.54 NI NI A 502 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 5 2 # 5 E 143 GLU A 124 GLU.? 14.10 NI NI A 502 E 231 HIS B 31 HIS~? -3.92 NI NI A 502s coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 6 2 # 6 E 143 GLU B 28 GLU~? 10.98 NI NI A 502 E 231 HIS A 126 HIS.? -3.75 NI NI A 502s coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 7 2 # 7 E 143 GLU B 86 GLU.? 9.13 NI NI A 501 E 231 HIS B 127 HIS.? 5.53 NI NI A 501 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 8 2 # 8 E 143 GLU B 124 GLU.? 12.68 NI NI A 501 E 231 HIS A 31 HIS~? -4.16 NI NI A 501s coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1tlp_c00 THERMOLYSIN (E.C.3.4.24.27) COMPLEX user 9 2 # 9 E 143 GLU B 124 GLU.? 12.68 NI NI A 501 E 231 HIS B 127 HIS.? 5.53 NI NI A 501 coo 50.69 23.59 -3.14 51.24 21.98 -4.34 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 56.10 14.71 -7.53 54.39 15.79 -7.85 -36.21 5.24 -15.46 -36.02 3.20 -15.94 1tlp_c00 source 1tlp THERMOLYSIN (E.C.3.4.24.27) COMPLEX WITH PHOSP: 9 hits 1tlp_c00 naa= 2 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 2 # 1 117 ASP A 13 ASP~? 13.27 NI NI A 502 265 ASP A 82 ASP~? 15.20 NI NI A 502 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 2 # 2 117 ASP A 82 ASP~? 15.20 NI NI A 502 265 ASP A 13 ASP~? 13.27 NI NI A 502 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 3 2 # 3 117 ASP A 82 ASP~? 15.20 NI NI A 502 265 ASP A 88 ASP^? 14.52 NI NI A 501 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 4 2 # 4 117 ASP A 82 ASP~? 15.20 NI NI A 502 265 ASP B 88 ASP^? 15.06 NI NI A 502 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 5 2 # 5 117 ASP A 88 ASP^? 14.52 NI NI A 501 265 ASP A 82 ASP~? 15.20 NI NI A 502 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 6 2 # 6 117 ASP A 88 ASP^? 14.52 NI NI A 501 265 ASP B 82 ASP~? 13.99 NI NI A 501 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 7 2 # 7 117 ASP B 13 ASP~? 14.49 NI NI A 501 265 ASP B 82 ASP~? 13.99 NI NI A 501 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 8 2 # 8 117 ASP B 82 ASP~? 13.99 NI NI A 501 265 ASP A 88 ASP^? 14.52 NI NI A 501 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 9 2 # 9 117 ASP B 82 ASP~? 13.99 NI NI A 501 265 ASP B 13 ASP~? 14.49 NI NI A 501 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 10 2 # 10 117 ASP B 82 ASP~? 13.99 NI NI A 501 265 ASP B 88 ASP^? 15.06 NI NI A 502 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 11 2 # 11 117 ASP B 88 ASP^? 15.06 NI NI A 502 265 ASP A 82 ASP~? 15.20 NI NI A 502 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 12 2 # 12 117 ASP B 88 ASP^? 15.06 NI NI A 502 265 ASP B 82 ASP~? 13.99 NI NI A 501 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1tml_c01 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 12 hits 1tml_c01 naa= 2 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 A 418 GLU A 28 GLU~? 13.04 NI NI A 501 A 481 HIS B 126 HIS.? -4.79 NI NI A 501s coo 14.10 66.39 26.65 14.11 68.21 25.54 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 14.95 77.09 31.69 15.34 77.40 29.70 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 A 418 GLU A 86 GLU.? 9.00 NI NI A 502 A 481 HIS A 127 HIS.? 7.54 NI NI A 502 coo 14.10 66.39 26.65 14.11 68.21 25.54 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 14.95 77.09 31.69 15.34 77.40 29.70 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 3 2 # 3 A 418 GLU A 124 GLU.? 14.10 NI NI A 502 A 481 HIS A 127 HIS.? 7.54 NI NI A 502 coo 14.10 66.39 26.65 14.11 68.21 25.54 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 14.95 77.09 31.69 15.34 77.40 29.70 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 4 2 # 4 A 418 GLU A 124 GLU.? 14.10 NI NI A 502 A 481 HIS B 31 HIS~? -3.92 NI NI A 502s coo 14.10 66.39 26.65 14.11 68.21 25.54 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 14.95 77.09 31.69 15.34 77.40 29.70 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1trk_c04 TRANSKETOLASE (E.C.2.2.1.1) user 5 2 # 5 A 418 GLU B 124 GLU.? 12.68 NI NI A 501 A 481 HIS A 31 HIS~? -4.16 NI NI A 501s coo 14.10 66.39 26.65 14.11 68.21 25.54 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 14.95 77.09 31.69 15.34 77.40 29.70 -28.46 6.43 -14.65 -28.67 4.98 -16.17 1trk_c04 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 5 hits 1trk_c04 naa= 2 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 B 418 GLU A 28 GLU~? 13.04 NI NI A 501 B 481 HIS B 126 HIS.? -4.79 NI NI A 501s coo -2.49 65.64 20.85 -1.68 63.95 19.85 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 B 418 GLU A 86 GLU.? 9.00 NI NI A 502 B 481 HIS A 127 HIS.? 7.54 NI NI A 502 coo -2.49 65.64 20.85 -1.68 63.95 19.85 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 3 2 # 3 B 418 GLU A 124 GLU.? 14.10 NI NI A 502 B 481 HIS A 127 HIS.? 7.54 NI NI A 502 coo -2.49 65.64 20.85 -1.68 63.95 19.85 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 4 2 # 4 B 418 GLU A 124 GLU.? 14.10 NI NI A 502 B 481 HIS B 31 HIS~? -3.92 NI NI A 502s coo -2.49 65.64 20.85 -1.68 63.95 19.85 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1trk_c05 TRANSKETOLASE (E.C.2.2.1.1) user 5 2 # 5 B 418 GLU B 124 GLU.? 12.68 NI NI A 501 B 481 HIS A 31 HIS~? -4.16 NI NI A 501s coo -2.49 65.64 20.85 -1.68 63.95 19.85 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -28.46 6.43 -14.65 -28.67 4.98 -16.17 1trk_c05 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 5 hits 1trk_c05 naa= 2 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 B 30 HIS A 31 HIS~? -4.16 NI NI A 501s B 263 HIS B 126 HIS.? -4.79 NI NI A 501s coo 22.56 81.67 27.05 21.63 80.48 28.39 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 25.28 77.43 24.09 23.29 77.31 24.60 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 B 30 HIS A 126 HIS.? -3.75 NI NI A 502s B 263 HIS A 127 HIS.? 7.54 NI NI A 502 coo 22.56 81.67 27.05 21.63 80.48 28.39 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.28 77.43 24.09 23.29 77.31 24.60 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 3 2 # 3 B 30 HIS A 126 HIS.? -3.75 NI NI A 502s B 263 HIS B 31 HIS~? -3.92 NI NI A 502s coo 22.56 81.67 27.05 21.63 80.48 28.39 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.28 77.43 24.09 23.29 77.31 24.60 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 4 2 # 4 B 30 HIS A 127 HIS.? 7.54 NI NI A 502 B 263 HIS A 126 HIS.? -3.75 NI NI A 502s coo 22.56 81.67 27.05 21.63 80.48 28.39 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 25.28 77.43 24.09 23.29 77.31 24.60 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 5 2 # 5 B 30 HIS B 31 HIS~? -3.92 NI NI A 502s B 263 HIS A 126 HIS.? -3.75 NI NI A 502s coo 22.56 81.67 27.05 21.63 80.48 28.39 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 25.28 77.43 24.09 23.29 77.31 24.60 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 6 2 # 6 B 30 HIS B 126 HIS.? -4.79 NI NI A 501s B 263 HIS A 31 HIS~? -4.16 NI NI A 501s coo 22.56 81.67 27.05 21.63 80.48 28.39 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 25.28 77.43 24.09 23.29 77.31 24.60 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 7 2 # 7 B 30 HIS B 126 HIS.? -4.79 NI NI A 501s B 263 HIS B 127 HIS.? 5.53 NI NI A 501 coo 22.56 81.67 27.05 21.63 80.48 28.39 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 25.28 77.43 24.09 23.29 77.31 24.60 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1trk_c06 TRANSKETOLASE (E.C.2.2.1.1) user 8 2 # 8 B 30 HIS B 127 HIS.? 5.53 NI NI A 501 B 263 HIS B 126 HIS.? -4.79 NI NI A 501s coo 22.56 81.67 27.05 21.63 80.48 28.39 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 25.28 77.43 24.09 23.29 77.31 24.60 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1trk_c06 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 8 hits 1trk_c06 naa= 2 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 A 30 HIS A 31 HIS~? -4.16 NI NI A 501s A 263 HIS B 126 HIS.? -4.79 NI NI A 501s coo -9.47 50.71 16.18 -9.50 51.94 17.79 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 A 30 HIS A 126 HIS.? -3.75 NI NI A 502s A 263 HIS A 127 HIS.? 7.54 NI NI A 502 coo -9.47 50.71 16.18 -9.50 51.94 17.79 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 3 2 # 3 A 30 HIS A 126 HIS.? -3.75 NI NI A 502s A 263 HIS B 31 HIS~? -3.92 NI NI A 502s coo -9.47 50.71 16.18 -9.50 51.94 17.79 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 4 2 # 4 A 30 HIS A 127 HIS.? 7.54 NI NI A 502 A 263 HIS A 126 HIS.? -3.75 NI NI A 502s coo -9.47 50.71 16.18 -9.50 51.94 17.79 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 5 2 # 5 A 30 HIS B 31 HIS~? -3.92 NI NI A 502s A 263 HIS A 126 HIS.? -3.75 NI NI A 502s coo -9.47 50.71 16.18 -9.50 51.94 17.79 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 6 2 # 6 A 30 HIS B 126 HIS.? -4.79 NI NI A 501s A 263 HIS A 31 HIS~? -4.16 NI NI A 501s coo -9.47 50.71 16.18 -9.50 51.94 17.79 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 7 2 # 7 A 30 HIS B 126 HIS.? -4.79 NI NI A 501s A 263 HIS B 127 HIS.? 5.53 NI NI A 501 coo -9.47 50.71 16.18 -9.50 51.94 17.79 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1trk_c07 TRANSKETOLASE (E.C.2.2.1.1) user 8 2 # 8 A 30 HIS B 127 HIS.? 5.53 NI NI A 501 A 263 HIS B 126 HIS.? -4.79 NI NI A 501s coo -9.47 50.71 16.18 -9.50 51.94 17.79 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo -9.86 54.72 12.15 -8.65 55.01 13.75 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1trk_c07 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 8 hits 1trk_c07 naa= 2 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 1 2 # 1 A 130 ASP A 13 ASP~? 13.27 NI NI A 502 A 185 ASP A 82 ASP~? 15.20 NI NI A 502 coo 8.81 3.41 29.07 10.49 4.61 29.53 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 17.44 9.63 28.94 15.61 8.68 29.31 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 2 2 # 2 A 130 ASP A 82 ASP~? 15.20 NI NI A 502 A 185 ASP A 13 ASP~? 13.27 NI NI A 502 coo 8.81 3.41 29.07 10.49 4.61 29.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 17.44 9.63 28.94 15.61 8.68 29.31 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 3 2 # 3 A 130 ASP A 82 ASP~? 15.20 NI NI A 502 A 185 ASP B 88 ASP^? 15.06 NI NI A 502 coo 8.81 3.41 29.07 10.49 4.61 29.53 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 17.44 9.63 28.94 15.61 8.68 29.31 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 4 2 # 4 A 130 ASP A 88 ASP^? 14.52 NI NI A 501 A 185 ASP B 82 ASP~? 13.99 NI NI A 501 coo 8.81 3.41 29.07 10.49 4.61 29.53 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 17.44 9.63 28.94 15.61 8.68 29.31 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 5 2 # 5 A 130 ASP B 13 ASP~? 14.49 NI NI A 501 A 185 ASP B 82 ASP~? 13.99 NI NI A 501 coo 8.81 3.41 29.07 10.49 4.61 29.53 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 17.44 9.63 28.94 15.61 8.68 29.31 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 6 2 # 6 A 130 ASP B 82 ASP~? 13.99 NI NI A 501 A 185 ASP A 88 ASP^? 14.52 NI NI A 501 coo 8.81 3.41 29.07 10.49 4.61 29.53 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 17.44 9.63 28.94 15.61 8.68 29.31 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 7 2 # 7 A 130 ASP B 82 ASP~? 13.99 NI NI A 501 A 185 ASP B 13 ASP~? 14.49 NI NI A 501 coo 8.81 3.41 29.07 10.49 4.61 29.53 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 17.44 9.63 28.94 15.61 8.68 29.31 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 8 2 # 8 A 130 ASP B 88 ASP^? 15.06 NI NI A 502 A 185 ASP A 82 ASP~? 15.20 NI NI A 502 coo 8.81 3.41 29.07 10.49 4.61 29.53 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 17.44 9.63 28.94 15.61 8.68 29.31 -29.79 30.16 -22.23 -31.29 29.65 -23.60 1uas_c00 source 1uas ALPHA-GALACTOSIDASE : 8 hits 1uas_c00 naa= 2 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 1 2 # 1 199 ASP A 88 ASP^? 14.52 NI NI A 501 255 GLU A 86 GLU.? 9.00 NI NI A 502 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.57 37.12 10.17 53.37 35.95 11.75 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 2 2 # 2 199 ASP A 88 ASP^? 14.52 NI NI A 501 255 GLU A 124 GLU.? 14.10 NI NI A 502 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.57 37.12 10.17 53.37 35.95 11.75 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 3 2 # 3 199 ASP A 88 ASP^? 14.52 NI NI A 501 255 GLU B 86 GLU.? 9.13 NI NI A 501 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 52.57 37.12 10.17 53.37 35.95 11.75 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 4 2 # 4 199 ASP B 88 ASP^? 15.06 NI NI A 502 255 GLU A 86 GLU.? 9.00 NI NI A 502 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 52.57 37.12 10.17 53.37 35.95 11.75 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 5 2 # 5 199 ASP B 88 ASP^? 15.06 NI NI A 502 255 GLU B 86 GLU.? 9.13 NI NI A 501 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 52.57 37.12 10.17 53.37 35.95 11.75 -31.72 11.77 -20.56 -30.07 12.65 -19.61 1uok_c01 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c01 naa= 2 ULMN 2 1uox_c00 URATE OXIDASE user 1 2 # 1 28 THR A 14 THR~? 17.42 NI NI A 502 76 PRO A 73 PRO.? 25.57 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -17.69 30.48 -14.71 -15.64 30.77 -13.94 coo 23.62 58.48 37.29 23.51 60.61 36.65 -31.74 34.51 -10.94 -30.18 35.31 -9.48 ULMN 2 1uox_c00 URATE OXIDASE user 2 2 # 2 28 THR A 65 THR.? 13.82 NI NI A 501 76 PRO B 113 PRO.? 25.89 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -35.39 14.99 -13.24 -37.04 15.69 -14.45 coo 23.62 58.48 37.29 23.51 60.61 36.65 -38.42 22.45 -2.53 -38.86 24.43 -3.51 ULMN 2 1uox_c00 URATE OXIDASE user 3 2 # 3 28 THR A 83 THR~? 11.66 NI NI A 502 76 PRO A 73 PRO.? 25.57 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo 23.62 58.48 37.29 23.51 60.61 36.65 -31.74 34.51 -10.94 -30.18 35.31 -9.48 ULMN 2 1uox_c00 URATE OXIDASE user 4 2 # 4 28 THR A 83 THR~? 11.66 NI NI A 502 76 PRO A 74 PRO.? 24.58 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo 23.62 58.48 37.29 23.51 60.61 36.65 -25.55 36.81 -9.90 -27.49 37.32 -10.87 ULMN 2 1uox_c00 URATE OXIDASE user 5 2 # 5 28 THR A 83 THR~? 11.66 NI NI A 502 76 PRO B 34 PRO.? 9.33 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo 23.62 58.48 37.29 23.51 60.61 36.65 -19.80 26.53 -38.25 -21.53 25.95 -39.54 ULMN 2 1uox_c00 URATE OXIDASE user 6 2 # 6 28 THR A 85 THR~? 12.80 NI NI A 502 76 PRO A 73 PRO.? 25.57 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 23.62 58.48 37.29 23.51 60.61 36.65 -31.74 34.51 -10.94 -30.18 35.31 -9.48 ULMN 2 1uox_c00 URATE OXIDASE user 7 2 # 7 28 THR A 85 THR~? 12.80 NI NI A 502 76 PRO B 34 PRO.? 9.33 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 23.62 58.48 37.29 23.51 60.61 36.65 -19.80 26.53 -38.25 -21.53 25.95 -39.54 ULMN 2 1uox_c00 URATE OXIDASE user 8 2 # 8 28 THR A 100 THR^? 19.44 NI NI A 501 76 PRO A 111 PRO.? 21.97 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -44.82 16.79 -25.89 -42.97 17.43 -25.07 coo 23.62 58.48 37.29 23.51 60.61 36.65 -37.36 23.77 -38.99 -39.40 24.61 -39.45 ULMN 2 1uox_c00 URATE OXIDASE user 9 2 # 9 28 THR A 100 THR^? 19.44 NI NI A 501 76 PRO A 115 PRO.? 29.96 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -44.82 16.79 -25.89 -42.97 17.43 -25.07 coo 23.62 58.48 37.29 23.51 60.61 36.65 -44.78 15.77 -42.24 -44.84 17.85 -41.56 ULMN 2 1uox_c00 URATE OXIDASE user 10 2 # 10 28 THR A 106 THR^? 23.59 NI NI A 501 76 PRO A 111 PRO.? 21.97 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -44.11 24.18 -26.65 -42.38 22.71 -26.31 coo 23.62 58.48 37.29 23.51 60.61 36.65 -37.36 23.77 -38.99 -39.40 24.61 -39.45 ULMN 2 1uox_c00 URATE OXIDASE user 11 2 # 11 28 THR B 14 THR~? 17.57 NI NI A 501 76 PRO B 48 PRO.? 22.56 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -35.43 0.02 -33.01 -34.98 -1.69 -34.29 coo 23.62 58.48 37.29 23.51 60.61 36.65 -24.03 4.11 -38.25 -22.85 4.40 -40.21 ULMN 2 1uox_c00 URATE OXIDASE user 12 2 # 12 28 THR B 14 THR~? 17.57 NI NI A 501 76 PRO B 73 PRO.? 25.12 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -35.43 0.02 -33.01 -34.98 -1.69 -34.29 coo 23.62 58.48 37.29 23.51 60.61 36.65 -47.10 9.61 -36.27 -45.99 8.59 -37.95 ULMN 2 1uox_c00 URATE OXIDASE user 13 2 # 13 28 THR B 65 THR^? 14.18 NI NI A 502 76 PRO A 113 PRO.? 26.00 NI NI A 502 coo 16.78 65.34 48.92 15.62 64.41 47.34 -30.21 23.51 -34.34 -32.04 24.61 -34.02 coo 23.62 58.48 37.29 23.51 60.61 36.65 -38.85 21.48 -44.99 -40.79 21.38 -43.94 ULMN 2 1uox_c00 URATE OXIDASE user 14 2 # 14 28 THR B 83 THR~? 9.81 NI NI A 501 76 PRO A 34 PRO.? 10.31 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo 23.62 58.48 37.29 23.51 60.61 36.65 -33.68 3.46 -7.99 -33.66 5.72 -8.15 ULMN 2 1uox_c00 URATE OXIDASE user 15 2 # 15 28 THR B 83 THR~? 9.81 NI NI A 501 76 PRO B 73 PRO.? 25.12 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo 23.62 58.48 37.29 23.51 60.61 36.65 -47.10 9.61 -36.27 -45.99 8.59 -37.95 ULMN 2 1uox_c00 URATE OXIDASE user 16 2 # 16 28 THR B 83 THR~? 9.81 NI NI A 501 76 PRO B 74 PRO.? 23.86 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo 23.62 58.48 37.29 23.51 60.61 36.65 -44.28 4.15 -37.86 -45.98 5.10 -36.77 ULMN 2 1uox_c00 URATE OXIDASE user 17 2 # 17 28 THR B 100 THR.? 19.64 NI NI A 502 76 PRO B 111 PRO.? 21.79 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -36.82 30.10 -22.17 -36.51 28.20 -23.14 coo 23.62 58.48 37.29 23.51 60.61 36.65 -38.90 20.44 -8.37 -40.51 21.99 -8.18 ULMN 2 1uox_c00 URATE OXIDASE user 18 2 # 18 28 THR B 106 THR^? 23.70 NI NI A 502 76 PRO B 111 PRO.? 21.79 NI NI A 501 coo 16.78 65.34 48.92 15.62 64.41 47.34 -42.71 26.17 -21.12 -40.64 25.57 -21.68 coo 23.62 58.48 37.29 23.51 60.61 36.65 -38.90 20.44 -8.37 -40.51 21.99 -8.18 1uox_c00 source 1uox URATE OXIDASE : 18 hits 1uox_c00 naa= 2 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 A 154 HIS A 126 HIS.? -3.75 NI NI A 502s A 361 ASP A 13 ASP~? 13.27 NI NI A 502 coo 38.53 29.77 11.27 37.61 30.69 9.62 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 36.69 27.02 21.98 35.77 25.65 20.58 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 2 2 # 2 A 154 HIS A 126 HIS.? -3.75 NI NI A 502s A 361 ASP A 82 ASP~? 15.20 NI NI A 502 coo 38.53 29.77 11.27 37.61 30.69 9.62 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 36.69 27.02 21.98 35.77 25.65 20.58 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 3 2 # 3 A 154 HIS A 126 HIS.? -3.75 NI NI A 502s A 361 ASP A 88 ASP^? 14.52 NI NI A 501 coo 38.53 29.77 11.27 37.61 30.69 9.62 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 36.69 27.02 21.98 35.77 25.65 20.58 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 4 2 # 4 A 154 HIS A 126 HIS.? -3.75 NI NI A 502s A 361 ASP B 88 ASP^? 15.06 NI NI A 502 coo 38.53 29.77 11.27 37.61 30.69 9.62 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 36.69 27.02 21.98 35.77 25.65 20.58 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 5 2 # 5 A 154 HIS A 127 HIS.? 7.54 NI NI A 502 A 361 ASP A 13 ASP~? 13.27 NI NI A 502 coo 38.53 29.77 11.27 37.61 30.69 9.62 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 36.69 27.02 21.98 35.77 25.65 20.58 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 6 2 # 6 A 154 HIS A 127 HIS.? 7.54 NI NI A 502 A 361 ASP A 82 ASP~? 15.20 NI NI A 502 coo 38.53 29.77 11.27 37.61 30.69 9.62 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 36.69 27.02 21.98 35.77 25.65 20.58 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 7 2 # 7 A 154 HIS B 126 HIS.? -4.79 NI NI A 501s A 361 ASP A 88 ASP^? 14.52 NI NI A 501 coo 38.53 29.77 11.27 37.61 30.69 9.62 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 36.69 27.02 21.98 35.77 25.65 20.58 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 8 2 # 8 A 154 HIS B 126 HIS.? -4.79 NI NI A 501s A 361 ASP B 88 ASP^? 15.06 NI NI A 502 coo 38.53 29.77 11.27 37.61 30.69 9.62 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 36.69 27.02 21.98 35.77 25.65 20.58 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 9 2 # 9 A 154 HIS B 127 HIS.? 5.53 NI NI A 501 A 361 ASP B 82 ASP~? 13.99 NI NI A 501 coo 38.53 29.77 11.27 37.61 30.69 9.62 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 36.69 27.02 21.98 35.77 25.65 20.58 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1uqt_c00 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 9 hits 1uqt_c00 naa= 2 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 B 154 HIS A 126 HIS.? -3.75 NI NI A 502s B 361 ASP A 13 ASP~? 13.27 NI NI A 502 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 2 2 # 2 B 154 HIS A 126 HIS.? -3.75 NI NI A 502s B 361 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 3 2 # 3 B 154 HIS A 126 HIS.? -3.75 NI NI A 502s B 361 ASP A 88 ASP^? 14.52 NI NI A 501 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 4 2 # 4 B 154 HIS A 126 HIS.? -3.75 NI NI A 502s B 361 ASP B 88 ASP^? 15.06 NI NI A 502 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 5 2 # 5 B 154 HIS A 127 HIS.? 7.54 NI NI A 502 B 361 ASP A 13 ASP~? 13.27 NI NI A 502 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 6 2 # 6 B 154 HIS A 127 HIS.? 7.54 NI NI A 502 B 361 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 7 2 # 7 B 154 HIS B 126 HIS.? -4.79 NI NI A 501s B 361 ASP A 88 ASP^? 14.52 NI NI A 501 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 8 2 # 8 B 154 HIS B 126 HIS.? -4.79 NI NI A 501s B 361 ASP B 88 ASP^? 15.06 NI NI A 502 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 9 2 # 9 B 154 HIS B 127 HIS.? 5.53 NI NI A 501 B 361 ASP B 82 ASP~? 13.99 NI NI A 501 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -40.67 10.76 -25.27 -41.01 11.92 -23.57 1uqt_c01 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 9 hits 1uqt_c01 naa= 2 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 1 2 # 1 A 86 ASP A 42 ASP.? 24.20 NI NI A 501 A 164 TYR A 22 TYR~? 21.39 NI NI A 501 coo 9.32 71.14 66.67 9.35 73.22 66.22 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 10.68 80.16 70.30 11.55 80.13 67.63 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 2 2 # 2 A 86 ASP A 42 ASP.? 24.20 NI NI A 501 A 164 TYR A 29 TYR~? 15.38 NI NI A 501 coo 9.32 71.14 66.67 9.35 73.22 66.22 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 10.68 80.16 70.30 11.55 80.13 67.63 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 3 2 # 3 A 86 ASP A 88 ASP^? 14.52 NI NI A 501 A 164 TYR B 67 TYR^? 18.53 NI NI A 502 coo 9.32 71.14 66.67 9.35 73.22 66.22 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 10.68 80.16 70.30 11.55 80.13 67.63 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 4 2 # 4 A 86 ASP B 42 ASP.? 24.38 NI NI A 502 A 164 TYR B 29 TYR~? 14.52 NI NI A 502 coo 9.32 71.14 66.67 9.35 73.22 66.22 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 10.68 80.16 70.30 11.55 80.13 67.63 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 5 2 # 5 A 86 ASP B 88 ASP^? 15.06 NI NI A 502 A 164 TYR A 67 TYR^? 18.49 NI NI A 501 coo 9.32 71.14 66.67 9.35 73.22 66.22 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 10.68 80.16 70.30 11.55 80.13 67.63 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1uro_c00 source 1uro UROPORPHYRINOGEN DECARBOXYLASE : 5 hits 1uro_c00 naa= 2 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 1 2 # 1 A 92 ARG A 25 ARG~? 18.03 NI NI A 501 A 162 GLU A 28 GLU~? 13.04 NI NI A 501 coo 22.28 19.87 14.60 19.43 20.27 13.40 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 20.49 15.91 11.17 19.72 15.53 13.15 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 2 2 # 2 A 92 ARG A 93 ARG^? 27.22 NI NI A 502 A 162 GLU A 116 GLU.? 34.96 NI NI A 501 coo 22.28 19.87 14.60 19.43 20.27 13.40 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 20.49 15.91 11.17 19.72 15.53 13.15 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 3 2 # 3 A 92 ARG A 94 ARG.? 33.91 NI NI A 501 A 162 GLU A 116 GLU.? 34.96 NI NI A 501 coo 22.28 19.87 14.60 19.43 20.27 13.40 -52.83 19.63 -33.61 -55.45 21.14 -33.98 coo 20.49 15.91 11.17 19.72 15.53 13.15 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 4 2 # 4 A 92 ARG A 102 ARG.? 15.26 NI NI A 501 A 162 GLU B 124 GLU.? 12.68 NI NI A 501 coo 22.28 19.87 14.60 19.43 20.27 13.40 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo 20.49 15.91 11.17 19.72 15.53 13.15 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 5 2 # 5 A 92 ARG B 25 ARG~? 17.38 NI NI A 502 A 162 GLU B 28 GLU~? 10.98 NI NI A 502 coo 22.28 19.87 14.60 19.43 20.27 13.40 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 20.49 15.91 11.17 19.72 15.53 13.15 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 6 2 # 6 A 92 ARG B 93 ARG^? 28.43 NI NI A 501 A 162 GLU B 116 GLU.? 34.45 NI NI A 502 coo 22.28 19.87 14.60 19.43 20.27 13.40 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 20.49 15.91 11.17 19.72 15.53 13.15 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 7 2 # 7 A 92 ARG B 102 ARG.? 15.54 NI NI A 502 A 162 GLU A 124 GLU.? 14.10 NI NI A 502 coo 22.28 19.87 14.60 19.43 20.27 13.40 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 20.49 15.91 11.17 19.72 15.53 13.15 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1uw8_c02 source 1uw8 OXALATE DECARBOXYLASE OXDC : 7 hits 1uw8_c02 naa= 2 ULMN 2 1v04_c00 SERUM PARAOXONASE/ARYLESTERASE 1 user 1 2 # 1 A 115 HIS A 126 HIS.? -3.75 NI NI A 502s A 134 HIS A 127 HIS.? 7.54 NI NI A 502 coo 7.97 27.26 28.50 9.01 25.66 27.59 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 6.14 25.18 33.23 5.82 24.63 31.22 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1v04_c00 SERUM PARAOXONASE/ARYLESTERASE 1 user 2 2 # 2 A 115 HIS A 126 HIS.? -3.75 NI NI A 502s A 134 HIS B 31 HIS~? -3.92 NI NI A 502s coo 7.97 27.26 28.50 9.01 25.66 27.59 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 6.14 25.18 33.23 5.82 24.63 31.22 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1v04_c00 SERUM PARAOXONASE/ARYLESTERASE 1 user 3 2 # 3 A 115 HIS A 127 HIS.? 7.54 NI NI A 502 A 134 HIS A 126 HIS.? -3.75 NI NI A 502s coo 7.97 27.26 28.50 9.01 25.66 27.59 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 6.14 25.18 33.23 5.82 24.63 31.22 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1v04_c00 SERUM PARAOXONASE/ARYLESTERASE 1 user 4 2 # 4 A 115 HIS B 31 HIS~? -3.92 NI NI A 502s A 134 HIS A 126 HIS.? -3.75 NI NI A 502s coo 7.97 27.26 28.50 9.01 25.66 27.59 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 6.14 25.18 33.23 5.82 24.63 31.22 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1v04_c00 SERUM PARAOXONASE/ARYLESTERASE 1 user 5 2 # 5 A 115 HIS B 126 HIS.? -4.79 NI NI A 501s A 134 HIS B 127 HIS.? 5.53 NI NI A 501 coo 7.97 27.26 28.50 9.01 25.66 27.59 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 6.14 25.18 33.23 5.82 24.63 31.22 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1v04_c00 SERUM PARAOXONASE/ARYLESTERASE 1 user 6 2 # 6 A 115 HIS B 127 HIS.? 5.53 NI NI A 501 A 134 HIS B 126 HIS.? -4.79 NI NI A 501s coo 7.97 27.26 28.50 9.01 25.66 27.59 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 6.14 25.18 33.23 5.82 24.63 31.22 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1v04_c00 source 1v04 SERUM PARAOXONASE/ARYLESTERASE 1 : 6 hits 1v04_c00 naa= 2 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 1 2 # 1 144 LYS A 53 LYS.? 25.39 NI NI A 501 199 GLU A 11 GLU.? 16.09 NI NI A 502 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 2 2 # 2 144 LYS A 123 LYS^? 12.92 NI NI A 502 199 GLU B 86 GLU.? 9.13 NI NI A 501 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 3 2 # 3 144 LYS A 123 LYS^? 12.92 NI NI A 502 199 GLU B 124 GLU.? 12.68 NI NI A 501 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 4 2 # 4 144 LYS B 123 LYS^? 13.38 NI NI A 501 199 GLU A 124 GLU.? 14.10 NI NI A 502 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1vid_c00 source 1vid CATECHOL O-METHYLTRANSFERASE : 4 hits 1vid_c00 naa= 2 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 1 2 # 1 A 501 ARG A 17 ARG~? 9.21 NI NI A 502 A 869 GLU A 11 GLU.? 16.09 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 2 2 # 2 A 501 ARG A 23 ARG~? 15.85 NI NI A 502 A 869 GLU A 28 GLU~? 13.04 NI NI A 501 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 3 2 # 3 A 501 ARG A 23 ARG~? 15.85 NI NI A 502 A 869 GLU B 86 GLU.? 9.13 NI NI A 501 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 4 2 # 4 A 501 ARG A 23 ARG~? 15.85 NI NI A 502 A 869 GLU B 124 GLU.? 12.68 NI NI A 501 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 5 2 # 5 A 501 ARG A 101 ARG.? 18.18 NI NI A 501 A 869 GLU B 124 GLU.? 12.68 NI NI A 501 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 6 2 # 6 A 501 ARG B 17 ARG~? 8.61 NI NI A 501 A 869 GLU B 11 GLU~? 14.38 NI NI A 501 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 7 2 # 7 A 501 ARG B 23 ARG~? 15.67 NI NI A 501 A 869 GLU A 86 GLU.? 9.00 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 8 2 # 8 A 501 ARG B 23 ARG~? 15.67 NI NI A 501 A 869 GLU A 124 GLU.? 14.10 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 9 2 # 9 A 501 ARG B 23 ARG~? 15.67 NI NI A 501 A 869 GLU B 28 GLU~? 10.98 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 10 2 # 10 A 501 ARG B 94 ARG^? 29.28 NI NI A 502 A 869 GLU B 116 GLU.? 34.45 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -40.67 35.58 -16.18 -42.20 37.17 -18.35 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 11 2 # 11 A 501 ARG B 101 ARG.? 17.16 NI NI A 502 A 869 GLU A 124 GLU.? 14.10 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 12 2 # 12 A 501 ARG B 102 ARG.? 15.54 NI NI A 502 A 869 GLU A 86 GLU.? 9.00 NI NI A 502 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -26.26 21.66 -27.12 -25.44 19.73 -27.04 1vlb_c01 source 1vlb ALDEHYDE OXIDOREDUCTASE : 12 hits 1vlb_c01 naa= 2 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 1 2 # 1 353 LYS A 123 LYS^? 12.92 NI NI A 502 404 HIS B 31 HIS~? -3.92 NI NI A 502s coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 2 2 # 2 353 LYS A 123 LYS^? 12.92 NI NI A 502 404 HIS B 126 HIS.? -4.79 NI NI A 501s coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 3 2 # 3 353 LYS B 123 LYS^? 13.38 NI NI A 501 404 HIS A 31 HIS~? -4.16 NI NI A 501s coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 4 2 # 4 353 LYS B 123 LYS^? 13.38 NI NI A 501 404 HIS B 127 HIS.? 5.53 NI NI A 501 coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -36.21 5.24 -15.46 -36.02 3.20 -15.94 1vnc_c00 source 1vnc VANADIUM-CONTAINING CHLOROPEROXIDASE : 4 hits 1vnc_c00 naa= 2 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 1 2 # 1 A 136 GLU A 28 GLU~? 13.04 NI NI A 501 A 293 HIS A 31 HIS~? -4.16 NI NI A 501s coo 9.79 77.23 39.90 9.95 75.15 39.48 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 8.49 71.12 42.20 8.38 69.13 41.54 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 2 2 # 2 A 136 GLU A 86 GLU.? 9.00 NI NI A 502 A 293 HIS A 126 HIS.? -3.75 NI NI A 502s coo 9.79 77.23 39.90 9.95 75.15 39.48 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 8.49 71.12 42.20 8.38 69.13 41.54 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 3 2 # 3 A 136 GLU B 28 GLU~? 10.98 NI NI A 502 A 293 HIS B 31 HIS~? -3.92 NI NI A 502s coo 9.79 77.23 39.90 9.95 75.15 39.48 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 8.49 71.12 42.20 8.38 69.13 41.54 -20.11 22.22 -33.67 -18.33 23.04 -32.88 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 4 2 # 4 A 136 GLU B 86 GLU.? 9.13 NI NI A 501 A 293 HIS A 31 HIS~? -4.16 NI NI A 501s coo 9.79 77.23 39.90 9.95 75.15 39.48 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 8.49 71.12 42.20 8.38 69.13 41.54 -28.46 6.43 -14.65 -28.67 4.98 -16.17 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 5 2 # 5 A 136 GLU B 124 GLU.? 12.68 NI NI A 501 A 293 HIS B 126 HIS.? -4.79 NI NI A 501s coo 9.79 77.23 39.90 9.95 75.15 39.48 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 8.49 71.12 42.20 8.38 69.13 41.54 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1w0h_c00 source 1w0h 3-5 EXONUCLEASE ERI1 : 5 hits 1w0h_c00 naa= 2 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 1 2 # 1 A 400 PHE A 36 PHE.? 17.17 NI NI A 501 B 351 TYR A 29 TYR~? 15.38 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 12.26 15.31 35.10 13.20 15.01 32.53 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 2 2 # 2 A 400 PHE A 36 PHE.? 17.17 NI NI A 501 B 351 TYR A 60 TYR^? 20.44 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 3 2 # 3 A 400 PHE A 51 PHE.? 22.00 NI NI A 502 B 351 TYR A 22 TYR~? 21.39 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -17.08 22.63 -7.72 -19.58 23.81 -8.31 coo 12.26 15.31 35.10 13.20 15.01 32.53 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 4 2 # 4 A 400 PHE A 69 PHE^? 24.58 NI NI A 501 B 351 TYR A 60 TYR^? 20.44 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 5 2 # 5 A 400 PHE A 69 PHE^? 24.58 NI NI A 501 B 351 TYR A 67 TYR^? 18.49 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 6 2 # 6 A 400 PHE B 36 PHE.? 17.03 NI NI A 502 B 351 TYR B 29 TYR~? 14.52 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -26.15 23.36 -43.90 -26.62 21.39 -45.87 coo 12.26 15.31 35.10 13.20 15.01 32.53 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 7 2 # 7 A 400 PHE B 51 PHE.? 21.73 NI NI A 501 B 351 TYR B 22 TYR~? 21.09 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -28.14 3.62 -40.16 -30.39 4.96 -39.18 coo 12.26 15.31 35.10 13.20 15.01 32.53 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 8 2 # 8 A 400 PHE B 69 PHE^? 24.35 NI NI A 502 B 351 TYR B 60 TYR^? 21.49 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.15 21.17 -42.13 -35.63 23.37 -43.86 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 9 2 # 9 A 400 PHE B 69 PHE^? 24.35 NI NI A 502 B 351 TYR B 67 TYR^? 18.53 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.67 20.34 -36.33 -35.75 23.11 -35.83 1w27_c00 source 1w27 PHENYLALANINE AMMONIA-LYASE 1 : 9 hits 1w27_c00 naa= 2 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 1 2 # 1 A 400 PHE A 36 PHE.? 17.17 NI NI A 501 B 351 TYR A 29 TYR~? 15.38 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 12.26 15.31 35.10 13.20 15.01 32.53 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 2 2 # 2 A 400 PHE A 36 PHE.? 17.17 NI NI A 501 B 351 TYR A 60 TYR^? 20.44 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -33.77 10.70 -3.73 -32.61 12.88 -2.30 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 3 2 # 3 A 400 PHE A 51 PHE.? 22.00 NI NI A 502 B 351 TYR A 22 TYR~? 21.39 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -17.08 22.63 -7.72 -19.58 23.81 -8.31 coo 12.26 15.31 35.10 13.20 15.01 32.53 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 4 2 # 4 A 400 PHE A 69 PHE^? 24.58 NI NI A 501 B 351 TYR A 60 TYR^? 20.44 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.80 19.06 -5.58 -37.88 17.67 -4.34 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 5 2 # 5 A 400 PHE A 69 PHE^? 24.58 NI NI A 501 B 351 TYR A 67 TYR^? 18.49 NI NI A 501 coo 18.03 16.65 31.65 16.97 14.73 33.36 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 6 2 # 6 A 400 PHE B 36 PHE.? 17.03 NI NI A 502 B 351 TYR B 29 TYR~? 14.52 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -26.15 23.36 -43.90 -26.62 21.39 -45.87 coo 12.26 15.31 35.10 13.20 15.01 32.53 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 7 2 # 7 A 400 PHE B 51 PHE.? 21.73 NI NI A 501 B 351 TYR B 22 TYR~? 21.09 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -28.14 3.62 -40.16 -30.39 4.96 -39.18 coo 12.26 15.31 35.10 13.20 15.01 32.53 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 8 2 # 8 A 400 PHE B 69 PHE^? 24.35 NI NI A 502 B 351 TYR B 60 TYR^? 21.49 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.15 21.17 -42.13 -35.63 23.37 -43.86 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 9 2 # 9 A 400 PHE B 69 PHE^? 24.35 NI NI A 502 B 351 TYR B 67 TYR^? 18.53 NI NI A 502 coo 18.03 16.65 31.65 16.97 14.73 33.36 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo 12.26 15.31 35.10 13.20 15.01 32.53 -35.67 20.34 -36.33 -35.75 23.11 -35.83 1w27_c02 source 1w27 PHENYLALANINE AMMONIA-LYASE 1 : 9 hits 1w27_c02 naa= 2 ULMN 2 1wnw_c00 HEME OXYGENASE user 1 2 # 1 A 136 ASN A 33 ASN.? 14.07 NI NI A 501 A 140 GLY A 35 GLY.? 13.51 NI NI A 501 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -30.87 7.88 -5.92 -29.26 7.53 -4.61 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -37.56 6.81 -6.55 -36.81 7.00 -6.45 ULMN 2 1wnw_c00 HEME OXYGENASE user 2 2 # 2 A 136 ASN A 95 ASN.? 33.32 NI NI A 501 A 140 GLY A 96 GLY.? 29.04 NI NI A 502 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -51.35 22.78 -35.72 -51.57 21.49 -37.42 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -46.93 24.64 -35.65 -47.09 24.13 -34.99 ULMN 2 1wnw_c00 HEME OXYGENASE user 3 2 # 3 A 136 ASN B 95 ASN.? 31.89 NI NI A 501 A 140 GLY B 96 GLY.? 29.19 NI NI A 501 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -44.53 31.85 -10.19 -42.56 32.26 -9.56 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -46.09 28.23 -12.79 -45.33 28.55 -13.13 1wnw_c00 source 1wnw HEME OXYGENASE : 3 hits 1wnw_c00 naa= 2 ULMN 2 1wnw_c01 HEME OXYGENASE user 1 2 # 1 B 136 ASN A 33 ASN.? 14.07 NI NI A 501 B 140 GLY A 35 GLY.? 13.51 NI NI A 501 coo 10.41 13.55 22.30 12.49 13.88 22.44 -30.87 7.88 -5.92 -29.26 7.53 -4.61 coo 12.77 16.12 18.53 12.82 15.99 17.73 -37.56 6.81 -6.55 -36.81 7.00 -6.45 ULMN 2 1wnw_c01 HEME OXYGENASE user 2 2 # 2 B 136 ASN A 95 ASN.? 33.32 NI NI A 501 B 140 GLY A 96 GLY.? 29.04 NI NI A 502 coo 10.41 13.55 22.30 12.49 13.88 22.44 -51.35 22.78 -35.72 -51.57 21.49 -37.42 coo 12.77 16.12 18.53 12.82 15.99 17.73 -46.93 24.64 -35.65 -47.09 24.13 -34.99 ULMN 2 1wnw_c01 HEME OXYGENASE user 3 2 # 3 B 136 ASN B 33 ASN.? 13.74 NI NI A 502 B 140 GLY B 35 GLY.? 13.50 NI NI A 502 coo 10.41 13.55 22.30 12.49 13.88 22.44 -21.15 22.18 -41.67 -19.86 21.73 -43.34 coo 12.77 16.12 18.53 12.82 15.99 17.73 -24.49 28.39 -41.44 -24.36 27.52 -41.42 ULMN 2 1wnw_c01 HEME OXYGENASE user 4 2 # 4 B 136 ASN B 95 ASN.? 31.89 NI NI A 501 B 140 GLY B 96 GLY.? 29.19 NI NI A 501 coo 10.41 13.55 22.30 12.49 13.88 22.44 -44.53 31.85 -10.19 -42.56 32.26 -9.56 coo 12.77 16.12 18.53 12.82 15.99 17.73 -46.09 28.23 -12.79 -45.33 28.55 -13.13 1wnw_c01 source 1wnw HEME OXYGENASE : 4 hits 1wnw_c01 naa= 2 ULMN 2 1wnw_c02 HEME OXYGENASE user 1 2 # 1 C 136 ASN A 33 ASN.? 14.07 NI NI A 501 C 140 GLY A 35 GLY.? 13.51 NI NI A 501 coo 26.63 1.54 53.35 24.49 1.91 53.34 -30.87 7.88 -5.92 -29.26 7.53 -4.61 coo 23.86 0.66 57.49 23.81 0.02 58.00 -37.56 6.81 -6.55 -36.81 7.00 -6.45 ULMN 2 1wnw_c02 HEME OXYGENASE user 2 2 # 2 C 136 ASN A 95 ASN.? 33.32 NI NI A 501 C 140 GLY A 96 GLY.? 29.04 NI NI A 502 coo 26.63 1.54 53.35 24.49 1.91 53.34 -51.35 22.78 -35.72 -51.57 21.49 -37.42 coo 23.86 0.66 57.49 23.81 0.02 58.00 -46.93 24.64 -35.65 -47.09 24.13 -34.99 ULMN 2 1wnw_c02 HEME OXYGENASE user 3 2 # 3 C 136 ASN B 33 ASN.? 13.74 NI NI A 502 C 140 GLY B 35 GLY.? 13.50 NI NI A 502 coo 26.63 1.54 53.35 24.49 1.91 53.34 -21.15 22.18 -41.67 -19.86 21.73 -43.34 coo 23.86 0.66 57.49 23.81 0.02 58.00 -24.49 28.39 -41.44 -24.36 27.52 -41.42 ULMN 2 1wnw_c02 HEME OXYGENASE user 4 2 # 4 C 136 ASN B 95 ASN.? 31.89 NI NI A 501 C 140 GLY B 96 GLY.? 29.19 NI NI A 501 coo 26.63 1.54 53.35 24.49 1.91 53.34 -44.53 31.85 -10.19 -42.56 32.26 -9.56 coo 23.86 0.66 57.49 23.81 0.02 58.00 -46.09 28.23 -12.79 -45.33 28.55 -13.13 1wnw_c02 source 1wnw HEME OXYGENASE : 4 hits 1wnw_c02 naa= 2 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 1 2 # 1 A 56 GLU A 86 GLU.? 9.00 NI NI A 502 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 coo 27.49 35.40 20.60 28.62 36.02 22.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 33.88 38.22 25.20 34.46 38.14 23.17 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 2 2 # 2 A 56 GLU A 86 GLU.? 9.00 NI NI A 502 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 27.49 35.40 20.60 28.62 36.02 22.28 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 33.88 38.22 25.20 34.46 38.14 23.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 3 2 # 3 A 56 GLU A 124 GLU.? 14.10 NI NI A 502 A 228 ASP A 82 ASP~? 15.20 NI NI A 502 coo 27.49 35.40 20.60 28.62 36.02 22.28 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 33.88 38.22 25.20 34.46 38.14 23.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 4 2 # 4 A 56 GLU A 124 GLU.? 14.10 NI NI A 502 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 coo 27.49 35.40 20.60 28.62 36.02 22.28 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 33.88 38.22 25.20 34.46 38.14 23.17 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 5 2 # 5 A 56 GLU A 124 GLU.? 14.10 NI NI A 502 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 27.49 35.40 20.60 28.62 36.02 22.28 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 33.88 38.22 25.20 34.46 38.14 23.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 6 2 # 6 A 56 GLU B 86 GLU.? 9.13 NI NI A 501 A 228 ASP A 88 ASP^? 14.52 NI NI A 501 coo 27.49 35.40 20.60 28.62 36.02 22.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 33.88 38.22 25.20 34.46 38.14 23.17 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 7 2 # 7 A 56 GLU B 86 GLU.? 9.13 NI NI A 501 A 228 ASP B 82 ASP~? 13.99 NI NI A 501 coo 27.49 35.40 20.60 28.62 36.02 22.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 33.88 38.22 25.20 34.46 38.14 23.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 8 2 # 8 A 56 GLU B 86 GLU.? 9.13 NI NI A 501 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 27.49 35.40 20.60 28.62 36.02 22.28 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 33.88 38.22 25.20 34.46 38.14 23.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 9 2 # 9 A 56 GLU B 124 GLU.? 12.68 NI NI A 501 A 228 ASP B 82 ASP~? 13.99 NI NI A 501 coo 27.49 35.40 20.60 28.62 36.02 22.28 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 33.88 38.22 25.20 34.46 38.14 23.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 10 2 # 10 A 56 GLU B 124 GLU.? 12.68 NI NI A 501 A 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 27.49 35.40 20.60 28.62 36.02 22.28 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 33.88 38.22 25.20 34.46 38.14 23.17 -31.42 19.31 -21.85 -30.03 20.81 -21.11 1x7d_c00 source 1x7d ORNITHINE CYCLODEAMINASE : 10 hits 1x7d_c00 naa= 2 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 1 2 # 1 B 56 GLU A 86 GLU.? 9.00 NI NI A 502 B 228 ASP A 88 ASP^? 14.52 NI NI A 501 coo 8.97 35.22 21.27 7.95 33.38 21.10 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 2.71 29.91 19.58 2.03 31.89 19.36 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 2 2 # 2 B 56 GLU A 86 GLU.? 9.00 NI NI A 502 B 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 8.97 35.22 21.27 7.95 33.38 21.10 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 2.71 29.91 19.58 2.03 31.89 19.36 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 3 2 # 3 B 56 GLU A 124 GLU.? 14.10 NI NI A 502 B 228 ASP A 82 ASP~? 15.20 NI NI A 502 coo 8.97 35.22 21.27 7.95 33.38 21.10 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 2.71 29.91 19.58 2.03 31.89 19.36 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 4 2 # 4 B 56 GLU A 124 GLU.? 14.10 NI NI A 502 B 228 ASP A 88 ASP^? 14.52 NI NI A 501 coo 8.97 35.22 21.27 7.95 33.38 21.10 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 2.71 29.91 19.58 2.03 31.89 19.36 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 5 2 # 5 B 56 GLU A 124 GLU.? 14.10 NI NI A 502 B 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 8.97 35.22 21.27 7.95 33.38 21.10 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 2.71 29.91 19.58 2.03 31.89 19.36 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 6 2 # 6 B 56 GLU B 86 GLU.? 9.13 NI NI A 501 B 228 ASP A 88 ASP^? 14.52 NI NI A 501 coo 8.97 35.22 21.27 7.95 33.38 21.10 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 2.71 29.91 19.58 2.03 31.89 19.36 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 7 2 # 7 B 56 GLU B 86 GLU.? 9.13 NI NI A 501 B 228 ASP B 82 ASP~? 13.99 NI NI A 501 coo 8.97 35.22 21.27 7.95 33.38 21.10 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 2.71 29.91 19.58 2.03 31.89 19.36 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 8 2 # 8 B 56 GLU B 86 GLU.? 9.13 NI NI A 501 B 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 8.97 35.22 21.27 7.95 33.38 21.10 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 2.71 29.91 19.58 2.03 31.89 19.36 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 9 2 # 9 B 56 GLU B 124 GLU.? 12.68 NI NI A 501 B 228 ASP B 82 ASP~? 13.99 NI NI A 501 coo 8.97 35.22 21.27 7.95 33.38 21.10 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 2.71 29.91 19.58 2.03 31.89 19.36 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 10 2 # 10 B 56 GLU B 124 GLU.? 12.68 NI NI A 501 B 228 ASP B 88 ASP^? 15.06 NI NI A 502 coo 8.97 35.22 21.27 7.95 33.38 21.10 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 2.71 29.91 19.58 2.03 31.89 19.36 -31.42 19.31 -21.85 -30.03 20.81 -21.11 1x7d_c01 source 1x7d ORNITHINE CYCLODEAMINASE : 10 hits 1x7d_c01 naa= 2 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 1 2 # 1 A 165 SER A 18 SER~? 18.69 NI NI A 502 A 187 GLU A 11 GLU.? 16.09 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 6.50 51.89 29.29 8.22 51.77 30.59 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 2 2 # 2 A 165 SER A 24 SER~? 14.80 NI NI A 501 A 187 GLU B 86 GLU.? 9.13 NI NI A 501 coo 8.34 44.73 23.71 9.07 45.54 21.52 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 6.50 51.89 29.29 8.22 51.77 30.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 3 2 # 3 A 165 SER A 66 SER^? 13.16 NI NI A 501 A 187 GLU A 28 GLU~? 13.04 NI NI A 501 coo 8.34 44.73 23.71 9.07 45.54 21.52 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 6.50 51.89 29.29 8.22 51.77 30.59 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 4 2 # 4 A 165 SER A 66 SER^? 13.16 NI NI A 501 A 187 GLU B 86 GLU.? 9.13 NI NI A 501 coo 8.34 44.73 23.71 9.07 45.54 21.52 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 6.50 51.89 29.29 8.22 51.77 30.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 5 2 # 5 A 165 SER A 66 SER^? 13.16 NI NI A 501 A 187 GLU B 124 GLU.? 12.68 NI NI A 501 coo 8.34 44.73 23.71 9.07 45.54 21.52 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 6.50 51.89 29.29 8.22 51.77 30.59 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 6 2 # 6 A 165 SER A 72 SER.? 30.35 NI NI A 502 A 187 GLU B 116 GLU.? 34.45 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -31.43 35.56 -6.74 -30.88 37.60 -5.53 coo 6.50 51.89 29.29 8.22 51.77 30.59 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 7 2 # 7 A 165 SER A 87 SER.? 14.75 NI NI A 502 A 187 GLU B 86 GLU.? 9.13 NI NI A 501 coo 8.34 44.73 23.71 9.07 45.54 21.52 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 6.50 51.89 29.29 8.22 51.77 30.59 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 8 2 # 8 A 165 SER B 24 SER~? 15.42 NI NI A 502 A 187 GLU A 86 GLU.? 9.00 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 6.50 51.89 29.29 8.22 51.77 30.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 9 2 # 9 A 165 SER B 66 SER^? 13.28 NI NI A 502 A 187 GLU A 86 GLU.? 9.00 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 6.50 51.89 29.29 8.22 51.77 30.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 10 2 # 10 A 165 SER B 66 SER^? 13.28 NI NI A 502 A 187 GLU A 124 GLU.? 14.10 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 6.50 51.89 29.29 8.22 51.77 30.59 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 11 2 # 11 A 165 SER B 66 SER^? 13.28 NI NI A 502 A 187 GLU B 28 GLU~? 10.98 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 6.50 51.89 29.29 8.22 51.77 30.59 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 12 2 # 12 A 165 SER B 72 SER.? 30.04 NI NI A 501 A 187 GLU A 116 GLU.? 34.96 NI NI A 501 coo 8.34 44.73 23.71 9.07 45.54 21.52 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo 6.50 51.89 29.29 8.22 51.77 30.59 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 13 2 # 13 A 165 SER B 87 SER.? 15.38 NI NI A 501 A 187 GLU A 86 GLU.? 9.00 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 6.50 51.89 29.29 8.22 51.77 30.59 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 14 2 # 14 A 165 SER B 87 SER.? 15.38 NI NI A 501 A 187 GLU A 124 GLU.? 14.10 NI NI A 502 coo 8.34 44.73 23.71 9.07 45.54 21.52 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 6.50 51.89 29.29 8.22 51.77 30.59 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1xgm_c00 source 1xgm METHIONINE AMINOPEPTIDASE : 14 hits 1xgm_c00 naa= 2 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 1 2 # 1 B 165 SER A 18 SER~? 18.69 NI NI A 502 B 187 GLU A 11 GLU.? 16.09 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo 12.85 44.05 6.07 11.44 42.52 5.44 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 2 2 # 2 B 165 SER A 24 SER~? 14.80 NI NI A 501 B 187 GLU B 86 GLU.? 9.13 NI NI A 501 coo 12.53 42.28 15.16 11.35 44.10 16.30 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 12.85 44.05 6.07 11.44 42.52 5.44 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 3 2 # 3 B 165 SER A 66 SER^? 13.16 NI NI A 501 B 187 GLU A 28 GLU~? 13.04 NI NI A 501 coo 12.53 42.28 15.16 11.35 44.10 16.30 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 12.85 44.05 6.07 11.44 42.52 5.44 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 4 2 # 4 B 165 SER A 66 SER^? 13.16 NI NI A 501 B 187 GLU B 86 GLU.? 9.13 NI NI A 501 coo 12.53 42.28 15.16 11.35 44.10 16.30 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 12.85 44.05 6.07 11.44 42.52 5.44 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 5 2 # 5 B 165 SER A 66 SER^? 13.16 NI NI A 501 B 187 GLU B 124 GLU.? 12.68 NI NI A 501 coo 12.53 42.28 15.16 11.35 44.10 16.30 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 12.85 44.05 6.07 11.44 42.52 5.44 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 6 2 # 6 B 165 SER A 72 SER.? 30.35 NI NI A 502 B 187 GLU B 116 GLU.? 34.45 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -31.43 35.56 -6.74 -30.88 37.60 -5.53 coo 12.85 44.05 6.07 11.44 42.52 5.44 -40.98 33.61 -5.94 -39.53 34.29 -4.51 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 7 2 # 7 B 165 SER A 87 SER.? 14.75 NI NI A 502 B 187 GLU B 86 GLU.? 9.13 NI NI A 501 coo 12.53 42.28 15.16 11.35 44.10 16.30 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 12.85 44.05 6.07 11.44 42.52 5.44 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 8 2 # 8 B 165 SER B 24 SER~? 15.42 NI NI A 502 B 187 GLU A 86 GLU.? 9.00 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 12.85 44.05 6.07 11.44 42.52 5.44 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 9 2 # 9 B 165 SER B 66 SER^? 13.28 NI NI A 502 B 187 GLU A 86 GLU.? 9.00 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 12.85 44.05 6.07 11.44 42.52 5.44 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 10 2 # 10 B 165 SER B 66 SER^? 13.28 NI NI A 502 B 187 GLU A 124 GLU.? 14.10 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 12.85 44.05 6.07 11.44 42.52 5.44 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 11 2 # 11 B 165 SER B 66 SER^? 13.28 NI NI A 502 B 187 GLU B 28 GLU~? 10.98 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 12.85 44.05 6.07 11.44 42.52 5.44 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 12 2 # 12 B 165 SER B 72 SER.? 30.04 NI NI A 501 B 187 GLU A 116 GLU.? 34.96 NI NI A 501 coo 12.53 42.28 15.16 11.35 44.10 16.30 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo 12.85 44.05 6.07 11.44 42.52 5.44 -49.93 20.01 -40.14 -51.36 19.66 -41.66 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 13 2 # 13 B 165 SER B 87 SER.? 15.38 NI NI A 501 B 187 GLU A 86 GLU.? 9.00 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 12.85 44.05 6.07 11.44 42.52 5.44 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 14 2 # 14 B 165 SER B 87 SER.? 15.38 NI NI A 501 B 187 GLU A 124 GLU.? 14.10 NI NI A 502 coo 12.53 42.28 15.16 11.35 44.10 16.30 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 12.85 44.05 6.07 11.44 42.52 5.44 -31.64 24.06 -29.50 -32.42 25.73 -28.36 1xgm_c01 source 1xgm METHIONINE AMINOPEPTIDASE : 14 hits 1xgm_c01 naa= 2 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 1 2 # 1 A 242 ALA A 16 ALA~? 14.70 NI NI A 502 A 243 THR A 14 THR~? 17.42 NI NI A 502 coo 7.23 22.00 24.48 6.68 23.42 24.57 -22.94 29.19 -15.51 -23.04 29.75 -16.99 coo 9.58 21.79 21.50 11.25 23.03 20.90 -17.69 30.48 -14.71 -15.64 30.77 -13.94 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 2 2 # 2 A 242 ALA A 62 ALA.? 17.78 NI NI A 501 A 243 THR A 65 THR.? 13.82 NI NI A 501 coo 7.23 22.00 24.48 6.68 23.42 24.57 -38.10 15.26 -8.14 -38.70 16.62 -8.41 coo 9.58 21.79 21.50 11.25 23.03 20.90 -35.39 14.99 -13.24 -37.04 15.69 -14.45 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 3 2 # 3 A 242 ALA A 80 ALA~? 15.06 NI NI A 502 A 243 THR A 83 THR~? 11.66 NI NI A 502 coo 7.23 22.00 24.48 6.68 23.42 24.57 -24.77 32.46 -19.75 -23.88 32.85 -18.61 coo 9.58 21.79 21.50 11.25 23.03 20.90 -25.75 29.45 -24.12 -25.45 31.51 -23.71 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 4 2 # 4 A 242 ALA A 105 ALA^? 27.14 NI NI A 501 A 243 THR A 106 THR^? 23.59 NI NI A 501 coo 7.23 22.00 24.48 6.68 23.42 24.57 -47.30 22.15 -25.93 -48.55 22.67 -26.61 coo 9.58 21.79 21.50 11.25 23.03 20.90 -44.11 24.18 -26.65 -42.38 22.71 -26.31 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 5 2 # 5 A 242 ALA A 107 ALA.? 26.77 NI NI A 502 A 243 THR A 106 THR^? 23.59 NI NI A 501 coo 7.23 22.00 24.48 6.68 23.42 24.57 -44.08 26.82 -29.53 -45.00 28.05 -29.65 coo 9.58 21.79 21.50 11.25 23.03 20.90 -44.11 24.18 -26.65 -42.38 22.71 -26.31 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 6 2 # 6 A 242 ALA B 16 ALA~? 14.52 NI NI A 501 A 243 THR B 14 THR~? 17.57 NI NI A 501 coo 7.23 22.00 24.48 6.68 23.42 24.57 -36.81 5.30 -32.32 -37.54 5.16 -30.96 coo 9.58 21.79 21.50 11.25 23.03 20.90 -35.43 0.02 -33.01 -34.98 -1.69 -34.29 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 7 2 # 7 A 242 ALA B 62 ALA^? 18.18 NI NI A 502 A 243 THR B 65 THR^? 14.18 NI NI A 502 coo 7.23 22.00 24.48 6.68 23.42 24.57 -32.70 25.58 -39.02 -34.22 25.50 -38.99 coo 9.58 21.79 21.50 11.25 23.03 20.90 -30.21 23.51 -34.34 -32.04 24.61 -34.02 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 8 2 # 8 A 242 ALA B 63 ALA.? 14.26 NI NI A 502 A 243 THR B 65 THR^? 14.18 NI NI A 502 coo 7.23 22.00 24.48 6.68 23.42 24.57 -30.51 27.97 -37.07 -31.04 28.21 -35.63 coo 9.58 21.79 21.50 11.25 23.03 20.90 -30.21 23.51 -34.34 -32.04 24.61 -34.02 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 9 2 # 9 A 242 ALA B 80 ALA~? 14.09 NI NI A 501 A 243 THR B 83 THR~? 9.81 NI NI A 501 coo 7.23 22.00 24.48 6.68 23.42 24.57 -40.53 5.12 -27.34 -40.58 4.10 -28.46 coo 9.58 21.79 21.50 11.25 23.03 20.90 -37.96 7.70 -23.50 -39.15 5.98 -23.18 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 10 2 # 10 A 242 ALA B 105 ALA^? 27.51 NI NI A 502 A 243 THR B 106 THR^? 23.70 NI NI A 502 coo 7.23 22.00 24.48 6.68 23.42 24.57 -42.68 29.91 -21.65 -43.74 30.78 -21.05 coo 9.58 21.79 21.50 11.25 23.03 20.90 -42.71 26.17 -21.12 -40.64 25.57 -21.68 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 11 2 # 11 A 242 ALA B 107 ALA.? 26.54 NI NI A 501 A 243 THR B 106 THR^? 23.70 NI NI A 502 coo 7.23 22.00 24.48 6.68 23.42 24.57 -45.21 25.17 -18.39 -46.70 25.20 -18.67 coo 9.58 21.79 21.50 11.25 23.03 20.90 -42.71 26.17 -21.12 -40.64 25.57 -21.68 1xqd_c00 source 1xqd CYTOCHROME P450 55A1 : 11 hits 1xqd_c00 naa= 2 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 1 2 # 1 A 286 SER A 43 SER.? 23.77 NI NI A 501 A 393 ASP A 42 ASP.? 24.20 NI NI A 501 coo 13.16 26.08 17.48 14.86 26.70 19.08 -20.78 14.34 -0.26 -20.70 12.54 1.43 coo 8.26 27.79 16.87 9.99 28.97 17.08 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 2 2 # 2 A 286 SER A 87 SER.? 14.75 NI NI A 502 A 393 ASP A 88 ASP^? 14.52 NI NI A 501 coo 13.16 26.08 17.48 14.86 26.70 19.08 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 8.26 27.79 16.87 9.99 28.97 17.08 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 3 2 # 3 A 286 SER A 87 SER.? 14.75 NI NI A 502 A 393 ASP B 88 ASP^? 15.06 NI NI A 502 coo 13.16 26.08 17.48 14.86 26.70 19.08 -31.76 21.87 -25.29 -32.13 24.17 -24.48 coo 8.26 27.79 16.87 9.99 28.97 17.08 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 4 2 # 4 A 286 SER B 43 SER.? 24.88 NI NI A 502 A 393 ASP B 42 ASP.? 24.38 NI NI A 502 coo 13.16 26.08 17.48 14.86 26.70 19.08 -23.40 10.48 -47.49 -24.52 10.60 -49.63 coo 8.26 27.79 16.87 9.99 28.97 17.08 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 5 2 # 5 A 286 SER B 87 SER.? 15.38 NI NI A 501 A 393 ASP A 88 ASP^? 14.52 NI NI A 501 coo 13.16 26.08 17.48 14.86 26.70 19.08 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 8.26 27.79 16.87 9.99 28.97 17.08 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 6 2 # 6 A 286 SER B 87 SER.? 15.38 NI NI A 501 A 393 ASP B 88 ASP^? 15.06 NI NI A 502 coo 13.16 26.08 17.48 14.86 26.70 19.08 -34.52 16.29 -22.30 -36.75 17.25 -22.69 coo 8.26 27.79 16.87 9.99 28.97 17.08 -31.42 19.31 -21.85 -30.03 20.81 -21.11 1xqd_c01 source 1xqd CYTOCHROME P450 55A1 : 6 hits 1xqd_c01 naa= 2 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 128 ASP A 82 ASP~? 15.20 NI NI A 502 A 130 GLY A 84 GLY~? 9.33 NI NI A 502 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 128 ASP A 82 ASP~? 15.20 NI NI A 502 A 130 GLY B 91 GLY^? 20.73 NI NI A 502 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 128 ASP B 42 ASP.? 24.38 NI NI A 502 A 130 GLY B 46 GLY.? 19.27 NI NI A 502 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 128 ASP B 82 ASP~? 13.99 NI NI A 501 A 130 GLY A 91 GLY^? 20.30 NI NI A 501 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 A 128 ASP B 82 ASP~? 13.99 NI NI A 501 A 130 GLY B 84 GLY~? 8.68 NI NI A 501 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -34.57 7.23 -25.18 -34.90 7.95 -25.10 1xs1_c00 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c00 naa= 2 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 128 ASP A 42 ASP.? 24.20 NI NI A 501 B 130 GLY A 46 GLY.? 19.33 NI NI A 501 coo 8.08 5.58 9.89 6.73 6.58 11.12 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.94 13.11 -6.31 -19.18 13.89 -6.25 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 128 ASP A 82 ASP~? 15.20 NI NI A 502 B 130 GLY A 84 GLY~? 9.33 NI NI A 502 coo 8.08 5.58 9.89 6.73 6.58 11.12 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 12.76 4.19 5.97 12.32 3.80 6.57 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 128 ASP A 82 ASP~? 15.20 NI NI A 502 B 130 GLY B 91 GLY^? 20.73 NI NI A 502 coo 8.08 5.58 9.89 6.73 6.58 11.12 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 12.76 4.19 5.97 12.32 3.80 6.57 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 128 ASP B 42 ASP.? 24.38 NI NI A 502 B 130 GLY B 46 GLY.? 19.27 NI NI A 502 coo 8.08 5.58 9.89 6.73 6.58 11.12 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 12.76 4.19 5.97 12.32 3.80 6.57 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 B 128 ASP B 82 ASP~? 13.99 NI NI A 501 B 130 GLY A 91 GLY^? 20.30 NI NI A 501 coo 8.08 5.58 9.89 6.73 6.58 11.12 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 12.76 4.19 5.97 12.32 3.80 6.57 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 B 128 ASP B 82 ASP~? 13.99 NI NI A 501 B 130 GLY B 84 GLY~? 8.68 NI NI A 501 coo 8.08 5.58 9.89 6.73 6.58 11.12 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 12.76 4.19 5.97 12.32 3.80 6.57 -34.57 7.23 -25.18 -34.90 7.95 -25.10 1xs1_c01 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c01 naa= 2 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 C 128 ASP A 82 ASP~? 15.20 NI NI A 502 C 130 GLY A 84 GLY~? 9.33 NI NI A 502 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 C 128 ASP A 82 ASP~? 15.20 NI NI A 502 C 130 GLY B 91 GLY^? 20.73 NI NI A 502 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 C 128 ASP B 42 ASP.? 24.38 NI NI A 502 C 130 GLY B 46 GLY.? 19.27 NI NI A 502 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 C 128 ASP B 82 ASP~? 13.99 NI NI A 501 C 130 GLY A 91 GLY^? 20.30 NI NI A 501 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 C 128 ASP B 82 ASP~? 13.99 NI NI A 501 C 130 GLY B 84 GLY~? 8.68 NI NI A 501 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -34.57 7.23 -25.18 -34.90 7.95 -25.10 1xs1_c02 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c02 naa= 2 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 128 ASP A 82 ASP~? 15.20 NI NI A 502 D 130 GLY A 84 GLY~? 9.33 NI NI A 502 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 128 ASP A 82 ASP~? 15.20 NI NI A 502 D 130 GLY B 91 GLY^? 20.73 NI NI A 502 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 128 ASP B 42 ASP.? 24.38 NI NI A 502 D 130 GLY B 46 GLY.? 19.27 NI NI A 502 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 128 ASP B 82 ASP~? 13.99 NI NI A 501 D 130 GLY A 91 GLY^? 20.30 NI NI A 501 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 D 128 ASP B 82 ASP~? 13.99 NI NI A 501 D 130 GLY B 84 GLY~? 8.68 NI NI A 501 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -34.57 7.23 -25.18 -34.90 7.95 -25.10 1xs1_c03 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c03 naa= 2 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 128 ASP A 82 ASP~? 15.20 NI NI A 502 E 130 GLY A 84 GLY~? 9.33 NI NI A 502 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 128 ASP A 82 ASP~? 15.20 NI NI A 502 E 130 GLY B 91 GLY^? 20.73 NI NI A 502 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 128 ASP B 42 ASP.? 24.38 NI NI A 502 E 130 GLY B 46 GLY.? 19.27 NI NI A 502 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 128 ASP B 82 ASP~? 13.99 NI NI A 501 E 130 GLY A 91 GLY^? 20.30 NI NI A 501 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 E 128 ASP B 82 ASP~? 13.99 NI NI A 501 E 130 GLY B 84 GLY~? 8.68 NI NI A 501 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -34.57 7.23 -25.18 -34.90 7.95 -25.10 1xs1_c04 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c04 naa= 2 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 128 ASP A 82 ASP~? 15.20 NI NI A 502 F 130 GLY A 84 GLY~? 9.33 NI NI A 502 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 128 ASP A 82 ASP~? 15.20 NI NI A 502 F 130 GLY B 91 GLY^? 20.73 NI NI A 502 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 128 ASP B 42 ASP.? 24.38 NI NI A 502 F 130 GLY B 46 GLY.? 19.27 NI NI A 502 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 128 ASP B 82 ASP~? 13.99 NI NI A 501 F 130 GLY A 91 GLY^? 20.30 NI NI A 501 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 F 128 ASP B 82 ASP~? 13.99 NI NI A 501 F 130 GLY B 84 GLY~? 8.68 NI NI A 501 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -34.57 7.23 -25.18 -34.90 7.95 -25.10 1xs1_c05 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c05 naa= 2 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 111 SER A 24 SER~? 14.80 NI NI A 501 A 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo 6.26 6.70 20.48 8.06 5.10 20.15 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 10.04 5.32 23.68 11.46 4.45 21.05 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 111 SER A 24 SER~? 14.80 NI NI A 501 A 115 ARG A 25 ARG~? 18.03 NI NI A 501 coo 6.26 6.70 20.48 8.06 5.10 20.15 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 10.04 5.32 23.68 11.46 4.45 21.05 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 111 SER A 66 SER^? 13.16 NI NI A 501 A 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo 6.26 6.70 20.48 8.06 5.10 20.15 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 10.04 5.32 23.68 11.46 4.45 21.05 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 111 SER B 18 SER~? 18.56 NI NI A 501 A 115 ARG B 17 ARG~? 8.61 NI NI A 501 coo 6.26 6.70 20.48 8.06 5.10 20.15 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 10.04 5.32 23.68 11.46 4.45 21.05 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 A 111 SER B 24 SER~? 15.42 NI NI A 502 A 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo 6.26 6.70 20.48 8.06 5.10 20.15 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 10.04 5.32 23.68 11.46 4.45 21.05 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 A 111 SER B 24 SER~? 15.42 NI NI A 502 A 115 ARG B 25 ARG~? 17.38 NI NI A 502 coo 6.26 6.70 20.48 8.06 5.10 20.15 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 10.04 5.32 23.68 11.46 4.45 21.05 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 A 111 SER B 66 SER^? 13.28 NI NI A 502 A 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo 6.26 6.70 20.48 8.06 5.10 20.15 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 10.04 5.32 23.68 11.46 4.45 21.05 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 A 111 SER B 72 SER.? 30.04 NI NI A 501 A 115 ARG B 56 ARG.? 27.79 NI NI A 501 coo 6.26 6.70 20.48 8.06 5.10 20.15 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo 10.04 5.32 23.68 11.46 4.45 21.05 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1xs1_c13 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 8 hits 1xs1_c13 naa= 2 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 111 SER A 18 SER~? 18.69 NI NI A 502 B 115 ARG A 17 ARG~? 9.21 NI NI A 502 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 111 SER A 24 SER~? 14.80 NI NI A 501 B 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 111 SER A 24 SER~? 14.80 NI NI A 501 B 115 ARG A 25 ARG~? 18.03 NI NI A 501 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 111 SER A 66 SER^? 13.16 NI NI A 501 B 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 B 111 SER B 18 SER~? 18.56 NI NI A 501 B 115 ARG B 17 ARG~? 8.61 NI NI A 501 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 B 111 SER B 24 SER~? 15.42 NI NI A 502 B 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 B 111 SER B 24 SER~? 15.42 NI NI A 502 B 115 ARG B 25 ARG~? 17.38 NI NI A 502 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 B 111 SER B 66 SER^? 13.28 NI NI A 502 B 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 B 111 SER B 72 SER.? 30.04 NI NI A 501 B 115 ARG B 56 ARG.? 27.79 NI NI A 501 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1xs1_c14 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 9 hits 1xs1_c14 naa= 2 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 111 SER A 24 SER~? 14.80 NI NI A 501 D 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 111 SER A 24 SER~? 14.80 NI NI A 501 D 115 ARG A 25 ARG~? 18.03 NI NI A 501 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 111 SER A 66 SER^? 13.16 NI NI A 501 D 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 111 SER B 18 SER~? 18.56 NI NI A 501 D 115 ARG B 17 ARG~? 8.61 NI NI A 501 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 D 111 SER B 24 SER~? 15.42 NI NI A 502 D 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 D 111 SER B 24 SER~? 15.42 NI NI A 502 D 115 ARG B 25 ARG~? 17.38 NI NI A 502 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 D 111 SER B 66 SER^? 13.28 NI NI A 502 D 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 D 111 SER B 72 SER.? 30.04 NI NI A 501 D 115 ARG B 56 ARG.? 27.79 NI NI A 501 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1xs1_c15 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 8 hits 1xs1_c15 naa= 2 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 111 SER A 18 SER~? 18.69 NI NI A 502 E 115 ARG A 17 ARG~? 9.21 NI NI A 502 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -20.61 25.64 -12.14 -18.92 27.29 -11.48 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 111 SER A 24 SER~? 14.80 NI NI A 501 E 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 111 SER A 24 SER~? 14.80 NI NI A 501 E 115 ARG A 25 ARG~? 18.03 NI NI A 501 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 111 SER A 66 SER^? 13.16 NI NI A 501 E 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 E 111 SER B 18 SER~? 18.56 NI NI A 501 E 115 ARG B 17 ARG~? 8.61 NI NI A 501 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 E 111 SER B 24 SER~? 15.42 NI NI A 502 E 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 E 111 SER B 24 SER~? 15.42 NI NI A 502 E 115 ARG B 25 ARG~? 17.38 NI NI A 502 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 E 111 SER B 66 SER^? 13.28 NI NI A 502 E 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 E 111 SER B 72 SER.? 30.04 NI NI A 501 E 115 ARG B 56 ARG.? 27.79 NI NI A 501 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1xs1_c16 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 9 hits 1xs1_c16 naa= 2 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 111 SER A 24 SER~? 14.80 NI NI A 501 F 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 111 SER A 24 SER~? 14.80 NI NI A 501 F 115 ARG A 25 ARG~? 18.03 NI NI A 501 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -24.49 16.91 -14.42 -22.87 15.82 -15.86 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 111 SER A 66 SER^? 13.16 NI NI A 501 F 115 ARG A 23 ARG~? 15.85 NI NI A 502 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -32.58 17.24 -12.10 -30.98 15.55 -12.25 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 111 SER B 18 SER~? 18.56 NI NI A 501 F 115 ARG B 17 ARG~? 8.61 NI NI A 501 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -32.39 4.87 -35.49 -32.99 2.69 -36.46 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 F 111 SER B 24 SER~? 15.42 NI NI A 502 F 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 F 111 SER B 24 SER~? 15.42 NI NI A 502 F 115 ARG B 25 ARG~? 17.38 NI NI A 502 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -26.98 12.98 -33.60 -27.18 11.97 -31.48 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 F 111 SER B 66 SER^? 13.28 NI NI A 502 F 115 ARG B 23 ARG~? 15.67 NI NI A 501 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -31.33 20.29 -35.99 -29.23 19.21 -35.57 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 F 111 SER B 72 SER.? 30.04 NI NI A 501 F 115 ARG B 56 ARG.? 27.79 NI NI A 501 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -46.24 10.24 -40.52 -46.88 9.75 -42.88 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -40.99 6.23 -42.31 -42.32 3.75 -43.46 1xs1_c17 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 8 hits 1xs1_c17 naa= 2 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 A 175 ARG A 23 ARG~? 15.85 NI NI A 502 A 242 TYR A 22 TYR~? 21.39 NI NI A 501 coo 56.19 79.96 8.87 56.06 80.16 11.92 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 63.28 81.69 5.71 63.99 80.11 7.80 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 A 175 ARG A 23 ARG~? 15.85 NI NI A 502 A 242 TYR A 67 TYR^? 18.49 NI NI A 501 coo 56.19 79.96 8.87 56.06 80.16 11.92 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo 63.28 81.69 5.71 63.99 80.11 7.80 -35.76 20.58 -11.22 -38.22 19.54 -12.11 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 3 2 # 3 A 175 ARG A 25 ARG~? 18.03 NI NI A 501 A 242 TYR A 22 TYR~? 21.39 NI NI A 501 coo 56.19 79.96 8.87 56.06 80.16 11.92 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 63.28 81.69 5.71 63.99 80.11 7.80 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 4 2 # 4 A 175 ARG A 25 ARG~? 18.03 NI NI A 501 A 242 TYR A 29 TYR~? 15.38 NI NI A 501 coo 56.19 79.96 8.87 56.06 80.16 11.92 -20.54 14.84 -11.32 -17.83 13.50 -10.78 coo 63.28 81.69 5.71 63.99 80.11 7.80 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 5 2 # 5 A 175 ARG A 93 ARG^? 27.22 NI NI A 502 A 242 TYR B 67 TYR^? 18.53 NI NI A 502 coo 56.19 79.96 8.87 56.06 80.16 11.92 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 63.28 81.69 5.71 63.99 80.11 7.80 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 6 2 # 6 A 175 ARG B 23 ARG~? 15.67 NI NI A 501 A 242 TYR B 22 TYR~? 21.09 NI NI A 502 coo 56.19 79.96 8.87 56.06 80.16 11.92 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 63.28 81.69 5.71 63.99 80.11 7.80 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 7 2 # 7 A 175 ARG B 23 ARG~? 15.67 NI NI A 501 A 242 TYR B 67 TYR^? 18.53 NI NI A 502 coo 56.19 79.96 8.87 56.06 80.16 11.92 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo 63.28 81.69 5.71 63.99 80.11 7.80 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 8 2 # 8 A 175 ARG B 25 ARG~? 17.38 NI NI A 502 A 242 TYR B 22 TYR~? 21.09 NI NI A 502 coo 56.19 79.96 8.87 56.06 80.16 11.92 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 63.28 81.69 5.71 63.99 80.11 7.80 -30.89 10.60 -39.31 -31.13 12.07 -41.74 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 9 2 # 9 A 175 ARG B 25 ARG~? 17.38 NI NI A 502 A 242 TYR B 29 TYR~? 14.52 NI NI A 502 coo 56.19 79.96 8.87 56.06 80.16 11.92 -23.60 10.54 -37.24 -21.22 8.75 -36.58 coo 63.28 81.69 5.71 63.99 80.11 7.80 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 10 2 # 10 A 175 ARG B 93 ARG^? 28.43 NI NI A 501 A 242 TYR A 67 TYR^? 18.49 NI NI A 501 coo 56.19 79.96 8.87 56.06 80.16 11.92 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 63.28 81.69 5.71 63.99 80.11 7.80 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1xva_c02 source 1xva GLYCINE N-METHYLTRANSFERASE : 10 hits 1xva_c02 naa= 2 ULMN 2 1y9m_c00 EXO-INULINASE user 1 2 # 1 A 41 ASP A 82 ASP~? 15.20 NI NI A 502 A 241 GLU A 86 GLU.? 9.00 NI NI A 502 coo 24.90 6.62 22.11 24.45 8.58 22.70 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 19.12 12.64 24.04 21.16 13.15 23.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1y9m_c00 EXO-INULINASE user 2 2 # 2 A 41 ASP A 82 ASP~? 15.20 NI NI A 502 A 241 GLU A 124 GLU.? 14.10 NI NI A 502 coo 24.90 6.62 22.11 24.45 8.58 22.70 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 19.12 12.64 24.04 21.16 13.15 23.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1y9m_c00 EXO-INULINASE user 3 2 # 3 A 41 ASP A 88 ASP^? 14.52 NI NI A 501 A 241 GLU A 86 GLU.? 9.00 NI NI A 502 coo 24.90 6.62 22.11 24.45 8.58 22.70 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 19.12 12.64 24.04 21.16 13.15 23.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1y9m_c00 EXO-INULINASE user 4 2 # 4 A 41 ASP A 88 ASP^? 14.52 NI NI A 501 A 241 GLU A 124 GLU.? 14.10 NI NI A 502 coo 24.90 6.62 22.11 24.45 8.58 22.70 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 19.12 12.64 24.04 21.16 13.15 23.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1y9m_c00 EXO-INULINASE user 5 2 # 5 A 41 ASP A 88 ASP^? 14.52 NI NI A 501 A 241 GLU B 86 GLU.? 9.13 NI NI A 501 coo 24.90 6.62 22.11 24.45 8.58 22.70 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 19.12 12.64 24.04 21.16 13.15 23.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1y9m_c00 EXO-INULINASE user 6 2 # 6 A 41 ASP A 88 ASP^? 14.52 NI NI A 501 A 241 GLU B 124 GLU.? 12.68 NI NI A 501 coo 24.90 6.62 22.11 24.45 8.58 22.70 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 19.12 12.64 24.04 21.16 13.15 23.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1y9m_c00 EXO-INULINASE user 7 2 # 7 A 41 ASP B 82 ASP~? 13.99 NI NI A 501 A 241 GLU B 86 GLU.? 9.13 NI NI A 501 coo 24.90 6.62 22.11 24.45 8.58 22.70 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 19.12 12.64 24.04 21.16 13.15 23.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1y9m_c00 EXO-INULINASE user 8 2 # 8 A 41 ASP B 82 ASP~? 13.99 NI NI A 501 A 241 GLU B 124 GLU.? 12.68 NI NI A 501 coo 24.90 6.62 22.11 24.45 8.58 22.70 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 19.12 12.64 24.04 21.16 13.15 23.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 1y9m_c00 EXO-INULINASE user 9 2 # 9 A 41 ASP B 88 ASP^? 15.06 NI NI A 502 A 241 GLU A 86 GLU.? 9.00 NI NI A 502 coo 24.90 6.62 22.11 24.45 8.58 22.70 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 19.12 12.64 24.04 21.16 13.15 23.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 1y9m_c00 EXO-INULINASE user 10 2 # 10 A 41 ASP B 88 ASP^? 15.06 NI NI A 502 A 241 GLU A 124 GLU.? 14.10 NI NI A 502 coo 24.90 6.62 22.11 24.45 8.58 22.70 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 19.12 12.64 24.04 21.16 13.15 23.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 1y9m_c00 EXO-INULINASE user 11 2 # 11 A 41 ASP B 88 ASP^? 15.06 NI NI A 502 A 241 GLU B 86 GLU.? 9.13 NI NI A 501 coo 24.90 6.62 22.11 24.45 8.58 22.70 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 19.12 12.64 24.04 21.16 13.15 23.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 1y9m_c00 EXO-INULINASE user 12 2 # 12 A 41 ASP B 88 ASP^? 15.06 NI NI A 502 A 241 GLU B 124 GLU.? 12.68 NI NI A 501 coo 24.90 6.62 22.11 24.45 8.58 22.70 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 19.12 12.64 24.04 21.16 13.15 23.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 1y9m_c00 source 1y9m EXO-INULINASE : 12 hits 1y9m_c00 naa= 2 ULMN 2 1ybv_c04 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 175 HIS A 31 HIS~? -4.16 NI NI A 501s A 182 LYS B 123 LYS^? 13.38 NI NI A 501 coo 85.29 7.35 12.75 85.49 9.14 13.81 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 85.30 6.17 22.83 87.26 11.02 23.50 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1ybv_c04 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 A 175 HIS A 126 HIS.? -3.75 NI NI A 502s A 182 LYS A 123 LYS^? 12.92 NI NI A 502 coo 85.29 7.35 12.75 85.49 9.14 13.81 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 85.30 6.17 22.83 87.26 11.02 23.50 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1ybv_c04 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 A 175 HIS B 31 HIS~? -3.92 NI NI A 502s A 182 LYS A 123 LYS^? 12.92 NI NI A 502 coo 85.29 7.35 12.75 85.49 9.14 13.81 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 85.30 6.17 22.83 87.26 11.02 23.50 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1ybv_c04 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 A 175 HIS B 126 HIS.? -4.79 NI NI A 501s A 182 LYS B 123 LYS^? 13.38 NI NI A 501 coo 85.29 7.35 12.75 85.49 9.14 13.81 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 85.30 6.17 22.83 87.26 11.02 23.50 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1ybv_c04 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c04 naa= 2 ULMN 2 1ybv_c05 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 175 HIS A 31 HIS~? -4.16 NI NI A 501s B 182 LYS B 123 LYS^? 13.38 NI NI A 501 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 57.40 2.23 30.19 55.43 5.44 33.87 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1ybv_c05 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 B 175 HIS A 126 HIS.? -3.75 NI NI A 502s B 182 LYS A 123 LYS^? 12.92 NI NI A 502 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 57.40 2.23 30.19 55.43 5.44 33.87 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1ybv_c05 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 B 175 HIS B 31 HIS~? -3.92 NI NI A 502s B 182 LYS A 123 LYS^? 12.92 NI NI A 502 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 57.40 2.23 30.19 55.43 5.44 33.87 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 1ybv_c05 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 B 175 HIS B 126 HIS.? -4.79 NI NI A 501s B 182 LYS B 123 LYS^? 13.38 NI NI A 501 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 57.40 2.23 30.19 55.43 5.44 33.87 -32.29 17.60 -17.14 -27.15 16.48 -17.32 1ybv_c05 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c05 naa= 2 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 178 TYR A 22 TYR~? 21.39 NI NI A 501 A 182 LYS A 53 LYS.? 25.39 NI NI A 501 coo 87.67 8.69 17.10 86.62 10.83 18.52 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 85.30 6.17 22.83 87.26 11.02 23.50 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 A 178 TYR A 67 TYR^? 18.49 NI NI A 501 A 182 LYS B 123 LYS^? 13.38 NI NI A 501 coo 87.67 8.69 17.10 86.62 10.83 18.52 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 85.30 6.17 22.83 87.26 11.02 23.50 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 A 178 TYR B 22 TYR~? 21.09 NI NI A 502 A 182 LYS B 53 LYS.? 26.24 NI NI A 502 coo 87.67 8.69 17.10 86.62 10.83 18.52 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 85.30 6.17 22.83 87.26 11.02 23.50 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 A 178 TYR B 67 TYR^? 18.53 NI NI A 502 A 182 LYS A 123 LYS^? 12.92 NI NI A 502 coo 87.67 8.69 17.10 86.62 10.83 18.52 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 85.30 6.17 22.83 87.26 11.02 23.50 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1ybv_c06 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c06 naa= 2 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 178 TYR A 22 TYR~? 21.39 NI NI A 501 B 182 LYS A 53 LYS.? 25.39 NI NI A 501 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 57.40 2.23 30.19 55.43 5.44 33.87 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 B 178 TYR A 67 TYR^? 18.49 NI NI A 501 B 182 LYS B 123 LYS^? 13.38 NI NI A 501 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 57.40 2.23 30.19 55.43 5.44 33.87 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 B 178 TYR B 22 TYR~? 21.09 NI NI A 502 B 182 LYS B 53 LYS.? 26.24 NI NI A 502 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 57.40 2.23 30.19 55.43 5.44 33.87 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 B 178 TYR B 67 TYR^? 18.53 NI NI A 502 B 182 LYS A 123 LYS^? 12.92 NI NI A 502 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 57.40 2.23 30.19 55.43 5.44 33.87 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1ybv_c07 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c07 naa= 2 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 1 2 # 1 A 25 HIS A 31 HIS~? -4.16 NI NI A 501s A 195 TYR A 29 TYR~? 15.38 NI NI A 501 coo 106.34 45.08-158.07 106.22 43.60-156.59 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 107.73 45.82-148.69 107.70 43.47-150.21 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 2 2 # 2 A 25 HIS B 31 HIS~? -3.92 NI NI A 502s A 195 TYR B 29 TYR~? 14.52 NI NI A 502 coo 106.34 45.08-158.07 106.22 43.60-156.59 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 107.73 45.82-148.69 107.70 43.47-150.21 -23.12 17.96 -41.07 -23.10 19.18 -43.61 1ycf_c04 source 1ycf NITRIC OXIDE REDUCTASE : 2 hits 1ycf_c04 naa= 2 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 1 2 # 1 B 25 HIS A 31 HIS~? -4.16 NI NI A 501s B 195 TYR A 29 TYR~? 15.38 NI NI A 501 coo 96.60 74.58-169.45 95.48 75.58-170.91 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 98.52 74.63-178.64 97.12 76.54-177.16 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 2 2 # 2 B 25 HIS B 31 HIS~? -3.92 NI NI A 502s B 195 TYR B 29 TYR~? 14.52 NI NI A 502 coo 96.60 74.58-169.45 95.48 75.58-170.91 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 98.52 74.63-178.64 97.12 76.54-177.16 -23.12 17.96 -41.07 -23.10 19.18 -43.61 1ycf_c05 source 1ycf NITRIC OXIDE REDUCTASE : 2 hits 1ycf_c05 naa= 2 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 1 2 # 1 C 25 HIS A 31 HIS~? -4.16 NI NI A 501s C 195 TYR A 29 TYR~? 15.38 NI NI A 501 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 2 2 # 2 C 25 HIS B 31 HIS~? -3.92 NI NI A 502s C 195 TYR B 29 TYR~? 14.52 NI NI A 502 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -23.12 17.96 -41.07 -23.10 19.18 -43.61 1ycf_c06 source 1ycf NITRIC OXIDE REDUCTASE : 2 hits 1ycf_c06 naa= 2 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 1 2 # 1 D 25 HIS A 31 HIS~? -4.16 NI NI A 501s D 195 TYR A 29 TYR~? 15.38 NI NI A 501 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 2 2 # 2 D 25 HIS B 31 HIS~? -3.92 NI NI A 502s D 195 TYR B 29 TYR~? 14.52 NI NI A 502 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -23.12 17.96 -41.07 -23.10 19.18 -43.61 1ycf_c07 source 1ycf NITRIC OXIDE REDUCTASE : 2 hits 1ycf_c07 naa= 2 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 A 39 ASP A 42 ASP.? 24.20 NI NI A 501 A 67 TYR A 22 TYR~? 21.39 NI NI A 501 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 A 39 ASP A 42 ASP.? 24.20 NI NI A 501 A 67 TYR A 29 TYR~? 15.38 NI NI A 501 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 A 39 ASP A 88 ASP^? 14.52 NI NI A 501 A 67 TYR B 67 TYR^? 18.53 NI NI A 502 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 A 39 ASP B 42 ASP.? 24.38 NI NI A 502 A 67 TYR B 29 TYR~? 14.52 NI NI A 502 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 A 39 ASP B 88 ASP^? 15.06 NI NI A 502 A 67 TYR A 67 TYR^? 18.49 NI NI A 501 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1ze1_c00 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 5 hits 1ze1_c00 naa= 2 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 B 39 ASP A 42 ASP.? 24.20 NI NI A 501 B 67 TYR A 22 TYR~? 21.39 NI NI A 501 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 B 39 ASP A 42 ASP.? 24.20 NI NI A 501 B 67 TYR A 29 TYR~? 15.38 NI NI A 501 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 B 39 ASP A 88 ASP^? 14.52 NI NI A 501 B 67 TYR B 67 TYR^? 18.53 NI NI A 502 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 B 39 ASP B 42 ASP.? 24.38 NI NI A 502 B 67 TYR B 29 TYR~? 14.52 NI NI A 502 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 B 39 ASP B 88 ASP^? 15.06 NI NI A 502 B 67 TYR A 67 TYR^? 18.49 NI NI A 501 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1ze1_c01 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 5 hits 1ze1_c01 naa= 2 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 C 39 ASP A 42 ASP.? 24.20 NI NI A 501 C 67 TYR A 22 TYR~? 21.39 NI NI A 501 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 C 39 ASP A 42 ASP.? 24.20 NI NI A 501 C 67 TYR A 29 TYR~? 15.38 NI NI A 501 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 C 39 ASP A 88 ASP^? 14.52 NI NI A 501 C 67 TYR B 67 TYR^? 18.53 NI NI A 502 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 C 39 ASP B 42 ASP.? 24.38 NI NI A 502 C 67 TYR B 29 TYR~? 14.52 NI NI A 502 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 C 39 ASP B 88 ASP^? 15.06 NI NI A 502 C 67 TYR A 67 TYR^? 18.49 NI NI A 501 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1ze1_c02 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 5 hits 1ze1_c02 naa= 2 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 D 39 ASP A 42 ASP.? 24.20 NI NI A 501 D 67 TYR A 22 TYR~? 21.39 NI NI A 501 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -24.64 21.66 -8.58 -26.12 21.10 -6.23 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 D 39 ASP A 42 ASP.? 24.20 NI NI A 501 D 67 TYR A 29 TYR~? 15.38 NI NI A 501 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -27.09 11.47 -6.47 -27.56 10.92 -3.78 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 D 39 ASP A 88 ASP^? 14.52 NI NI A 501 D 67 TYR B 67 TYR^? 18.53 NI NI A 502 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -35.67 20.34 -36.33 -35.75 23.11 -35.83 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 D 39 ASP B 42 ASP.? 24.38 NI NI A 502 D 67 TYR B 29 TYR~? 14.52 NI NI A 502 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -23.12 17.96 -41.07 -23.10 19.18 -43.61 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 D 39 ASP B 88 ASP^? 15.06 NI NI A 502 D 67 TYR A 67 TYR^? 18.49 NI NI A 501 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -35.76 20.58 -11.22 -38.22 19.54 -12.11 1ze1_c03 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 5 hits 1ze1_c03 naa= 2 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 13 ASP~? 13.27 NI NI A 502 A 373 ASP A 82 ASP~? 15.20 NI NI A 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 82 ASP~? 15.20 NI NI A 502 A 373 ASP A 13 ASP~? 13.27 NI NI A 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -18.74 32.48 -18.59 -19.60 33.57 -20.27 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP A 82 ASP~? 15.20 NI NI A 502 A 373 ASP B 88 ASP^? 15.06 NI NI A 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 4 2 # 4 A 369 ASP A 88 ASP^? 14.52 NI NI A 501 A 373 ASP B 82 ASP~? 13.99 NI NI A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 5 2 # 5 A 369 ASP B 13 ASP~? 14.49 NI NI A 501 A 373 ASP B 82 ASP~? 13.99 NI NI A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 6 2 # 6 A 369 ASP B 82 ASP~? 13.99 NI NI A 501 A 373 ASP A 88 ASP^? 14.52 NI NI A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 7 2 # 7 A 369 ASP B 82 ASP~? 13.99 NI NI A 501 A 373 ASP B 13 ASP~? 14.49 NI NI A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 8 2 # 8 A 369 ASP B 88 ASP^? 15.06 NI NI A 502 A 373 ASP A 82 ASP~? 15.20 NI NI A 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -29.79 30.16 -22.23 -31.29 29.65 -23.60 1zrz_c00 source 1zrz PROTEIN KINASE C, IOTA : 8 hits 1zrz_c00 naa= 2 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 42 ASP.? 24.20 NI NI A 501 A 371 LYS A 53 LYS.? 25.39 NI NI A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 88 ASP^? 14.52 NI NI A 501 A 371 LYS B 123 LYS^? 13.38 NI NI A 501 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP B 42 ASP.? 24.38 NI NI A 502 A 371 LYS B 53 LYS.? 26.24 NI NI A 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 4 2 # 4 A 369 ASP B 88 ASP^? 15.06 NI NI A 502 A 371 LYS A 123 LYS^? 12.92 NI NI A 502 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -31.38 19.51 -30.63 -27.67 15.84 -27.69 1zrz_c01 source 1zrz PROTEIN KINASE C, IOTA : 4 hits 1zrz_c01 naa= 2 ULMN 2 1zym_c00 ENZYME I user 1 2 # 1 A 168 THR A 83 THR~? 11.66 NI NI A 502 A 189 HIS A 126 HIS.? -3.75 NI NI A 502s coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1zym_c00 ENZYME I user 2 2 # 2 A 168 THR A 83 THR~? 11.66 NI NI A 502 A 189 HIS A 127 HIS.? 7.54 NI NI A 502 coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1zym_c00 ENZYME I user 3 2 # 3 A 168 THR A 85 THR~? 12.80 NI NI A 502 A 189 HIS A 126 HIS.? -3.75 NI NI A 502s coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1zym_c00 ENZYME I user 4 2 # 4 A 168 THR B 83 THR~? 9.81 NI NI A 501 A 189 HIS B 126 HIS.? -4.79 NI NI A 501s coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1zym_c00 ENZYME I user 5 2 # 5 A 168 THR B 83 THR~? 9.81 NI NI A 501 A 189 HIS B 127 HIS.? 5.53 NI NI A 501 coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1zym_c00 ENZYME I user 6 2 # 6 A 168 THR B 85 THR.? 12.36 NI NI A 501 A 189 HIS B 126 HIS.? -4.79 NI NI A 501s coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1zym_c00 source 1zym ENZYME I : 6 hits 1zym_c00 naa= 2 ULMN 2 1zym_c01 ENZYME I user 1 2 # 1 B 168 THR A 83 THR~? 11.66 NI NI A 502 B 189 HIS A 126 HIS.? -3.75 NI NI A 502s coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1zym_c01 ENZYME I user 2 2 # 2 B 168 THR A 83 THR~? 11.66 NI NI A 502 B 189 HIS A 127 HIS.? 7.54 NI NI A 502 coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -25.75 29.45 -24.12 -25.45 31.51 -23.71 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -20.75 31.16 -30.30 -19.37 32.72 -30.66 ULMN 2 1zym_c01 ENZYME I user 3 2 # 3 B 168 THR A 85 THR~? 12.80 NI NI A 502 B 189 HIS A 126 HIS.? -3.75 NI NI A 502s coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -26.43 24.20 -22.83 -27.87 24.69 -21.30 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -22.12 24.45 -27.89 -21.28 22.78 -28.85 ULMN 2 1zym_c01 ENZYME I user 4 2 # 4 B 168 THR B 83 THR~? 9.81 NI NI A 501 B 189 HIS B 126 HIS.? -4.79 NI NI A 501s coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -33.66 8.52 -19.80 -32.10 7.12 -19.77 ULMN 2 1zym_c01 ENZYME I user 5 2 # 5 B 168 THR B 83 THR~? 9.81 NI NI A 501 B 189 HIS B 127 HIS.? 5.53 NI NI A 501 coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -37.96 7.70 -23.50 -39.15 5.98 -23.18 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -36.21 5.24 -15.46 -36.02 3.20 -15.94 ULMN 2 1zym_c01 ENZYME I user 6 2 # 6 B 168 THR B 85 THR.? 12.36 NI NI A 501 B 189 HIS B 126 HIS.? -4.79 NI NI A 501s coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -33.81 10.96 -25.09 -35.41 11.74 -26.39 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -33.66 8.52 -19.80 -32.10 7.12 -19.77 1zym_c01 source 1zym ENZYME I : 6 hits 1zym_c01 naa= 2 ULMN 2 206l_c00 LYSOZYME user 1 2 # 1 A 11 GLU A 86 GLU.? 9.00 NI NI A 502 A 20 ASP A 82 ASP~? 15.20 NI NI A 502 coo 40.46 12.70 11.55 39.54 14.42 10.81 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 39.78 21.54 11.61 37.90 22.43 11.16 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 206l_c00 LYSOZYME user 2 2 # 2 A 11 GLU A 86 GLU.? 9.00 NI NI A 502 A 20 ASP A 88 ASP^? 14.52 NI NI A 501 coo 40.46 12.70 11.55 39.54 14.42 10.81 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 39.78 21.54 11.61 37.90 22.43 11.16 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 206l_c00 LYSOZYME user 3 2 # 3 A 11 GLU A 86 GLU.? 9.00 NI NI A 502 A 20 ASP B 88 ASP^? 15.06 NI NI A 502 coo 40.46 12.70 11.55 39.54 14.42 10.81 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 39.78 21.54 11.61 37.90 22.43 11.16 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 206l_c00 LYSOZYME user 4 2 # 4 A 11 GLU A 124 GLU.? 14.10 NI NI A 502 A 20 ASP A 82 ASP~? 15.20 NI NI A 502 coo 40.46 12.70 11.55 39.54 14.42 10.81 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 39.78 21.54 11.61 37.90 22.43 11.16 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 206l_c00 LYSOZYME user 5 2 # 5 A 11 GLU A 124 GLU.? 14.10 NI NI A 502 A 20 ASP A 88 ASP^? 14.52 NI NI A 501 coo 40.46 12.70 11.55 39.54 14.42 10.81 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 39.78 21.54 11.61 37.90 22.43 11.16 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 206l_c00 LYSOZYME user 6 2 # 6 A 11 GLU A 124 GLU.? 14.10 NI NI A 502 A 20 ASP B 88 ASP^? 15.06 NI NI A 502 coo 40.46 12.70 11.55 39.54 14.42 10.81 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 39.78 21.54 11.61 37.90 22.43 11.16 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 206l_c00 LYSOZYME user 7 2 # 7 A 11 GLU B 86 GLU.? 9.13 NI NI A 501 A 20 ASP A 88 ASP^? 14.52 NI NI A 501 coo 40.46 12.70 11.55 39.54 14.42 10.81 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 39.78 21.54 11.61 37.90 22.43 11.16 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 206l_c00 LYSOZYME user 8 2 # 8 A 11 GLU B 86 GLU.? 9.13 NI NI A 501 A 20 ASP B 82 ASP~? 13.99 NI NI A 501 coo 40.46 12.70 11.55 39.54 14.42 10.81 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 39.78 21.54 11.61 37.90 22.43 11.16 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 206l_c00 LYSOZYME user 9 2 # 9 A 11 GLU B 86 GLU.? 9.13 NI NI A 501 A 20 ASP B 88 ASP^? 15.06 NI NI A 502 coo 40.46 12.70 11.55 39.54 14.42 10.81 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 39.78 21.54 11.61 37.90 22.43 11.16 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 206l_c00 LYSOZYME user 10 2 # 10 A 11 GLU B 124 GLU.? 12.68 NI NI A 501 A 20 ASP A 88 ASP^? 14.52 NI NI A 501 coo 40.46 12.70 11.55 39.54 14.42 10.81 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 39.78 21.54 11.61 37.90 22.43 11.16 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 206l_c00 LYSOZYME user 11 2 # 11 A 11 GLU B 124 GLU.? 12.68 NI NI A 501 A 20 ASP B 82 ASP~? 13.99 NI NI A 501 coo 40.46 12.70 11.55 39.54 14.42 10.81 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 39.78 21.54 11.61 37.90 22.43 11.16 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 206l_c00 LYSOZYME user 12 2 # 12 A 11 GLU B 124 GLU.? 12.68 NI NI A 501 A 20 ASP B 88 ASP^? 15.06 NI NI A 502 coo 40.46 12.70 11.55 39.54 14.42 10.81 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 39.78 21.54 11.61 37.90 22.43 11.16 -31.42 19.31 -21.85 -30.03 20.81 -21.11 206l_c00 source 206l LYSOZYME : 12 hits 206l_c00 naa= 2 ULMN 2 2a0n_c00 4.01.03.0000 user 1 2 # 1 A 11 ASP A 82 ASP~? 15.20 NI NI A 502 A 130 ASP A 88 ASP^? 14.52 NI NI A 501 coo 25.89 89.29 37.40 24.53 87.99 36.37 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 22.18 80.79 26.12 23.22 81.35 27.91 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2a0n_c00 4.01.03.0000 user 2 2 # 2 A 11 ASP A 88 ASP^? 14.52 NI NI A 501 A 130 ASP A 82 ASP~? 15.20 NI NI A 502 coo 25.89 89.29 37.40 24.53 87.99 36.37 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 22.18 80.79 26.12 23.22 81.35 27.91 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 2a0n_c00 4.01.03.0000 user 3 2 # 3 A 11 ASP B 82 ASP~? 13.99 NI NI A 501 A 130 ASP B 88 ASP^? 15.06 NI NI A 502 coo 25.89 89.29 37.40 24.53 87.99 36.37 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 22.18 80.79 26.12 23.22 81.35 27.91 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2a0n_c00 4.01.03.0000 user 4 2 # 4 A 11 ASP B 88 ASP^? 15.06 NI NI A 502 A 130 ASP B 82 ASP~? 13.99 NI NI A 501 coo 25.89 89.29 37.40 24.53 87.99 36.37 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 22.18 80.79 26.12 23.22 81.35 27.91 -40.67 10.76 -25.27 -41.01 11.92 -23.57 2a0n_c00 source 2a0n 4.01.03.0000 : 4 hits 2a0n_c00 naa= 2 ULMN 2 2abk_c00 ENDONUCLEASE III user 1 2 # 1 120 LYS A 53 LYS.? 25.39 NI NI A 501 138 ASP A 42 ASP.? 24.20 NI NI A 501 coo 35.70 11.61 29.91 35.27 16.84 33.08 -20.26 25.10 -4.42 -25.18 23.47 -3.20 coo 33.57 16.23 36.65 31.90 16.89 37.78 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2abk_c00 ENDONUCLEASE III user 2 2 # 2 120 LYS A 123 LYS^? 12.92 NI NI A 502 138 ASP B 88 ASP^? 15.06 NI NI A 502 coo 35.70 11.61 29.91 35.27 16.84 33.08 -31.38 19.51 -30.63 -27.67 15.84 -27.69 coo 33.57 16.23 36.65 31.90 16.89 37.78 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2abk_c00 ENDONUCLEASE III user 3 2 # 3 120 LYS B 53 LYS.? 26.24 NI NI A 502 138 ASP B 42 ASP.? 24.38 NI NI A 502 coo 35.70 11.61 29.91 35.27 16.84 33.08 -31.78 4.80 -43.31 -32.04 8.63 -45.75 coo 33.57 16.23 36.65 31.90 16.89 37.78 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2abk_c00 ENDONUCLEASE III user 4 2 # 4 120 LYS B 123 LYS^? 13.38 NI NI A 501 138 ASP A 88 ASP^? 14.52 NI NI A 501 coo 35.70 11.61 29.91 35.27 16.84 33.08 -32.29 17.60 -17.14 -27.15 16.48 -17.32 coo 33.57 16.23 36.65 31.90 16.89 37.78 -32.37 17.64 -25.93 -33.10 15.61 -26.13 2abk_c00 source 2abk ENDONUCLEASE III : 4 hits 2abk_c00 naa= 2 ULMN 2 2acy_c00 ACYLPHOSPHATASE user 1 2 # 1 23 ARG A 93 ARG^? 27.22 NI NI A 502 41 ASN A 95 ASN.? 33.32 NI NI A 501 coo 16.80 -14.98 16.98 17.50 -17.52 18.58 -45.46 21.14 -37.27 -43.99 23.01 -39.26 coo 21.33 -14.94 17.25 19.91 -14.30 18.68 -51.35 22.78 -35.72 -51.57 21.49 -37.42 ULMN 2 2acy_c00 ACYLPHOSPHATASE user 2 2 # 2 23 ARG A 94 ARG.? 33.91 NI NI A 501 41 ASN A 95 ASN.? 33.32 NI NI A 501 coo 16.80 -14.98 16.98 17.50 -17.52 18.58 -52.83 19.63 -33.61 -55.45 21.14 -33.98 coo 21.33 -14.94 17.25 19.91 -14.30 18.68 -51.35 22.78 -35.72 -51.57 21.49 -37.42 ULMN 2 2acy_c00 ACYLPHOSPHATASE user 3 2 # 3 23 ARG B 93 ARG^? 28.43 NI NI A 501 41 ASN B 95 ASN.? 31.89 NI NI A 501 coo 16.80 -14.98 16.98 17.50 -17.52 18.58 -40.21 29.12 -9.93 -42.89 27.96 -8.94 coo 21.33 -14.94 17.25 19.91 -14.30 18.68 -44.53 31.85 -10.19 -42.56 32.26 -9.56 2acy_c00 source 2acy ACYLPHOSPHATASE : 3 hits 2acy_c00 naa= 2 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 1 2 # 1 49 TYR A 22 TYR~? 21.39 NI NI A 501 79 LYS A 53 LYS.? 25.39 NI NI A 501 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 2 2 # 2 49 TYR A 67 TYR^? 18.49 NI NI A 501 79 LYS B 123 LYS^? 13.38 NI NI A 501 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 3 2 # 3 49 TYR B 22 TYR~? 21.09 NI NI A 502 79 LYS B 53 LYS.? 26.24 NI NI A 502 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 4 2 # 4 49 TYR B 67 TYR^? 18.53 NI NI A 502 79 LYS A 123 LYS^? 12.92 NI NI A 502 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2alr_c01 source 2alr ALDEHYDE REDUCTASE : 4 hits 2alr_c01 naa= 2 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 13 ASP~? 13.27 NI NI A 502 218 GLY A 76 GLY~? 19.91 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 21.10 106.02 13.04 21.16 106.76 12.59 -26.21 37.86 -17.31 -26.74 37.42 -16.86 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 13 ASP~? 13.27 NI NI A 502 218 GLY A 84 GLY~? 9.33 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 21.10 106.02 13.04 21.16 106.76 12.59 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 42 ASP.? 24.20 NI NI A 501 218 GLY A 46 GLY.? 19.33 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 21.10 106.02 13.04 21.16 106.76 12.59 -18.94 13.11 -6.31 -19.18 13.89 -6.25 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 82 ASP~? 15.20 NI NI A 502 218 GLY A 76 GLY~? 19.91 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 21.10 106.02 13.04 21.16 106.76 12.59 -26.21 37.86 -17.31 -26.74 37.42 -16.86 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 82 ASP~? 15.20 NI NI A 502 218 GLY A 84 GLY~? 9.33 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 21.10 106.02 13.04 21.16 106.76 12.59 -23.57 26.71 -22.47 -24.39 26.60 -22.61 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP A 82 ASP~? 15.20 NI NI A 502 218 GLY B 91 GLY^? 20.73 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 21.10 106.02 13.04 21.16 106.76 12.59 -34.90 29.27 -18.25 -34.72 28.89 -17.49 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 2 # 7 193 ASP B 13 ASP~? 14.49 NI NI A 501 218 GLY B 76 GLY~? 18.88 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 21.10 106.02 13.04 21.16 106.76 12.59 -45.85 3.88 -29.84 -45.63 4.32 -30.50 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 2 # 8 193 ASP B 13 ASP~? 14.49 NI NI A 501 218 GLY B 84 GLY~? 8.68 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 21.10 106.02 13.04 21.16 106.76 12.59 -34.57 7.23 -25.18 -34.90 7.95 -25.10 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 2 # 9 193 ASP B 42 ASP.? 24.38 NI NI A 502 218 GLY B 46 GLY.? 19.27 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 21.10 106.02 13.04 21.16 106.76 12.59 -21.06 9.89 -42.16 -21.89 9.75 -41.94 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 2 # 10 193 ASP B 42 ASP.? 24.38 NI NI A 502 218 GLY B 59 GLY^? 20.93 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 21.10 106.02 13.04 21.16 106.76 12.59 -33.81 15.50 -40.90 -34.10 15.72 -41.69 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 2 # 11 193 ASP B 82 ASP~? 13.99 NI NI A 501 218 GLY A 91 GLY^? 20.30 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 21.10 106.02 13.04 21.16 106.76 12.59 -42.92 15.52 -29.58 -42.49 15.51 -30.25 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 2 # 12 193 ASP B 82 ASP~? 13.99 NI NI A 501 218 GLY B 76 GLY~? 18.88 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 21.10 106.02 13.04 21.16 106.76 12.59 -45.85 3.88 -29.84 -45.63 4.32 -30.50 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 2 # 13 193 ASP B 82 ASP~? 13.99 NI NI A 501 218 GLY B 84 GLY~? 8.68 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 21.10 106.02 13.04 21.16 106.76 12.59 -34.57 7.23 -25.18 -34.90 7.95 -25.10 2amg_c00 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 13 hits 2amg_c00 naa= 2 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 88 ASP^? 14.52 NI NI A 501 219 GLU A 86 GLU.? 9.00 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 25.84 105.87 9.06 27.86 105.55 8.74 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 88 ASP^? 14.52 NI NI A 501 219 GLU A 124 GLU.? 14.10 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 25.84 105.87 9.06 27.86 105.55 8.74 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 88 ASP^? 14.52 NI NI A 501 219 GLU B 86 GLU.? 9.13 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 25.84 105.87 9.06 27.86 105.55 8.74 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP B 88 ASP^? 15.06 NI NI A 502 219 GLU A 86 GLU.? 9.00 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 25.84 105.87 9.06 27.86 105.55 8.74 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP B 88 ASP^? 15.06 NI NI A 502 219 GLU A 124 GLU.? 14.10 NI NI A 502 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 25.84 105.87 9.06 27.86 105.55 8.74 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP B 88 ASP^? 15.06 NI NI A 502 219 GLU B 86 GLU.? 9.13 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 25.84 105.87 9.06 27.86 105.55 8.74 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 2 # 7 193 ASP B 88 ASP^? 15.06 NI NI A 502 219 GLU B 124 GLU.? 12.68 NI NI A 501 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 25.84 105.87 9.06 27.86 105.55 8.74 -37.57 14.60 -17.43 -39.14 13.53 -18.53 2amg_c03 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 7 hits 2amg_c03 naa= 2 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 1 2 # 1 A 171 PHE A 69 PHE^? 24.58 NI NI A 501 A 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 2 2 # 2 A 171 PHE B 69 PHE^? 24.35 NI NI A 502 A 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c00 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c00 naa= 2 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 1 2 # 1 B 171 PHE A 69 PHE^? 24.58 NI NI A 501 B 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 2 2 # 2 B 171 PHE B 69 PHE^? 24.35 NI NI A 502 B 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c01 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c01 naa= 2 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 1 2 # 1 C 171 PHE A 69 PHE^? 24.58 NI NI A 501 C 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo 6.32 17.53 24.32 6.46 19.72 26.09 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo 3.63 7.30 27.09 2.92 9.52 32.06 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 2 2 # 2 C 171 PHE B 69 PHE^? 24.35 NI NI A 502 C 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo 6.32 17.53 24.32 6.46 19.72 26.09 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo 3.63 7.30 27.09 2.92 9.52 32.06 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c02 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c02 naa= 2 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 1 2 # 1 D 171 PHE A 69 PHE^? 24.58 NI NI A 501 D 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -32.81 26.09 -8.03 -33.53 24.93 -5.65 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 2 2 # 2 D 171 PHE B 69 PHE^? 24.35 NI NI A 502 D 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -38.98 15.50 -39.52 -38.34 16.96 -41.86 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c03 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c03 naa= 2 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 1 2 # 1 A 174 TYR A 22 TYR~? 21.39 NI NI A 501 A 178 LYS A 53 LYS.? 25.39 NI NI A 501 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 2 2 # 2 A 174 TYR A 67 TYR^? 18.49 NI NI A 501 A 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 3 2 # 3 A 174 TYR B 22 TYR~? 21.09 NI NI A 502 A 178 LYS B 53 LYS.? 26.24 NI NI A 502 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 4 2 # 4 A 174 TYR B 67 TYR^? 18.53 NI NI A 502 A 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c04 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c04 naa= 2 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 1 2 # 1 B 174 TYR A 22 TYR~? 21.39 NI NI A 501 B 178 LYS A 53 LYS.? 25.39 NI NI A 501 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 2 2 # 2 B 174 TYR A 67 TYR^? 18.49 NI NI A 501 B 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 3 2 # 3 B 174 TYR B 22 TYR~? 21.09 NI NI A 502 B 178 LYS B 53 LYS.? 26.24 NI NI A 502 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 4 2 # 4 B 174 TYR B 67 TYR^? 18.53 NI NI A 502 B 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c05 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c05 naa= 2 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 1 2 # 1 C 174 TYR A 22 TYR~? 21.39 NI NI A 501 C 178 LYS A 53 LYS.? 25.39 NI NI A 501 coo 5.94 13.28 27.17 3.53 13.05 28.58 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 3.63 7.30 27.09 2.92 9.52 32.06 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 2 2 # 2 C 174 TYR A 67 TYR^? 18.49 NI NI A 501 C 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo 5.94 13.28 27.17 3.53 13.05 28.58 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 3.63 7.30 27.09 2.92 9.52 32.06 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 3 2 # 3 C 174 TYR B 22 TYR~? 21.09 NI NI A 502 C 178 LYS B 53 LYS.? 26.24 NI NI A 502 coo 5.94 13.28 27.17 3.53 13.05 28.58 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 3.63 7.30 27.09 2.92 9.52 32.06 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 4 2 # 4 C 174 TYR B 67 TYR^? 18.53 NI NI A 502 C 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo 5.94 13.28 27.17 3.53 13.05 28.58 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 3.63 7.30 27.09 2.92 9.52 32.06 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c06 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c06 naa= 2 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 1 2 # 1 D 174 TYR A 22 TYR~? 21.39 NI NI A 501 D 178 LYS A 53 LYS.? 25.39 NI NI A 501 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 2 2 # 2 D 174 TYR A 67 TYR^? 18.49 NI NI A 501 D 178 LYS B 123 LYS^? 13.38 NI NI A 501 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 3 2 # 3 D 174 TYR B 22 TYR~? 21.09 NI NI A 502 D 178 LYS B 53 LYS.? 26.24 NI NI A 502 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 4 2 # 4 D 174 TYR B 67 TYR^? 18.53 NI NI A 502 D 178 LYS A 123 LYS^? 12.92 NI NI A 502 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2c7v_c07 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c07 naa= 2 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 1 2 # 1 105 HIS A 31 HIS~? -4.16 NI NI A 501s 183 GLU A 28 GLU~? 13.04 NI NI A 501 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -23.75 11.51 -14.04 -21.61 11.75 -14.14 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 2 2 # 2 105 HIS A 31 HIS~? -4.16 NI NI A 501s 183 GLU B 86 GLU.? 9.13 NI NI A 501 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 3 2 # 3 105 HIS B 31 HIS~? -3.92 NI NI A 502s 183 GLU A 86 GLU.? 9.00 NI NI A 502 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 4 2 # 4 105 HIS B 31 HIS~? -3.92 NI NI A 502s 183 GLU B 28 GLU~? 10.98 NI NI A 502 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 5 2 # 5 105 HIS B 126 HIS.? -4.79 NI NI A 501s 183 GLU B 124 GLU.? 12.68 NI NI A 501 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -37.57 14.60 -17.43 -39.14 13.53 -18.53 2cpo_c00 source 2cpo CHLOROPEROXIDASE : 5 hits 2cpo_c00 naa= 2 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 1 2 # 1 A 197 ASP A 82 ASP~? 15.20 NI NI A 502 A 236 ASP A 88 ASP^? 14.52 NI NI A 501 coo 12.51 17.07 49.46 12.44 16.89 47.35 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 2 2 # 2 A 197 ASP A 88 ASP^? 14.52 NI NI A 501 A 236 ASP A 82 ASP~? 15.20 NI NI A 502 coo 12.51 17.07 49.46 12.44 16.89 47.35 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -29.79 30.16 -22.23 -31.29 29.65 -23.60 2cpu_c00 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c00 naa= 2 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 1 2 # 1 22 GLU A 28 GLU~? 13.04 NI NI A 501 100 LYS B 123 LYS^? 13.38 NI NI A 501 coo 48.89 50.87 68.09 48.88 49.14 69.31 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo 41.76 43.63 69.91 46.12 48.11 71.43 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 2 2 # 2 22 GLU B 28 GLU~? 10.98 NI NI A 502 100 LYS A 123 LYS^? 12.92 NI NI A 502 coo 48.89 50.87 68.09 48.88 49.14 69.31 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo 41.76 43.63 69.91 46.12 48.11 71.43 -31.38 19.51 -30.63 -27.67 15.84 -27.69 2dhn_c00 source 2dhn 7,8-DIHYDRONEOPTERIN ALDOLASE : 2 hits 2dhn_c00 naa= 2 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 1 2 # 1 130 ASP A 13 ASP~? 13.27 NI NI A 502 132 GLU A 11 GLU.? 16.09 NI NI A 502 coo 25.19 32.92 18.85 27.07 32.05 18.66 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 30.29 33.92 17.74 30.60 31.83 17.87 -15.68 34.30 -16.31 -14.02 33.99 -17.68 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 2 2 # 2 130 ASP B 13 ASP~? 14.49 NI NI A 501 132 GLU B 11 GLU~? 14.38 NI NI A 501 coo 25.19 32.92 18.85 27.07 32.05 18.66 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 30.29 33.92 17.74 30.60 31.83 17.87 -38.52 -4.25 -30.02 -36.70 -3.43 -29.19 2ebn_c00 source 2ebn ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1 (E.C.3.2.: 2 hits 2ebn_c00 naa= 2 ULMN 2 2eng_c00 ENDOGLUCANASE V user 1 2 # 1 10 ASP A 82 ASP~? 15.20 NI NI A 502 121 ASP B 88 ASP^? 15.06 NI NI A 502 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2eng_c00 ENDOGLUCANASE V user 2 2 # 2 10 ASP A 88 ASP^? 14.52 NI NI A 501 121 ASP B 82 ASP~? 13.99 NI NI A 501 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 2eng_c00 ENDOGLUCANASE V user 3 2 # 3 10 ASP B 13 ASP~? 14.49 NI NI A 501 121 ASP B 82 ASP~? 13.99 NI NI A 501 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 2eng_c00 ENDOGLUCANASE V user 4 2 # 4 10 ASP B 82 ASP~? 13.99 NI NI A 501 121 ASP A 88 ASP^? 14.52 NI NI A 501 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2eng_c00 ENDOGLUCANASE V user 5 2 # 5 10 ASP B 82 ASP~? 13.99 NI NI A 501 121 ASP B 13 ASP~? 14.49 NI NI A 501 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 2eng_c00 ENDOGLUCANASE V user 6 2 # 6 10 ASP B 88 ASP^? 15.06 NI NI A 502 121 ASP A 82 ASP~? 15.20 NI NI A 502 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -29.79 30.16 -22.23 -31.29 29.65 -23.60 2eng_c00 source 2eng ENDOGLUCANASE V : 6 hits 2eng_c00 naa= 2 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 1 2 # 1 35 GLU A 86 GLU.? 9.00 NI NI A 502 53 ASP A 88 ASP^? 14.52 NI NI A 501 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 24.12 3.58 26.55 22.78 2.48 27.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 2 2 # 2 35 GLU A 86 GLU.? 9.00 NI NI A 502 53 ASP B 88 ASP^? 15.06 NI NI A 502 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -26.26 21.66 -27.12 -25.44 19.73 -27.04 coo 24.12 3.58 26.55 22.78 2.48 27.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 3 2 # 3 35 GLU A 124 GLU.? 14.10 NI NI A 502 53 ASP A 82 ASP~? 15.20 NI NI A 502 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 24.12 3.58 26.55 22.78 2.48 27.73 -29.79 30.16 -22.23 -31.29 29.65 -23.60 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 4 2 # 4 35 GLU A 124 GLU.? 14.10 NI NI A 502 53 ASP A 88 ASP^? 14.52 NI NI A 501 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 24.12 3.58 26.55 22.78 2.48 27.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 5 2 # 5 35 GLU A 124 GLU.? 14.10 NI NI A 502 53 ASP B 88 ASP^? 15.06 NI NI A 502 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -31.64 24.06 -29.50 -32.42 25.73 -28.36 coo 24.12 3.58 26.55 22.78 2.48 27.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 6 2 # 6 35 GLU B 86 GLU.? 9.13 NI NI A 501 53 ASP A 88 ASP^? 14.52 NI NI A 501 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 24.12 3.58 26.55 22.78 2.48 27.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 7 2 # 7 35 GLU B 86 GLU.? 9.13 NI NI A 501 53 ASP B 88 ASP^? 15.06 NI NI A 502 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -31.72 11.77 -20.56 -30.07 12.65 -19.61 coo 24.12 3.58 26.55 22.78 2.48 27.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 8 2 # 8 35 GLU B 124 GLU.? 12.68 NI NI A 501 53 ASP B 82 ASP~? 13.99 NI NI A 501 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 24.12 3.58 26.55 22.78 2.48 27.73 -40.67 10.76 -25.27 -41.01 11.92 -23.57 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 9 2 # 9 35 GLU B 124 GLU.? 12.68 NI NI A 501 53 ASP B 88 ASP^? 15.06 NI NI A 502 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -37.57 14.60 -17.43 -39.14 13.53 -18.53 coo 24.12 3.58 26.55 22.78 2.48 27.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 2eql_c00 source 2eql LYSOZYME (APO FORM) : 9 hits 2eql_c00 naa= 2 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 A 28 GLU A 28 GLU~? 13.04 NI NI A 501 A 120 ASP A 42 ASP.? 24.20 NI NI A 501 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 A 28 GLU A 28 GLU~? 13.04 NI NI A 501 A 120 ASP B 88 ASP^? 15.06 NI NI A 502 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 A 28 GLU B 8 GLU.? 22.17 NI NI A 501 A 120 ASP B 13 ASP~? 14.49 NI NI A 501 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 A 28 GLU B 28 GLU~? 10.98 NI NI A 502 A 120 ASP A 88 ASP^? 14.52 NI NI A 501 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 A 28 GLU B 28 GLU~? 10.98 NI NI A 502 A 120 ASP B 42 ASP.? 24.38 NI NI A 502 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 A 28 GLU B 28 GLU~? 10.98 NI NI A 502 A 120 ASP B 88 ASP^? 15.06 NI NI A 502 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -31.42 19.31 -21.85 -30.03 20.81 -21.11 2fmn_c00 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 6 hits 2fmn_c00 naa= 2 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 B 28 GLU A 28 GLU~? 13.04 NI NI A 501 B 120 ASP A 42 ASP.? 24.20 NI NI A 501 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 B 28 GLU A 28 GLU~? 13.04 NI NI A 501 B 120 ASP B 88 ASP^? 15.06 NI NI A 502 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 B 28 GLU B 8 GLU.? 22.17 NI NI A 501 B 120 ASP B 13 ASP~? 14.49 NI NI A 501 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 B 28 GLU B 28 GLU~? 10.98 NI NI A 502 B 120 ASP A 88 ASP^? 14.52 NI NI A 501 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 B 28 GLU B 28 GLU~? 10.98 NI NI A 502 B 120 ASP B 42 ASP.? 24.38 NI NI A 502 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 B 28 GLU B 28 GLU~? 10.98 NI NI A 502 B 120 ASP B 88 ASP^? 15.06 NI NI A 502 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -31.42 19.31 -21.85 -30.03 20.81 -21.11 2fmn_c01 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 6 hits 2fmn_c01 naa= 2 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 C 28 GLU A 28 GLU~? 13.04 NI NI A 501 C 120 ASP A 42 ASP.? 24.20 NI NI A 501 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 C 28 GLU A 28 GLU~? 13.04 NI NI A 501 C 120 ASP B 88 ASP^? 15.06 NI NI A 502 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -23.75 11.51 -14.04 -21.61 11.75 -14.14 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 C 28 GLU B 8 GLU.? 22.17 NI NI A 501 C 120 ASP B 13 ASP~? 14.49 NI NI A 501 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -46.12 -10.54 -28.06 -44.80 -11.45 -26.65 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 C 28 GLU B 28 GLU~? 10.98 NI NI A 502 C 120 ASP A 88 ASP^? 14.52 NI NI A 501 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 C 28 GLU B 28 GLU~? 10.98 NI NI A 502 C 120 ASP B 42 ASP.? 24.38 NI NI A 502 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 C 28 GLU B 28 GLU~? 10.98 NI NI A 502 C 120 ASP B 88 ASP^? 15.06 NI NI A 502 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -21.88 16.06 -32.91 -21.09 14.19 -32.27 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -31.42 19.31 -21.85 -30.03 20.81 -21.11 2fmn_c02 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 6 hits 2fmn_c02 naa= 2 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 A 150 TYR A 22 TYR~? 21.39 NI NI A 501 A 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 A 150 TYR A 29 TYR~? 15.38 NI NI A 501 A 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 A 150 TYR B 22 TYR~? 21.09 NI NI A 502 A 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 A 150 TYR B 29 TYR~? 14.52 NI NI A 502 A 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -27.64 9.52 -45.35 -29.70 9.87 -45.82 2gsa_c00 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c00 naa= 2 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 22 TYR~? 21.39 NI NI A 501 B 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR A 29 TYR~? 15.38 NI NI A 501 B 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 150 TYR B 22 TYR~? 21.09 NI NI A 502 B 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 B 150 TYR B 29 TYR~? 14.52 NI NI A 502 B 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -27.64 9.52 -45.35 -29.70 9.87 -45.82 2gsa_c01 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c01 naa= 2 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 22 TYR~? 21.39 NI NI A 501 B 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR A 29 TYR~? 15.38 NI NI A 501 B 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -27.09 11.47 -6.47 -27.56 10.92 -3.78 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 150 TYR B 22 TYR~? 21.09 NI NI A 502 B 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -27.64 9.52 -45.35 -29.70 9.87 -45.82 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 B 150 TYR B 29 TYR~? 14.52 NI NI A 502 B 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -27.64 9.52 -45.35 -29.70 9.87 -45.82 2gsa_c03 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c03 naa= 2 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 157 PHE A 51 PHE.? 22.00 NI NI A 502 B 245 ASP A 42 ASP.? 24.20 NI NI A 501 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -17.08 22.63 -7.72 -19.58 23.81 -8.31 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 157 PHE B 51 PHE.? 21.73 NI NI A 501 B 245 ASP B 42 ASP.? 24.38 NI NI A 502 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -28.14 3.62 -40.16 -30.39 4.96 -39.18 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -27.64 9.52 -45.35 -29.70 9.87 -45.82 2gsa_c05 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c05 naa= 2 ULMN 2 2jcw_c00 CU/ZN SUPEROXIDE DISMUTASE user 1 2 # 1 63 HIS A 126 HIS.? -3.75 NI NI A 502s 143 ARG A 17 ARG~? 9.21 NI NI A 502 coo 7.37 21.96 20.34 6.83 20.29 19.19 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 2.05 15.79 24.54 1.75 18.84 24.36 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 2 2jcw_c00 CU/ZN SUPEROXIDE DISMUTASE user 2 2 # 2 63 HIS B 126 HIS.? -4.79 NI NI A 501s 143 ARG A 102 ARG.? 15.26 NI NI A 501 coo 7.37 21.96 20.34 6.83 20.29 19.19 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 2.05 15.79 24.54 1.75 18.84 24.36 -43.90 12.11 -18.64 -45.27 9.35 -19.00 ULMN 2 2jcw_c00 CU/ZN SUPEROXIDE DISMUTASE user 3 2 # 3 63 HIS B 127 HIS.? 5.53 NI NI A 501 143 ARG A 102 ARG.? 15.26 NI NI A 501 coo 7.37 21.96 20.34 6.83 20.29 19.19 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 2.05 15.79 24.54 1.75 18.84 24.36 -43.90 12.11 -18.64 -45.27 9.35 -19.00 2jcw_c00 source 2jcw CU/ZN SUPEROXIDE DISMUTASE : 3 hits 2jcw_c00 naa= 2 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 1 2 # 1 131 ASP A 42 ASP.? 24.20 NI NI A 501 218 ARG A 25 ARG~? 18.03 NI NI A 501 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 2 2 # 2 131 ASP A 82 ASP~? 15.20 NI NI A 502 218 ARG A 17 ARG~? 9.21 NI NI A 502 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -19.20 27.45 -18.86 -18.35 28.58 -21.68 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 3 2 # 3 131 ASP A 82 ASP~? 15.20 NI NI A 502 218 ARG A 23 ARG~? 15.85 NI NI A 502 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 4 2 # 4 131 ASP A 88 ASP^? 14.52 NI NI A 501 218 ARG A 23 ARG~? 15.85 NI NI A 502 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 5 2 # 5 131 ASP A 88 ASP^? 14.52 NI NI A 501 218 ARG B 102 ARG.? 15.54 NI NI A 502 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -32.48 30.10 -28.35 -33.10 28.08 -26.10 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 6 2 # 6 131 ASP B 42 ASP.? 24.38 NI NI A 502 218 ARG B 52 ARG.? 29.95 NI NI A 501 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -30.29 0.12 -47.40 -29.74 3.21 -47.94 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 7 2 # 7 131 ASP B 82 ASP~? 13.99 NI NI A 501 218 ARG B 17 ARG~? 8.61 NI NI A 501 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -32.06 1.37 -29.33 -31.49 1.19 -26.24 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 8 2 # 8 131 ASP B 82 ASP~? 13.99 NI NI A 501 218 ARG B 23 ARG~? 15.67 NI NI A 501 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 9 2 # 9 131 ASP B 88 ASP^? 15.06 NI NI A 502 218 ARG B 23 ARG~? 15.67 NI NI A 501 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 10 2 # 10 131 ASP B 88 ASP^? 15.06 NI NI A 502 218 ARG B 102 ARG.? 15.54 NI NI A 502 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -32.48 30.10 -28.35 -33.10 28.08 -26.10 2pec_c00 source 2pec PECTATE LYASE C (PLC) (E.C.4.2.2.2) : 10 hits 2pec_c00 naa= 2 ULMN 2 2phk_c00 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 82 ASP~? 15.20 NI NI A 502 A 153 GLU A 86 GLU.? 9.00 NI NI A 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 51.07 15.29 42.97 50.55 17.18 42.21 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 2phk_c00 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 82 ASP~? 15.20 NI NI A 502 A 153 GLU A 124 GLU.? 14.10 NI NI A 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 51.07 15.29 42.97 50.55 17.18 42.21 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 2phk_c00 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 88 ASP^? 14.52 NI NI A 501 A 153 GLU B 124 GLU.? 12.68 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 51.07 15.29 42.97 50.55 17.18 42.21 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 2phk_c00 MC-PEPTIDE user 4 2 # 4 A 149 ASP B 82 ASP~? 13.99 NI NI A 501 A 153 GLU B 86 GLU.? 9.13 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 51.07 15.29 42.97 50.55 17.18 42.21 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 2phk_c00 MC-PEPTIDE user 5 2 # 5 A 149 ASP B 82 ASP~? 13.99 NI NI A 501 A 153 GLU B 124 GLU.? 12.68 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 51.07 15.29 42.97 50.55 17.18 42.21 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 2phk_c00 MC-PEPTIDE user 6 2 # 6 A 149 ASP B 88 ASP^? 15.06 NI NI A 502 A 153 GLU A 124 GLU.? 14.10 NI NI A 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 51.07 15.29 42.97 50.55 17.18 42.21 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 2phk_c00 MC-PEPTIDE user 7 2 # 7 A 149 ASP B 88 ASP^? 15.06 NI NI A 502 A 153 GLU B 124 GLU.? 12.68 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 51.07 15.29 42.97 50.55 17.18 42.21 -37.57 14.60 -17.43 -39.14 13.53 -18.53 2phk_c00 source 2phk MC-PEPTIDE : 7 hits 2phk_c00 naa= 2 ULMN 2 2phk_c01 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 42 ASP.? 24.20 NI NI A 501 A 151 LYS A 53 LYS.? 25.39 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.89 18.89 -1.49 -23.33 20.28 -2.19 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 2phk_c01 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 88 ASP^? 14.52 NI NI A 501 A 151 LYS A 123 LYS^? 12.92 NI NI A 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 45.75 16.58 39.61 47.43 18.26 45.54 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 2phk_c01 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 88 ASP^? 14.52 NI NI A 501 A 151 LYS B 123 LYS^? 13.38 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 45.75 16.58 39.61 47.43 18.26 45.54 -32.29 17.60 -17.14 -27.15 16.48 -17.32 ULMN 2 2phk_c01 MC-PEPTIDE user 4 2 # 4 A 149 ASP B 42 ASP.? 24.38 NI NI A 502 A 151 LYS B 53 LYS.? 26.24 NI NI A 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -27.64 9.52 -45.35 -29.70 9.87 -45.82 coo 45.75 16.58 39.61 47.43 18.26 45.54 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 2phk_c01 MC-PEPTIDE user 5 2 # 5 A 149 ASP B 88 ASP^? 15.06 NI NI A 502 A 151 LYS A 123 LYS^? 12.92 NI NI A 502 coo 41.42 17.90 44.98 43.39 18.36 45.61 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 45.75 16.58 39.61 47.43 18.26 45.54 -31.38 19.51 -30.63 -27.67 15.84 -27.69 ULMN 2 2phk_c01 MC-PEPTIDE user 6 2 # 6 A 149 ASP B 88 ASP^? 15.06 NI NI A 502 A 151 LYS B 123 LYS^? 13.38 NI NI A 501 coo 41.42 17.90 44.98 43.39 18.36 45.61 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 45.75 16.58 39.61 47.43 18.26 45.54 -32.29 17.60 -17.14 -27.15 16.48 -17.32 2phk_c01 source 2phk MC-PEPTIDE : 6 hits 2phk_c01 naa= 2 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 A 549 ASP A 13 ASP~? 13.27 NI NI A 502 A 655 ASP B 88 ASP^? 15.06 NI NI A 502 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 A 549 ASP A 88 ASP^? 14.52 NI NI A 501 A 655 ASP B 13 ASP~? 14.49 NI NI A 501 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 A 549 ASP B 13 ASP~? 14.49 NI NI A 501 A 655 ASP A 88 ASP^? 14.52 NI NI A 501 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 A 549 ASP B 88 ASP^? 15.06 NI NI A 502 A 655 ASP A 13 ASP~? 13.27 NI NI A 502 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -18.74 32.48 -18.59 -19.60 33.57 -20.27 2qf7_c00 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 4 hits 2qf7_c00 naa= 2 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 B 549 ASP A 13 ASP~? 13.27 NI NI A 502 B 655 ASP B 88 ASP^? 15.06 NI NI A 502 coo 76.34 71.89 30.92 75.58 70.99 29.16 -18.74 32.48 -18.59 -19.60 33.57 -20.27 coo 66.54 57.43 28.71 66.94 55.81 27.41 -31.42 19.31 -21.85 -30.03 20.81 -21.11 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 B 549 ASP A 88 ASP^? 14.52 NI NI A 501 B 655 ASP B 13 ASP~? 14.49 NI NI A 501 coo 76.34 71.89 30.92 75.58 70.99 29.16 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 66.54 57.43 28.71 66.94 55.81 27.41 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 B 549 ASP B 13 ASP~? 14.49 NI NI A 501 B 655 ASP A 88 ASP^? 14.52 NI NI A 501 coo 76.34 71.89 30.92 75.58 70.99 29.16 -38.07 0.00 -29.18 -40.15 -0.33 -28.61 coo 66.54 57.43 28.71 66.94 55.81 27.41 -32.37 17.64 -25.93 -33.10 15.61 -26.13 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 B 549 ASP B 88 ASP^? 15.06 NI NI A 502 B 655 ASP A 13 ASP~? 13.27 NI NI A 502 coo 76.34 71.89 30.92 75.58 70.99 29.16 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 66.54 57.43 28.71 66.94 55.81 27.41 -18.74 32.48 -18.59 -19.60 33.57 -20.27 2qf7_c01 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 4 hits 2qf7_c01 naa= 2 ULMN 2 2tpl_c00 TYROSINE PHENOL-LYASE user 1 2 # 1 A 123 PHE A 51 PHE.? 22.00 NI NI A 502 A 214 ASP A 42 ASP.? 24.20 NI NI A 501 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -17.08 22.63 -7.72 -19.58 23.81 -8.31 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2tpl_c00 TYROSINE PHENOL-LYASE user 2 2 # 2 A 123 PHE B 51 PHE.? 21.73 NI NI A 501 A 214 ASP B 42 ASP.? 24.38 NI NI A 502 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -28.14 3.62 -40.16 -30.39 4.96 -39.18 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -27.64 9.52 -45.35 -29.70 9.87 -45.82 2tpl_c00 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c00 naa= 2 ULMN 2 2tpl_c01 TYROSINE PHENOL-LYASE user 1 2 # 1 B 123 PHE A 51 PHE.? 22.00 NI NI A 502 B 214 ASP A 42 ASP.? 24.20 NI NI A 501 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -17.08 22.63 -7.72 -19.58 23.81 -8.31 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -21.89 18.89 -1.49 -23.33 20.28 -2.19 ULMN 2 2tpl_c01 TYROSINE PHENOL-LYASE user 2 2 # 2 B 123 PHE B 51 PHE.? 21.73 NI NI A 501 B 214 ASP B 42 ASP.? 24.38 NI NI A 502 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -28.14 3.62 -40.16 -30.39 4.96 -39.18 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -27.64 9.52 -45.35 -29.70 9.87 -45.82 2tpl_c01 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c01 naa= 2 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 M 447 TYR A 67 TYR^? 18.49 NI NI A 501 M 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo 8.49 10.09 43.76 9.92 11.66 45.61 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 11.10 10.60 38.12 12.56 8.02 36.96 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 M 447 TYR B 22 TYR~? 21.09 NI NI A 502 M 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo 8.49 10.09 43.76 9.92 11.66 45.61 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 11.10 10.60 38.12 12.56 8.02 36.96 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c00 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 M 447 TYR B 67 TYR^? 18.53 NI NI A 502 M 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo 8.49 10.09 43.76 9.92 11.66 45.61 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 11.10 10.60 38.12 12.56 8.02 36.96 -32.41 14.62 -32.24 -32.62 14.64 -29.16 3pca_c00 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 3 hits 3pca_c00 naa= 2 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 N 447 TYR A 22 TYR~? 21.39 NI NI A 501 N 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo 10.05 43.90 8.55 11.74 45.69 9.93 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 10.54 37.95 11.06 8.06 36.82 12.51 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 N 447 TYR A 22 TYR~? 21.39 NI NI A 501 N 457 ARG A 25 ARG~? 18.03 NI NI A 501 coo 10.05 43.90 8.55 11.74 45.69 9.93 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo 10.54 37.95 11.06 8.06 36.82 12.51 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 N 447 TYR A 67 TYR^? 18.49 NI NI A 501 N 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo 10.05 43.90 8.55 11.74 45.69 9.93 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 10.54 37.95 11.06 8.06 36.82 12.51 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 N 447 TYR B 22 TYR~? 21.09 NI NI A 502 N 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo 10.05 43.90 8.55 11.74 45.69 9.93 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 10.54 37.95 11.06 8.06 36.82 12.51 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 N 447 TYR B 22 TYR~? 21.09 NI NI A 502 N 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo 10.05 43.90 8.55 11.74 45.69 9.93 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 10.54 37.95 11.06 8.06 36.82 12.51 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 6 2 # 6 N 447 TYR B 29 TYR~? 14.52 NI NI A 502 N 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo 10.05 43.90 8.55 11.74 45.69 9.93 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 10.54 37.95 11.06 8.06 36.82 12.51 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 7 2 # 7 N 447 TYR B 67 TYR^? 18.53 NI NI A 502 N 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo 10.05 43.90 8.55 11.74 45.69 9.93 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 10.54 37.95 11.06 8.06 36.82 12.51 -32.41 14.62 -32.24 -32.62 14.64 -29.16 3pca_c01 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 7 hits 3pca_c01 naa= 2 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 O 447 TYR A 67 TYR^? 18.49 NI NI A 501 O 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo 43.82 8.53 10.01 45.63 9.88 11.69 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo 38.02 11.23 10.58 36.95 12.66 8.07 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 O 447 TYR B 22 TYR~? 21.09 NI NI A 502 O 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo 43.82 8.53 10.01 45.63 9.88 11.69 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 38.02 11.23 10.58 36.95 12.66 8.07 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 O 447 TYR B 22 TYR~? 21.09 NI NI A 502 O 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo 43.82 8.53 10.01 45.63 9.88 11.69 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo 38.02 11.23 10.58 36.95 12.66 8.07 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 O 447 TYR B 29 TYR~? 14.52 NI NI A 502 O 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo 43.82 8.53 10.01 45.63 9.88 11.69 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo 38.02 11.23 10.58 36.95 12.66 8.07 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c02 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 O 447 TYR B 67 TYR^? 18.53 NI NI A 502 O 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo 43.82 8.53 10.01 45.63 9.88 11.69 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo 38.02 11.23 10.58 36.95 12.66 8.07 -32.41 14.62 -32.24 -32.62 14.64 -29.16 3pca_c02 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 5 hits 3pca_c02 naa= 2 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 P 447 TYR A 67 TYR^? 18.49 NI NI A 501 P 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 P 447 TYR B 22 TYR~? 21.09 NI NI A 502 P 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 P 447 TYR B 22 TYR~? 21.09 NI NI A 502 P 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c03 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 P 447 TYR B 67 TYR^? 18.53 NI NI A 502 P 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo -8.57 -10.12 43.71 -9.76 -11.68 45.73 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -11.16 -10.53 38.02 -12.60 -7.93 36.86 -32.41 14.62 -32.24 -32.62 14.64 -29.16 3pca_c03 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 4 hits 3pca_c03 naa= 2 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 Q 447 TYR A 67 TYR^? 18.49 NI NI A 501 Q 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 Q 447 TYR B 22 TYR~? 21.09 NI NI A 502 Q 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 Q 447 TYR B 22 TYR~? 21.09 NI NI A 502 Q 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 Q 447 TYR B 29 TYR~? 14.52 NI NI A 502 Q 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c04 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 Q 447 TYR B 67 TYR^? 18.53 NI NI A 502 Q 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -32.41 14.62 -32.24 -32.62 14.64 -29.16 3pca_c04 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 5 hits 3pca_c04 naa= 2 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 R 447 TYR A 22 TYR~? 21.39 NI NI A 501 R 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 R 447 TYR A 22 TYR~? 21.39 NI NI A 501 R 457 ARG A 25 ARG~? 18.03 NI NI A 501 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -24.64 21.66 -8.58 -26.12 21.10 -6.23 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -20.54 14.84 -11.32 -17.83 13.50 -10.78 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 3 2 # 3 R 447 TYR A 67 TYR^? 18.49 NI NI A 501 R 457 ARG A 23 ARG~? 15.85 NI NI A 502 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -35.76 20.58 -11.22 -38.22 19.54 -12.11 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -29.17 20.32 -15.53 -28.78 20.89 -18.53 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 4 2 # 4 R 447 TYR B 22 TYR~? 21.09 NI NI A 502 R 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -32.41 14.62 -32.24 -32.62 14.64 -29.16 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 5 2 # 5 R 447 TYR B 22 TYR~? 21.09 NI NI A 502 R 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -30.89 10.60 -39.31 -31.13 12.07 -41.74 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 6 2 # 6 R 447 TYR B 29 TYR~? 14.52 NI NI A 502 R 457 ARG B 25 ARG~? 17.38 NI NI A 502 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -23.12 17.96 -41.07 -23.10 19.18 -43.61 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -23.60 10.54 -37.24 -21.22 8.75 -36.58 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 7 2 # 7 R 447 TYR B 67 TYR^? 18.53 NI NI A 502 R 457 ARG B 23 ARG~? 15.67 NI NI A 501 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -35.67 20.34 -36.33 -35.75 23.11 -35.83 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -32.41 14.62 -32.24 -32.62 14.64 -29.16 3pca_c05 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 7 hits 3pca_c05 naa= 2 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 2 # 1 127 ARG A 17 ARG~? 9.21 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -19.20 27.45 -18.86 -18.35 28.58 -21.68 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 2 # 2 127 ARG A 23 ARG~? 15.85 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -29.17 20.32 -15.53 -28.78 20.89 -18.53 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 2 # 3 127 ARG A 101 ARG.? 18.18 NI NI A 501 270 GLU B 124 GLU.? 12.68 NI NI A 501 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -45.57 11.90 -25.10 -47.16 9.28 -24.53 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 2 # 4 127 ARG A 102 ARG.? 15.26 NI NI A 501 270 GLU B 86 GLU.? 9.13 NI NI A 501 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -43.90 12.11 -18.64 -45.27 9.35 -19.00 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 2 # 5 127 ARG B 17 ARG~? 8.61 NI NI A 501 270 GLU B 86 GLU.? 9.13 NI NI A 501 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.06 1.37 -29.33 -31.49 1.19 -26.24 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 2 # 6 127 ARG B 23 ARG~? 15.67 NI NI A 501 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 2 # 7 127 ARG B 23 ARG~? 15.67 NI NI A 501 270 GLU B 28 GLU~? 10.98 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -21.88 16.06 -32.91 -21.09 14.19 -32.27 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 2 # 8 127 ARG B 23 ARG~? 15.67 NI NI A 501 270 GLU B 86 GLU.? 9.13 NI NI A 501 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.41 14.62 -32.24 -32.62 14.64 -29.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 2 # 9 127 ARG B 101 ARG.? 17.16 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 2 # 10 127 ARG B 101 ARG.? 17.16 NI NI A 502 270 GLU A 124 GLU.? 14.10 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -33.01 33.14 -24.23 -30.56 34.78 -23.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 2 # 11 127 ARG B 102 ARG.? 15.54 NI NI A 502 270 GLU A 86 GLU.? 9.00 NI NI A 502 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -32.48 30.10 -28.35 -33.10 28.08 -26.10 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -26.26 21.66 -27.12 -25.44 19.73 -27.04 5cpa_c00 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 11 hits 5cpa_c00 naa= 2 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 191 HIS A 31 HIS~? -4.16 NI NI A 501s 345 LYS B 53 LYS.? 26.24 NI NI A 502 coo 87.81 42.65 46.75 88.49 40.86 45.92 -28.46 6.43 -14.65 -28.67 4.98 -16.17 coo 103.66 43.57 23.68 98.86 47.65 23.32 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 191 HIS A 126 HIS.? -3.75 NI NI A 502s 345 LYS B 53 LYS.? 26.24 NI NI A 502 coo 87.81 42.65 46.75 88.49 40.86 45.92 -22.12 24.45 -27.89 -21.28 22.78 -28.85 coo 103.66 43.57 23.68 98.86 47.65 23.32 -31.78 4.80 -43.31 -32.04 8.63 -45.75 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 2 # 3 191 HIS A 127 HIS.? 7.54 NI NI A 502 345 LYS A 53 LYS.? 25.39 NI NI A 501 coo 87.81 42.65 46.75 88.49 40.86 45.92 -20.75 31.16 -30.30 -19.37 32.72 -30.66 coo 103.66 43.57 23.68 98.86 47.65 23.32 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 2 # 4 191 HIS B 31 HIS~? -3.92 NI NI A 502s 345 LYS A 53 LYS.? 25.39 NI NI A 501 coo 87.81 42.65 46.75 88.49 40.86 45.92 -20.11 22.22 -33.67 -18.33 23.04 -32.88 coo 103.66 43.57 23.68 98.86 47.65 23.32 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 5 2 # 5 191 HIS B 126 HIS.? -4.79 NI NI A 501s 345 LYS A 53 LYS.? 25.39 NI NI A 501 coo 87.81 42.65 46.75 88.49 40.86 45.92 -33.66 8.52 -19.80 -32.10 7.12 -19.77 coo 103.66 43.57 23.68 98.86 47.65 23.32 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 6 2 # 6 191 HIS B 127 HIS.? 5.53 NI NI A 501 345 LYS A 53 LYS.? 25.39 NI NI A 501 coo 87.81 42.65 46.75 88.49 40.86 45.92 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 103.66 43.57 23.68 98.86 47.65 23.32 -20.26 25.10 -4.42 -25.18 23.47 -3.20 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 7 2 # 7 191 HIS B 127 HIS.? 5.53 NI NI A 501 345 LYS B 53 LYS.? 26.24 NI NI A 502 coo 87.81 42.65 46.75 88.49 40.86 45.92 -36.21 5.24 -15.46 -36.02 3.20 -15.94 coo 103.66 43.57 23.68 98.86 47.65 23.32 -31.78 4.80 -43.31 -32.04 8.63 -45.75 5enl_c02 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 7 hits 5enl_c02 naa= 2 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 1 2 # 1 151 ASP A 82 ASP~? 15.20 NI NI A 502 277 GLU A 86 GLU.? 9.00 NI NI A 502 coo 25.08 13.39 65.77 24.68 15.22 66.73 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 24.99 20.41 57.94 24.48 20.83 59.94 -26.26 21.66 -27.12 -25.44 19.73 -27.04 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 2 2 # 2 151 ASP A 82 ASP~? 15.20 NI NI A 502 277 GLU A 124 GLU.? 14.10 NI NI A 502 coo 25.08 13.39 65.77 24.68 15.22 66.73 -29.79 30.16 -22.23 -31.29 29.65 -23.60 coo 24.99 20.41 57.94 24.48 20.83 59.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 3 2 # 3 151 ASP A 88 ASP^? 14.52 NI NI A 501 277 GLU B 124 GLU.? 12.68 NI NI A 501 coo 25.08 13.39 65.77 24.68 15.22 66.73 -32.37 17.64 -25.93 -33.10 15.61 -26.13 coo 24.99 20.41 57.94 24.48 20.83 59.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 4 2 # 4 151 ASP B 82 ASP~? 13.99 NI NI A 501 277 GLU B 86 GLU.? 9.13 NI NI A 501 coo 25.08 13.39 65.77 24.68 15.22 66.73 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 24.99 20.41 57.94 24.48 20.83 59.94 -31.72 11.77 -20.56 -30.07 12.65 -19.61 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 5 2 # 5 151 ASP B 82 ASP~? 13.99 NI NI A 501 277 GLU B 124 GLU.? 12.68 NI NI A 501 coo 25.08 13.39 65.77 24.68 15.22 66.73 -40.67 10.76 -25.27 -41.01 11.92 -23.57 coo 24.99 20.41 57.94 24.48 20.83 59.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 6 2 # 6 151 ASP B 88 ASP^? 15.06 NI NI A 502 277 GLU A 124 GLU.? 14.10 NI NI A 502 coo 25.08 13.39 65.77 24.68 15.22 66.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 24.99 20.41 57.94 24.48 20.83 59.94 -31.64 24.06 -29.50 -32.42 25.73 -28.36 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 7 2 # 7 151 ASP B 88 ASP^? 15.06 NI NI A 502 277 GLU B 124 GLU.? 12.68 NI NI A 501 coo 25.08 13.39 65.77 24.68 15.22 66.73 -31.42 19.31 -21.85 -30.03 20.81 -21.11 coo 24.99 20.41 57.94 24.48 20.83 59.94 -37.57 14.60 -17.43 -39.14 13.53 -18.53 7nn9_c00 source 7nn9 NEURAMINIDASE N9 : 7 hits 7nn9_c00 naa= 2 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 1 2 # 1 A 197 HIS A 31 HIS~? -4.16 NI NI A 501s A 274 GLU A 28 GLU~? 13.04 NI NI A 501 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -28.46 6.43 -14.65 -28.67 4.98 -16.17